US20090076345A1 - Adherent Device with Multiple Physiological Sensors - Google Patents
Adherent Device with Multiple Physiological Sensors Download PDFInfo
- Publication number
- US20090076345A1 US20090076345A1 US12/209,288 US20928808A US2009076345A1 US 20090076345 A1 US20090076345 A1 US 20090076345A1 US 20928808 A US20928808 A US 20928808A US 2009076345 A1 US2009076345 A1 US 2009076345A1
- Authority
- US
- United States
- Prior art keywords
- patient
- signal
- patch
- electrocardiogram
- electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001464 adherent effect Effects 0.000 title claims abstract description 263
- 230000000694 effects Effects 0.000 claims abstract description 74
- 230000004044 response Effects 0.000 claims abstract description 66
- 239000000853 adhesive Substances 0.000 claims abstract description 55
- 230000001070 adhesive effect Effects 0.000 claims abstract description 54
- 230000036571 hydration Effects 0.000 claims abstract description 50
- 238000006703 hydration reaction Methods 0.000 claims abstract description 50
- 230000008878 coupling Effects 0.000 claims abstract description 15
- 238000010168 coupling process Methods 0.000 claims abstract description 15
- 238000005859 coupling reaction Methods 0.000 claims abstract description 15
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 83
- 238000000034 method Methods 0.000 claims description 69
- 238000012544 monitoring process Methods 0.000 claims description 56
- 238000004891 communication Methods 0.000 claims description 49
- 230000000747 cardiac effect Effects 0.000 claims description 20
- 230000008859 change Effects 0.000 claims description 14
- 238000013480 data collection Methods 0.000 claims description 13
- 208000037656 Respiratory Sounds Diseases 0.000 claims description 11
- 239000004744 fabric Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 206010003119 arrhythmia Diseases 0.000 claims description 10
- 230000006793 arrhythmia Effects 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 206010003658 Atrial Fibrillation Diseases 0.000 claims description 9
- 230000001960 triggered effect Effects 0.000 claims description 9
- 206010049418 Sudden Cardiac Death Diseases 0.000 claims description 7
- 206010042434 Sudden death Diseases 0.000 claims description 6
- 230000002411 adverse Effects 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 claims description 6
- 208000010125 myocardial infarction Diseases 0.000 claims description 6
- 230000005236 sound signal Effects 0.000 claims description 6
- 206010059027 Brugada syndrome Diseases 0.000 claims description 5
- 206010000891 acute myocardial infarction Diseases 0.000 claims description 5
- 230000005540 biological transmission Effects 0.000 claims description 5
- 230000036471 bradycardia Effects 0.000 claims description 5
- 208000006218 bradycardia Diseases 0.000 claims description 5
- 230000001413 cellular effect Effects 0.000 claims description 5
- 238000003745 diagnosis Methods 0.000 claims description 5
- 229920000728 polyester Polymers 0.000 claims description 5
- 208000003663 ventricular fibrillation Diseases 0.000 claims description 5
- 206010047302 ventricular tachycardia Diseases 0.000 claims description 5
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 claims description 4
- 208000010496 Heart Arrest Diseases 0.000 claims description 4
- 210000003722 extracellular fluid Anatomy 0.000 claims description 4
- 230000004907 flux Effects 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 230000002459 sustained effect Effects 0.000 claims description 4
- 206010011376 Crepitations Diseases 0.000 claims description 3
- 241000288140 Gruiformes Species 0.000 claims description 3
- 230000001133 acceleration Effects 0.000 claims description 3
- 206010037833 rales Diseases 0.000 claims description 3
- 206010042772 syncope Diseases 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 2
- 238000012883 sequential measurement Methods 0.000 claims description 2
- 238000005259 measurement Methods 0.000 description 19
- 239000000463 material Substances 0.000 description 12
- 239000002934 diuretic Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000001882 diuretic effect Effects 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 238000002847 impedance measurement Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 206010019280 Heart failures Diseases 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 229920002334 Spandex Polymers 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009529 body temperature measurement Methods 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000002982 water resistant material Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- YFSLABAYQDPWPF-UHFFFAOYSA-N 1,2,3-trichloro-4-(2,3,5-trichlorophenyl)benzene Chemical compound ClC1=CC(Cl)=C(Cl)C(C=2C(=C(Cl)C(Cl)=CC=2)Cl)=C1 YFSLABAYQDPWPF-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 0 CC1C*CC1 Chemical compound CC1C*CC1 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 229940097420 Diuretic Drugs 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010031123 Orthopnoea Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- -1 antibiotic Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940066974 medicated patch Drugs 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 208000012144 orthopnea Diseases 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 230000036544 posture Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 239000003351 stiffener Substances 0.000 description 1
- 208000014221 sudden cardiac arrest Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0006—ECG or EEG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0535—Impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0806—Detecting, measuring or recording devices for evaluating the respiratory organs by whole-body plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0809—Detecting, measuring or recording devices for evaluating the respiratory organs by impedance pneumography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1118—Determining activity level
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/282—Holders for multiple electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/30—Input circuits therefor
- A61B5/307—Input circuits therefor specially adapted for particular uses
- A61B5/308—Input circuits therefor specially adapted for particular uses for electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/361—Detecting fibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/363—Detecting tachycardia or bradycardia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/366—Detecting abnormal QRS complex, e.g. widening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/443—Evaluating skin constituents, e.g. elastin, melanin, water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4875—Hydration status, fluid retention of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B7/00—Instruments for auscultation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/046—Specially adapted for shock therapy, e.g. defibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0406—Constructional details of apparatus specially shaped apparatus housings
- A61B2560/0412—Low-profile patch shaped housings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0209—Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
- A61B2562/0215—Silver or silver chloride containing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02438—Detecting, measuring or recording pulse rate or heart rate with portable devices, e.g. worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/0245—Detecting, measuring or recording pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals
- A61B5/02455—Detecting, measuring or recording pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals provided with high/low alarm devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1116—Determining posture transitions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B7/00—Instruments for auscultation
- A61B7/003—Detecting lung or respiration noise
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36521—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure the parameter being derived from measurement of an electrical impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36535—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by body position or posture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36542—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by body motion, e.g. acceleration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36592—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by the heart rate variability
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
Definitions
- the subject matter of the present application is related to the following applications: 60/972,512; 60/972,329; 60/972,354; 60/972,616; 60/972,363; 60/972,343; 60/972,581; 60/972,316; 60/972,333; 60/972,359; 60/972,336; 60/972,340 all of which were filed on Sep. 14, 2007; 61/046,196 filed Apr. 18, 2008; 61/047,875 filed Apr. 25, 2008; 61/055,656 and 61/055,662 both filed May 23, 2008; and 61/079,746 filed Jul. 10, 2008.
- the following applications are being filed concurrently with the present application, on Sep. 12, 2008: Attorney Docket Nos.
- 026843-000110US entitled “Multi-Sensor Patient Monitor to Detect Impending Cardiac Decompensation Prediction”; 026843-000410US entitled “Injectable Device for Physiological Monitoring”; 026843-000510US entitled “Delivery System for Injectable Physiological Monitoring System”; 026843-000620US entitled “Adherent Device for Cardiac Rhythm Management”; 026843-000710US entitled “Adherent Device for Respiratory Monitoring”; 026843-0008110US entitled “Adherent Athletic Monitor”; 026843-000910US entitled “Adherent Emergency Monitor”; 026843-001320US entitled “Adherent Device with Physiological Sensors”; 026843-001410US entitled “Medical Device Automatic Start-up upon Contact to Patient Tissue”; 026843-001900US entitled “System and Methods for Wireless Body Fluid Monitoring”; 026843-002010US entitled “Adherent Cardiac Monitor with Advanced Sensing Capabilities”;
- the present invention relates to patient monitoring.
- embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to many applications in which physiological monitoring is used, for example wireless physiological monitoring for extended periods.
- Patients are often treated for diseases and/or conditions associated with a compromised status of the patient, for example a compromised physiologic status.
- a patient may report symptoms that require diagnosis to determine the underlying cause.
- a patient may report fainting or dizziness that requires diagnosis, in which long term monitoring of the patient can provide useful information as to the physiologic status of the patient.
- a patient may have suffered a heart attack and require care and/or monitoring after release from the hospital.
- One example of a device to provide long term monitoring of a patient is the Holter monitor, or ambulatory electrocardiography device.
- known physiologic measurements include impedance measurements.
- transthoracic impedance measurements can be used to measure hydration and respiration.
- transthoracic measurements can be useful, such measurements may use electrodes that are positioned across the midline of the patient, and may be somewhat uncomfortable and/or cumbersome for the patient to wear.
- the present invention relates to patient monitoring.
- embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to any application in which physiological monitoring is used, for example wireless physiological monitoring for extended periods.
- embodiments of the present invention provide an adherent device to monitor a patient.
- the device comprises an adhesive patch to adhere to a skin of the patient.
- At least four electrodes are connected to the patch and capable of electrically coupling to the patient.
- Impedance circuitry can be coupled to the at least four electrodes to measure a hydration signal of the patient.
- Electrocardiogram circuitry can be coupled to at least two of the at least four electrodes to measure an electrocardiogram signal of the patient.
- An accelerometer can be mechanically coupled, for exampled adhered or affixed, to the adhesive patch to generate an accelerometer signal in response to at least one of an activity or a position of the patient.
- accelerometer signals can improve patient diagnosis, and can be especially useful when used with other signals, such as electrocardiogram signals and impedance signals for hydration and respiration.
- Mechanically coupling the accelerometer to the electrodes for measuring impedance and hydration may also improve the quality and/or usefulness of the impedance and/or electrocardiogram signals.
- mechanical coupling of the accelerometer to the electrodes and to the skin of the patient can improve the reliability, quality and/or accuracy of the accelerometer measurements, as the electrode signals can indicate the quality of mechanical coupling of the patch to the patient so as to indicate that the device is connected to the patient and that the accelerometer signals are valid.
- the adherent device may comprise a dimension across that is no more than about 8 inches, such that the device can be comfortably worn by at least some patients for an extended period to permit collection of the electrocardiogram, impedance and accelerometer signals for extended periods.
- the adhesive patch is mechanically coupled to the at least four electrodes, the impedance circuitry, the electrocardiogram circuitry and the accelerometer, such that the patch is capable of supporting the at least four electrodes, the impedance circuitry, the electrocardiogram circuitry and the accelerometer when the adherent patch is adhered to the skin of the patient.
- a wireless communication circuitry is coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a communication protocol at least one of the hydration signal, the electrocardiogram signal or the accelerometer signal.
- the wireless communication circuitry can be configured to transmit the hydration signal, the electrocardiogram signal and the accelerometer signal to the remote center with a single wireless hop from the wireless communication circuitry to an intermediate device.
- the communication protocol can comprise at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, a cellular protocol, amplitude modulation or frequency modulation.
- the intermediate device comprises a data collection system to collect and/or store data from the wireless transmitter, and the data collection system can be configured to communicate periodically with the remote center with wireless communication and/or wired communication.
- the communications protocol may comprise a two way protocol such that the remote center is capable of issuing commands to control data collection
- the adherent device may comprise many sensors configured to measure many different signals.
- the accelerometer comprises at least one of a piezoelectric accelerometer, capacitive accelerometer or electromechanical accelerometer and wherein the accelerometer comprises a 3-axis accelerometer to measure at least one of an inclination, a position, an orientation or acceleration of the patient in three dimensions.
- the impedance circuitry can be adapted to measure extracellular fluid of the patient with at least one frequency within a range from about 0.5 kHz to about 200 kHz., and the impedance circuitry is configured to determine a respiration of the patient.
- the device may comprise a microphone to detect an audio signal from within the patient, and the audio signal may comprise a heart sound with an S 3 heart sound and/or a respiratory sound with rales and/or crackles.
- the device may comprise a temperature sensor to measure a temperature of the patient. Work in relation to embodiments of the present invention suggest that patient temperature may effect impedance measurements, such that the impedance measurements can be corrected with the temperature measurement.
- the adherent device comprises a processor comprising a tangible medium, and the processor is configured to control a collection and transmission of data from the impedance circuitry, the electrocardiogram circuitry and the accelerometer.
- the adherent device may comprise a real time clock and a frequency generator.
- embodiments of the present invention provide a method of monitoring a patient.
- An adhesive patch is adhered to a skin of the patient to couple at least four electrodes to the skin of the patient.
- a hydration signal of the patient is measured with impedance circuitry coupled to the at least four electrodes.
- An electrocardiogram signal of the patient is measured with electrocardiogram circuitry coupled to at least two of the at least four electrodes.
- a signal from an accelerometer is measured in response to at least one of an activity or a position of the patient.
- the adhesive patch supports the at least four electrodes, the impedance circuitry, the electrocardiogram circuitry and the accelerometer when the adherent patch is adhered to the skin of the patient.
- inventions of the present invention provide an adherent device to monitor a patient.
- the adherent device comprises an adhesive patch to adhere to a skin of the patient.
- At least four electrodes are affixed to the patch and capable of electrically coupling to the patient.
- a maximum dimension across the at least 4 electrodes may comprise no more that about eight inches, such that the at least four electrodes are capable of adhering to either a left side or a right side of the patient.
- Impedance circuitry may be coupled to the at least four electrodes to measure hydration of the patient.
- Electrocardiogram circuitry may be coupled to at least two of the at least four electrodes to measure an electrocardiogram of the patient.
- the maximum distance across the at least four electrodes comprises no more than about six inches.
- the device comprises a maximum dimension across no more than about 8 inches, and the patch is capable of measuring the electrocardiogram and the impedance from a left side or a right side of the patient.
- an adherent device to monitor a patient for an extended period comprises a breathable tape comprising an adhesive coating to adhere the breathable tape to a skin of the patient, such that tape and device may be comfortable when worn by the patient.
- the breathable tape may comprise a porous material, for example a porous fabric, to allow transmission of water vapor while the device is worn by the patient.
- At least one electrode is affixed to the breathable tape and capable of electrically coupling to a skin of the patient.
- At least one gel can be disposed over a contact surface of the at least one electrode to electrically connect the electrode to the skin.
- a printed circuit board for example, a flex printed circuit board, can be connected to the breathable tape to support the printed circuit board with the breathable tape when the tape is adhered to the patient.
- Electronic components may be electrically connected to the printed circuit board and coupled to the at least one electrode to measure physiologic signals of the patient.
- a breathable cover which may be water resistant, can be disposed over the circuit board and electronic components and connected to at least one of the electronics components, the printed circuit board or the breathable tape.
- an electronics housing is adhered to at least one of the electronics circuitry or the printed circuit board, such that the electronics housing is disposed between the cover and the electronics components.
- a gel cover is positioned over a breathable tape to inhibit a flow of the gel through the breathable tape.
- the printed circuit board for example a flex printed circuit board, may be located over the gel cover such that the gel cover is disposed between the breathable tape and the printed circuit board.
- the breathable tape comprises a first porosity
- the gel cover comprises a breathable tape with a second porosity, in which the second porosity is less than the first porosity to inhibit flow of the gel through the breathable tape.
- the breathable tape comprises a tricot-knit polyester fabric backing with an acrylate adhesive coating
- the gel cover comprises a polyurethane, non-woven backing with an acrylate adhesive coating.
- the breathable tape, the adhesive coating, the at least one electrode and gel coating are separable from the printed circuit board, electronic components, and water resistant housing and cover, such that the printed circuit board, electronic components, water resistant housing and water proof cover are reusable.
- the at least one electrode extends through at least one aperture in the breathable tape. In some embodiments, the at least one electrode is configured to electrically couple to the printed circuit board through the breathable tape.
- embodiments of the present invention provide a method of monitoring a patient for an extended period.
- An electronics module is attached to a first adherent patch component of a plurality of adherent patch components.
- the first adherent patch component is adhered to a skin of the patient.
- the electronics module is removed from the first adherent patch component.
- the electronics module is attached to a second patch component of the plurality of patch components after the first adherent patch component has been removed.
- the electronics module is removed from the second adherent patch component, and the electronics module is attached to a third patch component of the plurality of patch components after the second adherent patch component has been removed.
- impedance signals are measured when the third adherent patch component is adhered to the patient.
- embodiments of the present invention provide a system to monitor a patient for an extended period.
- the system comprise a plurality of adherent patch components.
- An electronics module may be adapted to couple to each of the plurality of patch components for sequential measurements from each of the patch components.
- each of the plurality of adherent patch components comprises, a breathable tape with an adhesive coating to adhere the breathable tape to a skin of the patient, and at least one electrode affixed to the breathable tape.
- the electronics module comprises a printed circuit board configured to connect electrically to the at least one electrode to measure physiologic signals of the patient, electronic components electrically connected to the printed circuit board, and a housing adhered to at least one of the electronics module or the printed circuit board.
- embodiments of the present invention provide a method of monitoring a patient for an extended period of time.
- a first adherent patch is adhered on a first side of the patient, in which the first adherent patch comprises first electrodes to measure at least one of an electrocardiogram or an impedance.
- the at least one of the electrocardiogram or the impedance is measured from the first side of the patient for a first period of time.
- the first patch is removed from the first side of the patient.
- a second adherent patch is placed on a second side of the patient, in which the second adherent patch comprises second electrodes to measure the at least one of the electrocardiogram or the impedance.
- the at least one of the electrocardiogram or the impedance is measured from the second side of the patient for a second period of time after the first patch has been removed.
- the first side comprises at least one of a left side or a right side of the patient, and the second side is opposite the first side.
- the second patch is removed from the second side of the patient, and a third adherent patch is placed on the first side of the patient, in which the third patch comprises third electrodes to measure the at least one of the electrocardiogram or the impedance.
- the at least one of the electrocardiogram or the impedance is measured from the first side of the patient for a third period of time after the second patch has been removed.
- the third patch is removed from the first side of the patient.
- a fourth adherent patch is placed on the second side of the patient, in which the fourth patch comprising fourth electrodes to measure the at least one of the electrocardiogram or the impedance.
- the at least one of the electrocardiogram or the impedance is measured from the second side of the patient for a fourth period of time after the third patch has been removed.
- each of the first period of time, the second period of time, the third period of time and the fourth period of time comprises at least about 1 week.
- embodiments of the present invention provide a method of monitoring a patient for an extended period of time.
- a first adherent patch is placed on a skin location on a first side of the patient, in which the first adherent patch comprises first electrodes to measure at least one of an electrocardiogram or an impedance.
- the at least one of the electrocardiogram or the impedance is measured from the first adherent patch on the first skin location for a first period of time.
- the first patch is removed from the first skin location.
- a second adherent patch is placed on a second skin location on a second side of the patient, in which the second adherent patch comprises second electrodes to measure the at least one of the electrocardiogram or the impedance.
- the at least one of the electrocardiogram or the impedance is measured from the second skin location for a second period of time after the first patch has been removed.
- the first skin location heals during the second period of time.
- inventions of the present invention provide an adherent device to monitor a patient.
- the device comprises an adhesive patch to adhere to a skin of the patient.
- At least four electrodes are mechanically coupled to the patch and capable of electrically coupling to the patient.
- the at least four electrodes may comprise at least two force electrodes and at least two sense electrodes.
- Impedance circuitry may be electrically coupled to the at least two force electrodes to force an electrical current and to the at least two sense electrodes to measure a hydration signal of the patient.
- Electrocardiogram circuitry can be coupled to the at least two force electrodes to measure an electrocardiogram signal of the patient.
- the adherent device comprises electrical switches connected to the at least two force electrodes to isolate the at least two force electrodes from the impedance circuitry when the electrocardiogram circuitry measures the electrocardiogram.
- a processor an be configured to control the impedance circuitry and the electrocardiogram circuitry so as to time division multiplex collection the hydration signal and the electrocardiogram signal.
- the processor may be configured to decouple the at least two force electrodes from the impedance circuitry when the electrocardiogram circuitry measures the electrocardiogram signal.
- the at least four electrodes comprise no more than four electrodes.
- the at least two force electrodes comprise outer electrodes and the at least two sense electrodes comprise inner electrodes.
- the at least two force electrodes comprise inner electrodes and the at least two sense electrodes comprise outer electrodes.
- embodiments of the present invention provide a method of monitoring a patient.
- An adhesive patch is adhered to a skin of the patient so as to couple at least four electrodes to the skin of the patient, in which the at least four electrodes comprise at least two force electrodes and at least two sense electrodes.
- a hydration signal of the patient is measured with impedance circuitry electrically coupled to the at least two force electrodes and to the at least two sense electrodes, such that the at least two force electrodes force an electrical current between the at least two force electrodes.
- An electrocardiogram signal of the patient is measured with electrocardiogram circuitry coupled to the at least two force electrodes.
- electrical switches connected to the at least two force electrodes can be opened to isolate the at least two force electrodes from the impedance circuitry when the electrocardiogram circuitry measures the electrocardiogram.
- the hydration signal and the electrocardiogram signal can be time division multiplexed.
- inventions of the present inventions provide an adherent device to monitor a patient.
- the device comprises an adhesive patch and at least two electrodes connected to the patch.
- the device also comprises circuitry coupled to at least two electrodes to measure at least two of an electrocardiogram signal, a respiration signal of the patient or an activity signal of the patient, and a processor system.
- the adhesive patch can adhere to a skin of the patient.
- the electrodes are capable of electrically coupling to the patient.
- the processor system comprises a tangible medium configured to trigger an alarm in response to the at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- the processor system comprises a first processor and a second processor.
- the first processor may comprise a tangible medium attached to the adherent patch.
- the second processor may comprise a tangible medium at a remote center.
- the processor system is configured to combine at least two of the electrocardiogram signal, the respiration signal or the activity signal, the purpose of which may be to detect an impending cardiac decompensation.
- Combining may comprise at least one of adding, subtracting, multiplying, scaling, or dividing the at least two of the electrocardiogram signal, the hydration signal, the respiration signal, or the activity signal.
- the at least two of the electrocardiogram signal, the respiration signal, or the activity signal can be combined with at least one of a weighted combination, a tiered combination, or a logic gated combination, a time weighted combination or a rate of change.
- the processor system is configured to continuously monitor, store in tangible media, and transmit to a remote center at least two of the electrocardiogram signal, the respiration signal or the activity signal when the alarm is triggered.
- the processor system is configured to trigger the alarm and alert the patient and/or the physician in response to an adverse cardiac event.
- the processor system is configured to calculate and report a patient risk of sudden cardiac death to at least one of a remote center or a physician.
- the processor system is configured to detect at least one of a T-wave alternans, a pulsus alternans, an autonomic imbalance, a heart rate variability in response to at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- the processor system is configured to loop record at least two of the electrocardiogram signal, the respiration signal or the activity signal for diagnosis of an unexplained syncope and/or arrhythmia when the alarm is triggered.
- the processor system is configured to detect an event comprising at least one of an atrial fibrillation in response to the electrocardiogram signal or an acute myocardial infarction in response to an ST segment elevation of the electrocardiogram signal.
- the processor system is configured to monitor a high risk patient post myocardial infarction with at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- the processor system is configured to continuously monitor a bradycardia of the patient at risk for sudden death, the electrocardiogram signal comprising at least one of a Brugada Syndrome with an ST elevation and a short QT interval or long-QT interval.
- the processor system is configured to monitor the electrocardiogram signal and an alert at least one of a patient, a remote center a physician, emergency responder, or family/caregiver in response to an adverse event.
- the processor system is configured to determine a tiered response to at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- the tiered response may comprise a first tier to contact an emergency responder in response to an immediate life threatening event, a second tier to contact a physician in response to an event that requires medical care, a third tier to contact a family member and/or care giver, and a fourth tier to contact the center.
- the immediate life threatening event comprises at least one of a sustained ventricular tachycardia, a sustained ventricular fibrillation, an asystole, an arrhythmia with no respiration or an arrhythmia with no patient movement.
- the event that requires medical care comprises an atrial fibrillation that is not immediately life threatening.
- the wireless communication circuitry is configured to transmit at least two of the electrocardiogram signal, the respiration signal or the activity signal with a single wireless hop from the wireless communication circuitry to an intermediate device.
- embodiments of the present invention provides a method of monitoring a patient.
- An adhesive patch is adhered to a skin of the patient so as to couple at least two electrodes to the skin of the patient.
- Circuitry coupled to the at least two electrodes measures at least two of an electrocardiogram signal of the patient, a respiration signal of the patient or an activity signal of the patient.
- An alarm may be triggered by a processor system in response to the at least two of the electrocardiogram signal, the respiration signal or the activity signal with the processor system comprising a tangible medium.
- the processor system comprises a first processor and a second processor.
- the first processor comprises a tangible medium attached to the adherent patch and the second processor comprises a tangible medium at a remote center.
- At least two of the electrocardiogram signal, the respiration signal, or the activity signal are combined, which may be to detect am impending cardiac decompensation.
- combining may comprise at least one of adding, subtracting, multiplying, scaling or dividing the at least two of the electrocardiogram signal, the hydration signal, the respiration signal or the activity signal.
- the at least two of the electrocardiogram signal, the respiration signal, or the activity signal can be combined with at least one of a weighted combination, a tiered combination, or a logic gated combination, a time weighted combination or a rate of change.
- At least two of the electrocardiogram signal, the respiration signal, or the activity signal are continuously monitored, stored, and/or transmitted to a remote center.
- the alarm is triggered and the patient and/or the physician is alerted in response to an adverse cardiac event.
- a patient risk of sudden cardiac death is calculated and/or reported to at least one of a remote center or a physician.
- At least one of a T-wave alternans, a pulsus alternans, an autonomic imbalance, a heart rate variability in response to the at least two of the electrocardiogram signal, the respiration signal or the activity signal is detected.
- the at least two of the electrocardiogram signal, the respiration signal or the activity signal is loop recorded when the alarm is triggered.
- an event comprising at least one of an atrial fibrillation in response to the electrocardiogram signal or an acute myocardial infarction in response to an ST segment elevation of the electrocardiogram signal is detected.
- a high risk patent post myocardial infarction is monitored with the at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- a bradycardia of the patient at risk for sudden death the electrocardiogram signal comprising at least one of a Brugada Syndrome with an ST elevation and a short QT interval or long-QT interval are continuously monitored.
- the electrocardiogram signal is monitored and/or at least one of a patient, a remote center, a physician, emergency responder, or family/caregiver is alerted in response to an adverse event.
- a tiered response to the at least two of the electrocardiogram signal, the respiration signal or the activity signal is determined.
- the tiered response comprises a first tier to contact an emergency responder in response to an immediate life threatening event, a second tier to contact a physician in response to an event that requires medical care, a third tier to contact a family member and/or care giver, and a fourth tier to contact the center.
- the immediate life threatening event comprises at least one of a sustained ventricular tachycardia, a sustained ventricular fibrillation, an asystole, an arrhythmia with no respiration or an arrhythmia with no patient movement.
- the event that requires medical care comprises an atrial fibrillation that is not immediately life threatening.
- wireless communication circuitry transmits the at least two of the electrocardiogram signal, the respiration signal or the activity signal with a single wireless hop from the wireless communication circuitry to an intermediate device.
- FIG. 1A shows a patient and a monitoring system comprising an adherent device, according to embodiments of the present invention
- FIG. 1B shows a bottom view of the adherent device as in FIG. 1A comprising an adherent patch
- FIG. 1C shows a top view of the adherent patch, as in FIG. 1B ;
- FIG. 1D shows a printed circuit boards and electronic components over the adherent patch, as in FIG. 1C ;
- FIG. 1 D 1 shows an equivalent circuit that can be used to determine optimal frequencies for determining patient hydration, according to embodiments of the present invention
- FIG. 1E shows batteries positioned over the printed circuit board and electronic components as in FIG. 1D ;
- FIG. 1F shows a top view of an electronics housing and a breathable cover over the batteries, electronic components and printed circuit board as in FIG. 1E ;
- FIG. 1G shows a side view of the adherent device as in FIGS. 1A to 1F ;
- FIG. 1H shown a bottom isometric view of the adherent device as in FIGS. 1A to 1G ;
- FIGS. 1I and 1J show a side cross-sectional view and an exploded view, respectively, of the adherent device as in FIGS. 1A to 1H ;
- FIG. 1K shows at least one electrode configured to electrically couple to a skin of the patient through a breathable tape, according to embodiments of the present invention
- FIGS. 2A to 2C show a system to monitor a patient for an extended period comprising a reusable electronic component and a plurality of disposable patch components, according to embodiments of the present invention
- FIG. 2D shows a method of using the system as in FIGS. 2A to 2C ;
- FIGS. 3A to 3D show a method of monitoring a patient for an extended period with an adherent patch with adherent patches alternatively adhered to the right side or the left side of the patient;
- FIG. 4A shows an adherent device to measure an impedance signal and an electrocardiogram signal, according to embodiments of the present invention
- FIG. 4B shows a method of measuring the impedance signal and the electrocardiogram signal, according to embodiments of the present invention
- FIG. 5A shows a method for monitoring a patient and responding to a signal event
- FIGS. 6A and 6B show clinical data measured with an adherent patch device.
- Embodiments of the present invention relate to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to any application in which physiological monitoring is used, for example wireless physiological monitoring for extended periods.
- Decompensation is failure of the heart to maintain adequate blood circulation. Although the heart can maintain at least some pumping of blood, the quantity is inadequate to maintain healthy tissues. Several symptoms can result from decompensation including pulmonary congestion, breathlessness, faintness, cardiac palpitation, edema of the extremities, and enlargement of the liver. Cardiac decompensation can result in slow or sudden death. Sudden Cardiac Arrest (hereinafter “SCA”), also referred to as sudden cardiac death, is an abrupt loss of cardiac pumping function that can be caused by a ventricular arrhythmia, for example ventricular tachycardia and/or ventricular fibrillation.
- SCA Sudden Cardiac Arrest
- decompensation and SCA can be related in that patients with decompensation are also at an increased risk for SCA, decompensation is primarily a mechanical dysfunction caused by inadequate blood flow, and SCA is primarily an electrical dysfunction caused by inadequate and/or inappropriate electrical signals of the heart.
- the adherent devices described herein may be used for 90 day monitoring, or more, and may comprise completely disposable components and/or reusable components, and can provide reliable data acquisition and transfer.
- the patch is configured for patient comfort, such that the adherent patch can be worn and/or tolerated by the patient for extended periods, for example 90 days or more.
- the patch may be worn continuously for at least seven days, for example 14 days, and then replaced with another patch.
- Adherent devices with comfortable patches that can be worn for extended periods and in which patches can be replaced and the electronics modules reused are described in U.S. patent application Nos.
- the adherent patch comprises a tape, which comprises a material, preferably breathable, with an adhesive, such that trauma to the patient skin can be minimized while the patch is worn for the extended period.
- the printed circuit board may comprise a flex printed circuit board that can flex with the patient to provide improved patient comfort.
- FIG. 1A shows a patient P and a monitoring system 10 .
- Patient P comprises a midline M, a first side S 1 , for example a right side, and a second side S 2 , for example a left side.
- Monitoring system 10 comprises an adherent device 100 .
- Adherent device 100 can be adhered to a patient P at many locations, for example thorax T of patient P. In many embodiments, the adherent device may adhere to one side of the patient, from which side data can be collected. Work in relation with embodiments of the present invention suggests that location on a side of the patient can provide comfort for the patient while the device is adhered to the patient.
- Monitoring system 10 includes components to transmit data to a remote center 106 .
- Remote center 106 can be located in a different building from the patient, for example in the same town as the patient, and can be located as far from the patient as a separate continent from the patient, for example the patient located on a first continent and the remote center located on a second continent.
- Adherent device 100 can communicate wirelessly to an intermediate device 102 , for example with a single wireless hop from the adherent device on the patient to the intermediate device.
- Intermediate device 102 can communicate with remote center 106 in many ways, for example with an internet connection and/or with a cellular connection.
- monitoring system 10 comprises a distributed processing system with at least one processor comprising a tangible medium of device 100 , at least one processor 102 P of intermediate device 102 , and at least one processor 106 P at remote center 106 , each of which processors can be in electronic communication with the other processors.
- At least one processor 102 P comprises a tangible medium 102 T
- at least one processor 106 P comprises a tangible medium 106 T.
- Remote processor 106 P may comprise a backend server located at the remote center.
- Remote center 106 can be in communication with a health care provider 108 A with a communication system 107 A, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.
- Health care provider 108 A for example a family member, can be in communication with patient P with a communication, for example with a two way communication system, as indicated by arrow 109 A, for example by cell phone, email, landline.
- Remote center 106 can be in communication with a health care professional, for example a physician 108 B, with a communication system 107 B, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.
- Physician 108 B can be in communication with patient P with a communication, for example with a two way communication system, as indicated by arrow 109 B, for example by cell phone, email, landline.
- Remote center 106 can be in communication with an emergency responder 108 C, for example a 911 operator and/or paramedic, with a communication system 107 C, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.
- Emergency responder 108 C can travel to the patient as indicated by arrow 109 C.
- monitoring system 10 comprises a closed loop system in which patient care can be monitored and implemented from the remote center in response to signals from the adherent device.
- the adherent device may continuously monitor physiological parameters, communicate wirelessly with a remote center, and provide alerts when necessary.
- the system may comprise an adherent patch, which attaches to the patient's thorax and contains sensing electrodes, battery, memory, logic, and wireless communication capabilities.
- the patch can communicate with the remote center, via the intermediate device in the patient's home.
- remote center 106 receives the patient data and applies a patient evaluation algorithm, for example the prediction algorithm to predict cardiac decompensation.
- the algorithm may comprise an algorithm to predict impending cardiac decompensation is described in U.S. patent application No. 60/972,512, the full disclosure of which has been previously incorporated herein by reference.
- the center may communicate with the patient, hospital, nurse, and/or physician to allow for therapeutic intervention, for example to prevent decompensation.
- the adherent device may be affixed and/or adhered to the body in many ways. For example, with at least one of the following an adhesive tape, a constant-force spring, suspenders around shoulders, a screw-in microneedle electrode, a pre-shaped electronics module to shape fabric to a thorax, a pinch onto roll of skin, or transcutaneous anchoring.
- Patch and/or device replacement may occur with a keyed patch (e.g. two-part patch), an outline or anatomical mark, a low-adhesive guide (place guide
- the patch and/or device may comprise an adhesiveless embodiment (e.g. chest strap), and/or a low-irritation adhesive for sensitive skin.
- the adherent patch and/or device can comprise many shapes, for example at least one of a dogbone, an hourglass, an oblong, a circular or an oval shape.
- the adherent device may comprise a reusable electronics module with replaceable patches, and each of the replaceable patches may include a battery.
- the module may collect cumulative data for approximately 90 days and/or the entire adherent component (electronics+patch) may be disposable.
- a “baton” mechanism may be used for data transfer and retention, for example baton transfer may include baseline information.
- the device may have a rechargeable module, and may use dual battery and/or electronics modules, wherein one module 101 A can be recharged using a charging station 103 while the other module 101 B is placed on the adherent patch with connectors.
- the intermediate device 102 may comprise the charging module, data transfer, storage and/or transmission, such that one of the electronics modules can be placed in the intermediate device for charging and/or data transfer while the other electronics module is worn by the patient.
- the adherent device may contain a subset of the following physiological sensors: bioimpedance, respiration, respiration rate variability, heart rate (ave, min, max), heart rhythm, hear rate variability (HRV), heart rate turbulence (HRT), heart sounds (e.g. S 3 ), respiratory sounds, blood pressure, activity, posture, wake/sleep, orthopnea, temperature/heat flux, and weight.
- the activity sensor may comprise one or more of the following: ball switch, accelerometer, minute ventilation, HR, bioimpedance noise, skin temperature/heat flux, BP, muscle noise, posture.
- the adherent device can wirelessly communicate with remote center 106 .
- the communication may occur directly (via a cellular or Wi-Fi network), or indirectly through intermediate device 102 .
- Intermediate device 102 may consist of multiple devices, which can communicate wired or wirelessly to relay data to remote center 106 .
- instructions are transmitted from remote site 106 to a processor supported with the adherent patch on the patient, and the processor supported with the patient can receive updated instructions for the patient treatment and/or monitoring, for example while worn by the patient.
- FIG. 1B shows a bottom view of adherent device 100 as in FIG. 1A comprising an adherent patch 110 .
- Adherent patch 110 comprises a first side, or a lower side 110 A, that is oriented toward the skin of the patient when placed on the patient.
- adherent patch 110 comprises a tape 110 T which is a material, preferably breathable, with an adhesive 116 A.
- Patient side 110 A comprises adhesive 116 A to adhere the patch 110 and adherent device 100 to patient P.
- Electrodes 112 A, 112 B, 112 C and 112 D are affixed to adherent patch 110 .
- at least four electrodes are attached to the patch, for example six electrodes.
- the patch comprises two electrodes, for example two electrodes to measure the electrocardiogram (ECG) of the patient.
- Gel 114 A, gel 114 B, gel 114 C and gel 114 D can each be positioned over electrodes 112 A, 112 B, 112 C and 112 D, respectively, to provide electrical conductivity between the electrodes and the skin of the patient.
- the electrodes can be affixed to the patch 110 , for example with known methods and structures such as rivets, adhesive, stitches, etc.
- patch 110 comprises a breathable material to permit air and/or vapor to flow to and from the surface of the skin.
- FIG. 1C shows a top view of the adherent patch 100 , as in FIG. 1B .
- Adherent patch 100 comprises a second side, or upper side 110 B.
- electrodes 112 A, 112 B, 112 C and 112 D extend from lower side 110 A through adherent patch 110 to upper side 110 B.
- An adhesive 116 B can be applied to upper side 110 B to adhere structures, for example a breathable cover, to the patch such that the patch can support the electronics and other structures when the patch is adhered to the patient.
- the PCB may comprise completely flex PCB, rigid PCB, rigid PCB combined flex PCB and/or rigid PCB boards connected by cable.
- FIG. 1D shows a printed circuit boards and electronic components over adherent patch 110 , as in FIGS. 1A to 1C .
- a printed circuit board for example flex printed circuit board 120
- Flex printed circuit board 120 may be connected to electrodes 112 A, 112 B, 112 C and 112 D with connectors 122 A, 122 B, 122 C and 122 D.
- Flex printed circuit board 120 can include traces 123 A, 123 B, 123 C and 123 D that extend to connectors 122 A, 122 B, 122 C and 122 D, respectively, on the flex PCB.
- Connectors 122 A, 122 B, 122 C and 122 D can be positioned on flex printed circuit board 120 in alignment with electrodes 112 A, 112 B, 112 C and 112 D so as to electrically couple the flex PCB with the electrodes.
- connectors 122 A, 122 B, 122 C and 122 D may comprise insulated wires and/or a film with conductive ink that provide strain relief between the PCB and the electrodes.
- connectors 122 A, 122 B, 122 C and 122 D may comprise a flexible polyester film coated with conductive silver ink.
- additional PCB's for example rigid PCB's 120 A, 120 B, 120 C and 120 D, can be connected to flex printed circuit board 120 .
- Electronic components 130 can be connected to flex printed circuit board 120 and/or mounted thereon. In some embodiments, electronic components 130 can be mounted on the additional PCB's.
- Electronic components 130 comprise components to take physiologic measurements, transmit data to remote center 106 and receive commands from remote center 106 .
- electronics components 130 may comprise known low power circuitry, for example complementary metal oxide semiconductor (CMOS) circuitry components.
- Electronics components 130 comprise an activity sensor and activity circuitry 134 , impedance circuitry 136 and electrocardiogram circuitry, for example ECG circuitry 136 .
- electronics circuitry 130 may comprise a microphone and microphone circuitry 142 to detect an audio signal from within the patient, and the audio signal may comprise a heart sound and/or a respiratory sound, for example an S 3 heart sound and a respiratory sound with rales and/or crackles.
- Electronics circuitry 130 may comprise a temperature sensor, for example a thermistor in contact with the skin of the patient, and temperature sensor circuitry 144 to measure a temperature of the patient, for example a temperature of the skin of the patient.
- a temperature sensor may be used to determine the sleep and wake state of the patient. The temperature of the patient can decrease as the patient goes to sleep and increase when the patient wakes up.
- skin temperature may effect impedance and/or hydration measurements, and that skin temperature measurements may be used to correct impedance and/or hydration measurements.
- increase in skin temperature or heat flux can be associated with increased vaso-dilation near the skin surface, such that measured impedance measurement decreased, even through the hydration of the patient in deeper tissues under the skin remains substantially unchanged.
- use of the temperature sensor can allow for correction of the hydration signals to more accurately assess the hydration, for example extra cellular hydration, of deeper tissues of the patient, for example deeper tissues in the thorax.
- Electronics circuitry 130 may comprise a processor 146 .
- Processor 146 comprises a tangible medium, for example read only memory (ROM), electrically erasable programmable read only memory (EEPROM) and/or random access memory (RAM).
- Electronic circuitry 130 may comprise real time clock and frequency generator circuitry 148 .
- processor 136 may comprise the frequency generator and real time clock.
- the processor can be configured to control a collection and transmission of data from the impedance circuitry electrocardiogram circuitry and the accelerometer.
- device 100 comprise a distributed processor system, for example with multiple processors on device 100 .
- electronics components 130 comprise wireless communications circuitry 132 to communicate with remote center 106 .
- the wireless communication circuitry can be coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a communication protocol at least one of the hydration signal, the electrocardiogram signal or the inclination signal.
- wireless communication circuitry is configured to transmit the hydration signal, the electrocardiogram signal and the inclination signal to the remote center with a single wireless hop, for example from wireless communication circuitry 132 to intermediate device 102 .
- the communication protocol comprises at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, amplitude modulation or frequency modulation.
- the communications protocol comprises a two way protocol such that the remote center is capable of issuing commands to control data collection.
- Intermediate device 102 may comprise a data collection system to collect and store data from the wireless transmitter.
- the data collection system can be configured to communicate periodically with the remote center.
- the data collection system can transmit data in response to commands from remote center 106 and/or in response to commands from the adherent device.
- Activity sensor and activity circuitry 134 can comprise many known activity sensors and circuitry.
- the accelerometer comprises at least one of a piezoelectric accelerometer, capacitive accelerometer or electromechanical accelerometer.
- the accelerometer may comprises a 3-axis accelerometer to measure at least one of an inclination, a position, an orientation or acceleration of the patient in three dimensions. Work in relation to embodiments of the present invention suggests that three dimensional orientation of the patient and associated positions, for example sitting, standing, lying down, can be very useful when combined with data from other sensors, for example ECG data and/or hydration data.
- Impedance circuitry 136 can generate both hydration data and respiration data.
- impedance circuitry 136 is electrically connected to electrodes 112 A, 112 B, 112 C and 112 D in a four pole configuration, such that electrodes 112 A and 112 D comprise outer electrodes that are driven with a current and comprise force electrodes that force the current through the tissue.
- the current delivered between electrodes 112 A and 112 D generates a measurable voltage between electrodes 112 B and 112 C, such that electrodes 112 B and 112 C comprise inner, sense, electrodes that sense and/or measure the voltage in response to the current from the force electrodes.
- electrodes 112 B and 112 C may comprise force electrodes and electrodes 112 A and 112 B may comprise sense electrodes.
- the voltage measured by the sense electrodes can be used to measure the impedance of the patient and determine the respiration rate and/or hydration of the patient.
- FIG. 1 D 1 shows an equivalent circuit 152 that can be used to determine optimal frequencies for measuring patient hydration.
- Work in relation to embodiments of the present invention indicates that the frequency of the current and/or voltage at the force electrodes can be selected so as to provide impedance signals related to the extracellular and/or intracellular hydration of the patient tissue.
- Equivalent circuit 152 comprises an intracellular resistance 156 , or R(ICW) in series with a capacitor 154 , and an extracellular resistance 158 , or R(ECW). Extracellular resistance 158 is in parallel with intracellular resistance 156 and capacitor 154 related to capacitance of cell membranes.
- impedances can be measured and provide useful information over a wide range of frequencies, for example from about 0.5 kHz to about 200 KHz.
- Work in relation to embodiments of the present invention suggests that extracellular resistance 158 can be significantly related extracellular fluid and to cardiac decompensation, and that extracellular resistance 158 and extracellular fluid can be effectively measured with frequencies in a range from about 0.5 kHz to about 20 kHz, for example from about 1 kHz to about 10 kHz.
- a single frequency can be used to determine the extracellular resistance and/or fluid.
- hydration As sample frequencies increase from about 10 kHz to about 20 kHz, capacitance related to cell membranes decrease the impedance, such that the intracellular fluid contributes to the impedance and/or hydration measurements.
- many embodiments of the present invention measure hydration with frequencies from about 0.5 kHz to about 20 kHz to determine patient hydration.
- impedance circuitry 136 can be configured to determine respiration of the patient.
- the impedance circuitry can measure the hydration at 25 Hz intervals, for example at 25 Hz intervals using impedance measurements with a frequency from about 0.5 kHz to about 20 kHz.
- ECG circuitry 138 can generate electrocardiogram signals and data from two or more of electrodes 112 A, 112 B, 112 C and 112 D in many ways.
- ECG circuitry 138 is connected to inner electrodes 112 B and 122 C, which may comprise sense electrodes of the impedance circuitry as described above.
- ECG circuitry 138 can be connected to electrodes 112 A and 112 D so as to increase spacing of the electrodes.
- the inner electrodes may be positioned near the outer electrodes to increase the voltage of the ECG signal measured by ECG circuitry 138 .
- the ECG circuitry may measure the ECG signal from electrodes 112 A and 112 D when current is not passed through electrodes 112 A and 112 D, for example with switches as described in U.S. App. No. 60/972,527, the full disclosure of which has been previously incorporated herein by reference.
- FIG. 1E shows batteries 150 positioned over the flex printed circuit board and electronic components as in FIG. 1D .
- Batteries 150 may comprise rechargeable batteries that can be removed and/or recharged. In some embodiments, batteries 150 can be removed from the adherent patch and recharged and/or replaced.
- FIG. 1F shows a top view of a cover 162 over the batteries, electronic components and flex printed circuit board as in FIGS. 1A to 1E .
- an electronics housing 160 may be disposed under cover 162 to protect the electronic components, and in some embodiments electronics housing 160 may comprise an encapsulant over the electronic components and PCB.
- cover 162 can be adhered to adherent patch 110 with an adhesive 164 on an underside of cover 162 .
- electronics housing 160 may comprise a water proof material, for example a sealant adhesive such as epoxy or silicone coated over the electronics components and/or PCB.
- electronics housing 160 may comprise metal and/or plastic. Metal or plastic may be potted with a material such as epoxy or silicone.
- Cover 162 may comprise many known biocompatible cover, casing and/or housing materials, such as elastomers, for example silicone.
- the elastomer may be fenestrated to improve breathability.
- cover 162 may comprise many known breathable materials, for example polyester, polyamide, and/or elastane (SpandexTM).
- the breathable fabric may be coated to make it water resistant, waterproof, and/or to aid in wicking moisture away from the patch.
- FIG. 1G shows a side view of adherent device 100 as in FIGS. 1A to 1F .
- Adherent device 100 comprises a maximum dimension, for example a length 170 from about 4 to 10 inches (from about 100 mm to about 250 mm), for example from about 6 to 8 inches (from about 150 mm to about 200 mm). In some embodiments, length 170 may be no more than about 6 inches (no more than about 150 mm).
- Adherent device 100 comprises a thickness 172 . Thickness 172 may comprise a maximum thickness along a profile of the device. Thickness 172 can be from about 0.2 inches to about 0.4 inches (from about 5 mm to about 10 mm), for example about 0.3 inches (about 7.5 mm).
- FIG. 1H shown a bottom isometric view of adherent device 100 as in FIGS. 1A to 1G .
- Adherent device 100 comprises a width 174 , for example a maximum width along a width profile of adherent device 100 .
- Width 174 can be from about 2 to about 4 inches (from about 50 mm to 100 mm), for example about 3 inches (about 75 mm).
- FIGS. 1I and 1J show a side cross-sectional view and an exploded view, respectively, of adherent device 100 as in FIGS. 1A to 1H .
- Device 100 comprises several layers.
- Gel 114 A, or gel layer, is positioned on electrode 112 A to provide electrical conductivity between the electrode and the skin.
- Electrode 112 A may comprise an electrode layer.
- Adherent patch 110 may comprise a layer of breathable tape 110 T, for example a known breathable tape, such as tricot-knit polyester fabric.
- An adhesive 116 A for example a layer of acrylate pressure sensitive adhesive, can be disposed on underside 110 A of adherent patch 110 .
- a gel cover 180 can be positioned over patch 110 comprising the breathable tape.
- a PCB layer for example flex printed circuit board 120 , or flex PCB layer, can be positioned over gel cover 180 with electronic components 130 connected and/or mounted to flex printed circuit board 120 , for example mounted on flex PCB so as to comprise an electronics layer disposed on the flex PCB layer.
- the adherent device may comprise a segmented inner component, for example the PCB may be segmented to provide at least some flexibility.
- the electronics layer may be encapsulated in electronics housing 160 which may comprise a waterproof material, for example silicone or epoxy.
- the electrodes are connected to the PCB with a flex connection, for example trace 123 A of flex printed circuit board 120 , so as to provide strain relive between the electrodes 112 A, 112 B, 112 C and 112 D and the PCB.
- Gel cover 180 can inhibit flow of gel 114 A and liquid. In many embodiments, gel cover 180 can inhibit gel 114 A from seeping through breathable tape 110 T to maintain gel integrity over time. Gel cover 180 can also keep external moisture, for example liquid water, from penetrating though the gel cover into gel 114 A while allowing moisture vapor from the gel, for example moisture vapor from the skin, to transmit through the gel cover.
- external moisture for example liquid water
- cover 162 can encase the flex PCB and/or electronics and can be adhered to at least one of the electronics, the flex PCB or adherent patch 110 , so as to protect at least the electronics components and the PCB.
- Cover 162 can attach to adherent patch 110 with adhesive 1116 B.
- Cover 162 can comprise many known biocompatible cover materials, for example silicone.
- Cover 162 can comprise an outer polymer cover to provide smooth contour without limiting flexibility.
- cover 162 may comprise a breathable fabric.
- Cover 162 may comprise many known breathable fabrics, for example breathable fabrics as described above.
- the breathable cover may comprise a breathable water resistant cover.
- the breathable fabric may comprise polyester, nylon, polyamide, and/or elastane (SpandexTM) to allow the breathable fabric to stretch with body movement.
- the breathable tape may contain and elute a pharmaceutical agent, such as an antibiotic, anti-inflammatory or antifungal agent, when the adherent device is placed on the patient.
- the breathable cover 162 and adherent patch 110 comprise breathable tape can be configured to couple continuously for at least one week the at least one electrode to the skin so as to measure breathing of the patient.
- the breathable tape may comprise the stretchable breathable material with the adhesive and the breathable cover may comprises a stretchable water resistant material connected to the breathable tape, as described above, such that both the adherent patch and cover can stretch with the skin of the patient.
- Arrows 182 show stretching of adherent patch 110 , and the stretching of adherent patch can be at least two dimensional along the surface of the skin of the patient.
- connectors 122 A, 122 B, 122 C and 122 D between PCB 130 and electrodes 112 A, 112 B, 112 C and 112 D may comprise insulated wires that provide strain relief between the PCB and the electrodes, such that the electrodes can move with the adherent patch as the adherent patch comprising breathable tape stretches.
- Arrows 184 show stretching of cover 162 , and the stretching of the cover can be at least two dimensional along the surface of the skin of the patient.
- Cover 162 can be attached to adherent patch 110 with adhesive 116 B such that cover 162 stretches and/or retracts when adherent patch 110 stretches and/or retracts with the skin of the patient.
- cover 162 and adherent patch 110 can stretch in two dimensions along length 170 and width 174 with the skin of the patient, and stretching along length 170 can increase spacing between electrodes. Stretching of the cover and adherent patch 110 , for example in two dimensions, can extend the time the patch is adhered to the skin as the patch can move with the skin such that the patch remains adhered to the skin.
- Electronics housing 160 can be smooth and allow breathable cover 162 to slide over electronics housing 160 , such that motion and/or stretching of cover 162 is slidably coupled with housing 160 .
- the printed circuit board can be slidably coupled with adherent patch 110 that comprises breathable tape 110 T, such that the breathable tape can stretch with the skin of the patient when the breathable tape is adhered to the skin of the patient, for example along two dimensions comprising length 170 and width 174 .
- Electronics components 130 can be affixed to printed circuit board 120 , for example with solder, and the electronics housing can be affixed over the PCB and electronics components, for example with dip coating, such that electronics components 130 , printed circuit board 120 and electronics housing 160 are coupled together.
- Electronics components 130 , printed circuit board 120 , and electronics housing 160 are disposed between the stretchable breathable material of adherent patch 110 and the stretchable water resistant material of cover 160 so as to allow the adherent patch 110 and cover 160 to stretch together while electronics components 130 , printed circuit board 120 , and electronics housing 160 do not stretch substantially, if at all.
- This decoupling of electronics housing 160 , printed circuit board 120 and electronic components 130 can allow the adherent patch 110 comprising breathable tape to move with the skin of the patient, such that the adherent patch can remain adhered to the skin for an extended time of at least one week, for example two or more weeks.
- An air gap 169 may extend from adherent patch 110 to the electronics module and/or PCB, so as to provide patient comfort.
- Air gap 169 allows adherent patch 110 and breathable tape 110 T to remain supple and move, for example bend, with the skin of the patient with minimal flexing and/or bending of printed circuit board 120 and electronic components 130 , as indicated by arrows 186 .
- Printed circuit board 120 and electronics components 130 that are separated from the breathable tape 110 T with air gap 169 can allow the skin to release moisture as water vapor through the breathable tape, gel cover, and breathable cover. This release of moisture from the skin through the air gap can minimize, and even avoid, excess moisture, for example when the patient sweats and/or showers.
- the breathable tape of adherent patch 110 may comprise a first mesh with a first porosity and gel cover 180 may comprise a breathable tape with a second porosity, in which the second porosity is less than the first porosity to minimize, and even inhibit, flow of the gel through the breathable tape.
- the gel cover may comprise a polyurethane film with the second porosity.
- the adherent device comprises a patch component and at least one electronics module.
- the patch component may comprise adherent patch 110 comprising the breathable tape with adhesive coating 116 A, at least one electrode, for example electrode 114 A and gel 114 .
- the at least one electronics module can be separable from the patch component.
- the at least one electronics module comprises the flex printed circuit board 120 , electronic components 130 , electronics housing 160 and cover 162 , such that the flex printed circuit board, electronic components, electronics housing and cover are reusable and/or removable for recharging and data transfer, for example as described above.
- adhesive 116 B is coated on upper side 110 A of adherent patch 110 B, such that the electronics module can be adhered to and/or separated from the adhesive component.
- the electronic module can be adhered to the patch component with a releasable connection, for example with VelcroTM, a known hook and loop connection, and/or snap directly to the electrodes.
- Two electronics modules can be provided, such that one electronics module can be worn by the patient while the other is charged, as described above. Monitoring with multiple adherent patches for an extended period is described in U.S. patent application No. 60/972,537, the full disclosure of which has been previously incorporated herein by reference. Many patch components can be provided for monitoring over the extended period. For example, about 12 patches can be used to monitor the patient for at least 90 days with at least one electronics module, for example with two reusable electronics modules.
- At least one electrode 112 A can extend through at least one aperture 180 A in the breathable tape 110 and gel cover 180 .
- the adhesive patch may comprise a medicated patch that releases a medicament, such as antibiotic, beta-blocker, ACE inhibitor, diuretic, or steroid to reduce skin irritation.
- the adhesive patch may comprise a thin, flexible, breathable patch with a polymer grid for stiffening. This grid may be anisotropic, may use electronic components to act as a stiffener, may use electronics-enhanced adhesive elution, and may use an alternating elution of adhesive and steroid.
- FIG. 1K shows at least one electrode 190 configured to electrically couple to a skin of the patient through a breathable tape 192 .
- at least one electrode 190 and breathable tape 192 comprise electrodes and materials similar to those described above. Electrode 190 and breathable tape 192 can be incorporated into adherent devices as described above, so as to provide electrical coupling between the skin an electrode through the breathable tape, for example with the gel.
- FIGS. 2A to 2C show a schematic illustration of a system 200 to monitor a patient for an extended period.
- FIG. 2A shows a schematic illustration of system 200 comprising a reusable electronics module 210 and a plurality of disposable patch components comprising a first disposable patch component 220 A, a second disposable patch component 220 B, a third disposable patch component 220 C and a fourth disposable patch component 220 D.
- the plurality may comprise as few as two patch component and as many as three or more patch components, for example 25 patch components.
- FIG. 2B shows a schematic illustration of a side cross-sectional view of reusable electronics module 210 .
- Reusable electronics module 210 may comprises many of the structures described above that may comprise the electronics module.
- reusable electronics module 210 comprises a PCB, for example a flex PCB 212 , electronics components 216 , batteries 216 , and a cover 217 , for example as described above.
- reusable electronics module 210 may comprise an electronics housing over the electronics components and/or PCB as described above.
- the electronics components may comprise circuitry and/or sensors for measuring ECG signals, hydration impedance signals, respiration impedance signals and accelerometer signals, for example as described above.
- reusable electronics module 210 comprises a connector 219 adapted to connect to each of the disposable patch components, sequentially, for example one disposable patch component at a time.
- Connector 219 can be formed in many ways, and may comprise known connectors as described above, for example a snap.
- the connectors on the electronics module and adhesive component can be disposed at several locations on the reusable electronics module and disposable patch component, for example near each electrode, such that each electrode can couple directly to a corresponding location on the flex PCB of the reusable electronics component.
- each of the plurality of disposable patch components may comprise a disposable battery.
- first disposable patch component 220 A may comprise a disposable battery 214 A
- second disposable patch component 220 B may comprise a disposable battery 214 B
- third disposable patch component 220 C may comprise a disposable battery 214 C
- fourth disposable patch component 220 D may comprise a disposable battery 214 D.
- Each of the disposable batteries, 214 A, 214 B, 214 C and 214 D may be affixed to each of disposable patches 220 A, 220 B, 220 C and 220 D, respectively, such that the batteries are adhered to the disposable patch component before, during and after the respective patch component is adhered to the patient.
- Each of the disposable batteries, 214 A, 214 B, 214 C and 214 D may be coupled to connectors 215 A, 215 B, 215 C and 215 D, respectively.
- Each of connectors 215 A, 215 B, 215 C and 215 D can be configured to couple to a connector of the reusable module 220 , so as to power the reusable module with the disposable battery coupled thereto.
- Each of the disposable batteries, 214 A, 214 B, 214 C and 214 D may be coupled to connectors 215 A, 215 B, 215 C and 215 D, respectively, such that the batteries are not coupled to the electrodes of the respective patch component, so as to minimize, and even avoid, degradation of the electrodes and/or gel during storage when each disposable battery is adhered to each respective disposable patch component.
- FIG. 2C shows a schematic illustration first disposable patch component 220 A of the plurality of disposable patch components that is similar to the other disposable patch components, for example second disposable patch component 220 B, third disposable patch component 220 C and fourth disposable patch component 220 C.
- the disposable patch component comprises a breathable tape 227 A, an adhesive 226 A on an underside of breathable tape 227 A to adhere to the skin of the patient, and at least four electrodes 222 A.
- the at least four electrodes 224 A are configured to couple to the skin of a patient, for example with a gel 226 A, in some embodiments the electrodes may extend through the breathable tape to couple directly to the skin of the patient with aid form the gel.
- the at least four electrodes may be indirectly coupled to the skin through a gel and/or the breathable tape, for example as described above.
- a connector 229 A on the upper side of the disposable adhesive component can be configured for attachment to connector 219 on reusable electronics module 210 so as to electrically couple the electrodes with the electronics module.
- the upper side of the disposable patch component may comprise an adhesive 224 A to connect the disposable patch component to the reusable electronics module.
- the reusable electronics module can be adhered to the patch component with many additional known ways to adhere components, for example with VelcroTM comprising hooks and loops, snaps, a snap fit, a lock and key mechanisms, magnets, detents and the like.
- FIG. 2D shows a method 250 of using system 200 , as in FIGS. 2A to 2C .
- a step 252 adheres electronics module 210 to first disposable adherent patch component 220 A of the plurality of adherent patch components and adheres the first disposable patch component to the skin of the patient, for example with the first adherent patch component adhered to the reusable electronics module.
- a step 254 removes the first disposable adherent patch from the patient and separates first disposable adherent patch component 220 A from reusable electronics module 210 .
- a step 256 adheres electronics module 210 to second disposable adherent patch component 220 B and adheres the second disposable patch component to the skin of the patient, for example with the second adherent patch component adhered to the reusable electronics module.
- a step 258 removes the second disposable adherent patch from the patient and separates second disposable adherent patch component 220 B from reusable electronics module 210 .
- a step 260 adheres electronics module 210 to third disposable adherent patch component 220 C and adheres the third disposable patch component to the skin of the patient, for example with the third adherent patch component adhered to the reusable electronics module.
- a step 262 removes the third disposable adherent patch from the patient and separates third disposable adherent patch component 220 C from reusable electronics module 210 .
- a step 264 adheres electronics module 210 to fourth disposable adherent patch component 220 D and adheres the fourth disposable patch component to the skin of the patient, for example with the third adherent patch component adhered to the reusable electronics module.
- a step 268 removes the fourth disposable adherent patch from the patient and separates fourth disposable adherent patch component 220 D from reusable electronics module 210 .
- physiologic signals for example ECG, hydration impedance, respiration impedance and accelerometer impedance are measured when the adherent patch component is adhered to the patient, for example when any of the first, second, third or fourth disposable adherent patches is adhered to the patient.
- FIGS. 3A to 3D show a method 300 of monitoring a patient for an extended period with adherent patches alternatively adhered to a right side 302 and a left side 304 of the patient.
- Work in relation to embodiments of the present invention suggests that repeated positioning of a patch at the same location can irritate the skin and may cause patient discomfort. This can be avoided by alternating the patch placement between left and right sides of the patient, often a front left and a front right side of the patient where the patient can reach easily to replace the patch.
- the patch location can be alternated on the same side of the patient, for example higher and/or lower on the same side of the patient without substantial overlap to allow the skin to recover and/or heal.
- the patch can be symmetrically positioned on an opposite side such that signals may be similar to a previous position of the patch symmetrically disposed on an opposite side of the patient.
- the duration between removal of one patch and placement of the other patch can be short, such that any differences between the signals may be assumed to be related to placement of the patch, and these differences can be removed with signal processing.
- each patch comprises at least four electrodes configured to measure an ECG signal and impedance, for example hydration and/or respiration impedance.
- the patient comprises a midline 306 , with first side, for example right side 302 , and second side, for example left side 304 , symmetrically disposed about the midline.
- a step 310 adheres a first adherent patch 312 to at a first location 314 on a first side 302 of the patient for a first period of time, for example about 1 week. While the adherent patch 312 is position at first location 314 on the first side of the patient, the electrodes of the patch are coupled to the skin of the patient to measure the ECG signal and impedance signals.
- a step 320 removes patch 312 and adheres a second adherent patch 322 at a second location 324 on a second side 206 of the patient for a second period of time, for example about 1 week.
- second location 324 can be symmetrically disposed opposite first location 314 across midline 304 , for example so as to minimize changes in the sequential impedance signals measured from the second side and first side.
- adherent patch 322 is position at second location 324 on the second side of the patient, the electrodes of the patch are coupled to the skin of the patient to measure the ECG signal and impedance signals.
- adherent patch 322 while adherent patch 322 is positioned at second location 324 , skin at first location 314 can heal and recover from adherent coverage of the first patch.
- second location 324 is symmetrically disposed opposite first location 314 across midline 304 , for example so as to minimize changes in the impedance signals measured between the first side and second side.
- the duration between removal of one patch and placement of the other patch can be short, such that any differences between the signals may be assumed to be related to placement of the patch, and these differences can be removed with signal processing.
- a step 330 removes second patch 322 and adheres a third adherent patch 332 at a third location 334 on the first side, for example right side 302 , of the patient for a third period of time, for example about 1 week.
- third location 334 can be symmetrically disposed opposite second location 324 across midline 304 , for example so as to minimize changes in the sequential impedance signals measured from the third side and second side.
- third location 334 substantially overlaps with first location 314 , so as to minimize differences in measurements between the first adherent patch and third adherent patch that may be due to patch location.
- adherent patch 332 While adherent patch 332 is positioned at third location 334 on the first side of the patient, the electrodes of the patch are coupled to the skin of the patient to measure the ECG signal and impedance signals. In many embodiments, while adherent patch 332 is positioned at third location 334 , skin at second location 324 can heal and recover from adherent coverage of the second patch. In many embodiments, the duration between removal of one patch and placement of the other patch can be short, such that any differences between the signals may be assumed to be related to placement of the patch, and these differences can be removed with signal processing.
- a step 340 removes third patch 332 and adheres a fourth adherent patch 342 at a fourth location 344 on the second side, for example left side 306 , of the patient for a fourth period of time, for example about 1 week.
- fourth location 344 can be symmetrically disposed opposite third location 334 across midline 304 , for example so as to minimize changes in the sequential impedance signal measured from the fourth side and third side.
- fourth location 344 substantially overlaps with second location 324 , so as to minimize differences in measurements between the second adherent patch and fourth adherent patch that may be due to patch location.
- adherent patch 342 While adherent patch 342 is positioned at fourth location 344 on the second side of the patient, the electrodes of the patch are coupled to the skin of the patient to measure the ECG signal and impedance signals. In many embodiments, while adherent patch 342 is positioned at fourth location 324 , skin at third location 334 can heal and recover from adherent coverage of the third patch. In many embodiments, the duration between removal of one patch and placement of the other patch can be short, such that any differences between the signals may be assumed to be related to placement of the patch, and these differences can be removed with signal processing.
- FIGS. 3A to 3D provide a particular method of monitoring a patient for an extended period, according to an embodiment of the present invention.
- Other sequences of steps may also be performed according to alternative embodiments.
- alternative embodiments of the present invention may perform the steps outlined above in a different order.
- the individual steps illustrated in FIGS. 3A to 3D may include multiple sub-steps that may be performed in various sequences as appropriate to the individual step.
- additional steps may be added or removed depending on the particular applications.
- One of ordinary skill in the art would recognize many variations, modifications, and alternatives.
- FIG. 4A shows a monitoring system 400 comprising an adherent device 410 to measure an impedance signal and an electrocardiogram signal.
- Device 410 may comprise wireless communication circuitry, accelerometer sensors and/or circuitry and many sensors and electronics components and structures as described above.
- Adherent device 410 comprises at least four electrodes.
- the at least four electrodes comprises four electrodes, for example a first electrode 412 A, a second electrode 412 B, a third electrode 412 C and a fourth electrode 412 D.
- Work in relation to embodiments of the present invention suggests that embodiments in which the at least four electrodes comprises four electrodes can decrease a footprint, or size, of the device on the patient and may provide improved patient comfort.
- first electrode 412 A and fourth electrode 412 D comprise outer electrodes
- second electrode 412 B and third electrode 412 C comprise inner electrodes, for example in embodiments where the electrodes are arranged in an elongate pattern.
- Adherent device 410 comprises impedance circuitry 420 that can be used to measure hydration and respiration of the patient, and ECG circuitry 430 that is used to measure an electrocardiogram signal of the patient.
- Impedance circuitry 420 comprises force circuitry connected to the outer electrodes to drive a current between the electrodes.
- Impedance circuitry 420 comprises sense circuitry to measure a voltage between the inner electrodes resulting from the current passed between the outer force electrodes, such that the impedance of the tissue can be determined.
- Impedance circuitry 420 may comprise known 4-pole, or quadrature, low power circuitry.
- ECG circuitry 430 can be connected to the outer electrodes, or force electrodes, to measure an ECG signal.
- ECG circuitry 430 may comprise known ECG circuitry and components, for example low power instrumentation and/or operational amplifiers.
- electronic switch 432 A and electronic switch 432 D are connected in series between impedance circuitry 420 and electrode 412 A and 412 D, respectively. In many embodiments, electronic switch 432 A and electronic switch 432 D open such that the outer electrodes can be isolated from the impedance circuitry when the ECG circuitry measures ECG signals. When electronic switch 432 A and electronic switch 432 D are closed, impedance circuitry 420 can force electrical current through the outer electrodes to measure impedance. In many embodiments, electronic switch 432 A and electronic switch 432 D can be located in the same packaging, and may comprise CMOS, precision, analog switches with low power consumption, low leakage currents, and fast switching speeds.
- a processor 440 can be connected to electronic switch 423 A, electronic switch 432 D, impedance circuitry 420 and ECG circuitry 430 to control measurement of the ECG and impedance signals.
- Processor 430 comprises a tangible medium, for example read only memory (ROM), electrically erasable programmable read only memory (EEPROM) and/or random access memory (RAM).
- processor 440 controls the measurements such that the measurements from impedance circuitry 420 and ECG circuitry 430 are time division multiplexed in response to control signals from processor 440 .
- FIG. 4B shows a method 450 of measuring the impedance signal and the electrocardiogram signal with processor 440 .
- a step 452 closes the switches.
- a step 454 drives the force electrodes.
- a step 456 measures the impedance signal with the inner electrodes.
- a step 458 determines the impedance, hydration and/or respiration from the impedance signal.
- a step 460 opens the switches.
- a step 462 measures the ECG signal with the outer electrodes.
- a step 464 stores the data from the impedance signals and ECG signals.
- a step 466 processes the data.
- a step 468 transmits the data, for example wirelessly to the remove center.
- a step 470 repeats the above steps.
- FIG. 4B provides a particular method of measuring signals, according to an embodiment of the present invention.
- Other sequences of steps may also be performed according to alternative embodiments.
- alternative embodiments of the present invention may perform the steps outlined above in a different order.
- the individual steps illustrated in FIG. 4B may include multiple sub-steps that may be performed in various sequences as appropriate to the individual step.
- additional steps may be added or removed depending on the particular applications.
- One of ordinary skill in the art would recognize many variations, modifications, and alternatives.
- FIG. 5A shows a method 500 for monitoring a patient and responding to a signal event.
- a step 501 activates a processor system.
- a step 503 calculates a risk of sudden cardiac death.
- a step 506 reports to a remote center and/or physician.
- a step 509 combines at least two of the electrocardiogram signal, respiration signal, and/or activity signals.
- a step 512 detects an adverse cardiac event.
- An adverse cardiac event may comprise an atrial fibrillation in response to the electrocardiogram signal and/or an acute myocardial infarction in response to an ST segment elevation of the electrocardiogram signal.
- a step 515 triggers an alarm.
- a step 518 continuously monitors and stores in tangible media at least two of the electrocardiogram signal, the respiration signal, or the activity signal.
- a step may also comprise monitoring a high risk patent post myocardial infarction with the at least two of the electrocardiogram signal, the respiration signal or the activity signal, and/or a bradycardia of the patient at risk for sudden death.
- the electrocardiogram signal may comprise at least one of a Brugada Syndrome with an ST elevation and a short QT interval or long-QT interval.
- a step 521 loop records the aforementioned data.
- a step 524 determines a tiered response.
- the tiered response may comprise tiers, or levels, appropriate to the detected status of the patient.
- a step 527 comprises a first tier response which alerts an emergency responder.
- a step 530 comprises a second tier response which alerts a physician.
- a step 533 comprises a third tier response which alerts a patient, family, or caregiver.
- a step 537 comprises a fourth tier response which alerts a remote center.
- a tiered response may also comprise of wirelessly transmitting the at least two of the electro cardiogram signal, the respiration signal, or the activity signal with a single wireless hop from a wireless communication circuitry to an intermediate device.
- the signals can be combined in many ways. In some embodiments, the signals can be used simultaneously to determine the impending cardiac decompensation.
- the signals can be combined by using the at least two of the electrocardiogram signal, the respiration signal or the activity signal to look up a value in a previously existing array.
- Table 1 shows combination of the electrocardiogram signal with the respiration signal to look up a value in a pre-existing array. For example, at a heart rate in the range from A to B bpm and a respiration rate in the range from U to V per minute triggers a response of N.
- the values in the table may comprise a tier or level of the response, for example four tiers.
- the values of the look up table can be determined in response to empirical data measured for a patient population of at least about 100 patients, for example measurements on about 1000 to 10,000 patients.
- the look up table shown in Table 1 illustrates the use of a look up table according to one embodiment, and one will recognize that many variables can be combined with a look up table.
- the table may comprise a three or more dimensional look up table, and the look up table may comprises a tier, or level, of the response, for example an alarm.
- the signals may be combined with at least one of adding, subtracting, multiplying, scaling or dividing the at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- the measurement signals can be combined with positive and or negative coefficients determined in response to empirical data measured for a patient population of at least about 100 patients, for example data on about 1000 to 10,000 patients.
- a weighted combination may combine at least two measurement signals to generate an output value according to a formula of the general form
- a and b comprise positive or negative coefficients determined from empirical data and X, and Z comprise measured signals for the patient, for example at least two of the electrocardiogram signal, the respiration signal or the activity signal. While two coefficients and two variables are shown, the data may be combined with multiplication and/or division. One or more of the variables may be the inverse of a measured variable.
- the ECG signal comprises a heart rate signal that can be divided by the activity signal. Work in relation to embodiments of the present invention suggest that an increase in heart rate with a decrease in activity can indicate an impending decompensation.
- the signals can be combined to generate an output value with an equation of the general form
- X comprise a heart rate signal
- Y comprises an activity signal
- Z comprises a respiration signal
- the data may be combined with a tiered combination. While many tiered combinations can be used a tiered combination with three measurement signals can be expressed as
- ( ⁇ X), ( ⁇ Y), ( ⁇ Z) may comprise change in heart rate signal from baseline, change in respiration signal from baseline and change in activity signal from baseline, and each may have a value of zero or one, based on the values of the signals. For example if the heart rate increase by 10%, ( ⁇ X) can be assigned a value of 1. If respiration increases by 5%, ( ⁇ Y) can be assigned a value of 1. If activity decreases below 10% of a baseline value ( ⁇ Z) can be assigned a value of 1. When the output signal is three, a flag may be set to trigger an alarm.
- the data may be combined with a logic gated combination. While many logic gated combinations can be used, a logic gated combination with three measurement signals can be expressed as
- ( ⁇ X), ( ⁇ Y), ( ⁇ Z) may comprise change in heart rate signal from baseline, change in respiration signal from baseline and change in activity signal from baseline, and each may have a value of zero or one, based on the values of the signals. For example if the heart rate increase by 10%, ( ⁇ X) can be assigned a value of 1. If respiration increases by 5%, ( ⁇ Y) can be assigned a value of 1. If activity decreases below 10% of a baseline value ( ⁇ Z) can be assigned a value of 1. When each of ( ⁇ X), ( ⁇ Y), ( ⁇ Z) is one, the output signal is one, and a flag may be set to trigger an alarm.
- the output signal is zero and a flag may be set so as not to trigger an alarm. While a specific example with AND gates has been shown the data can be combined in may ways with known gates for example NAND, NOR, OR, NOT, XOR, XNOR gates. In some embodiments, the gated logic may be embodied in a truth table.
- the processor system performs the methods 500 , including many of the steps described above. It should be appreciated that the specific steps illustrated in FIG. 5A provide a particular method of monitoring a patient and responding to a signal event, according to an embodiment of the present invention. Other sequences of steps may also be performed according to alternative embodiments. For example, alternative embodiments of the present invention may perform the steps outlined above in a different order. Moreover, the individual steps illustrated in FIG. 5A may include multiple sub-steps that may be performed in various sequences as appropriate to the individual step. Furthermore, additional steps may be added or removed depending on the particular applications. One of ordinary skill in the art would recognize many variations, modifications, and alternatives.
- the protocol below has been used to measure signals from actual patients with an adherent device. These data show that an adherent patch as described above can be continuously adhered for at least one week. These data also show that 90 day continuous in home monitoring can be achieved with a set of 13 patches in which one of the patches is replaced each week.
- the clinical testing device used an adherent device with modifications, as described more fully below and referred to as the MS system (multi-sensor). Although the clinical device did not include wireless circuitry and processor circuitry supported with the patch adhered to the skin of the patient, these data do show that such a device, as described above, can be made by one of ordinary skill in the art based on the teachings described herein. Additional empirical studies can be conducted on a suitable number of patients.
- the MS clinical system includes many of the structure components described above. There is a flexible connection between the electrodes and the flex PCB, for example wires or polyurethane with silver ink.
- the cover can stretch with the breathable tape on both the clinical device and the above described wireless device. There is generally a gap between the flex PCB and breathable tape in both clinical and above described wireless devices.
- the tested device used weights to at least partially simulate the weight of wireless and processor circuitry.
- the adherent device of the MS clinical system comprises four electrodes to measure bioimpedance and ECG signals and a 3-axis accelerometer, as described above. Bioimpedance signals were used to determine patient respiration and patient hydration, and accelerometer signals were used to determine patient activity and posture.
- the MS clinical adherent patch device comprising the sensors and at least some sensor circuitry were connected to a processor to record data.
- the processor was connected to the tested adherent device with wires and supported away from the tested adherent patch device, for example around the patient's waist. Data were collected at regular intervals and uploaded to a remote site, as described above.
- Clinical testing of the MS clinical system shows the effectiveness of the structures for continuous adherence of at least one week and data collection, and that patches can be successively removed and replaced by the patient for in-home monitoring. This effectiveness has been shown without requiring fully functional electronics circuitry such as a battery, wireless circuitry and process circuitry on the adherent device.
- the MS system includes an insert with about 20 g of additional weight. Although an insert with a 20 gram weight was used for the MS clinical device, greater amounts of weight and circuitry can be used, for example about 30-50 g.
- the patch device may be modified to accommodate additional weight, for example by increasing the size of the adherent surface.
- the shape of the MS clinical patch is generally elongate, similar to the elongate shape shown above.
- the MS System is used in a clinical study of heart failure patients to gather data that can be used to develop an algorithm for diagnosing and predicting impending heart failure decompensation events. Events typically manifest as heart failure-related hospitalization, emergency room or urgent care visits leading to a change in oral or IV diuretic treatment.
- AHFD events are defined as any of the following:
- a change in diuretic defined as a change in diuretic directed by the health care provider occurring inside a hospital, emergency room, or urgent care setting (i.e. no patient self-directed changes to medications not approved by a health care provider would be included), that satisfies one or more of the following: a) a change in the type of diuretic the patient is taking, b) a dose increase of an existing diuretic, or c) the addition of another diuretic.
- the study can enroll at least about 550 patients.
- the patient was provided with a kit comprising 13 patches for replacement. The patches were placed on alternating left and right sides of the patient's thorax, as described above, to minimize progressive irritation.
- the data collected in the study can be used to develop an algorithm to at least one of detect, diagnose or predict an impending cardiac decompensation.
- the algorithm can be implemented on a processor system as described above. Known methods can be used to analyze the data, for example splitting the patients into two groups, one to develop parameters for the algorithm and a second group to test the algorithm developed with the first group.
- the signal of the algorithm may comprise a simple binary output for impending cardiac decompensation of the patient.
- the logic output yes or no, can be determined in response to patient data combined as described above.
- the logic output may comprise a signal, such as a binary Y or N signal.
- the developed algorithm can be evaluated with composite sensitivity and false positive patient signal status rates.
- the sensitivity may be defined as the percent of true positive events out of all condition present events, and the false positive patient status signal status rate can be defined as the number of false positive patient status signals per patient-years of follow up.
- the sensitivity can be at least 50%, for example at least 60%, at least 70%, or even at least 80%.
- the false positive patient signal status rate may be limited to no more than about 1.1 false positive patient status signals per patient year, for example no more than about 1.0 false positive patient status signals per patient year, no more than about 0.9 false positive patient status signals per patient year, and even no more than about 0.8 false positive patient status signals per patient year.
- Clinical data are available for the first 180 patients enrolled in the study.
- FIGS. 6A and 6B show clinical data measured with an adherent patch device, in accordance with the above protocol.
- FIG. 6A shows data from a patient with the MS patch adhered to a first patient, and the data was acquired over the 90 day period with the series of 13 patches. The signals measured included Heart Rate (beats per minute), Heart Rate Variability (ms), Respiratory Rate (breaths per minute), Activity (m-G's) and Body Fluid (Ohms).
- FIG. 6B shows data from a second patient similar to FIG. 6A .
- the wireless adherent patch device can be constructed for in home wireless patient monitoring for an extended period of at least 90 day, in which each patch of a set is continuously adhered to a patient for at least one week and each patch is configured to support the measurement circuitry, the processor, the wireless communication circuitry and the battery with the skin of the patient.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Hematology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Dermatology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
- The present application claims the benefit under 35 USC 119(e) of U.S. Provisional Application No. 60/972,537 and 60/972,629 both filed Sep. 14, 2007, and 61/055,645 and 61/055,666 both filed May 23, 2008; the full disclosures of which are incorporated herein by reference in their entirety.
- The subject matter of the present application is related to the following applications: 60/972,512; 60/972,329; 60/972,354; 60/972,616; 60/972,363; 60/972,343; 60/972,581; 60/972,316; 60/972,333; 60/972,359; 60/972,336; 60/972,340 all of which were filed on Sep. 14, 2007; 61/046,196 filed Apr. 18, 2008; 61/047,875 filed Apr. 25, 2008; 61/055,656 and 61/055,662 both filed May 23, 2008; and 61/079,746 filed Jul. 10, 2008. The following applications are being filed concurrently with the present application, on Sep. 12, 2008: Attorney Docket Nos. 026843-000110US entitled “Multi-Sensor Patient Monitor to Detect Impending Cardiac Decompensation Prediction”; 026843-000410US entitled “Injectable Device for Physiological Monitoring”; 026843-000510US entitled “Delivery System for Injectable Physiological Monitoring System”; 026843-000620US entitled “Adherent Device for Cardiac Rhythm Management”; 026843-000710US entitled “Adherent Device for Respiratory Monitoring”; 026843-0008110US entitled “Adherent Athletic Monitor”; 026843-000910US entitled “Adherent Emergency Monitor”; 026843-001320US entitled “Adherent Device with Physiological Sensors”; 026843-001410US entitled “Medical Device Automatic Start-up upon Contact to Patient Tissue”; 026843-001900US entitled “System and Methods for Wireless Body Fluid Monitoring”; 026843-002010US entitled “Adherent Cardiac Monitor with Advanced Sensing Capabilities”; 026843-002410US entitled “Adherent Device for Sleep Disordered Breathing”; 026843-002710US entitled “Dynamic Pairing of Patients to Data Collection Gateways”; 026843-003010US entitled “Adherent Multi-Sensor Device with Implantable Device Communications Capabilities”; 026843-003110US entitled “Data Collection in a Multi-Sensor Patient Monitor”; 026843-003210US entitled “Adherent Multi-Sensor Device with Empathic Monitoring”; 026843-003310US entitled “Energy Management for Adherent Patient Monitor”; and 026843-003410US entitled “Tracking and Security for Adherent Patient Monitor.”
- 1. Field of the Invention
- The present invention relates to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to many applications in which physiological monitoring is used, for example wireless physiological monitoring for extended periods.
- Patients are often treated for diseases and/or conditions associated with a compromised status of the patient, for example a compromised physiologic status. In some instances, a patient may report symptoms that require diagnosis to determine the underlying cause. For example, a patient may report fainting or dizziness that requires diagnosis, in which long term monitoring of the patient can provide useful information as to the physiologic status of the patient. In some instances a patient may have suffered a heart attack and require care and/or monitoring after release from the hospital. One example of a device to provide long term monitoring of a patient is the Holter monitor, or ambulatory electrocardiography device.
- In addition to measuring heart signals with electrocardiograms, known physiologic measurements include impedance measurements. For example, transthoracic impedance measurements can be used to measure hydration and respiration. Although transthoracic measurements can be useful, such measurements may use electrodes that are positioned across the midline of the patient, and may be somewhat uncomfortable and/or cumbersome for the patient to wear.
- Work in relation to embodiments of the present invention suggests that known methods and apparatus for long term monitoring of patients may be less than ideal. At least some of the known devices may not collect the right kinds of data to treat patients optimally. For example, although successful at detecting and storing electrocardiogram signals, devices such as the Holter monitor can be somewhat bulky and may not collect all of the kinds of data that would be ideal to diagnose and/or treat a patient. In at least some instances, devices that are worn by the patient may be somewhat uncomfortable, which may lead to patients not wearing the devices and not complying with direction from the health care provider, such that data collected may be less than ideal. Although implantable devices may be used in some instances, many of these devices can be invasive and/or costly, and may suffer at least some of the shortcomings of known wearable devices.
- Therefore, a need exists for improved patient monitoring. Ideally, such improved patient monitoring would avoid at least some of the short-comings of the present methods and devices.
- 2. Description of Background Art
- The following U.S. patents and Publications may describe relevant background art: U.S. Pat. Nos. 3,370,459; 3,805,769; 3,845,757; 3,972,329; 4,121,573; 4,141,366; 4,838,273; 4,955,381; 4,981,139; 5,080,099; 5,353,793; 5,511,553; 5,544,661; 5,558,638; 5,724,025; 5,772,586; 5,862,802; 6,047,203; 6,117,077; 6,129,744; 6,225,901; 6,385,473; 6,416,471; 6,454,707; 6,527,711; 6,527,729; 6,551,252; 6,595,927; 6,595,929; 6,605,038; 6,645,153; 6,795,722; 6,821,249; 6,980,851; 7,020,508; 7,054,679; 7,153,262; 2003/0092975; 2005/0113703; 2005/0131288; 2006/0010090; 2006/0031102; 2006/0089679; 2006/0155183; 2006/122474; 2006/0224051; 2006/0264730; 2007/0021678; and 2007/0038038.
- The present invention relates to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to any application in which physiological monitoring is used, for example wireless physiological monitoring for extended periods.
- In a first aspect, embodiments of the present invention provide an adherent device to monitor a patient. The device comprises an adhesive patch to adhere to a skin of the patient. At least four electrodes are connected to the patch and capable of electrically coupling to the patient. Impedance circuitry can be coupled to the at least four electrodes to measure a hydration signal of the patient. Electrocardiogram circuitry can be coupled to at least two of the at least four electrodes to measure an electrocardiogram signal of the patient. An accelerometer can be mechanically coupled, for exampled adhered or affixed, to the adhesive patch to generate an accelerometer signal in response to at least one of an activity or a position of the patient. Work in relation to embodiments of the present invention suggests accelerometer signals can improve patient diagnosis, and can be especially useful when used with other signals, such as electrocardiogram signals and impedance signals for hydration and respiration. Mechanically coupling the accelerometer to the electrodes for measuring impedance and hydration may also improve the quality and/or usefulness of the impedance and/or electrocardiogram signals. For example, mechanical coupling of the accelerometer to the electrodes and to the skin of the patient can improve the reliability, quality and/or accuracy of the accelerometer measurements, as the electrode signals can indicate the quality of mechanical coupling of the patch to the patient so as to indicate that the device is connected to the patient and that the accelerometer signals are valid. In some embodiments, the adherent device may comprise a dimension across that is no more than about 8 inches, such that the device can be comfortably worn by at least some patients for an extended period to permit collection of the electrocardiogram, impedance and accelerometer signals for extended periods.
- In many embodiments, the adhesive patch is mechanically coupled to the at least four electrodes, the impedance circuitry, the electrocardiogram circuitry and the accelerometer, such that the patch is capable of supporting the at least four electrodes, the impedance circuitry, the electrocardiogram circuitry and the accelerometer when the adherent patch is adhered to the skin of the patient.
- In many embodiments, a wireless communication circuitry is coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a communication protocol at least one of the hydration signal, the electrocardiogram signal or the accelerometer signal. The wireless communication circuitry can be configured to transmit the hydration signal, the electrocardiogram signal and the accelerometer signal to the remote center with a single wireless hop from the wireless communication circuitry to an intermediate device. In specific embodiments, the communication protocol can comprise at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, a cellular protocol, amplitude modulation or frequency modulation. In many embodiments, the intermediate device comprises a data collection system to collect and/or store data from the wireless transmitter, and the data collection system can be configured to communicate periodically with the remote center with wireless communication and/or wired communication. The communications protocol may comprise a two way protocol such that the remote center is capable of issuing commands to control data collection
- The adherent device may comprise many sensors configured to measure many different signals. In many embodiments, the accelerometer comprises at least one of a piezoelectric accelerometer, capacitive accelerometer or electromechanical accelerometer and wherein the accelerometer comprises a 3-axis accelerometer to measure at least one of an inclination, a position, an orientation or acceleration of the patient in three dimensions. The impedance circuitry can be adapted to measure extracellular fluid of the patient with at least one frequency within a range from about 0.5 kHz to about 200 kHz., and the impedance circuitry is configured to determine a respiration of the patient. The device may comprise a microphone to detect an audio signal from within the patient, and the audio signal may comprise a heart sound with an S3 heart sound and/or a respiratory sound with rales and/or crackles. The device may comprise a temperature sensor to measure a temperature of the patient. Work in relation to embodiments of the present invention suggest that patient temperature may effect impedance measurements, such that the impedance measurements can be corrected with the temperature measurement.
- In many embodiments, the adherent device comprises a processor comprising a tangible medium, and the processor is configured to control a collection and transmission of data from the impedance circuitry, the electrocardiogram circuitry and the accelerometer. The adherent device may comprise a real time clock and a frequency generator.
- In another aspect, embodiments of the present invention provide a method of monitoring a patient. An adhesive patch is adhered to a skin of the patient to couple at least four electrodes to the skin of the patient. A hydration signal of the patient is measured with impedance circuitry coupled to the at least four electrodes. An electrocardiogram signal of the patient is measured with electrocardiogram circuitry coupled to at least two of the at least four electrodes. A signal from an accelerometer is measured in response to at least one of an activity or a position of the patient.
- In many embodiments, the adhesive patch supports the at least four electrodes, the impedance circuitry, the electrocardiogram circuitry and the accelerometer when the adherent patch is adhered to the skin of the patient.
- In another aspect, embodiments of the present invention provide an adherent device to monitor a patient. The adherent device comprises an adhesive patch to adhere to a skin of the patient. At least four electrodes are affixed to the patch and capable of electrically coupling to the patient. A maximum dimension across the at least 4 electrodes may comprise no more that about eight inches, such that the at least four electrodes are capable of adhering to either a left side or a right side of the patient. Impedance circuitry may be coupled to the at least four electrodes to measure hydration of the patient. Electrocardiogram circuitry may be coupled to at least two of the at least four electrodes to measure an electrocardiogram of the patient.
- In many embodiments, the maximum distance across the at least four electrodes comprises no more than about six inches. The device comprises a maximum dimension across no more than about 8 inches, and the patch is capable of measuring the electrocardiogram and the impedance from a left side or a right side of the patient.
- In another aspect, an adherent device to monitor a patient for an extended period is provided. The device comprises a breathable tape comprising an adhesive coating to adhere the breathable tape to a skin of the patient, such that tape and device may be comfortable when worn by the patient. The breathable tape may comprise a porous material, for example a porous fabric, to allow transmission of water vapor while the device is worn by the patient. At least one electrode is affixed to the breathable tape and capable of electrically coupling to a skin of the patient. At least one gel can be disposed over a contact surface of the at least one electrode to electrically connect the electrode to the skin. A printed circuit board, for example, a flex printed circuit board, can be connected to the breathable tape to support the printed circuit board with the breathable tape when the tape is adhered to the patient. Electronic components may be electrically connected to the printed circuit board and coupled to the at least one electrode to measure physiologic signals of the patient. A breathable cover, which may be water resistant, can be disposed over the circuit board and electronic components and connected to at least one of the electronics components, the printed circuit board or the breathable tape.
- In many embodiments, an electronics housing is adhered to at least one of the electronics circuitry or the printed circuit board, such that the electronics housing is disposed between the cover and the electronics components.
- In many embodiments, a gel cover is positioned over a breathable tape to inhibit a flow of the gel through the breathable tape. The printed circuit board, for example a flex printed circuit board, may be located over the gel cover such that the gel cover is disposed between the breathable tape and the printed circuit board.
- In many embodiments, the breathable tape comprises a first porosity, and the gel cover comprises a breathable tape with a second porosity, in which the second porosity is less than the first porosity to inhibit flow of the gel through the breathable tape. In specific embodiments, the breathable tape comprises a tricot-knit polyester fabric backing with an acrylate adhesive coating, and the gel cover comprises a polyurethane, non-woven backing with an acrylate adhesive coating.
- In many embodiments, the breathable tape, the adhesive coating, the at least one electrode and gel coating are separable from the printed circuit board, electronic components, and water resistant housing and cover, such that the printed circuit board, electronic components, water resistant housing and water proof cover are reusable.
- In many embodiments, the at least one electrode extends through at least one aperture in the breathable tape. In some embodiments, the at least one electrode is configured to electrically couple to the printed circuit board through the breathable tape.
- In another aspect, embodiments of the present invention provide a method of monitoring a patient for an extended period. An electronics module is attached to a first adherent patch component of a plurality of adherent patch components. The first adherent patch component is adhered to a skin of the patient. The electronics module is removed from the first adherent patch component. The electronics module is attached to a second patch component of the plurality of patch components after the first adherent patch component has been removed.
- In many embodiments, the electronics module is removed from the second adherent patch component, and the electronics module is attached to a third patch component of the plurality of patch components after the second adherent patch component has been removed.
- In many embodiments, impedance signals are measured when the third adherent patch component is adhered to the patient.
- In another aspect, embodiments of the present invention provide a system to monitor a patient for an extended period. The system comprise a plurality of adherent patch components. An electronics module may be adapted to couple to each of the plurality of patch components for sequential measurements from each of the patch components.
- In many embodiments, each of the plurality of adherent patch components comprises, a breathable tape with an adhesive coating to adhere the breathable tape to a skin of the patient, and at least one electrode affixed to the breathable tape.
- In many embodiments, the electronics module comprises a printed circuit board configured to connect electrically to the at least one electrode to measure physiologic signals of the patient, electronic components electrically connected to the printed circuit board, and a housing adhered to at least one of the electronics module or the printed circuit board.
- In another aspect, embodiments of the present invention provide a method of monitoring a patient for an extended period of time. A first adherent patch is adhered on a first side of the patient, in which the first adherent patch comprises first electrodes to measure at least one of an electrocardiogram or an impedance. The at least one of the electrocardiogram or the impedance is measured from the first side of the patient for a first period of time. The first patch is removed from the first side of the patient. A second adherent patch is placed on a second side of the patient, in which the second adherent patch comprises second electrodes to measure the at least one of the electrocardiogram or the impedance. The at least one of the electrocardiogram or the impedance is measured from the second side of the patient for a second period of time after the first patch has been removed.
- In many embodiments, the first side comprises at least one of a left side or a right side of the patient, and the second side is opposite the first side.
- In many embodiments, the second patch is removed from the second side of the patient, and a third adherent patch is placed on the first side of the patient, in which the third patch comprises third electrodes to measure the at least one of the electrocardiogram or the impedance. The at least one of the electrocardiogram or the impedance is measured from the first side of the patient for a third period of time after the second patch has been removed.
- In many embodiments, the third patch is removed from the first side of the patient. A fourth adherent patch is placed on the second side of the patient, in which the fourth patch comprising fourth electrodes to measure the at least one of the electrocardiogram or the impedance. The at least one of the electrocardiogram or the impedance is measured from the second side of the patient for a fourth period of time after the third patch has been removed.
- In specific embodiments, each of the first period of time, the second period of time, the third period of time and the fourth period of time comprises at least about 1 week.
- In another aspect, embodiments of the present invention provide a method of monitoring a patient for an extended period of time. A first adherent patch is placed on a skin location on a first side of the patient, in which the first adherent patch comprises first electrodes to measure at least one of an electrocardiogram or an impedance. The at least one of the electrocardiogram or the impedance is measured from the first adherent patch on the first skin location for a first period of time. The first patch is removed from the first skin location. A second adherent patch is placed on a second skin location on a second side of the patient, in which the second adherent patch comprises second electrodes to measure the at least one of the electrocardiogram or the impedance. The at least one of the electrocardiogram or the impedance is measured from the second skin location for a second period of time after the first patch has been removed.
- In many embodiments, the first skin location heals during the second period of time.
- In another aspect, embodiments of the present invention provide an adherent device to monitor a patient. The device comprises an adhesive patch to adhere to a skin of the patient. At least four electrodes are mechanically coupled to the patch and capable of electrically coupling to the patient. The at least four electrodes may comprise at least two force electrodes and at least two sense electrodes. Impedance circuitry may be electrically coupled to the at least two force electrodes to force an electrical current and to the at least two sense electrodes to measure a hydration signal of the patient. Electrocardiogram circuitry can be coupled to the at least two force electrodes to measure an electrocardiogram signal of the patient.
- In many embodiments, the adherent device comprises electrical switches connected to the at least two force electrodes to isolate the at least two force electrodes from the impedance circuitry when the electrocardiogram circuitry measures the electrocardiogram. In specific embodiments, a processor an be configured to control the impedance circuitry and the electrocardiogram circuitry so as to time division multiplex collection the hydration signal and the electrocardiogram signal. The processor may be configured to decouple the at least two force electrodes from the impedance circuitry when the electrocardiogram circuitry measures the electrocardiogram signal.
- In many embodiments, the at least four electrodes comprise no more than four electrodes.
- In some embodiments, the at least two force electrodes comprise outer electrodes and the at least two sense electrodes comprise inner electrodes.
- In some embodiments, the at least two force electrodes comprise inner electrodes and the at least two sense electrodes comprise outer electrodes.
- In another aspect, embodiments of the present invention provide a method of monitoring a patient. An adhesive patch is adhered to a skin of the patient so as to couple at least four electrodes to the skin of the patient, in which the at least four electrodes comprise at least two force electrodes and at least two sense electrodes. A hydration signal of the patient is measured with impedance circuitry electrically coupled to the at least two force electrodes and to the at least two sense electrodes, such that the at least two force electrodes force an electrical current between the at least two force electrodes. An electrocardiogram signal of the patient is measured with electrocardiogram circuitry coupled to the at least two force electrodes.
- In many embodiments, electrical switches connected to the at least two force electrodes can be opened to isolate the at least two force electrodes from the impedance circuitry when the electrocardiogram circuitry measures the electrocardiogram.
- In many embodiments, the hydration signal and the electrocardiogram signal can be time division multiplexed.
- In another aspect, embodiments of the present inventions provide an adherent device to monitor a patient. The device comprises an adhesive patch and at least two electrodes connected to the patch. The device also comprises circuitry coupled to at least two electrodes to measure at least two of an electrocardiogram signal, a respiration signal of the patient or an activity signal of the patient, and a processor system. The adhesive patch can adhere to a skin of the patient. The electrodes are capable of electrically coupling to the patient. The processor system comprises a tangible medium configured to trigger an alarm in response to the at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- In many embodiments, the processor system comprises a first processor and a second processor. The first processor may comprise a tangible medium attached to the adherent patch. The second processor may comprise a tangible medium at a remote center.
- In many embodiments, the processor system is configured to combine at least two of the electrocardiogram signal, the respiration signal or the activity signal, the purpose of which may be to detect an impending cardiac decompensation. Combining may comprise at least one of adding, subtracting, multiplying, scaling, or dividing the at least two of the electrocardiogram signal, the hydration signal, the respiration signal, or the activity signal. In some embodiments, the at least two of the electrocardiogram signal, the respiration signal, or the activity signal can be combined with at least one of a weighted combination, a tiered combination, or a logic gated combination, a time weighted combination or a rate of change.
- In many embodiments, the processor system is configured to continuously monitor, store in tangible media, and transmit to a remote center at least two of the electrocardiogram signal, the respiration signal or the activity signal when the alarm is triggered.
- In many embodiments, the processor system is configured to trigger the alarm and alert the patient and/or the physician in response to an adverse cardiac event.
- In many embodiments, the processor system is configured to calculate and report a patient risk of sudden cardiac death to at least one of a remote center or a physician.
- In many embodiments, the processor system is configured to detect at least one of a T-wave alternans, a pulsus alternans, an autonomic imbalance, a heart rate variability in response to at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- In many embodiments, the processor system is configured to loop record at least two of the electrocardiogram signal, the respiration signal or the activity signal for diagnosis of an unexplained syncope and/or arrhythmia when the alarm is triggered.
- In many embodiments, the processor system is configured to detect an event comprising at least one of an atrial fibrillation in response to the electrocardiogram signal or an acute myocardial infarction in response to an ST segment elevation of the electrocardiogram signal.
- In many embodiments, the processor system is configured to monitor a high risk patient post myocardial infarction with at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- In many embodiments, the processor system is configured to continuously monitor a bradycardia of the patient at risk for sudden death, the electrocardiogram signal comprising at least one of a Brugada Syndrome with an ST elevation and a short QT interval or long-QT interval.
- In many embodiments, the processor system is configured to monitor the electrocardiogram signal and an alert at least one of a patient, a remote center a physician, emergency responder, or family/caregiver in response to an adverse event.
- In many embodiments, the processor system is configured to determine a tiered response to at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- In some embodiments, the tiered response may comprise a first tier to contact an emergency responder in response to an immediate life threatening event, a second tier to contact a physician in response to an event that requires medical care, a third tier to contact a family member and/or care giver, and a fourth tier to contact the center.
- In some embodiments, the immediate life threatening event comprises at least one of a sustained ventricular tachycardia, a sustained ventricular fibrillation, an asystole, an arrhythmia with no respiration or an arrhythmia with no patient movement.
- In some embodiments, the event that requires medical care comprises an atrial fibrillation that is not immediately life threatening.
- In some embodiments, the wireless communication circuitry is configured to transmit at least two of the electrocardiogram signal, the respiration signal or the activity signal with a single wireless hop from the wireless communication circuitry to an intermediate device.
- In another aspect, embodiments of the present invention provides a method of monitoring a patient. An adhesive patch is adhered to a skin of the patient so as to couple at least two electrodes to the skin of the patient. Circuitry coupled to the at least two electrodes measures at least two of an electrocardiogram signal of the patient, a respiration signal of the patient or an activity signal of the patient. An alarm may be triggered by a processor system in response to the at least two of the electrocardiogram signal, the respiration signal or the activity signal with the processor system comprising a tangible medium.
- In many embodiments, the processor system comprises a first processor and a second processor. The first processor comprises a tangible medium attached to the adherent patch and the second processor comprises a tangible medium at a remote center.
- In many embodiments, at least two of the electrocardiogram signal, the respiration signal, or the activity signal are combined, which may be to detect am impending cardiac decompensation. In some embodiments, combining may comprise at least one of adding, subtracting, multiplying, scaling or dividing the at least two of the electrocardiogram signal, the hydration signal, the respiration signal or the activity signal. In some embodiments, the at least two of the electrocardiogram signal, the respiration signal, or the activity signal can be combined with at least one of a weighted combination, a tiered combination, or a logic gated combination, a time weighted combination or a rate of change.
- In many embodiments, at least two of the electrocardiogram signal, the respiration signal, or the activity signal are continuously monitored, stored, and/or transmitted to a remote center.
- In many embodiments, the alarm is triggered and the patient and/or the physician is alerted in response to an adverse cardiac event.
- In many embodiments, a patient risk of sudden cardiac death is calculated and/or reported to at least one of a remote center or a physician.
- In many embodiments, at least one of a T-wave alternans, a pulsus alternans, an autonomic imbalance, a heart rate variability in response to the at least two of the electrocardiogram signal, the respiration signal or the activity signal is detected.
- In many embodiments, the at least two of the electrocardiogram signal, the respiration signal or the activity signal is loop recorded when the alarm is triggered.
- In many embodiments, an event comprising at least one of an atrial fibrillation in response to the electrocardiogram signal or an acute myocardial infarction in response to an ST segment elevation of the electrocardiogram signal is detected.
- In many embodiments, a high risk patent post myocardial infarction is monitored with the at least two of the electrocardiogram signal, the respiration signal or the activity signal.
- In many embodiments, a bradycardia of the patient at risk for sudden death, the electrocardiogram signal comprising at least one of a Brugada Syndrome with an ST elevation and a short QT interval or long-QT interval are continuously monitored.
- In many embodiments, the electrocardiogram signal is monitored and/or at least one of a patient, a remote center, a physician, emergency responder, or family/caregiver is alerted in response to an adverse event.
- In many embodiments, a tiered response to the at least two of the electrocardiogram signal, the respiration signal or the activity signal is determined.
- In many embodiments, the tiered response comprises a first tier to contact an emergency responder in response to an immediate life threatening event, a second tier to contact a physician in response to an event that requires medical care, a third tier to contact a family member and/or care giver, and a fourth tier to contact the center.
- In many embodiments, the immediate life threatening event comprises at least one of a sustained ventricular tachycardia, a sustained ventricular fibrillation, an asystole, an arrhythmia with no respiration or an arrhythmia with no patient movement.
- In many embodiments, the event that requires medical care comprises an atrial fibrillation that is not immediately life threatening.
- In some embodiments, wireless communication circuitry transmits the at least two of the electrocardiogram signal, the respiration signal or the activity signal with a single wireless hop from the wireless communication circuitry to an intermediate device.
-
FIG. 1A shows a patient and a monitoring system comprising an adherent device, according to embodiments of the present invention; -
FIG. 1B shows a bottom view of the adherent device as inFIG. 1A comprising an adherent patch; -
FIG. 1C shows a top view of the adherent patch, as inFIG. 1B ; -
FIG. 1D shows a printed circuit boards and electronic components over the adherent patch, as inFIG. 1C ; - FIG. 1D1 shows an equivalent circuit that can be used to determine optimal frequencies for determining patient hydration, according to embodiments of the present invention;
-
FIG. 1E shows batteries positioned over the printed circuit board and electronic components as inFIG. 1D ; -
FIG. 1F shows a top view of an electronics housing and a breathable cover over the batteries, electronic components and printed circuit board as inFIG. 1E ; -
FIG. 1G shows a side view of the adherent device as inFIGS. 1A to 1F ; -
FIG. 1H shown a bottom isometric view of the adherent device as inFIGS. 1A to 1G ; -
FIGS. 1I and 1J show a side cross-sectional view and an exploded view, respectively, of the adherent device as inFIGS. 1A to 1H ; -
FIG. 1K shows at least one electrode configured to electrically couple to a skin of the patient through a breathable tape, according to embodiments of the present invention; -
FIGS. 2A to 2C show a system to monitor a patient for an extended period comprising a reusable electronic component and a plurality of disposable patch components, according to embodiments of the present invention; -
FIG. 2D shows a method of using the system as inFIGS. 2A to 2C ; -
FIGS. 3A to 3D show a method of monitoring a patient for an extended period with an adherent patch with adherent patches alternatively adhered to the right side or the left side of the patient; -
FIG. 4A shows an adherent device to measure an impedance signal and an electrocardiogram signal, according to embodiments of the present invention; -
FIG. 4B shows a method of measuring the impedance signal and the electrocardiogram signal, according to embodiments of the present invention; -
FIG. 5A shows a method for monitoring a patient and responding to a signal event; and -
FIGS. 6A and 6B show clinical data measured with an adherent patch device. - Embodiments of the present invention relate to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to any application in which physiological monitoring is used, for example wireless physiological monitoring for extended periods.
- Decompensation is failure of the heart to maintain adequate blood circulation. Although the heart can maintain at least some pumping of blood, the quantity is inadequate to maintain healthy tissues. Several symptoms can result from decompensation including pulmonary congestion, breathlessness, faintness, cardiac palpitation, edema of the extremities, and enlargement of the liver. Cardiac decompensation can result in slow or sudden death. Sudden Cardiac Arrest (hereinafter “SCA”), also referred to as sudden cardiac death, is an abrupt loss of cardiac pumping function that can be caused by a ventricular arrhythmia, for example ventricular tachycardia and/or ventricular fibrillation. Although decompensation and SCA can be related in that patients with decompensation are also at an increased risk for SCA, decompensation is primarily a mechanical dysfunction caused by inadequate blood flow, and SCA is primarily an electrical dysfunction caused by inadequate and/or inappropriate electrical signals of the heart.
- In many embodiments, the adherent devices described herein may be used for 90 day monitoring, or more, and may comprise completely disposable components and/or reusable components, and can provide reliable data acquisition and transfer. In many embodiments, the patch is configured for patient comfort, such that the adherent patch can be worn and/or tolerated by the patient for extended periods, for example 90 days or more. The patch may be worn continuously for at least seven days, for example 14 days, and then replaced with another patch. Adherent devices with comfortable patches that can be worn for extended periods and in which patches can be replaced and the electronics modules reused are described in U.S. patent application Nos. 60/972,537, entitled “Adherent Device with Multiple Physiological Sensors”; and 60/972,629, entitled “Adherent Device with Multiple Physiological Sensors”, both filed on Sep. 14, 2007, the full disclosures of which have been previously incorporated herein by reference. In many embodiments, the adherent patch comprises a tape, which comprises a material, preferably breathable, with an adhesive, such that trauma to the patient skin can be minimized while the patch is worn for the extended period. The printed circuit board may comprise a flex printed circuit board that can flex with the patient to provide improved patient comfort.
-
FIG. 1A shows a patient P and amonitoring system 10. Patient P comprises a midline M, a first side S1, for example a right side, and a second side S2, for example a left side.Monitoring system 10 comprises anadherent device 100.Adherent device 100 can be adhered to a patient P at many locations, for example thorax T of patient P. In many embodiments, the adherent device may adhere to one side of the patient, from which side data can be collected. Work in relation with embodiments of the present invention suggests that location on a side of the patient can provide comfort for the patient while the device is adhered to the patient. -
Monitoring system 10 includes components to transmit data to aremote center 106.Remote center 106 can be located in a different building from the patient, for example in the same town as the patient, and can be located as far from the patient as a separate continent from the patient, for example the patient located on a first continent and the remote center located on a second continent.Adherent device 100 can communicate wirelessly to anintermediate device 102, for example with a single wireless hop from the adherent device on the patient to the intermediate device.Intermediate device 102 can communicate withremote center 106 in many ways, for example with an internet connection and/or with a cellular connection. In many embodiments,monitoring system 10 comprises a distributed processing system with at least one processor comprising a tangible medium ofdevice 100, at least oneprocessor 102P ofintermediate device 102, and at least oneprocessor 106P atremote center 106, each of which processors can be in electronic communication with the other processors. At least oneprocessor 102P comprises atangible medium 102T, and at least oneprocessor 106P comprises atangible medium 106T.Remote processor 106P may comprise a backend server located at the remote center.Remote center 106 can be in communication with ahealth care provider 108A with acommunication system 107A, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.Health care provider 108A, for example a family member, can be in communication with patient P with a communication, for example with a two way communication system, as indicated byarrow 109A, for example by cell phone, email, landline.Remote center 106 can be in communication with a health care professional, for example aphysician 108B, with acommunication system 107B, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.Physician 108B can be in communication with patient P with a communication, for example with a two way communication system, as indicated byarrow 109B, for example by cell phone, email, landline.Remote center 106 can be in communication with anemergency responder 108C, for example a 911 operator and/or paramedic, with acommunication system 107C, such as the Internet, an intranet, phone lines, wireless and/or satellite phone.Emergency responder 108C can travel to the patient as indicated byarrow 109C. Thus, in many embodiments,monitoring system 10 comprises a closed loop system in which patient care can be monitored and implemented from the remote center in response to signals from the adherent device. - In many embodiments, the adherent device may continuously monitor physiological parameters, communicate wirelessly with a remote center, and provide alerts when necessary. The system may comprise an adherent patch, which attaches to the patient's thorax and contains sensing electrodes, battery, memory, logic, and wireless communication capabilities. In some embodiments, the patch can communicate with the remote center, via the intermediate device in the patient's home. In some embodiments,
remote center 106 receives the patient data and applies a patient evaluation algorithm, for example the prediction algorithm to predict cardiac decompensation. In some embodiments, the algorithm may comprise an algorithm to predict impending cardiac decompensation is described in U.S. patent application No. 60/972,512, the full disclosure of which has been previously incorporated herein by reference. When a flag is raised, the center may communicate with the patient, hospital, nurse, and/or physician to allow for therapeutic intervention, for example to prevent decompensation. - The adherent device may be affixed and/or adhered to the body in many ways. For example, with at least one of the following an adhesive tape, a constant-force spring, suspenders around shoulders, a screw-in microneedle electrode, a pre-shaped electronics module to shape fabric to a thorax, a pinch onto roll of skin, or transcutaneous anchoring. Patch and/or device replacement may occur with a keyed patch (e.g. two-part patch), an outline or anatomical mark, a low-adhesive guide (place guide|remove old patch|place new patch|remove guide), or a keyed attachment for chatter reduction. The patch and/or device may comprise an adhesiveless embodiment (e.g. chest strap), and/or a low-irritation adhesive for sensitive skin. The adherent patch and/or device can comprise many shapes, for example at least one of a dogbone, an hourglass, an oblong, a circular or an oval shape.
- In many embodiments, the adherent device may comprise a reusable electronics module with replaceable patches, and each of the replaceable patches may include a battery. The module may collect cumulative data for approximately 90 days and/or the entire adherent component (electronics+patch) may be disposable. In a completely disposable embodiment, a “baton” mechanism may be used for data transfer and retention, for example baton transfer may include baseline information. In some embodiments, the device may have a rechargeable module, and may use dual battery and/or electronics modules, wherein one
module 101A can be recharged using a chargingstation 103 while theother module 101B is placed on the adherent patch with connectors. In some embodiments, theintermediate device 102 may comprise the charging module, data transfer, storage and/or transmission, such that one of the electronics modules can be placed in the intermediate device for charging and/or data transfer while the other electronics module is worn by the patient. -
System 10 can perform the following functions: initiation, programming, measuring, storing, analyzing, communicating, predicting, and displaying. The adherent device may contain a subset of the following physiological sensors: bioimpedance, respiration, respiration rate variability, heart rate (ave, min, max), heart rhythm, hear rate variability (HRV), heart rate turbulence (HRT), heart sounds (e.g. S3), respiratory sounds, blood pressure, activity, posture, wake/sleep, orthopnea, temperature/heat flux, and weight. The activity sensor may comprise one or more of the following: ball switch, accelerometer, minute ventilation, HR, bioimpedance noise, skin temperature/heat flux, BP, muscle noise, posture. - The adherent device can wirelessly communicate with
remote center 106. The communication may occur directly (via a cellular or Wi-Fi network), or indirectly throughintermediate device 102.Intermediate device 102 may consist of multiple devices, which can communicate wired or wirelessly to relay data toremote center 106. - In many embodiments, instructions are transmitted from
remote site 106 to a processor supported with the adherent patch on the patient, and the processor supported with the patient can receive updated instructions for the patient treatment and/or monitoring, for example while worn by the patient. -
FIG. 1B shows a bottom view ofadherent device 100 as inFIG. 1A comprising anadherent patch 110.Adherent patch 110 comprises a first side, or alower side 110A, that is oriented toward the skin of the patient when placed on the patient. In many embodiments,adherent patch 110 comprises atape 110T which is a material, preferably breathable, with an adhesive 116A.Patient side 110A comprises adhesive 116A to adhere thepatch 110 andadherent device 100 topatient P. Electrodes adherent patch 110. In many embodiments, at least four electrodes are attached to the patch, for example six electrodes. In some embodiments the patch comprises two electrodes, for example two electrodes to measure the electrocardiogram (ECG) of the patient.Gel 114A,gel 114B,gel 114C andgel 114D can each be positioned overelectrodes patch 110, for example with known methods and structures such as rivets, adhesive, stitches, etc. In many embodiments,patch 110 comprises a breathable material to permit air and/or vapor to flow to and from the surface of the skin. -
FIG. 1C shows a top view of theadherent patch 100, as inFIG. 1B .Adherent patch 100 comprises a second side, orupper side 110B. In many embodiments,electrodes lower side 110A throughadherent patch 110 toupper side 110B. An adhesive 116B can be applied toupper side 110B to adhere structures, for example a breathable cover, to the patch such that the patch can support the electronics and other structures when the patch is adhered to the patient. The PCB may comprise completely flex PCB, rigid PCB, rigid PCB combined flex PCB and/or rigid PCB boards connected by cable. -
FIG. 1D shows a printed circuit boards and electronic components overadherent patch 110, as inFIGS. 1A to 1C . In some embodiments, a printed circuit board (PCB), for example flex printedcircuit board 120, may be connected toelectrodes connectors circuit board 120 can includetraces connectors Connectors circuit board 120 in alignment withelectrodes connectors connectors circuit board 120.Electronic components 130 can be connected to flex printedcircuit board 120 and/or mounted thereon. In some embodiments,electronic components 130 can be mounted on the additional PCB's. -
Electronic components 130 comprise components to take physiologic measurements, transmit data toremote center 106 and receive commands fromremote center 106. In many embodiments,electronics components 130 may comprise known low power circuitry, for example complementary metal oxide semiconductor (CMOS) circuitry components.Electronics components 130 comprise an activity sensor andactivity circuitry 134,impedance circuitry 136 and electrocardiogram circuitry, forexample ECG circuitry 136. In some embodiments,electronics circuitry 130 may comprise a microphone andmicrophone circuitry 142 to detect an audio signal from within the patient, and the audio signal may comprise a heart sound and/or a respiratory sound, for example an S3 heart sound and a respiratory sound with rales and/or crackles. -
Electronics circuitry 130 may comprise a temperature sensor, for example a thermistor in contact with the skin of the patient, andtemperature sensor circuitry 144 to measure a temperature of the patient, for example a temperature of the skin of the patient. A temperature sensor may be used to determine the sleep and wake state of the patient. The temperature of the patient can decrease as the patient goes to sleep and increase when the patient wakes up. - Work in relation to embodiments of the present invention suggests that skin temperature may effect impedance and/or hydration measurements, and that skin temperature measurements may be used to correct impedance and/or hydration measurements. In some embodiments, increase in skin temperature or heat flux can be associated with increased vaso-dilation near the skin surface, such that measured impedance measurement decreased, even through the hydration of the patient in deeper tissues under the skin remains substantially unchanged. Thus, use of the temperature sensor can allow for correction of the hydration signals to more accurately assess the hydration, for example extra cellular hydration, of deeper tissues of the patient, for example deeper tissues in the thorax.
-
Electronics circuitry 130 may comprise aprocessor 146.Processor 146 comprises a tangible medium, for example read only memory (ROM), electrically erasable programmable read only memory (EEPROM) and/or random access memory (RAM).Electronic circuitry 130 may comprise real time clock andfrequency generator circuitry 148. In some embodiments,processor 136 may comprise the frequency generator and real time clock. The processor can be configured to control a collection and transmission of data from the impedance circuitry electrocardiogram circuitry and the accelerometer. In many embodiments,device 100 comprise a distributed processor system, for example with multiple processors ondevice 100. - In many embodiments,
electronics components 130 comprisewireless communications circuitry 132 to communicate withremote center 106. The wireless communication circuitry can be coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a communication protocol at least one of the hydration signal, the electrocardiogram signal or the inclination signal. In specific embodiments, wireless communication circuitry is configured to transmit the hydration signal, the electrocardiogram signal and the inclination signal to the remote center with a single wireless hop, for example fromwireless communication circuitry 132 tointermediate device 102. The communication protocol comprises at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, amplitude modulation or frequency modulation. In many embodiments, the communications protocol comprises a two way protocol such that the remote center is capable of issuing commands to control data collection. -
Intermediate device 102 may comprise a data collection system to collect and store data from the wireless transmitter. The data collection system can be configured to communicate periodically with the remote center. The data collection system can transmit data in response to commands fromremote center 106 and/or in response to commands from the adherent device. - Activity sensor and
activity circuitry 134 can comprise many known activity sensors and circuitry. In many embodiments, the accelerometer comprises at least one of a piezoelectric accelerometer, capacitive accelerometer or electromechanical accelerometer. The accelerometer may comprises a 3-axis accelerometer to measure at least one of an inclination, a position, an orientation or acceleration of the patient in three dimensions. Work in relation to embodiments of the present invention suggests that three dimensional orientation of the patient and associated positions, for example sitting, standing, lying down, can be very useful when combined with data from other sensors, for example ECG data and/or hydration data. -
Impedance circuitry 136 can generate both hydration data and respiration data. In many embodiments,impedance circuitry 136 is electrically connected toelectrodes electrodes electrodes electrodes electrodes electrodes electrodes - FIG. 1D1 shows an
equivalent circuit 152 that can be used to determine optimal frequencies for measuring patient hydration. Work in relation to embodiments of the present invention indicates that the frequency of the current and/or voltage at the force electrodes can be selected so as to provide impedance signals related to the extracellular and/or intracellular hydration of the patient tissue.Equivalent circuit 152 comprises anintracellular resistance 156, or R(ICW) in series with acapacitor 154, and anextracellular resistance 158, or R(ECW).Extracellular resistance 158 is in parallel withintracellular resistance 156 andcapacitor 154 related to capacitance of cell membranes. In many embodiments, impedances can be measured and provide useful information over a wide range of frequencies, for example from about 0.5 kHz to about 200 KHz. Work in relation to embodiments of the present invention suggests thatextracellular resistance 158 can be significantly related extracellular fluid and to cardiac decompensation, and thatextracellular resistance 158 and extracellular fluid can be effectively measured with frequencies in a range from about 0.5 kHz to about 20 kHz, for example from about 1 kHz to about 10 kHz. In some embodiments, a single frequency can be used to determine the extracellular resistance and/or fluid. As sample frequencies increase from about 10 kHz to about 20 kHz, capacitance related to cell membranes decrease the impedance, such that the intracellular fluid contributes to the impedance and/or hydration measurements. Thus, many embodiments of the present invention measure hydration with frequencies from about 0.5 kHz to about 20 kHz to determine patient hydration. - In many embodiments,
impedance circuitry 136 can be configured to determine respiration of the patient. In specific embodiments, the impedance circuitry can measure the hydration at 25 Hz intervals, for example at 25 Hz intervals using impedance measurements with a frequency from about 0.5 kHz to about 20 kHz. -
ECG circuitry 138 can generate electrocardiogram signals and data from two or more ofelectrodes ECG circuitry 138 is connected toinner electrodes ECG circuitry 138 can be connected toelectrodes ECG circuitry 138. In many embodiments, the ECG circuitry may measure the ECG signal fromelectrodes electrodes -
FIG. 1E showsbatteries 150 positioned over the flex printed circuit board and electronic components as inFIG. 1D .Batteries 150 may comprise rechargeable batteries that can be removed and/or recharged. In some embodiments,batteries 150 can be removed from the adherent patch and recharged and/or replaced. -
FIG. 1F shows a top view of acover 162 over the batteries, electronic components and flex printed circuit board as inFIGS. 1A to 1E . In many embodiments, anelectronics housing 160 may be disposed undercover 162 to protect the electronic components, and in some embodiments electronics housing 160 may comprise an encapsulant over the electronic components and PCB. In some embodiments, cover 162 can be adhered toadherent patch 110 with an adhesive 164 on an underside ofcover 162. In many embodiments, electronics housing 160 may comprise a water proof material, for example a sealant adhesive such as epoxy or silicone coated over the electronics components and/or PCB. In some embodiments, electronics housing 160 may comprise metal and/or plastic. Metal or plastic may be potted with a material such as epoxy or silicone. - Cover 162 may comprise many known biocompatible cover, casing and/or housing materials, such as elastomers, for example silicone. The elastomer may be fenestrated to improve breathability. In some embodiments, cover 162 may comprise many known breathable materials, for example polyester, polyamide, and/or elastane (Spandex™). The breathable fabric may be coated to make it water resistant, waterproof, and/or to aid in wicking moisture away from the patch.
-
FIG. 1G shows a side view ofadherent device 100 as inFIGS. 1A to 1F .Adherent device 100 comprises a maximum dimension, for example alength 170 from about 4 to 10 inches (from about 100 mm to about 250 mm), for example from about 6 to 8 inches (from about 150 mm to about 200 mm). In some embodiments,length 170 may be no more than about 6 inches (no more than about 150 mm).Adherent device 100 comprises athickness 172.Thickness 172 may comprise a maximum thickness along a profile of the device.Thickness 172 can be from about 0.2 inches to about 0.4 inches (from about 5 mm to about 10 mm), for example about 0.3 inches (about 7.5 mm). -
FIG. 1H shown a bottom isometric view ofadherent device 100 as inFIGS. 1A to 1G .Adherent device 100 comprises awidth 174, for example a maximum width along a width profile ofadherent device 100.Width 174 can be from about 2 to about 4 inches (from about 50 mm to 100 mm), for example about 3 inches (about 75 mm). -
FIGS. 1I and 1J show a side cross-sectional view and an exploded view, respectively, ofadherent device 100 as inFIGS. 1A to 1H .Device 100 comprises several layers.Gel 114A, or gel layer, is positioned onelectrode 112A to provide electrical conductivity between the electrode and the skin.Electrode 112A may comprise an electrode layer.Adherent patch 110 may comprise a layer ofbreathable tape 110T, for example a known breathable tape, such as tricot-knit polyester fabric. An adhesive 116A, for example a layer of acrylate pressure sensitive adhesive, can be disposed onunderside 110A ofadherent patch 110. - A
gel cover 180, or gel cover layer, for example a polyurethane non-woven tape, can be positioned overpatch 110 comprising the breathable tape. A PCB layer, for example flex printedcircuit board 120, or flex PCB layer, can be positioned overgel cover 180 withelectronic components 130 connected and/or mounted to flex printedcircuit board 120, for example mounted on flex PCB so as to comprise an electronics layer disposed on the flex PCB layer. In many embodiments, the adherent device may comprise a segmented inner component, for example the PCB may be segmented to provide at least some flexibility. In many embodiments, the electronics layer may be encapsulated inelectronics housing 160 which may comprise a waterproof material, for example silicone or epoxy. In many embodiments, the electrodes are connected to the PCB with a flex connection, forexample trace 123A of flex printedcircuit board 120, so as to provide strain relive between theelectrodes -
Gel cover 180 can inhibit flow ofgel 114A and liquid. In many embodiments,gel cover 180 can inhibitgel 114A from seeping throughbreathable tape 110T to maintain gel integrity over time.Gel cover 180 can also keep external moisture, for example liquid water, from penetrating though the gel cover intogel 114A while allowing moisture vapor from the gel, for example moisture vapor from the skin, to transmit through the gel cover. - In many embodiments, cover 162 can encase the flex PCB and/or electronics and can be adhered to at least one of the electronics, the flex PCB or
adherent patch 110, so as to protect at least the electronics components and the PCB. Cover 162 can attach toadherent patch 110 with adhesive 1116B. Cover 162 can comprise many known biocompatible cover materials, for example silicone. Cover 162 can comprise an outer polymer cover to provide smooth contour without limiting flexibility. In many embodiments, cover 162 may comprise a breathable fabric. - Cover 162 may comprise many known breathable fabrics, for example breathable fabrics as described above. In some embodiments, the breathable cover may comprise a breathable water resistant cover. In some embodiments, the breathable fabric may comprise polyester, nylon, polyamide, and/or elastane (Spandex™) to allow the breathable fabric to stretch with body movement. In some embodiments, the breathable tape may contain and elute a pharmaceutical agent, such as an antibiotic, anti-inflammatory or antifungal agent, when the adherent device is placed on the patient.
- The
breathable cover 162 andadherent patch 110 comprise breathable tape can be configured to couple continuously for at least one week the at least one electrode to the skin so as to measure breathing of the patient. The breathable tape may comprise the stretchable breathable material with the adhesive and the breathable cover may comprises a stretchable water resistant material connected to the breathable tape, as described above, such that both the adherent patch and cover can stretch with the skin of the patient.Arrows 182 show stretching ofadherent patch 110, and the stretching of adherent patch can be at least two dimensional along the surface of the skin of the patient. As noted above,connectors PCB 130 andelectrodes Arrows 184 show stretching ofcover 162, and the stretching of the cover can be at least two dimensional along the surface of the skin of the patient. Cover 162 can be attached toadherent patch 110 with adhesive 116B such thatcover 162 stretches and/or retracts whenadherent patch 110 stretches and/or retracts with the skin of the patient. For example, cover 162 andadherent patch 110 can stretch in two dimensions alonglength 170 andwidth 174 with the skin of the patient, and stretching alonglength 170 can increase spacing between electrodes. Stretching of the cover andadherent patch 110, for example in two dimensions, can extend the time the patch is adhered to the skin as the patch can move with the skin such that the patch remains adhered to the skin.Electronics housing 160 can be smooth and allowbreathable cover 162 to slide over electronics housing 160, such that motion and/or stretching ofcover 162 is slidably coupled withhousing 160. The printed circuit board can be slidably coupled withadherent patch 110 that comprisesbreathable tape 110T, such that the breathable tape can stretch with the skin of the patient when the breathable tape is adhered to the skin of the patient, for example along twodimensions comprising length 170 andwidth 174.Electronics components 130 can be affixed to printedcircuit board 120, for example with solder, and the electronics housing can be affixed over the PCB and electronics components, for example with dip coating, such thatelectronics components 130, printedcircuit board 120 andelectronics housing 160 are coupled together.Electronics components 130, printedcircuit board 120, andelectronics housing 160 are disposed between the stretchable breathable material ofadherent patch 110 and the stretchable water resistant material ofcover 160 so as to allow theadherent patch 110 and cover 160 to stretch together whileelectronics components 130, printedcircuit board 120, andelectronics housing 160 do not stretch substantially, if at all. This decoupling ofelectronics housing 160, printedcircuit board 120 andelectronic components 130 can allow theadherent patch 110 comprising breathable tape to move with the skin of the patient, such that the adherent patch can remain adhered to the skin for an extended time of at least one week, for example two or more weeks. - An
air gap 169 may extend fromadherent patch 110 to the electronics module and/or PCB, so as to provide patient comfort.Air gap 169 allowsadherent patch 110 andbreathable tape 110T to remain supple and move, for example bend, with the skin of the patient with minimal flexing and/or bending of printedcircuit board 120 andelectronic components 130, as indicated byarrows 186. Printedcircuit board 120 andelectronics components 130 that are separated from thebreathable tape 110T withair gap 169 can allow the skin to release moisture as water vapor through the breathable tape, gel cover, and breathable cover. This release of moisture from the skin through the air gap can minimize, and even avoid, excess moisture, for example when the patient sweats and/or showers. - The breathable tape of
adherent patch 110 may comprise a first mesh with a first porosity andgel cover 180 may comprise a breathable tape with a second porosity, in which the second porosity is less than the first porosity to minimize, and even inhibit, flow of the gel through the breathable tape. The gel cover may comprise a polyurethane film with the second porosity. - In many embodiments, the adherent device comprises a patch component and at least one electronics module. The patch component may comprise
adherent patch 110 comprising the breathable tape withadhesive coating 116A, at least one electrode, forexample electrode 114A and gel 114. The at least one electronics module can be separable from the patch component. In many embodiments, the at least one electronics module comprises the flex printedcircuit board 120,electronic components 130,electronics housing 160 and cover 162, such that the flex printed circuit board, electronic components, electronics housing and cover are reusable and/or removable for recharging and data transfer, for example as described above. In many embodiments, adhesive 116B is coated onupper side 110A ofadherent patch 110B, such that the electronics module can be adhered to and/or separated from the adhesive component. In specific embodiments, the electronic module can be adhered to the patch component with a releasable connection, for example with Velcro™, a known hook and loop connection, and/or snap directly to the electrodes. Two electronics modules can be provided, such that one electronics module can be worn by the patient while the other is charged, as described above. Monitoring with multiple adherent patches for an extended period is described in U.S. patent application No. 60/972,537, the full disclosure of which has been previously incorporated herein by reference. Many patch components can be provided for monitoring over the extended period. For example, about 12 patches can be used to monitor the patient for at least 90 days with at least one electronics module, for example with two reusable electronics modules. - At least one
electrode 112A can extend through at least oneaperture 180A in thebreathable tape 110 andgel cover 180. - In some embodiments, the adhesive patch may comprise a medicated patch that releases a medicament, such as antibiotic, beta-blocker, ACE inhibitor, diuretic, or steroid to reduce skin irritation. The adhesive patch may comprise a thin, flexible, breathable patch with a polymer grid for stiffening. This grid may be anisotropic, may use electronic components to act as a stiffener, may use electronics-enhanced adhesive elution, and may use an alternating elution of adhesive and steroid.
-
FIG. 1K shows at least oneelectrode 190 configured to electrically couple to a skin of the patient through abreathable tape 192. In many embodiments, at least oneelectrode 190 andbreathable tape 192 comprise electrodes and materials similar to those described above.Electrode 190 andbreathable tape 192 can be incorporated into adherent devices as described above, so as to provide electrical coupling between the skin an electrode through the breathable tape, for example with the gel. -
FIGS. 2A to 2C show a schematic illustration of asystem 200 to monitor a patient for an extended period.FIG. 2A shows a schematic illustration ofsystem 200 comprising areusable electronics module 210 and a plurality of disposable patch components comprising a firstdisposable patch component 220A, a seconddisposable patch component 220B, a thirddisposable patch component 220C and a fourthdisposable patch component 220D. Although four patch components a shown the plurality may comprise as few as two patch component and as many as three or more patch components, for example 25 patch components. -
FIG. 2B shows a schematic illustration of a side cross-sectional view ofreusable electronics module 210.Reusable electronics module 210 may comprises many of the structures described above that may comprise the electronics module. In many embodiments,reusable electronics module 210 comprises a PCB, for example aflex PCB 212,electronics components 216,batteries 216, and acover 217, for example as described above. In some embodiments,reusable electronics module 210 may comprise an electronics housing over the electronics components and/or PCB as described above. The electronics components may comprise circuitry and/or sensors for measuring ECG signals, hydration impedance signals, respiration impedance signals and accelerometer signals, for example as described above. In many embodiments,reusable electronics module 210 comprises aconnector 219 adapted to connect to each of the disposable patch components, sequentially, for example one disposable patch component at a time.Connector 219 can be formed in many ways, and may comprise known connectors as described above, for example a snap. In some embodiments, the connectors on the electronics module and adhesive component can be disposed at several locations on the reusable electronics module and disposable patch component, for example near each electrode, such that each electrode can couple directly to a corresponding location on the flex PCB of the reusable electronics component. - Alternatively or in combination with
batteries 216, each of the plurality of disposable patch components may comprise a disposable battery. For example firstdisposable patch component 220A may comprise adisposable battery 214A; seconddisposable patch component 220B may comprise adisposable battery 214B; thirddisposable patch component 220C may comprise adisposable battery 214C; and a fourthdisposable patch component 220D may comprise adisposable battery 214D. Each of the disposable batteries, 214A, 214B, 214C and 214D may be affixed to each ofdisposable patches connectors connectors connectors -
FIG. 2C shows a schematic illustration firstdisposable patch component 220A of the plurality of disposable patch components that is similar to the other disposable patch components, for example seconddisposable patch component 220B, thirddisposable patch component 220C and fourthdisposable patch component 220C. The disposable patch component comprises abreathable tape 227A, an adhesive 226A on an underside ofbreathable tape 227A to adhere to the skin of the patient, and at least fourelectrodes 222A. The at least fourelectrodes 224A are configured to couple to the skin of a patient, for example with agel 226A, in some embodiments the electrodes may extend through the breathable tape to couple directly to the skin of the patient with aid form the gel. In some embodiments, the at least four electrodes may be indirectly coupled to the skin through a gel and/or the breathable tape, for example as described above. Aconnector 229A on the upper side of the disposable adhesive component can be configured for attachment toconnector 219 onreusable electronics module 210 so as to electrically couple the electrodes with the electronics module. The upper side of the disposable patch component may comprise an adhesive 224A to connect the disposable patch component to the reusable electronics module. The reusable electronics module can be adhered to the patch component with many additional known ways to adhere components, for example with Velcro™ comprising hooks and loops, snaps, a snap fit, a lock and key mechanisms, magnets, detents and the like. -
FIG. 2D shows amethod 250 of usingsystem 200, as inFIGS. 2A to 2C . Astep 252 adhereselectronics module 210 to first disposableadherent patch component 220A of the plurality of adherent patch components and adheres the first disposable patch component to the skin of the patient, for example with the first adherent patch component adhered to the reusable electronics module. Astep 254 removes the first disposable adherent patch from the patient and separates first disposableadherent patch component 220A fromreusable electronics module 210. Astep 256 adhereselectronics module 210 to second disposableadherent patch component 220B and adheres the second disposable patch component to the skin of the patient, for example with the second adherent patch component adhered to the reusable electronics module. Astep 258 removes the second disposable adherent patch from the patient and separates second disposableadherent patch component 220B fromreusable electronics module 210. Astep 260 adhereselectronics module 210 to third disposableadherent patch component 220C and adheres the third disposable patch component to the skin of the patient, for example with the third adherent patch component adhered to the reusable electronics module. Astep 262 removes the third disposable adherent patch from the patient and separates third disposableadherent patch component 220C fromreusable electronics module 210. Astep 264 adhereselectronics module 210 to fourth disposableadherent patch component 220D and adheres the fourth disposable patch component to the skin of the patient, for example with the third adherent patch component adhered to the reusable electronics module. Astep 268 removes the fourth disposable adherent patch from the patient and separates fourth disposableadherent patch component 220D fromreusable electronics module 210. - In many embodiments, physiologic signals, for example ECG, hydration impedance, respiration impedance and accelerometer impedance are measured when the adherent patch component is adhered to the patient, for example when any of the first, second, third or fourth disposable adherent patches is adhered to the patient.
-
FIGS. 3A to 3D show amethod 300 of monitoring a patient for an extended period with adherent patches alternatively adhered to aright side 302 and aleft side 304 of the patient. Work in relation to embodiments of the present invention suggests that repeated positioning of a patch at the same location can irritate the skin and may cause patient discomfort. This can be avoided by alternating the patch placement between left and right sides of the patient, often a front left and a front right side of the patient where the patient can reach easily to replace the patch. In some embodiments, the patch location can be alternated on the same side of the patient, for example higher and/or lower on the same side of the patient without substantial overlap to allow the skin to recover and/or heal. In many embodiments, the patch can be symmetrically positioned on an opposite side such that signals may be similar to a previous position of the patch symmetrically disposed on an opposite side of the patient. In many embodiments, the duration between removal of one patch and placement of the other patch can be short, such that any differences between the signals may be assumed to be related to placement of the patch, and these differences can be removed with signal processing. - In many embodiments each patch comprises at least four electrodes configured to measure an ECG signal and impedance, for example hydration and/or respiration impedance. In many embodiments, the patient comprises a
midline 306, with first side, for exampleright side 302, and second side, for exampleleft side 304, symmetrically disposed about the midline. Astep 310 adheres a firstadherent patch 312 to at afirst location 314 on afirst side 302 of the patient for a first period of time, for example about 1 week. While theadherent patch 312 is position atfirst location 314 on the first side of the patient, the electrodes of the patch are coupled to the skin of the patient to measure the ECG signal and impedance signals. - A
step 320 removespatch 312 and adheres a secondadherent patch 322 at asecond location 324 on a second side 206 of the patient for a second period of time, for example about 1 week. In many embodiments,second location 324 can be symmetrically disposed oppositefirst location 314 acrossmidline 304, for example so as to minimize changes in the sequential impedance signals measured from the second side and first side. Whileadherent patch 322 is position atsecond location 324 on the second side of the patient, the electrodes of the patch are coupled to the skin of the patient to measure the ECG signal and impedance signals. In many embodiments, whileadherent patch 322 is positioned atsecond location 324, skin atfirst location 314 can heal and recover from adherent coverage of the first patch. In many embodiments,second location 324 is symmetrically disposed oppositefirst location 314 acrossmidline 304, for example so as to minimize changes in the impedance signals measured between the first side and second side. In many embodiments, the duration between removal of one patch and placement of the other patch can be short, such that any differences between the signals may be assumed to be related to placement of the patch, and these differences can be removed with signal processing. - A
step 330 removessecond patch 322 and adheres a thirdadherent patch 332 at athird location 334 on the first side, for exampleright side 302, of the patient for a third period of time, for example about 1 week. In many embodiments,third location 334 can be symmetrically disposed oppositesecond location 324 acrossmidline 304, for example so as to minimize changes in the sequential impedance signals measured from the third side and second side. In many embodiments,third location 334 substantially overlaps withfirst location 314, so as to minimize differences in measurements between the first adherent patch and third adherent patch that may be due to patch location. Whileadherent patch 332 is positioned atthird location 334 on the first side of the patient, the electrodes of the patch are coupled to the skin of the patient to measure the ECG signal and impedance signals. In many embodiments, whileadherent patch 332 is positioned atthird location 334, skin atsecond location 324 can heal and recover from adherent coverage of the second patch. In many embodiments, the duration between removal of one patch and placement of the other patch can be short, such that any differences between the signals may be assumed to be related to placement of the patch, and these differences can be removed with signal processing. - A
step 340 removesthird patch 332 and adheres a fourthadherent patch 342 at a fourth location 344 on the second side, for exampleleft side 306, of the patient for a fourth period of time, for example about 1 week. In many embodiments, fourth location 344 can be symmetrically disposed oppositethird location 334 acrossmidline 304, for example so as to minimize changes in the sequential impedance signal measured from the fourth side and third side. In many embodiments, fourth location 344 substantially overlaps withsecond location 324, so as to minimize differences in measurements between the second adherent patch and fourth adherent patch that may be due to patch location. Whileadherent patch 342 is positioned at fourth location 344 on the second side of the patient, the electrodes of the patch are coupled to the skin of the patient to measure the ECG signal and impedance signals. In many embodiments, whileadherent patch 342 is positioned atfourth location 324, skin atthird location 334 can heal and recover from adherent coverage of the third patch. In many embodiments, the duration between removal of one patch and placement of the other patch can be short, such that any differences between the signals may be assumed to be related to placement of the patch, and these differences can be removed with signal processing. - It should be appreciated that the specific steps illustrated in
FIGS. 3A to 3D provide a particular method of monitoring a patient for an extended period, according to an embodiment of the present invention. Other sequences of steps may also be performed according to alternative embodiments. For example, alternative embodiments of the present invention may perform the steps outlined above in a different order. Moreover, the individual steps illustrated inFIGS. 3A to 3D may include multiple sub-steps that may be performed in various sequences as appropriate to the individual step. Furthermore, additional steps may be added or removed depending on the particular applications. One of ordinary skill in the art would recognize many variations, modifications, and alternatives. -
FIG. 4A shows amonitoring system 400 comprising anadherent device 410 to measure an impedance signal and an electrocardiogram signal.Device 410 may comprise wireless communication circuitry, accelerometer sensors and/or circuitry and many sensors and electronics components and structures as described above.Adherent device 410 comprises at least four electrodes. In many embodiments, the at least four electrodes comprises four electrodes, for example afirst electrode 412A, asecond electrode 412B, athird electrode 412C and afourth electrode 412D. Work in relation to embodiments of the present invention suggests that embodiments in which the at least four electrodes comprises four electrodes can decrease a footprint, or size, of the device on the patient and may provide improved patient comfort. In many embodiments,first electrode 412A andfourth electrode 412D comprise outer electrodes, andsecond electrode 412B andthird electrode 412C comprise inner electrodes, for example in embodiments where the electrodes are arranged in an elongate pattern. -
Adherent device 410 comprisesimpedance circuitry 420 that can be used to measure hydration and respiration of the patient, andECG circuitry 430 that is used to measure an electrocardiogram signal of the patient.Impedance circuitry 420 comprises force circuitry connected to the outer electrodes to drive a current between the electrodes.Impedance circuitry 420 comprises sense circuitry to measure a voltage between the inner electrodes resulting from the current passed between the outer force electrodes, such that the impedance of the tissue can be determined.Impedance circuitry 420 may comprise known 4-pole, or quadrature, low power circuitry.ECG circuitry 430 can be connected to the outer electrodes, or force electrodes, to measure an ECG signal. Work in relation to embodiments of the present invention suggests that this use of the outer electrodes can increase the ECG signal as compared to the inner electrodes, in some embodiments, that may be due to the increased distance between the outer electrodes.ECG circuitry 430 may comprise known ECG circuitry and components, for example low power instrumentation and/or operational amplifiers. - In many embodiments,
electronic switch 432A andelectronic switch 432D are connected in series betweenimpedance circuitry 420 andelectrode electronic switch 432A andelectronic switch 432D open such that the outer electrodes can be isolated from the impedance circuitry when the ECG circuitry measures ECG signals. Whenelectronic switch 432A andelectronic switch 432D are closed,impedance circuitry 420 can force electrical current through the outer electrodes to measure impedance. In many embodiments,electronic switch 432A andelectronic switch 432D can be located in the same packaging, and may comprise CMOS, precision, analog switches with low power consumption, low leakage currents, and fast switching speeds. - A
processor 440 can be connected to electronic switch 423A,electronic switch 432D,impedance circuitry 420 andECG circuitry 430 to control measurement of the ECG and impedance signals.Processor 430 comprises a tangible medium, for example read only memory (ROM), electrically erasable programmable read only memory (EEPROM) and/or random access memory (RAM). In many embodiments,processor 440 controls the measurements such that the measurements fromimpedance circuitry 420 andECG circuitry 430 are time division multiplexed in response to control signals fromprocessor 440. -
FIG. 4B shows amethod 450 of measuring the impedance signal and the electrocardiogram signal withprocessor 440. Astep 452 closes the switches. Astep 454 drives the force electrodes. Astep 456 measures the impedance signal with the inner electrodes. Astep 458 determines the impedance, hydration and/or respiration from the impedance signal. Astep 460 opens the switches. Astep 462 measures the ECG signal with the outer electrodes. Astep 464 stores the data from the impedance signals and ECG signals. Astep 466 processes the data. Astep 468 transmits the data, for example wirelessly to the remove center. Astep 470 repeats the above steps. - It should be appreciated that the specific steps illustrated in
FIG. 4B provide a particular method of measuring signals, according to an embodiment of the present invention. Other sequences of steps may also be performed according to alternative embodiments. For example, alternative embodiments of the present invention may perform the steps outlined above in a different order. Moreover, the individual steps illustrated inFIG. 4B may include multiple sub-steps that may be performed in various sequences as appropriate to the individual step. Furthermore, additional steps may be added or removed depending on the particular applications. One of ordinary skill in the art would recognize many variations, modifications, and alternatives. -
FIG. 5A shows amethod 500 for monitoring a patient and responding to a signal event. Astep 501 activates a processor system. Astep 503 calculates a risk of sudden cardiac death. Astep 506 reports to a remote center and/or physician. Astep 509 combines at least two of the electrocardiogram signal, respiration signal, and/or activity signals. Astep 512 detects an adverse cardiac event. An adverse cardiac event may comprise an atrial fibrillation in response to the electrocardiogram signal and/or an acute myocardial infarction in response to an ST segment elevation of the electrocardiogram signal. Astep 515 triggers an alarm. Astep 518 continuously monitors and stores in tangible media at least two of the electrocardiogram signal, the respiration signal, or the activity signal. In some embodiments, a step may also comprise monitoring a high risk patent post myocardial infarction with the at least two of the electrocardiogram signal, the respiration signal or the activity signal, and/or a bradycardia of the patient at risk for sudden death. The electrocardiogram signal may comprise at least one of a Brugada Syndrome with an ST elevation and a short QT interval or long-QT interval. Astep 521 loop records the aforementioned data. Astep 524 determines a tiered response. In many embodiments, the tiered response may comprise tiers, or levels, appropriate to the detected status of the patient. Astep 527 comprises a first tier response which alerts an emergency responder. Astep 530 comprises a second tier response which alerts a physician. Astep 533 comprises a third tier response which alerts a patient, family, or caregiver. Astep 537 comprises a fourth tier response which alerts a remote center. A tiered response may also comprise of wirelessly transmitting the at least two of the electro cardiogram signal, the respiration signal, or the activity signal with a single wireless hop from a wireless communication circuitry to an intermediate device. - The signals can be combined in many ways. In some embodiments, the signals can be used simultaneously to determine the impending cardiac decompensation.
- In some embodiments, the signals can be combined by using the at least two of the electrocardiogram signal, the respiration signal or the activity signal to look up a value in a previously existing array.
-
TABLE 1 Lookup Table for ECG and Respiration Signals. Heart Rate Respiration A-B bpm C-D bpm E-F bpm U-V per min N N Y W-X per min N Y Y Y-Z per min Y Y Y - Table 1 shows combination of the electrocardiogram signal with the respiration signal to look up a value in a pre-existing array. For example, at a heart rate in the range from A to B bpm and a respiration rate in the range from U to V per minute triggers a response of N. In some embodiments, the values in the table may comprise a tier or level of the response, for example four tiers. In specific embodiments, the values of the look up table can be determined in response to empirical data measured for a patient population of at least about 100 patients, for example measurements on about 1000 to 10,000 patients. The look up table shown in Table 1 illustrates the use of a look up table according to one embodiment, and one will recognize that many variables can be combined with a look up table.
- In some embodiments, the table may comprise a three or more dimensional look up table, and the look up table may comprises a tier, or level, of the response, for example an alarm.
- In some embodiments, the signals may be combined with at least one of adding, subtracting, multiplying, scaling or dividing the at least two of the electrocardiogram signal, the respiration signal or the activity signal. In specific embodiments, the measurement signals can be combined with positive and or negative coefficients determined in response to empirical data measured for a patient population of at least about 100 patients, for example data on about 1000 to 10,000 patients.
- In some embodiments, a weighted combination may combine at least two measurement signals to generate an output value according to a formula of the general form
-
OUTPUT=aX+bY - where a and b comprise positive or negative coefficients determined from empirical data and X, and Z comprise measured signals for the patient, for example at least two of the electrocardiogram signal, the respiration signal or the activity signal. While two coefficients and two variables are shown, the data may be combined with multiplication and/or division. One or more of the variables may be the inverse of a measured variable. In some embodiments, the ECG signal comprises a heart rate signal that can be divided by the activity signal. Work in relation to embodiments of the present invention suggest that an increase in heart rate with a decrease in activity can indicate an impending decompensation. The signals can be combined to generate an output value with an equation of the general form
-
OUTPUT=aX Y+bZ - where X comprise a heart rate signal, Y comprises an activity signal and Z comprises a respiration signal, with each of the coefficients determined in response to empirical data as described above.
- In some embodiments, the data may be combined with a tiered combination. While many tiered combinations can be used a tiered combination with three measurement signals can be expressed as
-
OUTPUT=(ΔX)+(ΔY)+(ΔZ) - where (ΔX), (ΔY), (ΔZ) may comprise change in heart rate signal from baseline, change in respiration signal from baseline and change in activity signal from baseline, and each may have a value of zero or one, based on the values of the signals. For example if the heart rate increase by 10%, (ΔX) can be assigned a value of 1. If respiration increases by 5%, (ΔY) can be assigned a value of 1. If activity decreases below 10% of a baseline value (ΔZ) can be assigned a value of 1. When the output signal is three, a flag may be set to trigger an alarm.
- In some embodiments, the data may be combined with a logic gated combination. While many logic gated combinations can be used, a logic gated combination with three measurement signals can be expressed as
-
OUTPUT=(ΔX) AND (ΔY) AND (ΔZ) - where (ΔX), (ΔY), (ΔZ) may comprise change in heart rate signal from baseline, change in respiration signal from baseline and change in activity signal from baseline, and each may have a value of zero or one, based on the values of the signals. For example if the heart rate increase by 10%, (ΔX) can be assigned a value of 1. If respiration increases by 5%, (ΔY) can be assigned a value of 1. If activity decreases below 10% of a baseline value (ΔZ) can be assigned a value of 1. When each of (ΔX), (ΔY), (ΔZ) is one, the output signal is one, and a flag may be set to trigger an alarm. If any one of (ΔX), (ΔY) or (ΔZ) is zero, the output signal is zero and a flag may be set so as not to trigger an alarm. While a specific example with AND gates has been shown the data can be combined in may ways with known gates for example NAND, NOR, OR, NOT, XOR, XNOR gates. In some embodiments, the gated logic may be embodied in a truth table.
- The processor system, as described above, performs the
methods 500, including many of the steps described above. It should be appreciated that the specific steps illustrated inFIG. 5A provide a particular method of monitoring a patient and responding to a signal event, according to an embodiment of the present invention. Other sequences of steps may also be performed according to alternative embodiments. For example, alternative embodiments of the present invention may perform the steps outlined above in a different order. Moreover, the individual steps illustrated inFIG. 5A may include multiple sub-steps that may be performed in various sequences as appropriate to the individual step. Furthermore, additional steps may be added or removed depending on the particular applications. One of ordinary skill in the art would recognize many variations, modifications, and alternatives. - Experimental Clinical Study
- The protocol below has been used to measure signals from actual patients with an adherent device. These data show that an adherent patch as described above can be continuously adhered for at least one week. These data also show that 90 day continuous in home monitoring can be achieved with a set of 13 patches in which one of the patches is replaced each week. The clinical testing device used an adherent device with modifications, as described more fully below and referred to as the MS system (multi-sensor). Although the clinical device did not include wireless circuitry and processor circuitry supported with the patch adhered to the skin of the patient, these data do show that such a device, as described above, can be made by one of ordinary skill in the art based on the teachings described herein. Additional empirical studies can be conducted on a suitable number of patients.
- MS Clinical System Description
- The MS clinical system includes many of the structure components described above. There is a flexible connection between the electrodes and the flex PCB, for example wires or polyurethane with silver ink. The cover can stretch with the breathable tape on both the clinical device and the above described wireless device. There is generally a gap between the flex PCB and breathable tape in both clinical and above described wireless devices. The tested device used weights to at least partially simulate the weight of wireless and processor circuitry. The adherent device of the MS clinical system comprises four electrodes to measure bioimpedance and ECG signals and a 3-axis accelerometer, as described above. Bioimpedance signals were used to determine patient respiration and patient hydration, and accelerometer signals were used to determine patient activity and posture. The MS clinical adherent patch device comprising the sensors and at least some sensor circuitry were connected to a processor to record data. The processor was connected to the tested adherent device with wires and supported away from the tested adherent patch device, for example around the patient's waist. Data were collected at regular intervals and uploaded to a remote site, as described above.
- Clinical testing of the MS clinical system shows the effectiveness of the structures for continuous adherence of at least one week and data collection, and that patches can be successively removed and replaced by the patient for in-home monitoring. This effectiveness has been shown without requiring fully functional electronics circuitry such as a battery, wireless circuitry and process circuitry on the adherent device. For example, the MS system includes an insert with about 20 g of additional weight. Although an insert with a 20 gram weight was used for the MS clinical device, greater amounts of weight and circuitry can be used, for example about 30-50 g. The patch device may be modified to accommodate additional weight, for example by increasing the size of the adherent surface. The shape of the MS clinical patch is generally elongate, similar to the elongate shape shown above.
- Study Design and Rationale
- The MS System is used in a clinical study of heart failure patients to gather data that can be used to develop an algorithm for diagnosing and predicting impending heart failure decompensation events. Events typically manifest as heart failure-related hospitalization, emergency room or urgent care visits leading to a change in oral or IV diuretic treatment.
- The purpose of the clinical study is to correlate physiological signals recorded by the system to clinical events of acute heart failure decompensation (AHFD). Signals from the patch can be weighted and combined to determine an index that associates physiologic parameters to impending events of decompensation. Patients who have been classified as New York Heart Association class III and IV within the last 12 months and have had a recent AHFD event can be enrolled into the study and are monitored with the MS system for approximately 90 days.
- AHFD events are defined as any of the following:
- 1) Any heart failure related ER, Urgent Care, in-office visit or hospitalization requiring administration of IV diuretics, administration of IV inotropes, or ultrafiltration for fluid removal.
- 2) A change in diuretic, defined as a change in diuretic directed by the health care provider occurring inside a hospital, emergency room, or urgent care setting (i.e. no patient self-directed changes to medications not approved by a health care provider would be included), that satisfies one or more of the following: a) a change in the type of diuretic the patient is taking, b) a dose increase of an existing diuretic, or c) the addition of another diuretic.
- 3) A heart failure decompensation event for which death is the outcome.
- Patients enrolled in the study were asked to replace the patch weekly. The study can enroll at least about 550 patients. The patient was provided with a kit comprising 13 patches for replacement. The patches were placed on alternating left and right sides of the patient's thorax, as described above, to minimize progressive irritation.
- The data collected in the study can be used to develop an algorithm to at least one of detect, diagnose or predict an impending cardiac decompensation. The algorithm can be implemented on a processor system as described above. Known methods can be used to analyze the data, for example splitting the patients into two groups, one to develop parameters for the algorithm and a second group to test the algorithm developed with the first group. In many embodiments, the signal of the algorithm may comprise a simple binary output for impending cardiac decompensation of the patient. The logic output, yes or no, can be determined in response to patient data combined as described above. The logic output may comprise a signal, such as a binary Y or N signal.
- The developed algorithm can be evaluated with composite sensitivity and false positive patient signal status rates. The sensitivity may be defined as the percent of true positive events out of all condition present events, and the false positive patient status signal status rate can be defined as the number of false positive patient status signals per patient-years of follow up. For example, the sensitivity can be at least 50%, for example at least 60%, at least 70%, or even at least 80%. The false positive patient signal status rate may be limited to no more than about 1.1 false positive patient status signals per patient year, for example no more than about 1.0 false positive patient status signals per patient year, no more than about 0.9 false positive patient status signals per patient year, and even no more than about 0.8 false positive patient status signals per patient year.
- Clinical Results
- Clinical data are available for the first 180 patients enrolled in the study.
-
FIGS. 6A and 6B show clinical data measured with an adherent patch device, in accordance with the above protocol.FIG. 6A shows data from a patient with the MS patch adhered to a first patient, and the data was acquired over the 90 day period with the series of 13 patches. The signals measured included Heart Rate (beats per minute), Heart Rate Variability (ms), Respiratory Rate (breaths per minute), Activity (m-G's) and Body Fluid (Ohms).FIG. 6B shows data from a second patient similar toFIG. 6A . - Of the 180 patients who have completed the study with the MS adherent patch, as described above, all patches in all patients adhered continuously without patch failure. In all patients, the first patch adhered continuously for the first week. With the exception of a handful of patient deaths and early withdrawals that were unrelated to device failure, all patients reached the end of 90-day follow-up period having used 13 weekly patches without incident. None of the 180 patients showed skin irritation or damage that required withdrawal from the study.
- The above data show that the wireless adherent patch device can be constructed for in home wireless patient monitoring for an extended period of at least 90 day, in which each patch of a set is continuously adhered to a patient for at least one week and each patch is configured to support the measurement circuitry, the processor, the wireless communication circuitry and the battery with the skin of the patient.
- While the exemplary embodiments have been described in some detail, by way of example and for clarity of understanding, those of skill in the art will recognize that a variety of modifications, adaptations, and changes may be employed. Hence, the scope of the present invention should be limited solely by the appended claims.
Claims (90)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/209,288 US20090076345A1 (en) | 2007-09-14 | 2008-09-12 | Adherent Device with Multiple Physiological Sensors |
US13/598,238 US8795174B2 (en) | 2007-09-14 | 2012-08-29 | Adherent device with multiple physiological sensors |
US14/322,676 US20140330136A1 (en) | 2007-09-14 | 2014-07-02 | Adherent device with multiple physiological sensors |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97253707P | 2007-09-14 | 2007-09-14 | |
US97262907P | 2007-09-14 | 2007-09-14 | |
US5564508P | 2008-05-23 | 2008-05-23 | |
US5566608P | 2008-05-23 | 2008-05-23 | |
US12/209,288 US20090076345A1 (en) | 2007-09-14 | 2008-09-12 | Adherent Device with Multiple Physiological Sensors |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/598,238 Division US8795174B2 (en) | 2007-09-14 | 2012-08-29 | Adherent device with multiple physiological sensors |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090076345A1 true US20090076345A1 (en) | 2009-03-19 |
Family
ID=40452526
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/209,288 Abandoned US20090076345A1 (en) | 2007-09-14 | 2008-09-12 | Adherent Device with Multiple Physiological Sensors |
US12/209,273 Active 2030-08-31 US8116841B2 (en) | 2007-09-14 | 2008-09-12 | Adherent device with multiple physiological sensors |
US13/347,238 Active US8285356B2 (en) | 2007-09-14 | 2012-01-10 | Adherent device with multiple physiological sensors |
US13/598,238 Expired - Fee Related US8795174B2 (en) | 2007-09-14 | 2012-08-29 | Adherent device with multiple physiological sensors |
US13/647,284 Ceased US8818481B2 (en) | 2007-09-14 | 2012-10-08 | Adherent device with multiple physiological sensors |
US14/322,676 Abandoned US20140330136A1 (en) | 2007-09-14 | 2014-07-02 | Adherent device with multiple physiological sensors |
US14/322,435 Active 2030-07-27 US9770182B2 (en) | 2007-09-14 | 2014-07-02 | Adherent device with multiple physiological sensors |
US15/247,458 Expired - Fee Related USRE46926E1 (en) | 2007-09-14 | 2016-08-25 | Adherent device with multiple physiological sensors |
Family Applications After (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/209,273 Active 2030-08-31 US8116841B2 (en) | 2007-09-14 | 2008-09-12 | Adherent device with multiple physiological sensors |
US13/347,238 Active US8285356B2 (en) | 2007-09-14 | 2012-01-10 | Adherent device with multiple physiological sensors |
US13/598,238 Expired - Fee Related US8795174B2 (en) | 2007-09-14 | 2012-08-29 | Adherent device with multiple physiological sensors |
US13/647,284 Ceased US8818481B2 (en) | 2007-09-14 | 2012-10-08 | Adherent device with multiple physiological sensors |
US14/322,676 Abandoned US20140330136A1 (en) | 2007-09-14 | 2014-07-02 | Adherent device with multiple physiological sensors |
US14/322,435 Active 2030-07-27 US9770182B2 (en) | 2007-09-14 | 2014-07-02 | Adherent device with multiple physiological sensors |
US15/247,458 Expired - Fee Related USRE46926E1 (en) | 2007-09-14 | 2016-08-25 | Adherent device with multiple physiological sensors |
Country Status (3)
Country | Link |
---|---|
US (8) | US20090076345A1 (en) |
EP (1) | EP2194847A1 (en) |
WO (1) | WO2009036313A1 (en) |
Cited By (178)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080270051A1 (en) * | 2005-08-02 | 2008-10-30 | Impedimed Limited | Impedance Parameter Values |
US20080306562A1 (en) * | 2007-06-07 | 2008-12-11 | Donnelly Edward J | Medical device configured to test for user responsiveness |
US20080306560A1 (en) * | 2007-06-06 | 2008-12-11 | Macho John D | Wearable defibrillator with audio input/output |
US20080306325A1 (en) * | 2006-10-02 | 2008-12-11 | Emkinetics | Method and apparatus for magnetic induction therapy |
US20080312709A1 (en) * | 2007-06-13 | 2008-12-18 | Volpe Shane S | Wearable medical treatment device with motion/position detection |
US20090287102A1 (en) * | 2008-02-15 | 2009-11-19 | Impedimed Limited | Blood flow assessment of venous insufficiency |
US20100081960A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | Bioimpedance System and Sensor and Technique for Using the Same |
US20100100003A1 (en) * | 2007-01-15 | 2010-04-22 | Impedimed Limited | Monitoring system |
US20100099958A1 (en) * | 2008-10-16 | 2010-04-22 | Fresenius Medical Care Holdings Inc. | Method of identifying when a patient undergoing hemodialysis is at increased risk of death |
US20100109739A1 (en) * | 2007-03-30 | 2010-05-06 | Impedimed Limited | Active guarding for reduction of resistive and capacitive signal loading with adjustable control of compensation level |
US20100160712A1 (en) * | 2006-10-02 | 2010-06-24 | Daniel Rogers Burnett | Method and apparatus for magnetic induction therapy |
US20100179421A1 (en) * | 2007-05-24 | 2010-07-15 | Joe Tupin | System and method for non-invasive instantaneous and continuous measurement of cardiac chamber volume. |
WO2010105203A2 (en) * | 2009-03-12 | 2010-09-16 | Corventis, Inc. | Method and apparatus for elder care monitoring |
US20100298899A1 (en) * | 2007-06-13 | 2010-11-25 | Donnelly Edward J | Wearable medical treatment device |
US20110021863A1 (en) * | 2009-07-24 | 2011-01-27 | Daniel Rogers Burnett | Cooling systems and methods for conductive coils |
US20110025348A1 (en) * | 2007-11-05 | 2011-02-03 | Impedimed Limited | Impedance determination |
US20110054343A1 (en) * | 2005-07-01 | 2011-03-03 | Impedimed Limited | Monitoring system |
US20110060215A1 (en) * | 2009-03-30 | 2011-03-10 | Tupin Jr Joe Paul | Apparatus and method for continuous noninvasive measurement of respiratory function and events |
US20110087129A1 (en) * | 2005-07-01 | 2011-04-14 | Impedimed Limited | Monitoring system |
WO2011050283A2 (en) | 2009-10-22 | 2011-04-28 | Corventis, Inc. | Remote detection and monitoring of functional chronotropic incompetence |
US20110137136A1 (en) * | 2008-10-16 | 2011-06-09 | Fresenius Medical Care Holdings, Inc. | Method of identifying when a patient undergoing hemodialysis is at increased risk of death |
WO2011081891A1 (en) | 2009-12-14 | 2011-07-07 | Corventis, Inc. | Body adherent patch with electronics for physiologic monitoring |
US20110178375A1 (en) * | 2010-01-19 | 2011-07-21 | Avery Dennison Corporation | Remote physiological monitoring |
US20110178565A1 (en) * | 2010-01-15 | 2011-07-21 | Dan Li | Automatic mechanical alternans detection |
WO2011126951A1 (en) | 2010-04-05 | 2011-10-13 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
US8103337B2 (en) | 2004-11-26 | 2012-01-24 | Impedimed Limited | Weighted gradient method and system for diagnosing disease |
US8116841B2 (en) | 2007-09-14 | 2012-02-14 | Corventis, Inc. | Adherent device with multiple physiological sensors |
US20120108917A1 (en) * | 2008-12-15 | 2012-05-03 | Corventis, Inc. | Patient monitoring systems and methods |
US20120123223A1 (en) * | 2010-11-11 | 2012-05-17 | Freeman Gary A | Acute care treatment systems dashboard |
US20120184878A1 (en) * | 2011-01-13 | 2012-07-19 | Bijan Najafi | Intelligent device to monitor and remind patients with footwear, walking aids, braces, or orthotics |
US20120191151A1 (en) * | 2011-01-21 | 2012-07-26 | Nader Kameli | Implantable cardiac devices and methods with body orientation unit |
US8233974B2 (en) | 1999-06-22 | 2012-07-31 | Impedimed Limited | Method and device for measuring tissue oedema |
WO2012106086A1 (en) | 2011-01-31 | 2012-08-09 | Medtronic, Inc. | External cardiac monitor |
FR2971137A1 (en) * | 2011-02-09 | 2012-08-10 | Univ Nancy 1 Henri Poincare | MOTION SENSOR ASSOCIATED WITH A DIAGNOSTIC ELECTRODE FOR MEDICAL IMAGING APPLICATIONS. |
US8249686B2 (en) | 2007-09-14 | 2012-08-21 | Corventis, Inc. | Adherent device for sleep disordered breathing |
US20120215076A1 (en) * | 2009-08-18 | 2012-08-23 | Ming Young Biomedical Corp. | Product, method and system for monitoring physiological function and posture |
US20120226170A1 (en) * | 2009-11-13 | 2012-09-06 | Omron Healthcare Co., Ltd. | Electronic sphygmomanometer |
WO2012125135A1 (en) * | 2011-03-11 | 2012-09-20 | Spacelabs Healthcare, Llc | Methods and systems to determine multi-parameter managed alarm hierarchy during patient monitoring |
US8374688B2 (en) | 2007-09-14 | 2013-02-12 | Corventis, Inc. | System and methods for wireless body fluid monitoring |
US8406842B2 (en) | 2010-12-09 | 2013-03-26 | Zoll Medical Corporation | Electrode with redundant impedance reduction |
US8412317B2 (en) | 2008-04-18 | 2013-04-02 | Corventis, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
US8460189B2 (en) | 2007-09-14 | 2013-06-11 | Corventis, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
US8478418B2 (en) | 2011-04-15 | 2013-07-02 | Infobionic, Inc. | Remote health monitoring system |
US8588884B2 (en) | 2010-05-28 | 2013-11-19 | Emkinetics, Inc. | Microneedle electrode |
US8600486B2 (en) | 2011-03-25 | 2013-12-03 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
US20140031663A1 (en) * | 2011-02-03 | 2014-01-30 | Isansys Lifecare Limited | Health Monitoring |
US8644925B2 (en) | 2011-09-01 | 2014-02-04 | Zoll Medical Corporation | Wearable monitoring and treatment device |
US8684925B2 (en) | 2007-09-14 | 2014-04-01 | Corventis, Inc. | Injectable device for physiological monitoring |
US8706215B2 (en) | 2010-05-18 | 2014-04-22 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US8718752B2 (en) | 2008-03-12 | 2014-05-06 | Corventis, Inc. | Heart failure decompensation prediction based on cardiac rhythm |
US8761870B2 (en) | 2006-05-30 | 2014-06-24 | Impedimed Limited | Impedance measurements |
US8814792B2 (en) | 2010-07-27 | 2014-08-26 | Carefusion 303, Inc. | System and method for storing and forwarding data from a vital-signs monitor |
WO2014157896A1 (en) * | 2013-03-24 | 2014-10-02 | 서울대학교산학협력단 | Film-type device for measuring biomedical signal, and blood pressure measurement device, cardiopulmonary endurance estimation device, and individual certification device using same |
US8880196B2 (en) | 2013-03-04 | 2014-11-04 | Zoll Medical Corporation | Flexible therapy electrode |
US8897860B2 (en) | 2011-03-25 | 2014-11-25 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
US8897868B2 (en) | 2007-09-14 | 2014-11-25 | Medtronic, Inc. | Medical device automatic start-up upon contact to patient tissue |
KR101489503B1 (en) | 2013-03-24 | 2015-02-04 | 서울대학교산학협력단 | Film-type bio-signal measurement device |
US20150057515A1 (en) * | 2012-04-04 | 2015-02-26 | University Of Cincinnati | Sweat simulation, collecting and sensing systems |
US20150073285A1 (en) * | 2011-05-16 | 2015-03-12 | Alivecor, Inc. | Universal ecg electrode module for smartphone |
US8979665B1 (en) | 2010-03-22 | 2015-03-17 | Bijan Najafi | Providing motion feedback based on user center of mass |
US8983597B2 (en) | 2012-05-31 | 2015-03-17 | Zoll Medical Corporation | Medical monitoring and treatment device with external pacing |
US9002477B2 (en) | 2006-01-17 | 2015-04-07 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
US9007216B2 (en) | 2010-12-10 | 2015-04-14 | Zoll Medical Corporation | Wearable therapeutic device |
US9005141B1 (en) | 2007-10-12 | 2015-04-14 | Biosensics, L.L.C. | Ambulatory system for measuring and monitoring physical activity and risk of falling and for automatic fall detection |
US9005102B2 (en) | 2006-10-02 | 2015-04-14 | Emkinetics, Inc. | Method and apparatus for electrical stimulation therapy |
US9008801B2 (en) | 2010-05-18 | 2015-04-14 | Zoll Medical Corporation | Wearable therapeutic device |
US20150106020A1 (en) * | 2013-10-10 | 2015-04-16 | Wireless Medical Monitoring Inc. | Method and Apparatus for Wireless Health Monitoring and Emergent Condition Prediction |
US9017255B2 (en) | 2010-07-27 | 2015-04-28 | Carefusion 303, Inc. | System and method for saving battery power in a patient monitoring system |
US9017256B2 (en) | 2010-09-22 | 2015-04-28 | Milieu Institute, Llc | System and method for physiological monitoring |
KR101524248B1 (en) * | 2014-02-27 | 2015-05-29 | 서울대학교산학협력단 | System and method for cardiopulmonary fitness estimatiion using film-type bio-signal measurement device |
US9055925B2 (en) | 2010-07-27 | 2015-06-16 | Carefusion 303, Inc. | System and method for reducing false alarms associated with vital-signs monitoring |
US9078582B2 (en) | 2009-04-22 | 2015-07-14 | Lifewave Biomedical, Inc. | Fetal monitoring device and methods |
US9135398B2 (en) | 2011-03-25 | 2015-09-15 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US9152765B2 (en) | 2010-03-21 | 2015-10-06 | Spacelabs Healthcare Llc | Multi-display bedside monitoring system |
US9149235B2 (en) | 2004-06-18 | 2015-10-06 | Impedimed Limited | Oedema detection |
US9173670B2 (en) | 2013-04-08 | 2015-11-03 | Irhythm Technologies, Inc. | Skin abrader |
FR3020959A1 (en) * | 2014-05-19 | 2015-11-20 | Commissariat Energie Atomique | CUTANE DEVICE, IN PARTICULAR PULSE GENERATOR FOR ELECTROSTIMULATION. |
WO2015127466A3 (en) * | 2014-02-24 | 2015-11-26 | Element Science, Inc | External defibrillator |
US9241649B2 (en) | 2010-05-12 | 2016-01-26 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
US9298889B2 (en) | 2007-03-09 | 2016-03-29 | Spacelabs Healthcare Llc | Health data collection tool |
US9311789B1 (en) | 2013-04-09 | 2016-04-12 | BioSensics LLC | Systems and methods for sensorimotor rehabilitation |
US9339641B2 (en) | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
WO2016081227A1 (en) | 2014-11-17 | 2016-05-26 | Medtronic Monitoring, Inc. | Qt interval determination methods and related devices |
US9357929B2 (en) | 2010-07-27 | 2016-06-07 | Carefusion 303, Inc. | System and method for monitoring body temperature of a person |
US9374698B2 (en) * | 2014-08-22 | 2016-06-21 | Verizon Patent And Licensing Inc. | Personalized emergency identification and communication |
US9384652B2 (en) | 2010-11-19 | 2016-07-05 | Spacelabs Healthcare, Llc | System and method for transfer of primary alarm notification on patient monitoring systems |
US9411936B2 (en) | 2007-09-14 | 2016-08-09 | Medtronic Monitoring, Inc. | Dynamic pairing of patients to data collection gateways |
US9420952B2 (en) | 2010-07-27 | 2016-08-23 | Carefusion 303, Inc. | Temperature probe suitable for axillary reading |
US9427165B2 (en) | 2012-03-02 | 2016-08-30 | Medtronic Monitoring, Inc. | Heuristic management of physiological data |
US9427564B2 (en) | 2010-12-16 | 2016-08-30 | Zoll Medical Corporation | Water resistant wearable medical device |
US9504406B2 (en) | 2006-11-30 | 2016-11-29 | Impedimed Limited | Measurement apparatus |
WO2016205187A1 (en) * | 2015-06-15 | 2016-12-22 | Medtronic Monitoring, Inc. | System and method for monitoring and classifying atrial fibrillations |
US9579516B2 (en) | 2013-06-28 | 2017-02-28 | Zoll Medical Corporation | Systems and methods of delivering therapy using an ambulatory medical device |
US9585593B2 (en) | 2009-11-18 | 2017-03-07 | Chung Shing Fan | Signal distribution for patient-electrode measurements |
US9585620B2 (en) * | 2010-07-27 | 2017-03-07 | Carefusion 303, Inc. | Vital-signs patch having a flexible attachment to electrodes |
US9597523B2 (en) | 2014-02-12 | 2017-03-21 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US9597004B2 (en) | 2014-10-31 | 2017-03-21 | Irhythm Technologies, Inc. | Wearable monitor |
US9604020B2 (en) | 2009-10-16 | 2017-03-28 | Spacelabs Healthcare Llc | Integrated, extendable anesthesia system |
US9615767B2 (en) | 2009-10-26 | 2017-04-11 | Impedimed Limited | Fluid level indicator determination |
US9615766B2 (en) | 2008-11-28 | 2017-04-11 | Impedimed Limited | Impedance measurement process |
US9615792B2 (en) | 2010-07-27 | 2017-04-11 | Carefusion 303, Inc. | System and method for conserving battery power in a patient monitoring system |
US9629566B2 (en) | 2011-03-11 | 2017-04-25 | Spacelabs Healthcare Llc | Methods and systems to determine multi-parameter managed alarm hierarchy during patient monitoring |
US9655518B2 (en) | 2009-03-27 | 2017-05-23 | Braemar Manufacturing, Llc | Ambulatory and centralized processing of a physiological signal |
US9684767B2 (en) | 2011-03-25 | 2017-06-20 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US9724012B2 (en) | 2005-10-11 | 2017-08-08 | Impedimed Limited | Hydration status monitoring |
USD794805S1 (en) | 2016-04-29 | 2017-08-15 | Infobionic, Inc. | Health monitoring device with a button |
USD794807S1 (en) | 2016-04-29 | 2017-08-15 | Infobionic, Inc. | Health monitoring device with a display |
USD794806S1 (en) | 2016-04-29 | 2017-08-15 | Infobionic, Inc. | Health monitoring device |
US9782578B2 (en) | 2011-05-02 | 2017-10-10 | Zoll Medical Corporation | Patient-worn energy delivery apparatus and techniques for sizing same |
US9782132B2 (en) | 2012-10-07 | 2017-10-10 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US9797764B2 (en) | 2009-10-16 | 2017-10-24 | Spacelabs Healthcare, Llc | Light enhanced flow tube |
US9814894B2 (en) | 2012-05-31 | 2017-11-14 | Zoll Medical Corporation | Systems and methods for detecting health disorders |
US9848779B2 (en) | 2014-02-24 | 2017-12-26 | Medtronic Monitoring, Inc. | Separable monitoring device and method |
US9872087B2 (en) | 2010-10-19 | 2018-01-16 | Welch Allyn, Inc. | Platform for patient monitoring |
US9878171B2 (en) | 2012-03-02 | 2018-01-30 | Zoll Medical Corporation | Systems and methods for configuring a wearable medical monitoring and/or treatment device |
US9925387B2 (en) | 2010-11-08 | 2018-03-27 | Zoll Medical Corporation | Remote medical device alarm |
US20180116598A1 (en) * | 2016-11-02 | 2018-05-03 | Medtronic Monitoring, Inc. | System and methods of determining etiology of undiagnosed symptomatic events |
US9968274B2 (en) | 2016-04-29 | 2018-05-15 | Infobionic, Inc. | Systems and methods for processing ECG data |
US20180153432A1 (en) * | 2015-04-22 | 2018-06-07 | Falko Skrabal | Body impedance measuring device |
US9999393B2 (en) | 2013-01-29 | 2018-06-19 | Zoll Medical Corporation | Delivery of electrode gel using CPR puck |
US20180206736A1 (en) * | 2017-01-25 | 2018-07-26 | Maisense Inc. | Blood pressure measurement device and method |
US10136831B2 (en) | 2013-10-18 | 2018-11-27 | University Of Cincinnati | Sweat sensing with chronological assurance |
US10203321B2 (en) | 2010-12-02 | 2019-02-12 | Fresenius Medical Care Holdings, Inc. | Method of identifying when a patient undergoing hemodialysis is at increased risk of death |
US10201711B2 (en) | 2014-12-18 | 2019-02-12 | Zoll Medical Corporation | Pacing device with acoustic sensor |
US10244949B2 (en) | 2012-10-07 | 2019-04-02 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US10271754B2 (en) | 2013-01-24 | 2019-04-30 | Irhythm Technologies, Inc. | Physiological monitoring device |
US10307074B2 (en) | 2007-04-20 | 2019-06-04 | Impedimed Limited | Monitoring system and probe |
USD850626S1 (en) | 2013-03-15 | 2019-06-04 | Rhythm Diagnostic Systems, Inc. | Health monitoring apparatuses |
US10321877B2 (en) | 2015-03-18 | 2019-06-18 | Zoll Medical Corporation | Medical device with acoustic sensor |
US10328266B2 (en) | 2012-05-31 | 2019-06-25 | Zoll Medical Corporation | External pacing device with discomfort management |
US10342445B2 (en) | 2016-11-03 | 2019-07-09 | Medtronic Monitoring, Inc. | Method and apparatus for detecting electrocardiographic abnormalities based on monitored high frequency QRS potentials |
US10368810B2 (en) | 2015-07-14 | 2019-08-06 | Welch Allyn, Inc. | Method and apparatus for monitoring a functional capacity of an individual |
US10368847B2 (en) | 2013-10-18 | 2019-08-06 | University Of Cincinnati | Devices for integrated, repeated, prolonged, and/or reliable sweat stimulation and biosensing |
US10405794B2 (en) | 2016-07-19 | 2019-09-10 | Eccrine Systems, Inc. | Sweat conductivity, volumetric sweat rate, and galvanic skin response devices and applications |
US10471249B2 (en) | 2016-06-08 | 2019-11-12 | University Of Cincinnati | Enhanced analyte access through epithelial tissue |
US10485460B2 (en) | 2015-02-13 | 2019-11-26 | University Of Cincinnati | Devices for integrated indirect sweat stimulation and sensing |
US10506968B2 (en) | 2015-10-23 | 2019-12-17 | Eccrine Systems, Inc. | Devices capable of fluid sample concentration for extended sensing of analytes |
US10610159B2 (en) | 2012-10-07 | 2020-04-07 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US10617350B2 (en) | 2015-09-14 | 2020-04-14 | Welch Allyn, Inc. | Method and apparatus for managing a biological condition |
US10639015B2 (en) | 2014-05-28 | 2020-05-05 | University Of Cincinnati | Devices with reduced sweat volumes between sensors and sweat glands |
US10646142B2 (en) | 2015-06-29 | 2020-05-12 | Eccrine Systems, Inc. | Smart sweat stimulation and sensing devices |
US10646707B2 (en) | 2017-11-30 | 2020-05-12 | Zoll Medical Corporation | Medical devices with rapid sensor recovery |
US10674946B2 (en) | 2015-12-18 | 2020-06-09 | Eccrine Systems, Inc. | Sweat sensing devices with sensor abrasion protection |
US10687781B2 (en) * | 2013-03-15 | 2020-06-23 | Nilus Medical Llc | Hemodynamic monitoring device and methods of using same |
US10729910B2 (en) | 2015-11-23 | 2020-08-04 | Zoll Medical Corporation | Garments for wearable medical devices |
US10736565B2 (en) | 2016-10-14 | 2020-08-11 | Eccrine Systems, Inc. | Sweat electrolyte loss monitoring devices |
US10786669B2 (en) | 2006-10-02 | 2020-09-29 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US10791994B2 (en) | 2016-08-04 | 2020-10-06 | Welch Allyn, Inc. | Method and apparatus for mitigating behavior adverse to a biological condition |
US20210000395A1 (en) * | 2017-06-02 | 2021-01-07 | Northwestern University | Microfluidic systems for epidermal sampling and sensing |
US10888244B2 (en) | 2013-10-18 | 2021-01-12 | University Of Cincinnati | Sweat sensing with chronological assurance |
US10918340B2 (en) | 2015-10-22 | 2021-02-16 | Welch Allyn, Inc. | Method and apparatus for detecting a biological condition |
US10932761B2 (en) | 2014-05-28 | 2021-03-02 | University Of Cincinnati | Advanced sweat sensor adhesion, sealing, and fluidic strategies |
US10953234B2 (en) | 2015-08-26 | 2021-03-23 | Element Science, Inc. | Wearable devices |
US10964421B2 (en) | 2015-10-22 | 2021-03-30 | Welch Allyn, Inc. | Method and apparatus for delivering a substance to an individual |
US10973416B2 (en) | 2016-08-02 | 2021-04-13 | Welch Allyn, Inc. | Method and apparatus for monitoring biological conditions |
US10987026B2 (en) | 2013-05-30 | 2021-04-27 | Spacelabs Healthcare Llc | Capnography module with automatic switching between mainstream and sidestream monitoring |
US11009870B2 (en) | 2017-06-06 | 2021-05-18 | Zoll Medical Corporation | Vehicle compatible ambulatory defibrillator |
USD921204S1 (en) | 2013-03-15 | 2021-06-01 | Rds | Health monitoring apparatus |
CN113116355A (en) * | 2019-12-31 | 2021-07-16 | 吴智良 | Physiological monitor |
US11083371B1 (en) | 2020-02-12 | 2021-08-10 | Irhythm Technologies, Inc. | Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network |
US11097107B2 (en) | 2012-05-31 | 2021-08-24 | Zoll Medical Corporation | External pacing device with discomfort management |
US11116397B2 (en) | 2015-07-14 | 2021-09-14 | Welch Allyn, Inc. | Method and apparatus for managing sensors |
US11129554B2 (en) | 2014-05-28 | 2021-09-28 | University Of Cincinnati | Sweat monitoring and control of drug delivery |
US11224742B2 (en) | 2006-10-02 | 2022-01-18 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
US11246523B1 (en) | 2020-08-06 | 2022-02-15 | Irhythm Technologies, Inc. | Wearable device with conductive traces and insulator |
US11253715B2 (en) | 2018-10-10 | 2022-02-22 | Element Science, Inc. | Wearable medical device with disposable and reusable components |
US11253190B2 (en) | 2016-07-01 | 2022-02-22 | University Of Cincinnati | Devices with reduced microfluidic volume between sensors and sweat glands |
US11317835B2 (en) | 2014-09-22 | 2022-05-03 | University Of Cincinnati | Sweat sensing with analytical assurance |
US11350864B2 (en) | 2020-08-06 | 2022-06-07 | Irhythm Technologies, Inc. | Adhesive physiological monitoring device |
US11375930B2 (en) | 2018-02-01 | 2022-07-05 | Samsung Electronics Co., Ltd. | Electronic device for sensing biometric information and control method thereof |
US11406307B2 (en) * | 2018-12-21 | 2022-08-09 | Biosense Webster (Israel) Ltd. | Impedance measurements using burst pulses to prevent noise on ECG |
US11523766B2 (en) | 2020-06-25 | 2022-12-13 | Spacelabs Healthcare L.L.C. | Systems and methods of analyzing and displaying ambulatory ECG data |
US11568984B2 (en) | 2018-09-28 | 2023-01-31 | Zoll Medical Corporation | Systems and methods for device inventory management and tracking |
US11571561B2 (en) | 2019-10-09 | 2023-02-07 | Zoll Medical Corporation | Modular electrical therapy device |
US11590354B2 (en) | 2018-12-28 | 2023-02-28 | Zoll Medical Corporation | Wearable medical device response mechanisms and methods of use |
US11617538B2 (en) | 2016-03-14 | 2023-04-04 | Zoll Medical Corporation | Proximity based processing systems and methods |
US11890461B2 (en) | 2018-09-28 | 2024-02-06 | Zoll Medical Corporation | Adhesively coupled wearable medical device |
US11903700B2 (en) | 2019-08-28 | 2024-02-20 | Rds | Vital signs monitoring systems and methods |
Families Citing this family (392)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
DK1889198T3 (en) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Pharma-informatics system |
JP5714210B2 (en) | 2005-09-01 | 2015-05-07 | プロテウス デジタル ヘルス, インコーポレイテッド | Implantable wireless communication system |
CA2650920C (en) | 2006-05-02 | 2016-10-18 | Proteus Biomedical, Inc. | Patient customized therapeutic regimens |
US9962098B2 (en) | 2006-06-02 | 2018-05-08 | Global Cardiac Monitors, Inc. | Heart monitor electrode system |
US8858325B2 (en) * | 2006-09-29 | 2014-10-14 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Team electronic gameplay combining different means of control |
SG175681A1 (en) | 2006-10-25 | 2011-11-28 | Proteus Biomedical Inc | Controlled activation ingestible identifier |
US8214007B2 (en) | 2006-11-01 | 2012-07-03 | Welch Allyn, Inc. | Body worn physiological sensor device having a disposable electrode module |
EP2069004A4 (en) | 2006-11-20 | 2014-07-09 | Proteus Digital Health Inc | Active signal processing personal health signal receivers |
MY165532A (en) | 2007-02-01 | 2018-04-02 | Proteus Digital Health Inc | Ingestible event marker systems |
AU2008216170B2 (en) | 2007-02-14 | 2012-07-26 | Otsuka Pharmaceutical Co., Ltd. | In-body power source having high surface area electrode |
WO2008112577A1 (en) | 2007-03-09 | 2008-09-18 | Proteus Biomedical, Inc. | In-body device having a multi-directional transmitter |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
US11330988B2 (en) | 2007-06-12 | 2022-05-17 | Sotera Wireless, Inc. | Body-worn system for measuring continuous non-invasive blood pressure (cNIBP) |
WO2008154643A1 (en) | 2007-06-12 | 2008-12-18 | Triage Wireless, Inc. | Vital sign monitor for measuring blood pressure using optical, electrical, and pressure waveforms |
US8602997B2 (en) | 2007-06-12 | 2013-12-10 | Sotera Wireless, Inc. | Body-worn system for measuring continuous non-invasive blood pressure (cNIBP) |
US11607152B2 (en) | 2007-06-12 | 2023-03-21 | Sotera Wireless, Inc. | Optical sensors for use in vital sign monitoring |
PT2192946T (en) | 2007-09-25 | 2022-11-17 | Otsuka Pharma Co Ltd | In-body device with virtual dipole signal amplification |
EP3087918B1 (en) * | 2007-11-06 | 2018-08-22 | Bio-signal Group Corp. | Device for performing electroencephalography |
ES2661739T3 (en) | 2007-11-27 | 2018-04-03 | Proteus Digital Health, Inc. | Transcorporeal communication systems that employ communication channels |
WO2009089390A2 (en) | 2008-01-08 | 2009-07-16 | Bluesky Medical Group Inc. | Sustained variable negative pressure wound treatment and method of controlling same |
ES2840773T3 (en) | 2008-03-05 | 2021-07-07 | Otsuka Pharma Co Ltd | Multimode Communication Ingestible Event Markers and Systems |
EP2257320A2 (en) | 2008-03-12 | 2010-12-08 | Bluesky Medical Group Inc. | Negative pressure dressing and method of using same |
CN102159134B (en) | 2008-07-08 | 2015-05-27 | 普罗透斯数字保健公司 | Ingestible event marker data framework |
US20100042012A1 (en) * | 2008-08-15 | 2010-02-18 | Karim Alhussiny | Diagnostic device for remote sensing and transmitting biophysiological signals |
US20150201858A1 (en) * | 2008-08-15 | 2015-07-23 | Global Cardiac Monitors, Inc. | Diagnostic device for remote sensing and transmitting biophysiological signals |
US8097926B2 (en) | 2008-10-07 | 2012-01-17 | Mc10, Inc. | Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
US9123614B2 (en) | 2008-10-07 | 2015-09-01 | Mc10, Inc. | Methods and applications of non-planar imaging arrays |
US8389862B2 (en) | 2008-10-07 | 2013-03-05 | Mc10, Inc. | Extremely stretchable electronics |
KR101126153B1 (en) | 2008-12-11 | 2012-03-22 | 프로테우스 바이오메디컬, 인코포레이티드 | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
TWI503101B (en) | 2008-12-15 | 2015-10-11 | Proteus Digital Health Inc | Body-associated receiver and method |
US8771204B2 (en) * | 2008-12-30 | 2014-07-08 | Masimo Corporation | Acoustic sensor assembly |
CA2750158A1 (en) | 2009-01-06 | 2010-07-15 | Proteus Biomedical, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
US8475370B2 (en) | 2009-05-20 | 2013-07-02 | Sotera Wireless, Inc. | Method for measuring patient motion, activity level, and posture along with PTT-based blood pressure |
US11896350B2 (en) | 2009-05-20 | 2024-02-13 | Sotera Wireless, Inc. | Cable system for generating signals for detecting motion and measuring vital signs |
US9492092B2 (en) | 2009-05-20 | 2016-11-15 | Sotera Wireless, Inc. | Method for continuously monitoring a patient using a body-worn device and associated system for alarms/alerts |
US10085657B2 (en) | 2009-06-17 | 2018-10-02 | Sotera Wireless, Inc. | Body-worn pulse oximeter |
US8622922B2 (en) | 2009-09-14 | 2014-01-07 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiration rate |
US11253169B2 (en) | 2009-09-14 | 2022-02-22 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiration rate |
US20110066044A1 (en) | 2009-09-15 | 2011-03-17 | Jim Moon | Body-worn vital sign monitor |
US8527038B2 (en) | 2009-09-15 | 2013-09-03 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8364250B2 (en) | 2009-09-15 | 2013-01-29 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US10806351B2 (en) | 2009-09-15 | 2020-10-20 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8321004B2 (en) | 2009-09-15 | 2012-11-27 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US10420476B2 (en) * | 2009-09-15 | 2019-09-24 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
SE534164C2 (en) * | 2009-10-13 | 2011-05-17 | Quickels Systems Ab | Vacuum-electrode assembly |
US8790268B2 (en) | 2009-10-15 | 2014-07-29 | Masimo Corporation | Bidirectional physiological information display |
US10463340B2 (en) | 2009-10-15 | 2019-11-05 | Masimo Corporation | Acoustic respiratory monitoring systems and methods |
WO2011047216A2 (en) | 2009-10-15 | 2011-04-21 | Masimo Corporation | Physiological acoustic monitoring system |
US8690799B2 (en) | 2009-10-15 | 2014-04-08 | Masimo Corporation | Acoustic respiratory monitoring sensor having multiple sensing elements |
US8834423B2 (en) | 2009-10-23 | 2014-09-16 | University of Pittsburgh—of the Commonwealth System of Higher Education | Dissolvable microneedle arrays for transdermal delivery to human skin |
US20110270112A1 (en) * | 2009-11-02 | 2011-11-03 | Applied Cardiac Systems, Inc. | Multi-Function Health Monitor |
TWI517050B (en) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | System for supply chain management |
BR112012019212A2 (en) | 2010-02-01 | 2017-06-13 | Proteus Digital Health Inc | data collection system |
US20110224499A1 (en) | 2010-03-10 | 2011-09-15 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US9173593B2 (en) | 2010-04-19 | 2015-11-03 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9339209B2 (en) | 2010-04-19 | 2016-05-17 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8747330B2 (en) | 2010-04-19 | 2014-06-10 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8798709B1 (en) * | 2010-04-19 | 2014-08-05 | Neotech Products, Inc. | Dermal sensing package and use |
US9173594B2 (en) | 2010-04-19 | 2015-11-03 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8979765B2 (en) | 2010-04-19 | 2015-03-17 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8888700B2 (en) | 2010-04-19 | 2014-11-18 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US10238362B2 (en) * | 2010-04-26 | 2019-03-26 | Gary And Mary West Health Institute | Integrated wearable device for detection of fetal heart rate and material uterine contractions with wireless communication capability |
KR101048662B1 (en) * | 2010-05-03 | 2011-07-14 | 한국과학기술원 | A body attaching type sensor and monitoring apparatus thereof |
US9228785B2 (en) | 2010-05-04 | 2016-01-05 | Alexander Poltorak | Fractal heat transfer device |
EP2569618B1 (en) | 2010-05-08 | 2017-03-01 | The Regents of the University of California | Sem scanner sensing apparatus, system and methodology for early detection of ulcers |
TWI557672B (en) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device |
CA2807340C (en) | 2010-05-21 | 2019-02-12 | Medicomp, Inc. | Retractable multi-use cardiac monitor |
US9585584B2 (en) | 2010-05-21 | 2017-03-07 | Medicomp, Inc. | Physiological signal monitor with retractable wires |
US9326712B1 (en) | 2010-06-02 | 2016-05-03 | Masimo Corporation | Opticoustic sensor |
US9351654B2 (en) | 2010-06-08 | 2016-05-31 | Alivecor, Inc. | Two electrode apparatus and methods for twelve lead ECG |
US8509882B2 (en) | 2010-06-08 | 2013-08-13 | Alivecor, Inc. | Heart monitoring system usable with a smartphone or computer |
US10493289B2 (en) | 2010-07-09 | 2019-12-03 | Zoll Medical Corporation | System and method for conserving power in a medical device |
US20120029300A1 (en) * | 2010-07-27 | 2012-02-02 | Carefusion 303, Inc. | System and method for reducing false alarms and false negatives based on motion and position sensing |
US8473047B2 (en) | 2010-08-03 | 2013-06-25 | Corventis, Inc. | Multifrequency bioimpedence device and related methods |
US9554725B2 (en) | 2010-08-03 | 2017-01-31 | Medtronic Monitoring, Inc. | Medical device and methods of monitoring a patient with renal dysfunction |
WO2012055029A1 (en) | 2010-10-29 | 2012-05-03 | Orpyx Medical Technologies Inc. | Peripheral sensory and supersensory replacement system |
US9717412B2 (en) | 2010-11-05 | 2017-08-01 | Gary And Mary West Health Institute | Wireless fetal monitoring system |
EP2465415B1 (en) * | 2010-12-20 | 2013-07-03 | General Electric Company | Single-use biomedical sensors |
US10856752B2 (en) | 2010-12-28 | 2020-12-08 | Sotera Wireless, Inc. | Body-worn system for continuous, noninvasive measurement of cardiac output, stroke volume, cardiac power, and blood pressure |
KR101747858B1 (en) * | 2011-01-03 | 2017-06-16 | 삼성전자주식회사 | Electrode for living body and device for measuring living body signal |
US20120197144A1 (en) * | 2011-01-27 | 2012-08-02 | Koninklijke Philips Electronics N.V. | Exchangeable electrode and ecg cable snap connector |
WO2012112885A1 (en) | 2011-02-18 | 2012-08-23 | Sotera Wireless, Inc. | Optical sensor for measuring physiological properties |
EP2675348B1 (en) | 2011-02-18 | 2019-11-06 | Sotera Wireless, Inc. | Modular wrist-worn processor for patient monitoring |
US8482418B1 (en) * | 2011-02-18 | 2013-07-09 | Pursuit Enterprises | Method and apparatus for monitoring and treatment of sleep-related conditions |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
KR101754095B1 (en) * | 2011-04-29 | 2017-07-05 | 인텔렉추얼디스커버리 주식회사 | RFID tag for laundry |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
CN103827914A (en) | 2011-07-21 | 2014-05-28 | 普罗秋斯数字健康公司 | Mobile communication device, system, and method |
US20130053668A1 (en) * | 2011-08-26 | 2013-02-28 | Compose Element Limited | Kit and method for detecting blood sugar |
US9220436B2 (en) * | 2011-09-26 | 2015-12-29 | Covidien Lp | Technique for remanufacturing a BIS sensor |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
US11247040B2 (en) | 2011-11-15 | 2022-02-15 | Neurometrix, Inc. | Dynamic control of transcutaneous electrical nerve stimulation therapy using continuous sleep detection |
US10112040B2 (en) | 2011-11-15 | 2018-10-30 | Neurometrix, Inc. | Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement |
US11259744B2 (en) | 2011-11-15 | 2022-03-01 | Neurometrix, Inc. | Transcutaneous electrical nerve stimulator with automatic detection of leg orientation and leg motion for enhanced sleep analysis, including enhanced transcutaneous electrical nerve stimulation (TENS) using the same |
PT2780073T (en) * | 2011-11-15 | 2017-12-18 | Neurometrix Inc | Apparatus for relieving pain using transcutaneous electrical nerve stimulation |
US9734304B2 (en) | 2011-12-02 | 2017-08-15 | Lumiradx Uk Ltd | Versatile sensors with data fusion functionality |
US9700222B2 (en) | 2011-12-02 | 2017-07-11 | Lumiradx Uk Ltd | Health-monitor patch |
AU2012351988B2 (en) | 2011-12-14 | 2017-05-04 | Impedimed Limited | Devices, systems and methods for determining the relative spatial change in subsurface resistivities across frequencies in tissue |
US9339691B2 (en) | 2012-01-05 | 2016-05-17 | Icon Health & Fitness, Inc. | System and method for controlling an exercise device |
EP4112112A1 (en) | 2012-05-01 | 2023-01-04 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Tip-loaded microneedle arrays for transdermal insertion |
US9277864B2 (en) | 2012-05-24 | 2016-03-08 | Vital Connect, Inc. | Modular wearable sensor device |
US20130331720A1 (en) * | 2012-06-11 | 2013-12-12 | Triomi Medical Innovations, Llc | Electrocardiograph system |
US9042596B2 (en) | 2012-06-14 | 2015-05-26 | Medibotics Llc | Willpower watch (TM)—a wearable food consumption monitor |
US9254099B2 (en) | 2013-05-23 | 2016-02-09 | Medibotics Llc | Smart watch and food-imaging member for monitoring food consumption |
US9536449B2 (en) | 2013-05-23 | 2017-01-03 | Medibotics Llc | Smart watch and food utensil for monitoring food consumption |
US9442100B2 (en) | 2013-12-18 | 2016-09-13 | Medibotics Llc | Caloric intake measuring system using spectroscopic and 3D imaging analysis |
US10314492B2 (en) | 2013-05-23 | 2019-06-11 | Medibotics Llc | Wearable spectroscopic sensor to measure food consumption based on interaction between light and the human body |
US9582035B2 (en) | 2014-02-25 | 2017-02-28 | Medibotics Llc | Wearable computing devices and methods for the wrist and/or forearm |
US9084933B1 (en) | 2012-06-22 | 2015-07-21 | The United States Of America As Represented By The Administrator Of The National Aeronatics And Space Administration | Method and system for physiologically modulating action role-playing open world video games and simulations which use gesture and body image sensing control input devices |
SG10201610941VA (en) * | 2012-06-29 | 2017-02-27 | Sunstar Suisse Sa | Gel pad dispenser |
DE102012106893B4 (en) * | 2012-07-30 | 2016-10-27 | Karlsruher Institut für Technologie | Electrode and measuring device for recording biomedical vital signs |
US9955937B2 (en) | 2012-09-20 | 2018-05-01 | Masimo Corporation | Acoustic patient sensor coupler |
US9171794B2 (en) | 2012-10-09 | 2015-10-27 | Mc10, Inc. | Embedding thin chips in polymer |
US9082025B2 (en) | 2012-10-09 | 2015-07-14 | Mc10, Inc. | Conformal electronics integrated with apparel |
FR2997600B1 (en) * | 2012-10-29 | 2015-12-25 | Controle Instrumentation Et Diagnostic Electroniques Sa Cidelec | SOUND DETECTOR HAVING TWO SENSORS FOR MEASURING SOUND AND STATIC PRESSURE |
CN104936513B (en) | 2012-11-01 | 2018-01-12 | 蓝色火花科技有限公司 | Temperature recording paster |
US9869594B2 (en) * | 2012-11-05 | 2018-01-16 | Steamist, Inc. | Controller for steam bath having multiple temperature sensors |
WO2014074913A1 (en) | 2012-11-08 | 2014-05-15 | Alivecor, Inc. | Electrocardiogram signal detection |
US20140187897A1 (en) * | 2012-12-31 | 2014-07-03 | Perminova Inc. | Body-worn sensor for characterizing patients with heart failure |
US10314509B2 (en) * | 2012-12-31 | 2019-06-11 | Tosense, Inc. | Body-worn sensor for characterizing patients with heart failure |
US9974444B2 (en) * | 2012-12-31 | 2018-05-22 | Tosense, Inc. | Body-worn sensor for characterizing patients with heart failure |
WO2014107700A1 (en) | 2013-01-07 | 2014-07-10 | Alivecor, Inc. | Methods and systems for electrode placement |
GB201317746D0 (en) | 2013-10-08 | 2013-11-20 | Smith & Nephew | PH indicator |
US10244986B2 (en) | 2013-01-23 | 2019-04-02 | Avery Dennison Corporation | Wireless sensor patches and methods of manufacturing |
CN105229168B (en) | 2013-02-20 | 2020-07-17 | 生物纳米基因有限公司 | Characterization of molecules in nanofluids |
WO2015130696A1 (en) | 2014-02-25 | 2015-09-03 | Bionano Genomics, Inc. | Reduction of bias in genomic coverage measurements |
US10844424B2 (en) | 2013-02-20 | 2020-11-24 | Bionano Genomics, Inc. | Reduction of bias in genomic coverage measurements |
US10772522B2 (en) * | 2013-03-12 | 2020-09-15 | Vital Connect, Inc. | Disposable biometric patch device |
US20140275817A1 (en) * | 2013-03-13 | 2014-09-18 | Guardit Technologies, Llc | Portable, Pediatric Medical Diagnostic Device |
WO2014153158A1 (en) | 2013-03-14 | 2014-09-25 | Icon Health & Fitness, Inc. | Strength training apparatus with flywheel and related methods |
US20140285326A1 (en) * | 2013-03-15 | 2014-09-25 | Aliphcom | Combination speaker and light source responsive to state(s) of an organism based on sensor data |
US9254092B2 (en) | 2013-03-15 | 2016-02-09 | Alivecor, Inc. | Systems and methods for processing and analyzing medical data |
WO2014151929A1 (en) | 2013-03-15 | 2014-09-25 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
DE102013205403A1 (en) * | 2013-03-27 | 2014-10-16 | Robert Bosch Gmbh | Method and device for detecting the state of hydration of a human or animal body |
WO2014161000A1 (en) | 2013-03-29 | 2014-10-02 | Neurometrix, Inc. | Detecting cutaneous electrode peeling using electrode-skin impedance |
US10940311B2 (en) | 2013-03-29 | 2021-03-09 | Neurometrix, Inc. | Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means |
WO2014172381A1 (en) | 2013-04-15 | 2014-10-23 | Neurometrix Inc. | Transcutaneous electrical nerves stimulator with automatic detection of user sleep-wake state |
US20140323818A1 (en) * | 2013-04-25 | 2014-10-30 | Melanie Axelgaard | Wireless Physiological Monitoring Device |
US9706647B2 (en) | 2013-05-14 | 2017-07-11 | Mc10, Inc. | Conformal electronics including nested serpentine interconnects |
US10314506B2 (en) * | 2013-05-15 | 2019-06-11 | Polar Electro Oy | Heart activity sensor structure |
BR112015028905A2 (en) | 2013-05-21 | 2017-07-25 | Orpyx Medical Tech Inc | pressure data acquisition set and method of acquiring pressure data |
US9529385B2 (en) | 2013-05-23 | 2016-12-27 | Medibotics Llc | Smart watch and human-to-computer interface for monitoring food consumption |
EP3968263A1 (en) | 2013-06-04 | 2022-03-16 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
CA3184173A1 (en) | 2013-06-06 | 2014-12-11 | Tricord Holdings, L.L.C. | Modular physiologic monitoring systems, kits, and methods |
AU2014301982A1 (en) * | 2013-06-24 | 2016-02-04 | Event Cardio Canada, Inc | Wireless cardiac event recorder |
WO2015002940A2 (en) * | 2013-07-01 | 2015-01-08 | Mayo Foundation For Medical Education And Research | Advanced health monitoring system |
US9247911B2 (en) | 2013-07-10 | 2016-02-02 | Alivecor, Inc. | Devices and methods for real-time denoising of electrocardiograms |
US9782585B2 (en) | 2013-08-27 | 2017-10-10 | Halo Neuro, Inc. | Method and system for providing electrical stimulation to a user |
US9630005B2 (en) | 2013-08-27 | 2017-04-25 | Halo Neuro, Inc. | Method and system for providing electrical stimulation to a user |
EP3038699A4 (en) | 2013-08-27 | 2017-03-29 | Halo Neuro, Inc. | Electrode system for electrical stimulation |
US9486618B2 (en) | 2013-08-27 | 2016-11-08 | Halo Neuro, Inc. | Electrode system for electrical stimulation |
CN105683724B (en) * | 2013-09-19 | 2018-09-14 | 欧莱雅公司 | The system and method that the color and spectrum on surface are measured and classified |
JP6043023B1 (en) | 2013-09-20 | 2016-12-14 | プロテウス デジタル ヘルス, インコーポレイテッド | Method, device and system for receiving and decoding signals in the presence of noise using slicing and warping |
WO2015044722A1 (en) | 2013-09-24 | 2015-04-02 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US9364155B2 (en) | 2013-09-25 | 2016-06-14 | Bardy Diagnostics, Inc. | Self-contained personal air flow sensing monitor |
US10624551B2 (en) | 2013-09-25 | 2020-04-21 | Bardy Diagnostics, Inc. | Insertable cardiac monitor for use in performing long term electrocardiographic monitoring |
US9615763B2 (en) | 2013-09-25 | 2017-04-11 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitor recorder optimized for capturing low amplitude cardiac action potential propagation |
US9345414B1 (en) | 2013-09-25 | 2016-05-24 | Bardy Diagnostics, Inc. | Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer |
US11723575B2 (en) | 2013-09-25 | 2023-08-15 | Bardy Diagnostics, Inc. | Electrocardiography patch |
US10463269B2 (en) | 2013-09-25 | 2019-11-05 | Bardy Diagnostics, Inc. | System and method for machine-learning-based atrial fibrillation detection |
US20190167139A1 (en) | 2017-12-05 | 2019-06-06 | Gust H. Bardy | Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring |
US9545204B2 (en) | 2013-09-25 | 2017-01-17 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch |
US9737224B2 (en) | 2013-09-25 | 2017-08-22 | Bardy Diagnostics, Inc. | Event alerting through actigraphy embedded within electrocardiographic data |
US9655537B2 (en) | 2013-09-25 | 2017-05-23 | Bardy Diagnostics, Inc. | Wearable electrocardiography and physiology monitoring ensemble |
US9433367B2 (en) | 2013-09-25 | 2016-09-06 | Bardy Diagnostics, Inc. | Remote interfacing of extended wear electrocardiography and physiological sensor monitor |
US9433380B1 (en) | 2013-09-25 | 2016-09-06 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch |
US9717433B2 (en) | 2013-09-25 | 2017-08-01 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation |
US10806360B2 (en) | 2013-09-25 | 2020-10-20 | Bardy Diagnostics, Inc. | Extended wear ambulatory electrocardiography and physiological sensor monitor |
US9408551B2 (en) | 2013-11-14 | 2016-08-09 | Bardy Diagnostics, Inc. | System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer |
WO2015048194A1 (en) | 2013-09-25 | 2015-04-02 | Bardy Diagnostics, Inc. | Self-contained personal air flow sensing monitor |
US9655538B2 (en) | 2013-09-25 | 2017-05-23 | Bardy Diagnostics, Inc. | Self-authenticating electrocardiography monitoring circuit |
US11213237B2 (en) | 2013-09-25 | 2022-01-04 | Bardy Diagnostics, Inc. | System and method for secure cloud-based physiological data processing and delivery |
US10736529B2 (en) | 2013-09-25 | 2020-08-11 | Bardy Diagnostics, Inc. | Subcutaneous insertable electrocardiography monitor |
US9700227B2 (en) | 2013-09-25 | 2017-07-11 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation |
US10799137B2 (en) | 2013-09-25 | 2020-10-13 | Bardy Diagnostics, Inc. | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer |
US10667711B1 (en) | 2013-09-25 | 2020-06-02 | Bardy Diagnostics, Inc. | Contact-activated extended wear electrocardiography and physiological sensor monitor recorder |
US10165946B2 (en) | 2013-09-25 | 2019-01-01 | Bardy Diagnostics, Inc. | Computer-implemented system and method for providing a personal mobile device-triggered medical intervention |
US9408545B2 (en) | 2013-09-25 | 2016-08-09 | Bardy Diagnostics, Inc. | Method for efficiently encoding and compressing ECG data optimized for use in an ambulatory ECG monitor |
US9504423B1 (en) | 2015-10-05 | 2016-11-29 | Bardy Diagnostics, Inc. | Method for addressing medical conditions through a wearable health monitor with the aid of a digital computer |
US9619660B1 (en) | 2013-09-25 | 2017-04-11 | Bardy Diagnostics, Inc. | Computer-implemented system for secure physiological data collection and processing |
US10888239B2 (en) | 2013-09-25 | 2021-01-12 | Bardy Diagnostics, Inc. | Remote interfacing electrocardiography patch |
US10433751B2 (en) | 2013-09-25 | 2019-10-08 | Bardy Diagnostics, Inc. | System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data |
US9717432B2 (en) | 2013-09-25 | 2017-08-01 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch using interlaced wire electrodes |
US10433748B2 (en) | 2013-09-25 | 2019-10-08 | Bardy Diagnostics, Inc. | Extended wear electrocardiography and physiological sensor monitor |
US10251576B2 (en) | 2013-09-25 | 2019-04-09 | Bardy Diagnostics, Inc. | System and method for ECG data classification for use in facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer |
US10820801B2 (en) | 2013-09-25 | 2020-11-03 | Bardy Diagnostics, Inc. | Electrocardiography monitor configured for self-optimizing ECG data compression |
US10736531B2 (en) | 2013-09-25 | 2020-08-11 | Bardy Diagnostics, Inc. | Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection |
US9775536B2 (en) | 2013-09-25 | 2017-10-03 | Bardy Diagnostics, Inc. | Method for constructing a stress-pliant physiological electrode assembly |
US10828007B1 (en) | 2013-10-11 | 2020-11-10 | Masimo Corporation | Acoustic sensor with attachment portion |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
USD717955S1 (en) | 2013-11-07 | 2014-11-18 | Bardy Diagnostics, Inc. | Electrocardiography monitor |
USD801528S1 (en) | 2013-11-07 | 2017-10-31 | Bardy Diagnostics, Inc. | Electrocardiography monitor |
USD831833S1 (en) | 2013-11-07 | 2018-10-23 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
USD744659S1 (en) | 2013-11-07 | 2015-12-01 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
USD793566S1 (en) | 2015-09-10 | 2017-08-01 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
USD892340S1 (en) | 2013-11-07 | 2020-08-04 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
CN105813545A (en) | 2013-11-22 | 2016-07-27 | Mc10股份有限公司 | Conformal sensor systems for sensing and analysis of cardiac activity |
EP3073916A1 (en) * | 2013-11-26 | 2016-10-05 | Cardiac Pacemakers, Inc. | Detection of chronic obstructive pulmonary disease exacerbations from breathing patterns |
EP3079571A4 (en) | 2013-12-12 | 2017-08-02 | Alivecor, Inc. | Methods and systems for arrhythmia tracking and scoring |
WO2015100429A1 (en) | 2013-12-26 | 2015-07-02 | Icon Health & Fitness, Inc. | Magnetic resistance mechanism in a cable machine |
WO2015123157A1 (en) * | 2014-02-14 | 2015-08-20 | Zansors | Wearable sensor |
US10429888B2 (en) | 2014-02-25 | 2019-10-01 | Medibotics Llc | Wearable computer display devices for the forearm, wrist, and/or hand |
KR20160129007A (en) | 2014-03-04 | 2016-11-08 | 엠씨10, 인크 | Multi-part flexible encapsulation housing for electronic devices |
WO2015138339A1 (en) | 2014-03-10 | 2015-09-17 | Icon Health & Fitness, Inc. | Pressure sensor to quantify work |
US20150257664A1 (en) * | 2014-03-17 | 2015-09-17 | Avatar Engineering Corporation | Heart monitoring sensor |
US9393437B2 (en) | 2014-04-02 | 2016-07-19 | West Affum Holdings Corp. | Pressure resistant conductive fluid containment |
US10621686B2 (en) | 2014-04-16 | 2020-04-14 | Vios Medical, Inc. | Patient care and health information management system |
US10449370B2 (en) | 2014-05-13 | 2019-10-22 | West Affum Holdings Corp. | Network-accessible data about patient with wearable cardiac defibrillator system |
WO2015187377A1 (en) * | 2014-06-02 | 2015-12-10 | Avery Dennison Corporation | Sensor patches |
CN106470739B (en) | 2014-06-09 | 2019-06-21 | 爱康保健健身有限公司 | It is incorporated to the funicular system of treadmill |
WO2015195965A1 (en) | 2014-06-20 | 2015-12-23 | Icon Health & Fitness, Inc. | Post workout massage device |
WO2016030869A1 (en) * | 2014-08-29 | 2016-03-03 | Ecole Polytechnique Federale De Lausanne (Epfl) | Wearable, multi-parametric wireless system-in-patch for hydration level monitoring |
GB2530355A (en) * | 2014-09-16 | 2016-03-23 | Joseph Duncanan Farley | Electric impedance tomographic device |
US10810479B2 (en) * | 2014-09-22 | 2020-10-20 | Idion | Cutaneous information devices and methods to manufacture the same |
USD781270S1 (en) | 2014-10-15 | 2017-03-14 | Mc10, Inc. | Electronic device having antenna |
US9833607B2 (en) | 2014-10-30 | 2017-12-05 | West Affum Holdings Corp. | Wearable cardiac defibrillation system with flexible electrodes |
US11540762B2 (en) | 2014-10-30 | 2023-01-03 | West Affum Holdings Dac | Wearable cardioverter defibrtillator with improved ECG electrodes |
JP2016126897A (en) * | 2014-12-26 | 2016-07-11 | 株式会社東芝 | Fitting apparatus and electronic device |
US9693689B2 (en) | 2014-12-31 | 2017-07-04 | Blue Spark Technologies, Inc. | Body temperature logging patch |
US20160206224A1 (en) * | 2015-01-20 | 2016-07-21 | Medicomp, Inc. | Ecg electrode snap connector and associated methods |
US10251605B2 (en) | 2015-02-16 | 2019-04-09 | Verily Life Sciences Llc | Bandage type of continuous glucose monitoring system |
US10154460B1 (en) | 2015-02-17 | 2018-12-11 | Halo Wearables LLC | Power management for wearable devices |
CN107530004A (en) | 2015-02-20 | 2018-01-02 | Mc10股份有限公司 | The automatic detection and construction of wearable device based on personal situation, position and/or orientation |
US10391361B2 (en) | 2015-02-27 | 2019-08-27 | Icon Health & Fitness, Inc. | Simulating real-world terrain on an exercise device |
US10098544B2 (en) | 2015-03-11 | 2018-10-16 | Medicomp, Inc. | Wireless ECG sensor system and method |
US10201295B2 (en) | 2015-03-13 | 2019-02-12 | Verily Life Sciences Llc | User interactions for a bandage type monitoring device |
WO2016149673A1 (en) | 2015-03-18 | 2016-09-22 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bioactive components conjugated to substrates of microneedle arrays |
US10272010B2 (en) | 2015-03-20 | 2019-04-30 | Zoll Medical Corporation | Systems and methods for testing a medical device |
US10835449B2 (en) | 2015-03-30 | 2020-11-17 | Zoll Medical Corporation | Modular components for medical devices |
KR101614153B1 (en) * | 2015-04-14 | 2016-05-11 | (주)하늘마음바이오 | Gel Type Electrode Unit for High Frequency Treatment Apparatus |
US10182740B2 (en) | 2015-04-24 | 2019-01-22 | Bruin Biometrics, Llc | Apparatus and methods for determining damaged tissue using sub-epidermal moisture measurements |
JP2018518227A (en) * | 2015-05-08 | 2018-07-12 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Wet / dry convertible electrode and method of use |
US9839363B2 (en) | 2015-05-13 | 2017-12-12 | Alivecor, Inc. | Discordance monitoring |
WO2016187536A1 (en) * | 2015-05-20 | 2016-11-24 | Mc10 Inc. | Ultra-thin wearable sensing device |
US10292630B2 (en) | 2015-06-01 | 2019-05-21 | Verily Life Sciences Llc | Optical sensor for bandage type monitoring device |
WO2016201135A1 (en) * | 2015-06-10 | 2016-12-15 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch |
WO2016205385A1 (en) * | 2015-06-15 | 2016-12-22 | Mc10, Inc. | Moisture wicking adhesives for skin-mounted devices |
US10765353B2 (en) | 2015-07-02 | 2020-09-08 | Verily Life Sciences Llc | Calibration methods for a bandage-type analyte sensor |
US9706269B2 (en) * | 2015-07-24 | 2017-07-11 | Hong Kong Applied Science and Technology Research Institute Company, Limited | Self-powered and battery-assisted CMOS wireless bio-sensing IC platform |
US10105100B2 (en) | 2015-07-28 | 2018-10-23 | Verily Life Sciences Llc | Display on a bandage-type monitoring device |
US10383527B2 (en) | 2015-08-31 | 2019-08-20 | Masimo Corporation | Wireless patient monitoring systems and methods |
US10252070B2 (en) | 2015-09-08 | 2019-04-09 | Zoll Medical Corporation | Secure limited components for use with medical devices |
USD766447S1 (en) | 2015-09-10 | 2016-09-13 | Bardy Diagnostics, Inc. | Extended wear electrode patch |
US11272864B2 (en) | 2015-09-14 | 2022-03-15 | Health Care Originals, Inc. | Respiratory disease monitoring wearable apparatus |
PL3349844T3 (en) | 2015-09-15 | 2021-09-27 | I-Lumen Scientific, Inc. | Apparatus for ocular microcurrent stimulation therapy |
CN108290070A (en) | 2015-10-01 | 2018-07-17 | Mc10股份有限公司 | Method and system for interacting with virtual environment |
US10827932B2 (en) | 2015-10-02 | 2020-11-10 | Cardiac Pacemakers, Inc. | Predictions of worsening heart failure |
CN108289630A (en) | 2015-10-05 | 2018-07-17 | Mc10股份有限公司 | Method and system for nerve modulation and stimulation |
US11083399B2 (en) | 2015-10-05 | 2021-08-10 | Infobionic, Inc. | Electrode patch for health monitoring |
US10327657B2 (en) * | 2015-10-05 | 2019-06-25 | Infobionic, Inc. | Electrode patch for health monitoring |
US10932683B2 (en) | 2015-10-12 | 2021-03-02 | Musc Foundation For Research Development | Needle electrode fixation device and associated methods |
JP6605134B2 (en) * | 2015-10-12 | 2019-11-13 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Multilayer surface electrode |
US11684763B2 (en) | 2015-10-16 | 2023-06-27 | University of Pittsburgh—of the Commonwealth System of Higher Education | Multi-component bio-active drug delivery and controlled release to the skin by microneedle array devices |
WO2017075086A1 (en) | 2015-10-26 | 2017-05-04 | Halo Neuro, Inc. | Electrode positioning system and method |
WO2017073861A1 (en) * | 2015-10-30 | 2017-05-04 | (주)하늘마음바이오 | Gel-type electrode unit for high frequency treatment device |
KR101786531B1 (en) * | 2015-11-05 | 2017-10-18 | 재단법인 구미전자정보기술원 | A method for manufacturing a patch type wearable temperature sensor |
US11744889B2 (en) | 2016-01-05 | 2023-09-05 | University of Pittsburgh—of the Commonwealth System of Higher Education | Skin microenvironment targeted delivery for promoting immune and other responses |
US11709747B2 (en) | 2016-01-08 | 2023-07-25 | Zoll Medical Corporation | Patient assurance system and method |
US11020035B2 (en) * | 2016-02-01 | 2021-06-01 | Epitel, Inc. | Self-contained EEG recording system |
EP3413966A4 (en) | 2016-02-08 | 2019-11-27 | Halo Neuro, Inc. | Method and system for improving provision of electrical stimulation |
WO2017147053A1 (en) | 2016-02-22 | 2017-08-31 | Mc10, Inc. | System, device, and method for coupled hub and sensor node on-body acquisition of sensor information |
US10277386B2 (en) | 2016-02-22 | 2019-04-30 | Mc10, Inc. | System, devices, and method for on-body data and power transmission |
US10625137B2 (en) | 2016-03-18 | 2020-04-21 | Icon Health & Fitness, Inc. | Coordinated displays in an exercise device |
US10272317B2 (en) | 2016-03-18 | 2019-04-30 | Icon Health & Fitness, Inc. | Lighted pace feature in a treadmill |
US10493349B2 (en) | 2016-03-18 | 2019-12-03 | Icon Health & Fitness, Inc. | Display on exercise device |
US10729900B2 (en) | 2016-03-29 | 2020-08-04 | Zoll Medical Corporation | Configurable electrodes and sensors |
US10674911B2 (en) | 2016-03-30 | 2020-06-09 | Zoll Medical Corporation | Systems and methods of integrating ambulatory medical devices |
US10426342B2 (en) | 2016-03-31 | 2019-10-01 | Zoll Medical Corporation | Remote access for ambulatory medical device |
FR3050024A1 (en) * | 2016-04-08 | 2017-10-13 | Henri Cedric Steeves Vouters | ADAPTER FOR INCLINOMETER (TYPE D7E-3) |
CN109310340A (en) | 2016-04-19 | 2019-02-05 | Mc10股份有限公司 | For measuring the method and system of sweat |
US10888281B2 (en) | 2016-05-13 | 2021-01-12 | PercuSense, Inc. | System and method for disease risk assessment and treatment |
WO2017195038A1 (en) | 2016-05-13 | 2017-11-16 | Smith & Nephew Plc | Sensor enabled wound monitoring and therapy apparatus |
US10955269B2 (en) * | 2016-05-20 | 2021-03-23 | Health Care Originals, Inc. | Wearable apparatus |
EP3251585A1 (en) * | 2016-05-30 | 2017-12-06 | Roche Diabetes Care GmbH | Body-mountable device |
US10485443B2 (en) | 2016-06-20 | 2019-11-26 | Halo Neuro, Inc. | Electrical interface system |
WO2018013668A1 (en) | 2016-07-12 | 2018-01-18 | Alexander Poltorak | System and method for maintaining efficiency of a heat sink |
US9954309B2 (en) | 2016-07-20 | 2018-04-24 | Intel Corporation | Magnetic detachable electrical connections between circuits |
US9735893B1 (en) * | 2016-07-21 | 2017-08-15 | Intel Corporation | Patch system for in-situ therapeutic treatment |
CN111493872B (en) | 2016-07-22 | 2023-05-05 | 大冢制药株式会社 | Electromagnetic sensing and detection of ingestible event markers |
US11213409B2 (en) * | 2016-08-11 | 2022-01-04 | Willowwood Global Llc | Conductive human interfaces |
US10447347B2 (en) | 2016-08-12 | 2019-10-15 | Mc10, Inc. | Wireless charger and high speed data off-loader |
JP6972523B2 (en) * | 2016-09-13 | 2021-11-24 | セイコーエプソン株式会社 | Electronics |
US20180070850A1 (en) * | 2016-09-15 | 2018-03-15 | Karen S. Stafford | Apparatus and method for detecting body composition and correlating it with cognitive efficiency |
US10039186B2 (en) | 2016-09-16 | 2018-07-31 | Intel Corporation | Stretchable and flexible electrical substrate interconnections |
JPWO2018051493A1 (en) * | 2016-09-16 | 2019-06-24 | 富士通株式会社 | Electronic device and method of manufacturing electronic device |
US10671705B2 (en) | 2016-09-28 | 2020-06-02 | Icon Health & Fitness, Inc. | Customizing recipe recommendations |
US9893438B1 (en) | 2016-09-30 | 2018-02-13 | Intel Corporation | Electrical connectors for high density attach to stretchable boards |
US10940323B2 (en) | 2016-10-04 | 2021-03-09 | West Affum Holdings Corp. | Wearable cardioverter defibrillator (WCD) with power-saving function |
JP7197473B2 (en) | 2016-10-13 | 2022-12-27 | マシモ・コーポレイション | System and method for patient fall detection |
US11052241B2 (en) | 2016-11-03 | 2021-07-06 | West Affum Holdings Corp. | Wearable cardioverter defibrillator (WCD) system measuring patient's respiration |
US10524726B2 (en) | 2016-11-17 | 2020-01-07 | Biointellisense, Inc. | Medication adherence and/or counterfeit detection wearable electronic device |
US10835205B2 (en) * | 2016-12-06 | 2020-11-17 | Gerardo Rodriquez | Stand-alone continuous cardiac doppler pulse monitoring patch with integral visual and auditory alerts, and patch-display system and method |
WO2018119424A1 (en) | 2016-12-23 | 2018-06-28 | Neurometrix, Inc. | Smart"electrode assembly for transcutaneous electrical nerve stimulation (tens) |
US11154230B2 (en) | 2017-01-05 | 2021-10-26 | West Affum Holdings Corp. | Wearable cardioverter defibrillator having reduced noise prompts |
US11400303B2 (en) | 2018-01-05 | 2022-08-02 | West Affum Holdings Corp. | Detecting walking in a wearable cardioverter defibrillator system |
US11938333B2 (en) | 2017-01-05 | 2024-03-26 | West Affum Holdings Dac | Detecting walking in a wearable cardioverter defibrillator system |
US11083906B2 (en) | 2017-01-05 | 2021-08-10 | West Affum Holdings Corp. | Wearable cardioverter defibrillator having adjustable alarm time |
US10926080B2 (en) | 2017-01-07 | 2021-02-23 | West Affum Holdings Corp. | Wearable cardioverter defibrillator with breast support |
GB2600253B (en) | 2017-02-03 | 2022-11-23 | Bruin Biometrics Llc | Measurement of edema |
KR102283395B1 (en) | 2017-02-03 | 2021-07-30 | 브루인 바이오메트릭스, 엘엘씨 | Determination of susceptibility to diabetic foot ulcers |
JP7015305B2 (en) | 2017-02-03 | 2022-02-02 | ブルーイン、バイオメトリクス、リミテッド、ライアビリティー、カンパニー | Measurement of tissue viability |
US11622716B2 (en) | 2017-02-13 | 2023-04-11 | Health Care Originals, Inc. | Wearable physiological monitoring systems and methods |
CN108451523A (en) * | 2017-02-22 | 2018-08-28 | 吴智良 | Rhythm of the heart monitoring device |
US11213691B2 (en) | 2017-02-27 | 2022-01-04 | Zoll Medical Corporation | Ambulatory medical device interaction |
US10512770B2 (en) | 2017-03-08 | 2019-12-24 | Halo Neuro, Inc. | System for electrical stimulation |
WO2018162736A1 (en) | 2017-03-09 | 2018-09-13 | Smith & Nephew Plc | Wound dressing, patch member and method of sensing one or more wound parameters |
US11324424B2 (en) | 2017-03-09 | 2022-05-10 | Smith & Nephew Plc | Apparatus and method for imaging blood in a target region of tissue |
US10111618B2 (en) * | 2017-03-13 | 2018-10-30 | VivaLnk, Inc. | Dual purpose wearable patch for measurement and treatment |
DE102017204491A1 (en) * | 2017-03-17 | 2018-09-20 | Henkel Ag & Co. Kgaa | Method and apparatus for determining skin moisture content |
CN110446464A (en) * | 2017-04-04 | 2019-11-12 | 豪夫迈·罗氏有限公司 | Medical sensor system, especially continuous glucose monitoring system |
SG11201909449TA (en) * | 2017-04-11 | 2019-11-28 | Smith & Nephew | Component positioning and stress relief for sensor enabled wound dressings |
GB201706354D0 (en) * | 2017-04-21 | 2017-06-07 | Surepulse Medical Ltd | Electrocardiogram sensor |
US10456080B2 (en) * | 2017-05-05 | 2019-10-29 | Bloomer Health Tech., Inc. | Padded, flexible encasing for body monitoring systems in fabrics |
EP3635732A1 (en) | 2017-05-15 | 2020-04-15 | Smith & Nephew plc | Wound analysis device and method |
ES2905929T3 (en) * | 2017-05-23 | 2022-04-12 | Hoffmann La Roche | Sensor system and procedure for its manufacture |
US11058877B2 (en) | 2017-05-30 | 2021-07-13 | Neurometrix, Inc. | Apparatus and method for the automated control of transcutaneous electrical nerve stimulation based on current and forecasted weather conditions |
AU2018288530B2 (en) | 2017-06-23 | 2024-03-28 | Smith & Nephew Plc | Positioning of sensors for sensor enabled wound monitoring or therapy |
GB201809007D0 (en) | 2018-06-01 | 2018-07-18 | Smith & Nephew | Restriction of sensor-monitored region for sensor-enabled wound dressings |
GB201804502D0 (en) | 2018-03-21 | 2018-05-02 | Smith & Nephew | Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings |
US11364387B2 (en) | 2017-07-28 | 2022-06-21 | West Affum Holdings Corp. | Heart rate calculator with reduced overcounting |
US10849501B2 (en) | 2017-08-09 | 2020-12-01 | Blue Spark Technologies, Inc. | Body temperature logging patch |
SG11202000913XA (en) | 2017-08-10 | 2020-02-27 | Smith & Nephew | Positioning of sensors for sensor enabled wound monitoring or therapy |
JP2020533093A (en) | 2017-09-10 | 2020-11-19 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Systems and methods for inspecting encapsulation, as well as components within wound dressings equipped with sensors |
GB201804971D0 (en) | 2018-03-28 | 2018-05-09 | Smith & Nephew | Electrostatic discharge protection for sensors in wound therapy |
GB201718870D0 (en) | 2017-11-15 | 2017-12-27 | Smith & Nephew Inc | Sensor enabled wound therapy dressings and systems |
GB201718859D0 (en) | 2017-11-15 | 2017-12-27 | Smith & Nephew | Sensor positioning for sensor enabled wound therapy dressings and systems |
JP7282079B2 (en) | 2017-09-27 | 2023-05-26 | スミス アンド ネフュー ピーエルシー | PH Sensing for Sensor-Enabled Negative Pressure Wound Monitoring and Therapy Devices |
US11839464B2 (en) | 2017-09-28 | 2023-12-12 | Smith & Nephew, Plc | Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus |
CN111182833A (en) | 2017-10-09 | 2020-05-19 | 琼和欧文·雅各布斯以色列理工学院-康奈尔研究所 | System, apparatus and method for detecting and monitoring chronic sleep disorders |
US11844954B2 (en) | 2017-11-09 | 2023-12-19 | West Affum Holdings Dac | WCD monitor supporting serviceability and reprocessing |
US11559438B2 (en) | 2017-11-15 | 2023-01-24 | Smith & Nephew Plc | Integrated sensor enabled wound monitoring and/or therapy dressings and systems |
MX2020005138A (en) | 2017-11-16 | 2020-08-17 | Bruin Biometrics Llc | Strategic treatment of pressure ulcer using sub-epidermal moisture values. |
US10507324B2 (en) | 2017-11-17 | 2019-12-17 | Halo Neuro, Inc. | System and method for individualizing modulation |
WO2019102242A1 (en) | 2017-11-24 | 2019-05-31 | Smartcardia Sa | Monitoring device for monitoring of vital signs |
US11647929B2 (en) * | 2017-12-14 | 2023-05-16 | Cambridge Heartwear Limited | ECG device |
SE541788C2 (en) * | 2017-12-22 | 2019-12-17 | Brighter Ab Publ | Skin patch for diagnosis comprising an evaporation layer |
PL3749181T3 (en) | 2018-02-09 | 2024-06-10 | Bruin Biometrics, Llc | Detection of tissue damage |
US10960213B2 (en) | 2018-03-12 | 2021-03-30 | Zoll Medical Corporation | Verification of cardiac arrhythmia prior to therapeutic stimulation |
US10602945B2 (en) | 2018-03-13 | 2020-03-31 | Zoll Medical Corporation | Telemetry of wearable medical device information to secondary medical device or system |
EP3764886B1 (en) | 2018-03-16 | 2024-01-10 | ZOLL Medical Corporation | Monitoring physiological status based on bio-vibrational and radio frequency data analysis |
US11324960B2 (en) | 2018-04-26 | 2022-05-10 | West Affum Holdings Corp. | Permission-based control of interfacing components with a medical device |
US11833360B2 (en) | 2018-05-29 | 2023-12-05 | West Affum Holdings Dac | Carry pack for a wearable cardioverter defibrillator |
WO2019246086A1 (en) | 2018-06-18 | 2019-12-26 | Zoll Medical Corporation | Medical device for estimating risk of patient deterioration |
US20210113132A1 (en) * | 2018-06-20 | 2021-04-22 | Nypro Inc. | Disposable Health and Vital Signs Monitoring Patch and Making of Same |
US11185287B2 (en) * | 2018-06-22 | 2021-11-30 | Vital Connect, Inc. | Adhesive overlay |
EP3594962A1 (en) * | 2018-07-11 | 2020-01-15 | Koninklijke Philips N.V. | Device, system and method for determining a stress level of a user |
US20210138232A1 (en) * | 2018-08-14 | 2021-05-13 | Neurotrigger Ltd. | Method and apparatus for transcutaneous facial nerve stimulation and applications thereof |
US11872156B2 (en) | 2018-08-22 | 2024-01-16 | Masimo Corporation | Core body temperature measurement |
WO2020053290A1 (en) | 2018-09-12 | 2020-03-19 | Smith & Nephew Plc | Device, apparatus and method of determining skin perfusion pressure |
US10918877B2 (en) | 2018-09-28 | 2021-02-16 | Zoll Medical Corporation | Battery lock for ambulatory medical device |
DK3861601T3 (en) | 2018-10-11 | 2024-02-26 | Bruin Biometrics Llc | Furnishing with element for single use |
CN113164049A (en) * | 2018-10-18 | 2021-07-23 | 波士顿科学医学有限公司 | Multilayer wearable device |
US11357412B2 (en) | 2018-11-20 | 2022-06-14 | 42 Health Sensor Holdings Ltd. | Wearable cardiovascular monitoring device |
US11883661B2 (en) | 2018-12-07 | 2024-01-30 | Neurometrix, Inc. | Intelligent determination of therapeutic stimulation intensity for transcutaneous electrical nerve stimulation |
ES2961009T3 (en) | 2018-12-20 | 2024-03-07 | I Lumen Scient Inc | Microcurrent stimulation therapy system |
GB201820927D0 (en) | 2018-12-21 | 2019-02-06 | Smith & Nephew | Wound therapy systems and methods with supercapacitors |
KR102206105B1 (en) * | 2018-12-31 | 2021-01-22 | 한국과학기술연구원 | Sensor patch |
US11334826B2 (en) | 2019-01-18 | 2022-05-17 | West Affum Holdings Corp. | WCD system prioritization of alerts based on severity and/or required timeliness of user response |
JP2022527042A (en) * | 2019-01-25 | 2022-05-30 | アールディーエス | Health monitoring system and method |
GB2597148B (en) | 2019-03-18 | 2022-12-21 | Smith & Nephew | Design rules for sensor integrated substrates |
US11116451B2 (en) | 2019-07-03 | 2021-09-14 | Bardy Diagnostics, Inc. | Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities |
US11696681B2 (en) | 2019-07-03 | 2023-07-11 | Bardy Diagnostics Inc. | Configurable hardware platform for physiological monitoring of a living body |
US11096579B2 (en) | 2019-07-03 | 2021-08-24 | Bardy Diagnostics, Inc. | System and method for remote ECG data streaming in real-time |
KR102288234B1 (en) * | 2019-08-02 | 2021-08-10 | (주)플렉스파워 | Micro current patch |
US10957453B2 (en) | 2019-08-15 | 2021-03-23 | West Affum Holdings Corp. | WCD system alert issuance and resolution |
GB201914443D0 (en) | 2019-10-07 | 2019-11-20 | Smith & Nephew | Sensor enabled negative pressure wound monitoring apparatus with different impedances inks |
US11344718B2 (en) | 2019-12-12 | 2022-05-31 | West Affum Holdings Corp. | Multichannel posture dependent template based rhythm discrimination in a wearable cardioverter defibrillator |
US11904176B1 (en) | 2020-01-27 | 2024-02-20 | West Affum Holdings Dac | Wearable defibrillator system forwarding patient information based on recipient profile and/or event type |
US20210296008A1 (en) | 2020-03-20 | 2021-09-23 | Masimo Corporation | Health monitoring system for limiting the spread of an infection in an organization |
US20210307672A1 (en) | 2020-04-05 | 2021-10-07 | Epitel, Inc. | Eeg recording and analysis |
USD980091S1 (en) | 2020-07-27 | 2023-03-07 | Masimo Corporation | Wearable temperature measurement device |
USD974193S1 (en) | 2020-07-27 | 2023-01-03 | Masimo Corporation | Wearable temperature measurement device |
US11116973B1 (en) | 2020-10-09 | 2021-09-14 | I-Lumen Scientific, Inc. | System and method for a medical device |
US20220133184A1 (en) * | 2020-10-30 | 2022-05-05 | Medtronic Minimed, Inc. | Low-profile wearable medical device |
TWI756929B (en) * | 2020-11-19 | 2022-03-01 | 準訊生醫股份有限公司 | Circuit connecting module for watertightly electrically connecting device detecting body surface potential |
WO2022109596A1 (en) * | 2020-11-23 | 2022-05-27 | Henkel IP & Holding GmbH | Wearable patches and devices |
CN114583492B (en) * | 2020-12-01 | 2024-01-02 | 吴智良 | Circuit connection module for waterproof electric connection detection body surface potential device |
US11918377B2 (en) * | 2021-01-19 | 2024-03-05 | Medtronic, Inc. | Dry electrodes in a wearable garment |
WO2022169850A1 (en) | 2021-02-03 | 2022-08-11 | Bruin Biometrics, Llc | Methods of treating deep and early-stage pressure induced tissue damage |
JP2022159909A (en) | 2021-04-05 | 2022-10-18 | 日本航空電子工業株式会社 | device |
US11800643B2 (en) * | 2021-04-05 | 2023-10-24 | Japan Aviation Electronics Industry, Limited | Device having closed space between overlapping sealing members |
USD987657S1 (en) | 2021-06-15 | 2023-05-30 | Wesper Inc. | Display screen with animated graphical user interface |
WO2023275342A1 (en) | 2021-07-01 | 2023-01-05 | Datwyler Pharma Packaging Belgium Nv | A flexible and stretchable cover for attaching a component to a patch |
USD1000975S1 (en) | 2021-09-22 | 2023-10-10 | Masimo Corporation | Wearable temperature measurement device |
JP2023113372A (en) * | 2022-02-03 | 2023-08-16 | 日本航空電子工業株式会社 | device |
WO2023183451A1 (en) * | 2022-03-25 | 2023-09-28 | Cardiac Pacemakers, Inc. | Systems and methods to predict mortality risk |
US11857330B1 (en) | 2022-10-19 | 2024-01-02 | Epitel, Inc. | Systems and methods for electroencephalogram monitoring |
Citations (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3170459A (en) * | 1962-03-20 | 1965-02-23 | Clifford G Phipps | Bio-medical instrumentation electrode |
US3370459A (en) * | 1964-04-16 | 1968-02-27 | Cescati Arturo | Device for detecting pressure existing in pneumatic tires |
US4008712A (en) * | 1975-11-14 | 1977-02-22 | J. M. Richards Laboratories | Method for monitoring body characteristics |
US4141366A (en) * | 1977-11-18 | 1979-02-27 | Medtronic, Inc. | Lead connector for tape electrode |
US4185621A (en) * | 1977-10-28 | 1980-01-29 | Triad, Inc. | Body parameter display incorporating a battery charger |
US4308872A (en) * | 1977-04-07 | 1982-01-05 | Respitrace Corporation | Method and apparatus for monitoring respiration |
US4498479A (en) * | 1981-06-24 | 1985-02-12 | Kone Oy | Electrocardiograph (ECG) electrode testing system |
US4721110A (en) * | 1984-08-06 | 1988-01-26 | Lampadius Michael S | Respiration-controlled cardiac pacemaker |
US4895163A (en) * | 1988-05-24 | 1990-01-23 | Bio Analogics, Inc. | System for body impedance data acquisition |
US4981139A (en) * | 1983-08-11 | 1991-01-01 | Pfohl Robert L | Vital signs monitoring and communication system |
US4988335A (en) * | 1988-08-16 | 1991-01-29 | Ideal Instruments, Inc. | Pellet implanter apparatus |
US5080099A (en) * | 1988-08-26 | 1992-01-14 | Cardiotronics, Inc. | Multi-pad, multi-function electrode |
US5083563A (en) * | 1990-02-16 | 1992-01-28 | Telectronics Pacing Systems, Inc. | Implantable automatic and haemodynamically responsive cardioverting/defibrillating pacemaker |
US5086781A (en) * | 1989-11-14 | 1992-02-11 | Bookspan Mark A | Bioelectric apparatus for monitoring body fluid compartments |
US5282840A (en) * | 1992-03-26 | 1994-02-01 | Medtronic, Inc. | Multiple frequency impedance measurement system |
US5482036A (en) * | 1991-03-07 | 1996-01-09 | Masimo Corporation | Signal processing apparatus and method |
US5718234A (en) * | 1996-09-30 | 1998-02-17 | Northrop Grumman Corporation | Physiological data communication system |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US5860860A (en) * | 1996-01-31 | 1999-01-19 | Federal Patent Corporation | Integral video game and cardio-waveform display |
US5862802A (en) * | 1981-04-03 | 1999-01-26 | Forrest M. Bird | Ventilator having an oscillatory inspiratory phase and method |
US5862803A (en) * | 1993-09-04 | 1999-01-26 | Besson; Marcus | Wireless medical diagnosis and monitoring equipment |
US5865733A (en) * | 1997-02-28 | 1999-02-02 | Spacelabs Medical, Inc. | Wireless optical patient monitoring apparatus |
US6027523A (en) * | 1997-10-06 | 2000-02-22 | Arthrex, Inc. | Suture anchor with attached disk |
US6181963B1 (en) * | 1998-11-02 | 2001-01-30 | Alza Corporation | Transdermal electrotransport delivery device including a cathodic reservoir containing a compatible antimicrobial agent |
US6185452B1 (en) * | 1997-02-26 | 2001-02-06 | Joseph H. Schulman | Battery-powered patient implantable device |
US6190324B1 (en) * | 1999-04-28 | 2001-02-20 | Medtronic, Inc. | Implantable medical device for tracking patient cardiac status |
US6190313B1 (en) * | 1998-04-20 | 2001-02-20 | Allen J. Hinkle | Interactive health care system and method |
US6336903B1 (en) * | 1999-11-16 | 2002-01-08 | Cardiac Intelligence Corp. | Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof |
US6339722B1 (en) * | 1995-09-26 | 2002-01-15 | A. J. Van Liebergen Holding B.V. | Apparatus for the in-vivo non-invasive measurement of a biological parameter concerning a bodily fluid of a person or animal |
US20020019588A1 (en) * | 2000-06-23 | 2002-02-14 | Marro Dominic P. | Frontal electrode array for patient EEG signal acquisition |
US20030009092A1 (en) * | 1998-10-15 | 2003-01-09 | Sensidyne, Inc. | Reusable pulse oximeter probe and disposable bandage apparatus |
US6512949B1 (en) * | 1999-07-12 | 2003-01-28 | Medtronic, Inc. | Implantable medical device for measuring time varying physiologic conditions especially edema and for responding thereto |
US20030023184A1 (en) * | 2001-07-23 | 2003-01-30 | Jonathan Pitts-Crick | Method and system for diagnosing and administering therapy of pulmonary congestion |
US20030028221A1 (en) * | 2001-07-31 | 2003-02-06 | Qingsheng Zhu | Cardiac rhythm management system for edema |
US20030028321A1 (en) * | 2001-06-29 | 2003-02-06 | The Regents Of The University Of California | Method and apparatus for ultra precise GPS-based mapping of seeds or vegetation during planting |
US6520967B1 (en) * | 1999-10-20 | 2003-02-18 | Cauthen Research Group, Inc. | Spinal implant insertion instrument for spinal interbody prostheses |
US20040006279A1 (en) * | 2002-07-03 | 2004-01-08 | Shimon Arad (Abboud) | Apparatus for monitoring CHF patients using bio-impedance technique |
US20040010303A1 (en) * | 2001-09-26 | 2004-01-15 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
US6687540B2 (en) * | 1999-03-12 | 2004-02-03 | Cardiac Pacemakers, Inc. | Discrimination of supraventricular tachycardia and ventricular tachycardia events |
US6697658B2 (en) * | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
US20050015095A1 (en) * | 2003-07-15 | 2005-01-20 | Cervitech, Inc. | Insertion instrument for cervical prostheses |
US20050015094A1 (en) * | 2003-07-15 | 2005-01-20 | Cervitech, Inc. | Arrangement of a cervical prosthesis and insertion instrument |
US20050020935A1 (en) * | 2001-11-20 | 2005-01-27 | Thomas Helzel | Electrode for biomedical measurements |
US20050027204A1 (en) * | 2003-06-26 | 2005-02-03 | Kligfield Paul D. | ECG diagnostic system and method |
US20050027175A1 (en) * | 2003-07-31 | 2005-02-03 | Zhongping Yang | Implantable biosensor |
US20050027918A1 (en) * | 2002-12-23 | 2005-02-03 | Microtune (Texas), L.P. | Automatically establishing a wireless connection between adapters |
US20050027207A1 (en) * | 2000-12-29 | 2005-02-03 | Westbrook Philip R. | Sleep apnea risk evaluation |
US6858006B2 (en) * | 2000-09-08 | 2005-02-22 | Wireless Medical, Inc. | Cardiopulmonary monitoring |
US20050043675A1 (en) * | 2003-08-21 | 2005-02-24 | Pastore Joseph M. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
US20050113703A1 (en) * | 2003-09-12 | 2005-05-26 | Jonathan Farringdon | Method and apparatus for measuring heart related parameters |
US20050192488A1 (en) * | 2004-02-12 | 2005-09-01 | Biopeak Corporation | Non-invasive method and apparatus for determining a physiological parameter |
US20060004300A1 (en) * | 2002-11-22 | 2006-01-05 | James Kennedy | Multifrequency bioimpedance determination |
US6985078B2 (en) * | 2000-03-14 | 2006-01-10 | Kabushiki Kaisha Toshiba | Wearable life support apparatus and method |
US20060010090A1 (en) * | 2004-07-12 | 2006-01-12 | Marina Brockway | Expert system for patient medical information analysis |
US20060009697A1 (en) * | 2004-04-07 | 2006-01-12 | Triage Wireless, Inc. | Wireless, internet-based system for measuring vital signs from a plurality of patients in a hospital or medical clinic |
US20060009701A1 (en) * | 2004-06-29 | 2006-01-12 | Polar Electro Oy | Method of monitoring human relaxation level, and user-operated heart rate monitor |
US6987965B2 (en) * | 2000-04-18 | 2006-01-17 | Motorola, Inc. | Programmable wireless electrode system for medical monitoring |
US6988989B2 (en) * | 2000-05-19 | 2006-01-24 | Welch Allyn Protocol, Inc. | Patient monitoring system |
US20060020218A1 (en) * | 2004-02-26 | 2006-01-26 | Warwick Freeman | Method and apparatus for continuous electrode impedance monitoring |
US6993378B2 (en) * | 2001-06-25 | 2006-01-31 | Science Applications International Corporation | Identification by analysis of physiometric variation |
US20060025661A1 (en) * | 2004-08-02 | 2006-02-02 | Sweeney Robert J | Device for monitoring fluid status |
US20060030781A1 (en) * | 2004-08-05 | 2006-02-09 | Adnan Shennib | Emergency heart sensor patch |
US20060031102A1 (en) * | 2000-06-16 | 2006-02-09 | Bodymedia, Inc. | System for detecting, monitoring, and reporting an individual's physiological or contextual status |
US20060030782A1 (en) * | 2004-08-05 | 2006-02-09 | Adnan Shennib | Heart disease detection patch |
US6997879B1 (en) * | 2002-07-09 | 2006-02-14 | Pacesetter, Inc. | Methods and devices for reduction of motion-induced noise in optical vascular plethysmography |
US20060041280A1 (en) * | 2004-08-19 | 2006-02-23 | Cardiac Pacemakers, Inc. | Thoracic impedance detection with blood resistivity compensation |
US7156808B2 (en) * | 1999-12-17 | 2007-01-02 | Q-Tec Systems Llc | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
US7160253B2 (en) * | 2002-11-08 | 2007-01-09 | Polar Electro Oy | Method and device for measuring stress |
US7160252B2 (en) * | 2003-01-10 | 2007-01-09 | Medtronic, Inc. | Method and apparatus for detecting respiratory disturbances |
US20070010750A1 (en) * | 2003-10-03 | 2007-01-11 | Akinori Ueno | Biometric sensor and biometric method |
US20070010721A1 (en) * | 2005-06-28 | 2007-01-11 | Chen Thomas C H | Apparatus and system of Internet-enabled wireless medical sensor scale |
US20070016089A1 (en) * | 2005-07-15 | 2007-01-18 | Fischell David R | Implantable device for vital signs monitoring |
US20070015976A1 (en) * | 2005-06-01 | 2007-01-18 | Medtronic, Inc. | Correlating a non-polysomnographic physiological parameter set with sleep states |
US20070015973A1 (en) * | 2005-06-03 | 2007-01-18 | Reuven Nanikashvili | Communication terminal, medical telemetry system and method for monitoring physiological data |
US7166063B2 (en) * | 2001-10-01 | 2007-01-23 | The Nemours Foundation | Brace compliance monitor |
US7167743B2 (en) * | 2004-03-16 | 2007-01-23 | Medtronic, Inc. | Collecting activity information to evaluate therapy |
US20070021678A1 (en) * | 2005-07-19 | 2007-01-25 | Cardiac Pacemakers, Inc. | Methods and apparatus for monitoring physiological responses to steady state activity |
US20070027497A1 (en) * | 2005-07-27 | 2007-02-01 | Cyberonics, Inc. | Nerve stimulation for treatment of syncope |
US20070027388A1 (en) * | 2005-08-01 | 2007-02-01 | Chang-An Chou | Patch-type physiological monitoring apparatus, system and network |
US20070038078A1 (en) * | 2005-07-08 | 2007-02-15 | Daniel Osadchy | Relative impedance measurement |
US20070038038A1 (en) * | 1999-10-18 | 2007-02-15 | Bodymedia, Inc. | Wearable human physiological and environmental data sensors and reporting system therefor |
US20070043301A1 (en) * | 2002-05-14 | 2007-02-22 | Idex Asa | Volume specific characterization of human skin by electrical immitance |
US20070043303A1 (en) * | 2005-08-17 | 2007-02-22 | Osypka Markus J | Method and apparatus for digital demodulation and further processing of signals obtained in the measurement of electrical bioimpedance or bioadmittance in an object |
US7184821B2 (en) * | 2003-12-03 | 2007-02-27 | Regents Of The University Of Minnesota | Monitoring thoracic fluid changes |
US20080004499A1 (en) * | 2006-06-28 | 2008-01-03 | Davis Carl C | System and method for the processing of alarm and communication information in centralized patient monitoring |
US7319386B2 (en) * | 2004-08-02 | 2008-01-15 | Hill-Rom Services, Inc. | Configurable system for alerting caregivers |
US7318808B2 (en) * | 2001-12-14 | 2008-01-15 | Isis Innovation Limited | Combining measurements from breathing rate sensors |
US20080024294A1 (en) * | 2003-06-23 | 2008-01-31 | Cardiac Pacemakers, Inc. | Systems, devices, and methods for selectively preventing data transfer from a medical device |
US20080024293A1 (en) * | 2006-07-28 | 2008-01-31 | Lee Stylos | Adaptations to optivol alert algorithm |
US20090018456A1 (en) * | 2007-07-11 | 2009-01-15 | Chin-Yeh Hung | Display storage apparatus capable of detecting a pulse |
US20090018410A1 (en) * | 2006-03-02 | 2009-01-15 | Koninklijke Philips Electronics N.V. | Body parameter sensing |
Family Cites Families (592)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US834261A (en) | 1906-04-04 | 1906-10-30 | Clarence S Chambers | Vaccine-injector. |
US2087124A (en) | 1936-10-08 | 1937-07-13 | Clarence O Smith | Wire cable cutter |
US2184511A (en) | 1937-10-28 | 1939-12-26 | Samuel M Bagno | Method and apparatus for measuring impedance |
US3232291A (en) | 1962-11-23 | 1966-02-01 | San Francisco Res Corp | Surgical adhesive tape and bandage |
USRE30101E (en) | 1964-08-19 | 1979-09-25 | Regents Of The University Of Minnesota | Impedance plethysmograph |
US3517999A (en) | 1966-01-07 | 1970-06-30 | Itt | Optical strain gauge |
US3584618A (en) | 1969-03-17 | 1971-06-15 | Beckman Instruments Inc | A system and method for monitoring a progressive sequence of physiological conditions |
US3620216A (en) | 1969-06-25 | 1971-11-16 | Abbott Lab | Implant trocar |
US3677260A (en) | 1970-09-04 | 1972-07-18 | Statham Instrument Inc | Arrhythmia detector |
US3805769A (en) | 1971-08-27 | 1974-04-23 | R Sessions | Disposable electrode |
US3845757A (en) | 1972-07-12 | 1974-11-05 | Minnesota Mining & Mfg | Biomedical monitoring electrode |
US3882853A (en) | 1973-02-15 | 1975-05-13 | Cardiodynamics | Biomedical electrode |
US3874368A (en) | 1973-04-19 | 1975-04-01 | Manfred Asrican | Impedance plethysmograph having blocking system |
US4121573A (en) | 1973-10-04 | 1978-10-24 | Goebel Fixture Co. | Wireless cardiac monitoring system and electrode-transmitter therefor |
US3942517A (en) | 1973-12-03 | 1976-03-09 | Dracard Limited | Electrodes |
US3972329A (en) | 1974-11-25 | 1976-08-03 | Kaufman John George | Body electrode for electro-medical use |
US4024312A (en) | 1976-06-23 | 1977-05-17 | Johnson & Johnson | Pressure-sensitive adhesive tape having extensible and elastic backing composed of a block copolymer |
US4077406A (en) | 1976-06-24 | 1978-03-07 | American Cyanamid Company | Pellet implanter for animal treatment |
US4216462A (en) | 1978-03-06 | 1980-08-05 | General Electric Company | Patient monitoring and data processing system |
JPS5746964Y2 (en) * | 1978-03-29 | 1982-10-15 | ||
US4674511A (en) | 1979-04-30 | 1987-06-23 | American Hospital Supply Corporation | Medical electrode |
US4838273A (en) | 1979-04-30 | 1989-06-13 | Baxter International Inc. | Medical electrode |
US4300575A (en) * | 1979-06-25 | 1981-11-17 | Staodynamics, Inc. | Air-permeable disposable electrode |
US4522211A (en) | 1979-12-06 | 1985-06-11 | C. R. Bard, Inc. | Medical electrode construction |
US4358678A (en) | 1980-11-19 | 1982-11-09 | Hersey Products, Inc. | Fiber optic transducer and method |
US4409983A (en) | 1981-08-20 | 1983-10-18 | Albert David E | Pulse measuring device |
US4699146A (en) | 1982-02-25 | 1987-10-13 | Valleylab, Inc. | Hydrophilic, elastomeric, pressure-sensitive adhesive |
US4451254A (en) | 1982-03-15 | 1984-05-29 | Eli Lilly And Company | Implant system |
SE455043B (en) | 1982-04-22 | 1988-06-20 | Karolinska Inst | DEVICE FOR MONITORING THE LIQUID BALANCE OF THE HUMAN BODY BY MEASURING THE IMPEDANCE OF THE BODY |
US4450527A (en) | 1982-06-29 | 1984-05-22 | Bomed Medical Mfg. Ltd. | Noninvasive continuous cardiac output monitor |
US4478223A (en) | 1982-12-06 | 1984-10-23 | Allor Douglas R | Three dimensional electrocardiograph |
US4692685A (en) | 1984-03-14 | 1987-09-08 | Blaze Kevin L | Electrical measuring apparatus, and methods for determining the condition or identity of biological material |
JPS60261431A (en) | 1984-06-11 | 1985-12-24 | 浅井 利夫 | Water-proof electrode with transmitter for recording cardiograph |
DE3513400A1 (en) | 1985-04-15 | 1986-10-16 | Philips Patentverwaltung Gmbh, 2000 Hamburg | OPTICAL MOTION SENSOR |
US4673387A (en) | 1985-05-06 | 1987-06-16 | N. J. Phillips Pty. Limited | Pellet injector |
US4781200A (en) | 1985-10-04 | 1988-11-01 | Baker Donald A | Ambulatory non-invasive automatic fetal monitoring system |
US4669480A (en) | 1985-10-16 | 1987-06-02 | Murray Electronics Associates Limited Partnership | Temperature indicating electrotherapy electrode/coil and method of use |
US4661103A (en) | 1986-03-03 | 1987-04-28 | Engineering Development Associates, Ltd. | Multiple implant injector |
US4733107A (en) | 1986-07-10 | 1988-03-22 | Western Digital Corporation | Low current high precision CMOS schmitt trigger circuit |
US4730611A (en) | 1986-09-02 | 1988-03-15 | Absorbent Cotton Company | Medical dressing device |
FR2604890A1 (en) | 1986-10-14 | 1988-04-15 | Thomson Csf | OPTICAL DEVICE FOR THE SIMULTANEOUS DETECTION OF HEART MOVEMENT AND BREATHING AND ITS USE IN THE SYNCHRONIZATION OF NUCLEAR MAGNETIC RESONANCE ACQUISITION IMAGING DEVICES |
US4838279A (en) | 1987-05-12 | 1989-06-13 | Fore Don C | Respiration monitor |
US4850370A (en) | 1987-07-22 | 1989-07-25 | Dower Gordon E | Method and apparatus for sensing and analyzing electrical activity of the human heart |
US4911175A (en) | 1987-09-17 | 1990-03-27 | Diana Twyman | Method for measuring total body cell mass and total extracellular mass by bioelectrical resistance and reactance |
JPH01126535A (en) | 1987-11-12 | 1989-05-18 | Kao Corp | Method and apparatus for measuring content of skin moisture |
US4880004A (en) | 1988-06-07 | 1989-11-14 | Intermedics, Inc. | Implantable cardiac stimulator with automatic gain control and bandpass filtering in feedback loop |
US4955381A (en) | 1988-08-26 | 1990-09-11 | Cardiotronics, Inc. | Multi-pad, multi-function electrode |
US5133355A (en) | 1988-09-22 | 1992-07-28 | Minnesota Mining And Manufacturing Company | Biomedical electrode construction |
US5012810A (en) | 1988-09-22 | 1991-05-07 | Minnesota Mining And Manufacturing Company | Biomedical electrode construction |
US5001632A (en) | 1989-12-22 | 1991-03-19 | Hall Tipping Justin | Video game difficulty level adjuster dependent upon player's aerobic activity level during exercise |
US5511553A (en) * | 1989-02-15 | 1996-04-30 | Segalowitz; Jacob | Device-system and method for monitoring multiple physiological parameters (MMPP) continuously and simultaneously |
US5168874A (en) | 1989-02-15 | 1992-12-08 | Jacob Segalowitz | Wireless electrode structure for use in patient monitoring system |
JPH0315502U (en) | 1989-06-28 | 1991-02-15 | ||
US5769793A (en) | 1989-09-08 | 1998-06-23 | Steven M. Pincus | System to determine a relative amount of patternness |
US5050612A (en) | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
US5027824A (en) | 1989-12-01 | 1991-07-02 | Edmond Dougherty | Method and apparatus for detecting, analyzing and recording cardiac rhythm disturbances |
US5140985A (en) | 1989-12-11 | 1992-08-25 | Schroeder Jon M | Noninvasive blood glucose measuring device |
US5125412A (en) | 1990-07-23 | 1992-06-30 | Thornton William E | Musculoskeletal activity monitor |
US5113869A (en) | 1990-08-21 | 1992-05-19 | Telectronics Pacing Systems, Inc. | Implantable ambulatory electrocardiogram monitor |
ATE175068T1 (en) | 1990-08-31 | 1999-01-15 | Gen Hospital Corp | SYSTEM FOR MANAGING MULTIPLE DEVICES, FOR EXAMPLE PORTABLE PATIENT MONITORING DEVICES IN A NETWORK |
US5063937A (en) | 1990-09-12 | 1991-11-12 | Wright State University | Multiple frequency bio-impedance measurement system |
US5271411A (en) | 1990-09-21 | 1993-12-21 | Colin Electronics Co., Ltd. | Method and apparatus for ECG signal analysis and cardiac arrhythmia detection |
US5642734A (en) | 1990-10-04 | 1997-07-01 | Microcor, Inc. | Method and apparatus for noninvasively determining hematocrit |
US5150708A (en) | 1990-12-03 | 1992-09-29 | Spacelabs, Inc. | Tabbed defibrillator electrode pad |
US5437285A (en) | 1991-02-20 | 1995-08-01 | Georgetown University | Method and apparatus for prediction of sudden cardiac death by simultaneous assessment of autonomic function and cardiac electrical stability |
US5632272A (en) | 1991-03-07 | 1997-05-27 | Masimo Corporation | Signal processing apparatus |
MX9702434A (en) | 1991-03-07 | 1998-05-31 | Masimo Corp | Signal processing apparatus. |
US5226417A (en) | 1991-03-11 | 1993-07-13 | Nellcor, Inc. | Apparatus for the detection of motion transients |
AU654552B2 (en) | 1991-04-05 | 1994-11-10 | Medtronic, Inc. | Subcutaneous multi-electrode sensing system |
EP0588982B1 (en) | 1991-06-12 | 2001-03-21 | Florida Atlantic University Research Corp. | Detecting atherosclerosis in humans |
NL9101489A (en) | 1991-09-03 | 1993-04-01 | Texas Instruments Holland | INJECTOR FOR IMMEDIATELY IMPLANTING AN OBJECT IN A LIVING BEING. |
US5309917A (en) | 1991-09-12 | 1994-05-10 | Drexel University | System and method of impedance cardiography and heartbeat determination |
US5335664A (en) | 1991-09-17 | 1994-08-09 | Casio Computer Co., Ltd. | Monitor system and biological signal transmitter therefor |
US5257627A (en) | 1991-11-14 | 1993-11-02 | Telmed, Inc. | Portable non-invasive testing apparatus |
US5353793A (en) | 1991-11-25 | 1994-10-11 | Oishi-Kogyo Company | Sensor apparatus |
US5291013A (en) | 1991-12-06 | 1994-03-01 | Alamed Corporation | Fiber optical monitor for detecting normal breathing and heartbeat motion based on changes in speckle patterns |
EP0553372B1 (en) | 1992-01-29 | 1996-11-13 | Hewlett-Packard GmbH | Method and system for monitoring vital signs |
US5301677A (en) | 1992-02-06 | 1994-04-12 | Cardiac Pacemakers, Inc. | Arrhythmia detector using delta modulated turning point morphology of the ECG wave |
WO1993019667A1 (en) * | 1992-04-03 | 1993-10-14 | Micromedical Industries Limited | Sensor and system for physiological monitoring |
US5241300B1 (en) | 1992-04-24 | 1995-10-31 | Johannes Buschmann | Sids detection apparatus and methods |
IL102300A (en) | 1992-06-24 | 1996-07-23 | N I Medical Ltd | Non-invasive system for determining of the main cardiorespiratory parameters of the human body |
US5984102A (en) | 1992-09-24 | 1999-11-16 | Survivalink Corporation | Medical electrode packaging technology |
US5411530A (en) | 1992-11-13 | 1995-05-02 | Akhtar; Masood | Sensing algorithm for anti-tachycardia devices using dual chamber sensing |
US5362069A (en) | 1992-12-03 | 1994-11-08 | Heartbeat Corporation | Combination exercise device/video game |
US5375604A (en) | 1992-12-11 | 1994-12-27 | Siemens Medical Electronics, Inc. | Transportable modular patient monitor |
US5450845A (en) | 1993-01-11 | 1995-09-19 | Axelgaard; Jens | Medical electrode system |
US5558638A (en) | 1993-04-30 | 1996-09-24 | Healthdyne, Inc. | Patient monitor and support system |
US5406945A (en) * | 1993-05-24 | 1995-04-18 | Ndm Acquisition Corp. | Biomedical electrode having a secured one-piece conductive terminal |
US5607454A (en) | 1993-08-06 | 1997-03-04 | Heartstream, Inc. | Electrotherapy method and apparatus |
US5464012A (en) | 1993-09-13 | 1995-11-07 | Hewlett-Packard Company | Patient alarm detection using target mode |
US5454377A (en) | 1993-10-08 | 1995-10-03 | The Ohio State University | Method for measuring the myocardial electrical impedance spectrum |
US5724025A (en) | 1993-10-21 | 1998-03-03 | Tavori; Itzchak | Portable vital signs monitor |
US5523742A (en) | 1993-11-18 | 1996-06-04 | The United States Of America As Represented By The Secretary Of The Army | Motion sensor |
US5544661A (en) | 1994-01-13 | 1996-08-13 | Charles L. Davis | Real time ambulatory patient monitor |
US5964703A (en) | 1994-01-14 | 1999-10-12 | E-Z-Em, Inc. | Extravasation detection electrode patch |
US5713367A (en) * | 1994-01-26 | 1998-02-03 | Cambridge Heart, Inc. | Measuring and assessing cardiac electrical stability |
US5447529A (en) | 1994-01-28 | 1995-09-05 | Philadelphia Heart Institute | Method of using endocardial impedance for determining electrode-tissue contact, appropriate sites for arrhythmia ablation and tissue heating during ablation |
US6067467A (en) | 1994-02-07 | 2000-05-23 | New York University | EEG operative and post-operative patient monitoring method |
US5458124A (en) | 1994-02-08 | 1995-10-17 | Stanko; Bruce E. | Electrocardiographic signal monitoring system |
US5598848A (en) | 1994-03-31 | 1997-02-04 | Ep Technologies, Inc. | Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium |
US5575284A (en) | 1994-04-01 | 1996-11-19 | University Of South Florida | Portable pulse oximeter |
US5566671A (en) | 1994-05-23 | 1996-10-22 | Lyons; Chad | Medical acoustic sensor receptacle |
AU2554795A (en) | 1994-06-07 | 1996-01-04 | Agrizap, Inc. | A portable pest electrocution device with resistive switch sensor |
US5518001A (en) | 1994-06-17 | 1996-05-21 | Pacesetter, Inc. | Cardiac device with patient-triggered storage of physiological sensor data |
NO180024C (en) | 1994-10-11 | 1997-01-29 | Oerjan G Martinsen | Measurement of moisture in the skin |
US5560368A (en) | 1994-11-15 | 1996-10-01 | Berger; Ronald D. | Methodology for automated QT variability measurement |
AUPM964094A0 (en) | 1994-11-24 | 1994-12-15 | Sullivan, C.E. | Biophysical foetal monitor |
US5778882A (en) | 1995-02-24 | 1998-07-14 | Brigham And Women's Hospital | Health monitoring system |
US5564434A (en) | 1995-02-27 | 1996-10-15 | Medtronic, Inc. | Implantable capacitive absolute pressure and temperature sensor |
US5503157A (en) | 1995-03-17 | 1996-04-02 | Sramek; Bohumir | System for detection of electrical bioimpedance signals |
US5788682A (en) * | 1995-04-28 | 1998-08-04 | Maget; Henri J.R. | Apparatus and method for controlling oxygen concentration in the vicinity of a wound |
US6327487B1 (en) | 1995-05-04 | 2001-12-04 | Robert A. Stratbucker | Bioelectric interface |
US5772508A (en) | 1995-09-28 | 1998-06-30 | Amtex Co., Ltd. | Game or play facilities controlled by physiological information |
US5807272A (en) | 1995-10-31 | 1998-09-15 | Worcester Polytechnic Institute | Impedance spectroscopy system for ischemia monitoring and detection |
US5678562A (en) | 1995-11-09 | 1997-10-21 | Burdick, Inc. | Ambulatory physiological monitor with removable disk cartridge and wireless modem |
US5748103A (en) | 1995-11-13 | 1998-05-05 | Vitalcom, Inc. | Two-way TDMA telemetry system with power conservation features |
US5944659A (en) | 1995-11-13 | 1999-08-31 | Vitalcom Inc. | Architecture for TDMA medical telemetry system |
US5803915A (en) | 1995-12-07 | 1998-09-08 | Ohmeda Inc. | System for detection of probe dislodgement |
US6035233A (en) | 1995-12-11 | 2000-03-07 | Intermedics Inc. | Implantable medical device responsive to heart rate variability analysis |
US5710376A (en) | 1995-12-22 | 1998-01-20 | International Business Machines Corporation | Charged mass thin film condenser accelerometer |
US6463328B1 (en) | 1996-02-02 | 2002-10-08 | Michael Sasha John | Adaptive brain stimulation method and system |
FI960636A (en) | 1996-02-12 | 1997-08-13 | Nokia Mobile Phones Ltd | A procedure for monitoring the health of a patient |
US5833603A (en) | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US6496715B1 (en) | 1996-07-11 | 2002-12-17 | Medtronic, Inc. | System and method for non-invasive determination of optimal orientation of an implantable sensing device |
WO1998002209A2 (en) | 1996-07-11 | 1998-01-22 | Medtronic, Inc. | Minimally invasive implantable device for monitoring physiologic events |
US5687717A (en) | 1996-08-06 | 1997-11-18 | Tremont Medical, Inc. | Patient monitoring system with chassis mounted or remotely operable modules and portable computer |
US6141575A (en) | 1996-08-16 | 2000-10-31 | Price; Michael A. | Electrode assemblies |
US6112224A (en) | 1996-09-20 | 2000-08-29 | Georgia Tech Research Corporation | Patient monitoring station using a single interrupt resource to support multiple measurement devices |
DE19638585A1 (en) | 1996-09-20 | 1998-03-26 | Biotronik Mess & Therapieg | Device for rejection diagnosis after organ transplantation |
US5814079A (en) | 1996-10-04 | 1998-09-29 | Medtronic, Inc. | Cardiac arrhythmia management by application of adnodal stimulation for hyperpolarization of myocardial cells |
US6198394B1 (en) | 1996-12-05 | 2001-03-06 | Stephen C. Jacobsen | System for remote monitoring of personnel |
US5876353A (en) | 1997-01-31 | 1999-03-02 | Medtronic, Inc. | Impedance monitor for discerning edema through evaluation of respiratory rate |
US5957861A (en) | 1997-01-31 | 1999-09-28 | Medtronic, Inc. | Impedance monitor for discerning edema through evaluation of respiratory rate |
US6102856A (en) | 1997-02-12 | 2000-08-15 | Groff; Clarence P | Wearable vital sign monitoring system |
US6164284A (en) | 1997-02-26 | 2000-12-26 | Schulman; Joseph H. | System of implantable devices for monitoring and/or affecting body parameters |
US6208894B1 (en) | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
US6148233A (en) | 1997-03-07 | 2000-11-14 | Cardiac Science, Inc. | Defibrillation system having segmented electrodes |
US5959529A (en) | 1997-03-07 | 1999-09-28 | Kail, Iv; Karl A. | Reprogrammable remote sensor monitoring system |
ATE477746T1 (en) | 1997-03-17 | 2010-09-15 | Adidas Ag | INFORMATION FEEDBACK SYSTEM FOR PHYSIOLOGICAL SIGNALS |
AUPO616697A0 (en) | 1997-04-11 | 1997-05-08 | Heartlink Pty Ltd | Method for diagnosing psychiatric disorders |
US7941534B2 (en) | 1997-04-14 | 2011-05-10 | Carlos De La Huerga | System and method to authenticate users to computer systems |
US5788643A (en) | 1997-04-22 | 1998-08-04 | Zymed Medical Instrumentation, Inc. | Process for monitoring patients with chronic congestive heart failure |
US6050267A (en) | 1997-04-28 | 2000-04-18 | American Cardiac Ablation Co. Inc. | Catheter positioning system |
FR2766376B1 (en) | 1997-07-25 | 1999-10-22 | Lhd Lab Hygiene Dietetique | WOUND THERAPEUTIC TREATMENT DEVICE |
WO1999008596A1 (en) | 1997-08-19 | 1999-02-25 | Philipp Lang | Measurement of capillary related interstitial fluid using ultrasound methods and devices |
US6259939B1 (en) | 1997-08-20 | 2001-07-10 | R. Z. Comparative Diagnostics Ltd. | Electrocardiography electrodes holder including electrocardiograph electronics |
US6090056A (en) | 1997-08-27 | 2000-07-18 | Emergency Medical Systems, Inc. | Resuscitation and alert system |
US6007532A (en) | 1997-08-29 | 1999-12-28 | 3M Innovative Properties Company | Method and apparatus for detecting loss of contact of biomedical electrodes with patient skin |
US5836990A (en) | 1997-09-19 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for determining electrode/tissue contact |
US6409674B1 (en) | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
US6080106A (en) | 1997-10-28 | 2000-06-27 | Alere Incorporated | Patient interface system with a scale |
US6050951A (en) | 1997-11-10 | 2000-04-18 | Critikon Company, L.L.C. | NIBP trigger in response to detected heart rate variability |
US20020180605A1 (en) * | 1997-11-11 | 2002-12-05 | Ozguz Volkan H. | Wearable biomonitor with flexible thinned integrated circuit |
US20050096513A1 (en) | 1997-11-11 | 2005-05-05 | Irvine Sensors Corporation | Wearable biomonitor with flexible thinned integrated circuit |
US6129744A (en) | 1997-12-04 | 2000-10-10 | Vitatron Medical, B.V. | Cardiac treatment system and method for sensing and responding to heart failure |
US6047259A (en) | 1997-12-30 | 2000-04-04 | Medical Management International, Inc. | Interactive method and system for managing physical exams, diagnosis and treatment protocols in a health care practice |
US6125297A (en) | 1998-02-06 | 2000-09-26 | The United States Of America As Represented By The United States National Aeronautics And Space Administration | Body fluids monitor |
US6038464A (en) | 1998-02-09 | 2000-03-14 | Axelgaard Manufacturing Co., Ltd. | Medical electrode |
US5904708A (en) | 1998-03-19 | 1999-05-18 | Medtronic, Inc. | System and method for deriving relative physiologic signals |
US6579231B1 (en) | 1998-03-27 | 2003-06-17 | Mci Communications Corporation | Personal medical monitoring unit and system |
US5941831A (en) | 1998-04-03 | 1999-08-24 | Pacesetter, Inc. | Method for diagnosing cardiac arrhythmias using interval irregularity |
US5967995A (en) | 1998-04-28 | 1999-10-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | System for prediction of life-threatening cardiac arrhythmias |
ATE220936T1 (en) * | 1998-05-13 | 2002-08-15 | Cygnus Therapeutic Systems | COLLECTION DEVICES FOR TRANSDERMAL SAMPLING SYSTEMS |
US6045513A (en) | 1998-05-13 | 2000-04-04 | Medtronic, Inc. | Implantable medical device for tracking patient functional status |
IL124964A (en) | 1998-06-17 | 2002-02-10 | Nimeda Ltd | Method for disclosing a physiological indication and a non-invasive diagnostic physiological monitoring system for use therewith |
US6095991A (en) | 1998-07-23 | 2000-08-01 | Individual Monitoring Systems, Inc. | Ambulatory body position monitor |
AU5394099A (en) | 1998-08-07 | 2000-02-28 | Infinite Biomedical Technologies, Incorporated | Implantable myocardial ischemia detection, indication and action technology |
US6052615A (en) | 1998-08-17 | 2000-04-18 | Zymed Medical Instrumentation, Inc. | Method and apparatus for sensing and analyzing electrical activity of the human heart using a four electrode arrangement |
US6267730B1 (en) | 1998-08-25 | 2001-07-31 | Kenneth M. Pacunas | Apnea detecting system |
DE69938663D1 (en) | 1998-08-26 | 2008-06-19 | Sensors For Medecine And Scien | OPTICALLY BASED SENSOR DEVICES |
US6104949A (en) | 1998-09-09 | 2000-08-15 | Vitatron Medical, B.V. | Medical device |
US6343140B1 (en) | 1998-09-11 | 2002-01-29 | Quid Technologies Llc | Method and apparatus for shooting using biometric recognition |
US6491647B1 (en) | 1998-09-23 | 2002-12-10 | Active Signal Technologies, Inc. | Physiological sensing device |
US6402689B1 (en) | 1998-09-30 | 2002-06-11 | Sicel Technologies, Inc. | Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors |
US6306088B1 (en) | 1998-10-03 | 2001-10-23 | Individual Monitoring Systems, Inc. | Ambulatory distributed recorders system for diagnosing medical disorders |
US6358208B1 (en) | 1998-11-21 | 2002-03-19 | Philipp Lang | Assessment of cardiovascular performance using ultrasound methods and devices that interrogate interstitial fluid |
US6398727B1 (en) | 1998-12-23 | 2002-06-04 | Baxter International Inc. | Method and apparatus for providing patient care |
US6049730A (en) | 1998-12-28 | 2000-04-11 | Flaga Hf | Method and apparatus for improving the accuracy of interpretation of ECG-signals |
US6206831B1 (en) | 1999-01-06 | 2001-03-27 | Scimed Life Systems, Inc. | Ultrasound-guided ablation catheter and methods of use |
AU2491300A (en) | 1999-01-06 | 2000-07-24 | Ball Semiconductor Inc. | Wireless ekg |
US6117077A (en) * | 1999-01-22 | 2000-09-12 | Del Mar Medical Systems, Llc | Long-term, ambulatory physiological recorder |
US6473640B1 (en) | 1999-01-25 | 2002-10-29 | Jay Erlebacher | Implantable device and method for long-term detection and monitoring of congestive heart failure |
WO2000044580A1 (en) | 1999-01-27 | 2000-08-03 | Compumedics Sleep Pty. Ltd. | Vigilance monitoring system |
US6305943B1 (en) | 1999-01-29 | 2001-10-23 | Biomed Usa, Inc. | Respiratory sinus arrhythmia training system |
US6212427B1 (en) | 1999-02-02 | 2001-04-03 | J&J Engineering | Heart rate variability feedback monitor system |
US6266554B1 (en) | 1999-02-12 | 2001-07-24 | Cardiac Pacemakers, Inc. | System and method for classifying cardiac complexes |
US6454707B1 (en) | 1999-03-08 | 2002-09-24 | Samuel W. Casscells, III | Method and apparatus for predicting mortality in congestive heart failure patients |
US6821249B2 (en) | 1999-03-08 | 2004-11-23 | Board Of Regents, The University Of Texas | Temperature monitoring of congestive heart failure patients as an indicator of worsening condition |
US6751498B1 (en) | 1999-03-15 | 2004-06-15 | The Johns Hopkins University | Apparatus and method for non-invasive, passive fetal heart monitoring |
GB2348707B (en) | 1999-04-07 | 2003-07-09 | Healthcare Technology Ltd | Heart activity detection apparatus |
US6454708B1 (en) | 1999-04-15 | 2002-09-24 | Nexan Limited | Portable remote patient telemonitoring system using a memory card or smart card |
US6450953B1 (en) | 1999-04-15 | 2002-09-17 | Nexan Limited | Portable signal transfer unit |
US6385473B1 (en) | 1999-04-15 | 2002-05-07 | Nexan Limited | Physiological sensor device |
US6494829B1 (en) | 1999-04-15 | 2002-12-17 | Nexan Limited | Physiological sensor array |
US6416471B1 (en) | 1999-04-15 | 2002-07-09 | Nexan Limited | Portable remote patient telemonitoring system |
US7577475B2 (en) | 1999-04-16 | 2009-08-18 | Cardiocom | System, method, and apparatus for combining information from an implanted device with information from a patient monitoring apparatus |
US6290646B1 (en) | 1999-04-16 | 2001-09-18 | Cardiocom | Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients |
AUPQ047899A0 (en) | 1999-05-21 | 1999-06-10 | Cooke, Michael | A device for use with computer games |
US6312378B1 (en) | 1999-06-03 | 2001-11-06 | Cardiac Intelligence Corporation | System and method for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
AUPQ113799A0 (en) | 1999-06-22 | 1999-07-15 | University Of Queensland, The | A method and device for measuring lymphoedema |
US7454359B2 (en) | 1999-06-23 | 2008-11-18 | Visicu, Inc. | System and method for displaying a health status of hospitalized patients |
US6287252B1 (en) | 1999-06-30 | 2001-09-11 | Monitrak | Patient monitor |
US7149773B2 (en) | 1999-07-07 | 2006-12-12 | Medtronic, Inc. | System and method of automated invoicing for communications between an implantable medical device and a remote computer system or health care provider |
US6450820B1 (en) | 1999-07-09 | 2002-09-17 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Method and apparatus for encouraging physiological self-regulation through modulation of an operator's control input to a video game or training simulator |
US6347245B1 (en) | 1999-07-14 | 2002-02-12 | Medtronic, Inc. | Medical device ECG marker for use in compressed data system |
US6221011B1 (en) | 1999-07-26 | 2001-04-24 | Cardiac Intelligence Corporation | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
CA2314517A1 (en) | 1999-07-26 | 2001-01-26 | Gust H. Bardy | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
JP2001052930A (en) | 1999-08-06 | 2001-02-23 | Tdk Corp | Laminated inductor and manufacture thereof |
US6442422B1 (en) | 1999-08-11 | 2002-08-27 | Ge Medical Systems Information Technologies, Inc. | Compliance monitoring apparatus and method |
US6718198B2 (en) | 1999-08-24 | 2004-04-06 | Cardiac Pacemakers, Inc. | Arrhythmia display |
EP1217942A1 (en) | 1999-09-24 | 2002-07-03 | Healthetech, Inc. | Physiological monitor and associated computation, display and communication unit |
US6272377B1 (en) | 1999-10-01 | 2001-08-07 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with arrhythmia prediction and prevention |
US6350237B1 (en) | 1999-11-05 | 2002-02-26 | General Electric Company | Method and apparatus for monitoring fetal status data |
US6527729B1 (en) | 1999-11-10 | 2003-03-04 | Pacesetter, Inc. | Method for monitoring patient using acoustic sensor |
US6942622B1 (en) | 1999-11-10 | 2005-09-13 | Pacesetter, Inc. | Method for monitoring autonomic tone |
US6480733B1 (en) | 1999-11-10 | 2002-11-12 | Pacesetter, Inc. | Method for monitoring heart failure |
US6600949B1 (en) | 1999-11-10 | 2003-07-29 | Pacesetter, Inc. | Method for monitoring heart failure via respiratory patterns |
US6368284B1 (en) | 1999-11-16 | 2002-04-09 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for diagnosing and monitoring myocardial ischemia and outcomes thereof |
US6277078B1 (en) | 1999-11-19 | 2001-08-21 | Remon Medical Technologies, Ltd. | System and method for monitoring a parameter associated with the performance of a heart |
US7127370B2 (en) | 2000-01-07 | 2006-10-24 | Nocwatch International Inc. | Attitude indicator and activity monitoring device |
US7483743B2 (en) | 2000-01-11 | 2009-01-27 | Cedars-Sinai Medical Center | System for detecting, diagnosing, and treating cardiovascular disease |
JP2001198098A (en) | 2000-01-21 | 2001-07-24 | Tanita Corp | Dropsy measurement method and dropsy measurement device |
US6551251B2 (en) | 2000-02-14 | 2003-04-22 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Passive fetal heart monitoring system |
US6699200B2 (en) | 2000-03-01 | 2004-03-02 | Medtronic, Inc. | Implantable medical device with multi-vector sensing electrodes |
US6893396B2 (en) | 2000-03-01 | 2005-05-17 | I-Medik, Inc. | Wireless internet bio-telemetry monitoring system and interface |
GB0005247D0 (en) | 2000-03-03 | 2000-04-26 | Btg Int Ltd | Electrical impedance method for differentiating tissue types |
US6584343B1 (en) | 2000-03-15 | 2003-06-24 | Resolution Medical, Inc. | Multi-electrode panel system for sensing electrical activity of the heart |
US6871211B2 (en) | 2000-03-28 | 2005-03-22 | Ge Medical Systems Information Technologies, Inc. | Intranet-based medical data distribution system |
AU5359901A (en) | 2000-04-17 | 2001-10-30 | Vivometrics Inc | Systems and methods for ambulatory monitoring of physiological signs |
JP2004512058A (en) | 2000-05-05 | 2004-04-22 | ヒル−ロム サービシーズ,インコーポレイティド | Hospital bed remote control |
FR2808609B1 (en) | 2000-05-05 | 2006-02-10 | Univ Rennes | DEVICE AND METHOD FOR DETECTING ABNORMAL SITUATIONS |
US6478800B1 (en) | 2000-05-08 | 2002-11-12 | Depuy Acromed, Inc. | Medical installation tool |
US6572557B2 (en) | 2000-05-09 | 2003-06-03 | Pacesetter, Inc. | System and method for monitoring progression of cardiac disease state using physiologic sensors |
US20040049132A1 (en) | 2000-06-15 | 2004-03-11 | The Procter & Gamble Company | Device for body activity detection and processing |
US20060122474A1 (en) | 2000-06-16 | 2006-06-08 | Bodymedia, Inc. | Apparatus for monitoring health, wellness and fitness |
US7261690B2 (en) | 2000-06-16 | 2007-08-28 | Bodymedia, Inc. | Apparatus for monitoring health, wellness and fitness |
US6605038B1 (en) | 2000-06-16 | 2003-08-12 | Bodymedia, Inc. | System for monitoring health, wellness and fitness |
WO2002000111A1 (en) | 2000-06-23 | 2002-01-03 | Bodymedia, Inc. | System for monitoring health, wellness and fitness |
US6480734B1 (en) | 2000-06-30 | 2002-11-12 | Cardiac Science Inc. | Cardiac arrhythmia detector using ECG waveform-factor and its irregularity |
US6569160B1 (en) | 2000-07-07 | 2003-05-27 | Biosense, Inc. | System and method for detecting electrode-tissue contact |
US6636754B1 (en) | 2000-07-10 | 2003-10-21 | Cardiodynamics International Corporation | Apparatus and method for determining cardiac output in a living subject |
US6602201B1 (en) | 2000-07-10 | 2003-08-05 | Cardiodynamics International Corporation | Apparatus and method for determining cardiac output in a living subject |
US7149576B1 (en) | 2000-07-10 | 2006-12-12 | Cardiodynamics International Corporation | Apparatus and method for defibrillation of a living subject |
US6659947B1 (en) | 2000-07-13 | 2003-12-09 | Ge Medical Systems Information Technologies, Inc. | Wireless LAN architecture for integrated time-critical and non-time-critical services within medical facilities |
US20020038310A1 (en) | 2000-07-17 | 2002-03-28 | Reitberg Donald P. | Single-patient drug trials used with accumulated database: genomic markers |
MXPA03000499A (en) | 2000-07-18 | 2003-06-24 | Motorola Inc | Wireless electrocardiograph system and method. |
JP3977983B2 (en) | 2000-07-31 | 2007-09-19 | 株式会社タニタ | Dehydration state determination device by bioimpedance measurement |
AU2001287856A1 (en) | 2000-09-12 | 2002-03-26 | Nexan Limited | Disposable vital signs monitoring sensor band with removable alignment sheet |
DE10046075A1 (en) | 2000-09-15 | 2002-04-04 | Friendly Sensors Ag | Device and method for generating measurement data |
US6572636B1 (en) | 2000-09-19 | 2003-06-03 | Robert Sean Hagen | Pulse sensing patch and associated methods |
US6752151B2 (en) | 2000-09-25 | 2004-06-22 | Respironics, Inc. | Method and apparatus for providing variable positive airway pressure |
US6490478B1 (en) | 2000-09-25 | 2002-12-03 | Cardiac Science Inc. | System and method for complexity analysis-based cardiac tachyarrhythmia detection |
US6665559B2 (en) | 2000-10-06 | 2003-12-16 | Ge Medical Systems Information Technologies, Inc. | Method and apparatus for perioperative assessment of cardiovascular risk |
WO2002030279A1 (en) | 2000-10-10 | 2002-04-18 | Alan Remy Magill | Health monitoring |
US20020045836A1 (en) | 2000-10-16 | 2002-04-18 | Dima Alkawwas | Operation of wireless biopotential monitoring system |
FI119716B (en) | 2000-10-18 | 2009-02-27 | Polar Electro Oy | Electrode structure and heart rate measurement arrangement |
US6738671B2 (en) | 2000-10-26 | 2004-05-18 | Medtronic, Inc. | Externally worn transceiver for use with an implantable medical device |
US6978177B1 (en) | 2000-11-14 | 2005-12-20 | Cardiac Pacemakers, Inc. | Method and apparatus for using atrial discrimination algorithms to determine optimal pacing therapy and therapy timing |
US6658300B2 (en) | 2000-12-18 | 2003-12-02 | Biosense, Inc. | Telemetric reader/charger device for medical sensor |
US20030051144A1 (en) | 2000-12-22 | 2003-03-13 | Williams Terry N. | Dynamic electronic chain-of-trust document with audit trail |
DE10103330B4 (en) * | 2001-01-25 | 2009-04-30 | Siemens Ag | Medical system for monitoring a blood clotting measured value of a patient |
US6821256B2 (en) * | 2001-02-01 | 2004-11-23 | Mayo Foundation For Medical Education And Research | Non-alternating beat-to-beat fluctuations in T wave morphology |
JP3927495B2 (en) | 2001-02-08 | 2007-06-06 | ミニ−ミッター カンパニー,インコーポレイテッド | Skin patch with built-in temperature sensor |
JP3967680B2 (en) | 2001-02-14 | 2007-08-29 | ドレーガー メディカル システムズ インコーポレイテッド | Patient monitoring area network |
ITBO20010110A1 (en) | 2001-03-01 | 2002-09-01 | Tre Esse Progettazione Biomedi | PROCEDURE AND IMPLANTABLE DEVICE FOR THE INTRA-PULMONARY MEASUREMENT OF PHYSICAL PROPERTIES OF THE PULMONARY FABRIC DEPENDENT ON ITS DENSIT |
US6595929B2 (en) | 2001-03-30 | 2003-07-22 | Bodymedia, Inc. | System for monitoring health, wellness and fitness having a method and apparatus for improved measurement of heat flow |
WO2002080762A1 (en) | 2001-04-06 | 2002-10-17 | Medic4All Inc. | A physiological monitoring system for a computational device of a human subject |
US20050283197A1 (en) | 2001-04-10 | 2005-12-22 | Daum Douglas R | Systems and methods for hypotension |
EP1249691A1 (en) | 2001-04-11 | 2002-10-16 | Omron Corporation | Electronic clinical thermometer |
US6453186B1 (en) | 2001-04-13 | 2002-09-17 | Ge Medical Systems Information Technologies, Inc. | Electrocardiogram electrode patch |
US6665385B2 (en) | 2001-04-23 | 2003-12-16 | Cardionet, Inc. | Medical monitoring system having multipath communications capability |
US6641542B2 (en) | 2001-04-30 | 2003-11-04 | Medtronic, Inc. | Method and apparatus to detect and treat sleep respiratory events |
US7702394B2 (en) | 2001-05-01 | 2010-04-20 | Intrapace, Inc. | Responsive gastric stimulator |
US6894204B2 (en) | 2001-05-02 | 2005-05-17 | 3M Innovative Properties Company | Tapered stretch removable adhesive articles and methods |
US20070104840A1 (en) | 2001-05-03 | 2007-05-10 | Singer Michael G | Method and system for the determination of palatability |
US6587715B2 (en) | 2001-05-03 | 2003-07-01 | The Nutrition Solutions Corporation | Assessment of organs for transplant, xenotransplant, and predicting time of death |
US20060161073A1 (en) | 2001-05-03 | 2006-07-20 | Singer Michael G | In vitro and in vivo assessment of organs and tissue and use, transplant, freshness and tissue conditions |
US7003346B2 (en) | 2001-05-03 | 2006-02-21 | Singer Michaeal G | Method for illness and disease determination and management |
JP2004529709A (en) | 2001-05-03 | 2004-09-30 | テルズート・テクノロジーズ・インコーポレーテッド | Medical wireless monitoring device and system |
US7242306B2 (en) | 2001-05-08 | 2007-07-10 | Hill-Rom Services, Inc. | Article locating and tracking apparatus and method |
US6622042B1 (en) | 2001-05-09 | 2003-09-16 | Pacesetter, Inc. | Implantable cardiac stimulation device and method utilizing electrogram spectral analysis for therapy administration |
US7269516B2 (en) | 2001-05-15 | 2007-09-11 | Psychogenics, Inc. | Systems and methods for monitoring behavior informatics |
US6952695B1 (en) | 2001-05-15 | 2005-10-04 | Global Safety Surveillance, Inc. | Spontaneous adverse events reporting |
US6701271B2 (en) | 2001-05-17 | 2004-03-02 | International Business Machines Corporation | Method and apparatus for using physical characteristic data collected from two or more subjects |
CN100548865C (en) | 2001-05-21 | 2009-10-14 | 科尔德产品公司 | Connecting device |
US20050065445A1 (en) | 2001-05-22 | 2005-03-24 | Arzbaecher Robert C. | Cardiac arrest monitor and alarm system |
CN1287729C (en) | 2001-05-29 | 2006-12-06 | 生殖健康技术公司 | System for detection and analysis of material uterine, material and fetal cardiac and fetal brain activity |
US6653014B2 (en) * | 2001-05-30 | 2003-11-25 | Birch Point Medical, Inc. | Power sources for iontophoretic drug delivery systems |
US6795722B2 (en) | 2001-06-18 | 2004-09-21 | Neotech Products, Inc. | Electrode sensor package and application to the skin of a newborn or infant |
US7044911B2 (en) | 2001-06-29 | 2006-05-16 | Philometron, Inc. | Gateway platform for biological monitoring and delivery of therapeutic compounds |
IL144110A0 (en) | 2001-07-02 | 2002-05-23 | Sharony Reuven | Methods and apparatus for objective fetal diagnosis |
US7933642B2 (en) * | 2001-07-17 | 2011-04-26 | Rud Istvan | Wireless ECG system |
US6972683B2 (en) | 2001-07-20 | 2005-12-06 | Hill-Rom Services, Inc. | Badge for a locating and tracking system |
US7257438B2 (en) | 2002-07-23 | 2007-08-14 | Datascope Investment Corp. | Patient-worn medical monitoring device |
ATE481922T1 (en) | 2001-09-28 | 2010-10-15 | Csem Ct Suisse Electronique | METHOD AND DEVICE FOR PULSE MEASUREMENT |
DE10148440A1 (en) | 2001-10-01 | 2003-04-17 | Inflow Dynamics Inc | Implantable medical device for monitoring congestive heart failure comprises electrodes for measuring lung and heart tissue impedance, with an increase in impedance above a threshold value triggering an alarm |
US20090182204A1 (en) | 2001-10-04 | 2009-07-16 | Semler Herbert J | Body composition, circulation, and vital signs monitor and method |
US20030069510A1 (en) | 2001-10-04 | 2003-04-10 | Semler Herbert J. | Disposable vital signs monitor |
US20030087244A1 (en) | 2001-10-09 | 2003-05-08 | Vitivity, Inc | Diagnosis and treatment of vascular disease |
US20030093298A1 (en) | 2001-10-12 | 2003-05-15 | Javier Hernandez | System and method for providing secure remote access to patient files by authenticating personnel with biometric data |
US6748254B2 (en) | 2001-10-12 | 2004-06-08 | Nellcor Puritan Bennett Incorporated | Stacked adhesive optical sensor |
US6748269B2 (en) | 2001-10-17 | 2004-06-08 | Cardiac Pacemakers, Inc. | Algorithm for discrimination of 1:1 tachycardias |
US6810282B2 (en) | 2001-10-25 | 2004-10-26 | GE Medical Systems Information Technolgies, Inc. | Method and apparatus for dynamically selecting an electrocardiogram compression process based on computerized analysis of cardiac rhythm and contour |
FR2831450B1 (en) | 2001-10-30 | 2004-07-30 | Ela Medical Sa | ACTIVE IMPLANTABLE MEDICAL DEVICE FOR THE TREATMENT OF HEART RATE DISORDERS, INCLUDING IMPROVED MEANS FOR DETECTING ATRIAL ARRHYTHMIAS |
US20030083559A1 (en) * | 2001-10-31 | 2003-05-01 | Thompson David L. | Non-contact monitor |
US7054679B2 (en) | 2001-10-31 | 2006-05-30 | Robert Hirsh | Non-invasive method and device to monitor cardiac parameters |
US6577139B2 (en) | 2001-11-06 | 2003-06-10 | Keystone Thermometrics | Impedance converter circuit |
US6894456B2 (en) | 2001-11-07 | 2005-05-17 | Quallion Llc | Implantable medical power module |
US6980851B2 (en) | 2001-11-15 | 2005-12-27 | Cardiac Pacemakers, Inc. | Method and apparatus for determining changes in heart failure status |
US6643541B2 (en) * | 2001-12-07 | 2003-11-04 | Motorola, Inc | Wireless electromyography sensor and system |
ES2287174T3 (en) | 2001-12-12 | 2007-12-16 | Fresenius Medical Care Deutschland Gmbh | DETERMINATION OF THE STATE OF HYDRATION OF A PATIENT. |
US20030149349A1 (en) | 2001-12-18 | 2003-08-07 | Jensen Thomas P. | Integral patch type electronic physiological sensor |
US20030143544A1 (en) | 2002-01-09 | 2003-07-31 | Vitivity, Inc. | Diagnosis and treatment of vascular disease |
US7169107B2 (en) | 2002-01-25 | 2007-01-30 | Karen Jersey-Willuhn | Conductivity reconstruction based on inverse finite element measurements in a tissue monitoring system |
US6912414B2 (en) | 2002-01-29 | 2005-06-28 | Southwest Research Institute | Electrode systems and methods for reducing motion artifact |
US6645153B2 (en) | 2002-02-07 | 2003-11-11 | Pacesetter, Inc. | System and method for evaluating risk of mortality due to congestive heart failure using physiologic sensors |
US7468032B2 (en) | 2002-12-18 | 2008-12-23 | Cardiac Pacemakers, Inc. | Advanced patient management for identifying, displaying and assisting with correlating health-related data |
US8043213B2 (en) * | 2002-12-18 | 2011-10-25 | Cardiac Pacemakers, Inc. | Advanced patient management for triaging health-related data using color codes |
US6936006B2 (en) | 2002-03-22 | 2005-08-30 | Novo Nordisk, A/S | Atraumatic insertion of a subcutaneous device |
CA2379268A1 (en) | 2002-03-26 | 2003-09-26 | Hans Kolpin | Skin impedance matched biopotential electrode |
EP1487536A4 (en) | 2002-03-27 | 2009-12-02 | Cvrx Inc | Devices and methods for cardiovascular reflex control via coupled electrodes |
US20030187370A1 (en) | 2002-03-27 | 2003-10-02 | Kodama Roy K. | Uterine contraction sensing system and method |
US7654901B2 (en) | 2002-04-10 | 2010-02-02 | Breving Joel S | Video game system using bio-feedback devices |
CA2699672C (en) | 2002-04-16 | 2014-08-19 | Carematix, Inc. | Method and apparatus for remotely monitoring the condition of a patient |
US7136703B1 (en) | 2002-04-16 | 2006-11-14 | Pacesetter, Inc. | Programmer and surface ECG system with wireless communication |
WO2003094720A1 (en) | 2002-05-07 | 2003-11-20 | Izmail Batkin | Remote monitoring of cardiac electrical activity using a cell phone device |
US20030221687A1 (en) | 2002-05-09 | 2003-12-04 | William Kaigler | Medication and compliance management system and method |
TW528593B (en) | 2002-05-17 | 2003-04-21 | Jang-Min Yang | Device for monitoring physiological status and method for using the device |
US6922586B2 (en) | 2002-05-20 | 2005-07-26 | Richard J. Davies | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue |
US6906530B2 (en) | 2002-05-30 | 2005-06-14 | D.J. Geisel Technology, Inc. | Apparatus and method to detect moisture |
US7047067B2 (en) | 2002-05-31 | 2006-05-16 | Uab Research Foundation | Apparatus, methods, and computer program products for evaluating a risk of cardiac arrhythmias from restitution properties |
GB2391625A (en) | 2002-08-09 | 2004-02-11 | Diagnostic Ultrasound Europ B | Instantaneous ultrasonic echo measurement of bladder urine volume with a limited number of ultrasound beams |
US7277752B2 (en) | 2002-06-11 | 2007-10-02 | Matos Jeffrey A | System for cardiac resuscitation |
US7027862B2 (en) | 2002-07-25 | 2006-04-11 | Medtronic, Inc. | Apparatus and method for transmitting an electrical signal in an implantable medical device |
US20040019292A1 (en) | 2002-07-29 | 2004-01-29 | Drinan Darrel Dean | Method and apparatus for bioelectric impedance based identification of subjects |
IL151029A0 (en) | 2002-08-01 | 2003-04-10 | Art Medical Instr Ltd | Bio-filter pad for facilitating the detection of an occurrence of a physiological action, and method therefor, and fetal activity monitoring apparatus |
US6879850B2 (en) | 2002-08-16 | 2005-04-12 | Optical Sensors Incorporated | Pulse oximeter with motion detection |
US20060149168A1 (en) | 2002-08-19 | 2006-07-06 | Robert Czarnek | Capacitive uterine contraction sensor |
US6745061B1 (en) | 2002-08-21 | 2004-06-01 | Datex-Ohmeda, Inc. | Disposable oximetry sensor |
US7020508B2 (en) | 2002-08-22 | 2006-03-28 | Bodymedia, Inc. | Apparatus for detecting human physiological and contextual information |
US7294105B1 (en) | 2002-09-03 | 2007-11-13 | Cheetah Omni, Llc | System and method for a wireless medical communication system |
US7118531B2 (en) | 2002-09-24 | 2006-10-10 | The Johns Hopkins University | Ingestible medical payload carrying capsule with wireless communication |
JP4813058B2 (en) | 2002-10-09 | 2011-11-09 | ボディーメディア インコーポレイテッド | Device for detecting, receiving, deriving and displaying human physiological and contextual information |
US20040073094A1 (en) | 2002-10-15 | 2004-04-15 | Baker Donald A. | Fetal monitoring systems with ambulatory patient units and telemetric links for improved uses |
US7336187B2 (en) | 2002-10-18 | 2008-02-26 | The Trustees Of Boston University | Patient activity monitor |
GB2394294A (en) | 2002-10-18 | 2004-04-21 | Cambridge Neurotechnology Ltd | Cardiac sensor with accelerometer |
GB0224425D0 (en) | 2002-10-21 | 2002-11-27 | Univ Leicester | Method for prediction of cardiac disease |
US6878121B2 (en) | 2002-11-01 | 2005-04-12 | David T. Krausman | Sleep scoring apparatus and method |
AR039364A1 (en) | 2002-11-07 | 2005-02-16 | Carlos Daniel Silva | RESPIRATORY MOVEMENT MONITOR |
US7130679B2 (en) | 2002-11-20 | 2006-10-31 | Medtronic, Inc. | Organ rejection monitoring |
US20040106951A1 (en) | 2002-11-22 | 2004-06-03 | Edman Carl Frederick | Use of electric fields to minimize rejection of implanted devices and materials |
US20040100376A1 (en) | 2002-11-26 | 2004-05-27 | Kimberly-Clark Worldwide, Inc. | Healthcare monitoring system |
WO2004047636A1 (en) | 2002-11-27 | 2004-06-10 | Z-Tech (Canada) Inc. | Apparatus for determining adequacy of electrode-to-skin contact and electrode quality for bioelectrical measurements |
US8814793B2 (en) | 2002-12-03 | 2014-08-26 | Neorad As | Respiration monitor |
US7072718B2 (en) | 2002-12-03 | 2006-07-04 | Cardiac Pacemakers, Inc. | Antenna systems for implantable medical device telemetry |
US7986994B2 (en) | 2002-12-04 | 2011-07-26 | Medtronic, Inc. | Method and apparatus for detecting change in intrathoracic electrical impedance |
US7452334B2 (en) | 2002-12-16 | 2008-11-18 | The Regents Of The University Of Michigan | Antenna stent device for wireless, intraluminal monitoring |
US20060155174A1 (en) | 2002-12-16 | 2006-07-13 | Arkady Glukhovsky | Device, system and method for selective activation of in vivo sensors |
US20040143170A1 (en) | 2002-12-20 | 2004-07-22 | Durousseau Donald R. | Intelligent deception verification system |
US7395117B2 (en) | 2002-12-23 | 2008-07-01 | Cardiac Pacemakers, Inc. | Implantable medical device having long-term wireless capabilities |
GB0230361D0 (en) | 2002-12-27 | 2003-02-05 | Koninkl Philips Electronics Nv | Electrode arrangement |
US20040133079A1 (en) | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
DE10300735A1 (en) | 2003-01-11 | 2004-07-22 | Corscience Gmbh & Co.Kg | Method for detecting a fibrillation state and device for defibrillation |
US7423526B2 (en) | 2003-01-29 | 2008-09-09 | Despotis George J | Integrated patient diagnostic and identification system |
US7445605B2 (en) | 2003-01-31 | 2008-11-04 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of apex motion for monitoring cardiac dysfunction |
US6956572B2 (en) | 2003-02-10 | 2005-10-18 | Siemens Medical Solutions Health Services Corporation | Patient medical parameter user interface system |
EP1594551A2 (en) | 2003-02-19 | 2005-11-16 | Sicel Technologies, Inc. | In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
JP2006520657A (en) | 2003-03-21 | 2006-09-14 | ウェルチ・アリン・インコーポレーテッド | Personal condition physiological monitoring system and structure, and monitoring method |
ES2320892T3 (en) * | 2003-03-31 | 2009-05-29 | Alza Corporation | ELECTROTRANSPORT DEVICE THAT HAS A DEPOSIT COVER WITH A FLEXIBLE DRIVING ELEMENT. |
US20040199056A1 (en) | 2003-04-03 | 2004-10-07 | International Business Machines Corporation | Body monitoring using local area wireless interfaces |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US20040215240A1 (en) | 2003-04-11 | 2004-10-28 | Lovett Eric G. | Reconfigurable subcutaneous cardiac device |
US7130684B2 (en) | 2003-04-30 | 2006-10-31 | Medtronic, Inc. | Method and apparatus for improving ventricular status using the force interval relationship |
US20040225203A1 (en) | 2003-05-06 | 2004-11-11 | Jemison Mae C. | Real-time and simultaneous monitoring of multiple parameters from multiple living beings |
US20040225199A1 (en) | 2003-05-08 | 2004-11-11 | Evanyk Shane Walter | Advanced physiological monitoring systems and methods |
AU2003902187A0 (en) | 2003-05-08 | 2003-05-22 | Aimedics Pty Ltd | Patient monitor |
US7149574B2 (en) | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
US20050158539A1 (en) | 2003-06-25 | 2005-07-21 | Andover Coated Products, Inc. | Pressure-sensitive adhesive tapes |
US7171258B2 (en) | 2003-06-25 | 2007-01-30 | Cardiac Pacemakers, Inc. | Method and apparatus for trending a physiological cardiac parameter |
US7142907B2 (en) | 2003-07-01 | 2006-11-28 | Ge Medical Systems Information Technologies, Inc. | Method and apparatus for algorithm fusion of high-resolution electrocardiograms |
US7145027B2 (en) | 2003-07-08 | 2006-12-05 | W.C. Heraeus Gmbh & Co. Kg | Method for producing chlorotris(triphenylphosphine) rhodium (i) |
US20060195020A1 (en) | 2003-08-01 | 2006-08-31 | Martin James S | Methods, systems, and apparatus for measuring a pulse rate |
US20050131288A1 (en) | 2003-08-15 | 2005-06-16 | Turner Christopher T. | Flexible, patient-worn, integrated, self-contained sensor systems for the acquisition and monitoring of physiologic data |
US7616988B2 (en) | 2003-09-18 | 2009-11-10 | Cardiac Pacemakers, Inc. | System and method for detecting an involuntary muscle movement disorder |
AU2004266725B2 (en) | 2003-08-20 | 2011-03-10 | Philometron, Inc. | Hydration monitoring |
US7194306B1 (en) | 2003-09-05 | 2007-03-20 | Pacesetter, Inc. | Cardiac optimization through low-frequency analysis of hemodynamic variables |
JP2005080720A (en) | 2003-09-05 | 2005-03-31 | Tanita Corp | Bioelectric impedance measuring apparatus |
WO2005025405A2 (en) | 2003-09-10 | 2005-03-24 | Maternus Partners, Ltd. | Periumbilical infant ecg sensor and monitoring system |
US20050059867A1 (en) | 2003-09-13 | 2005-03-17 | Cheng Chung Yuan | Method for monitoring temperature of patient |
US7088242B2 (en) | 2003-09-16 | 2006-08-08 | International Business Machines Corporation | Collective personal articles tracking |
WO2005027998A2 (en) | 2003-09-16 | 2005-03-31 | Cardiomems, Inc. | Implantable wireless sensor |
US7129836B2 (en) | 2003-09-23 | 2006-10-31 | Ge Medical Systems Information Technologies, Inc. | Wireless subject monitoring system |
US7225024B2 (en) | 2003-09-30 | 2007-05-29 | Cardiac Pacemakers, Inc. | Sensors having protective eluting coating and method therefor |
US8428717B2 (en) | 2003-10-14 | 2013-04-23 | Medtronic, Inc. | Method and apparatus for monitoring tissue fluid content for use in an implantable cardiac device |
US8467876B2 (en) | 2003-10-15 | 2013-06-18 | Rmx, Llc | Breathing disorder detection and therapy delivery device and method |
AU2004289288B2 (en) | 2003-11-10 | 2011-07-28 | Philometron, Inc. | Structures and devices for parenteral drug delivery and diagnostic sampling |
EP1684626B1 (en) | 2003-11-18 | 2016-09-14 | Adidas AG | Method and system for processing data from ambulatory physiological monitoring |
CA2544926C (en) | 2003-11-26 | 2013-12-31 | Cardionet, Inc. | System and method for processing and presenting arrhythmia information to facilitate heart arrhythmia identification and treatment |
US20050124901A1 (en) | 2003-12-05 | 2005-06-09 | Misczynski Dale J. | Method and apparatus for electrophysiological and hemodynamic real-time assessment of cardiovascular fitness of a user |
EP1706170A4 (en) | 2003-12-12 | 2010-03-24 | Philometron Inc | Multiple section parenteral drug delivery apparatus |
US20050137626A1 (en) | 2003-12-19 | 2005-06-23 | Pastore Joseph M. | Drug delivery system and method employing external drug delivery device in conjunction with computer network |
US20050137464A1 (en) | 2003-12-23 | 2005-06-23 | Bomba Frank C. | Wireless sensor and sensor initialization device and method |
US20050148895A1 (en) | 2004-01-06 | 2005-07-07 | Misczynski Dale J. | Method and apparatus for ECG derived sleep monitoring of a user |
JP5094125B2 (en) | 2004-01-15 | 2012-12-12 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Adaptive physiological monitoring system and method of using the system |
EP1720446B1 (en) * | 2004-02-27 | 2010-07-14 | Koninklijke Philips Electronics N.V. | Wearable wireless device for monitoring, analyzing and communicating physiological status |
US7277741B2 (en) | 2004-03-09 | 2007-10-02 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
JP2005253840A (en) | 2004-03-15 | 2005-09-22 | Tanita Corp | Skin condition estimating device |
US7805196B2 (en) | 2004-03-16 | 2010-09-28 | Medtronic, Inc. | Collecting activity information to evaluate therapy |
CN1968727B (en) | 2004-03-18 | 2010-12-22 | 里普朗尼克股份有限公司 | Methods and devices for relieving stress |
JP5051767B2 (en) * | 2004-03-22 | 2012-10-17 | ボディーメディア インコーポレイテッド | Device for monitoring human condition parameters |
US7474918B2 (en) | 2004-03-24 | 2009-01-06 | Noninvasive Medical Technologies, Inc. | Thoracic impedance monitor and electrode array and method of use |
JP2007530124A (en) | 2004-03-25 | 2007-11-01 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Defibrillation electrode with drug delivery capability |
US20050215844A1 (en) | 2004-03-25 | 2005-09-29 | Ten Eyck Lawrence G | Patient carestation |
US7505814B2 (en) | 2004-03-26 | 2009-03-17 | Pacesetter, Inc. | System and method for evaluating heart failure based on ventricular end-diastolic volume using an implantable medical device |
US20050261598A1 (en) | 2004-04-07 | 2005-11-24 | Triage Wireless, Inc. | Patch sensor system for measuring vital signs |
US20050228244A1 (en) | 2004-04-07 | 2005-10-13 | Triage Wireless, Inc. | Small-scale, vital-signs monitoring device, system and method |
US7238159B2 (en) | 2004-04-07 | 2007-07-03 | Triage Wireless, Inc. | Device, system and method for monitoring vital signs |
US20050228238A1 (en) | 2004-04-09 | 2005-10-13 | Arnold Monitzer | Patient parameter automatic acquisition system |
WO2005104930A1 (en) | 2004-04-30 | 2005-11-10 | Biowatch Pty Ltd | Animal health monitoring system |
US7470232B2 (en) | 2004-05-04 | 2008-12-30 | General Electric Company | Method and apparatus for non-invasive ultrasonic fetal heart rate monitoring |
US7899526B2 (en) | 2004-05-10 | 2011-03-01 | Regents Of The University Of Minnesota | Portable device for monitoring electrocardiographic signals and indices of blood flow |
US7324845B2 (en) | 2004-05-17 | 2008-01-29 | Beth Israel Deaconess Medical Center | Assessment of sleep quality and sleep disordered breathing based on cardiopulmonary coupling |
US20050261743A1 (en) | 2004-05-19 | 2005-11-24 | Kroll Mark W | System and method for automated fluid monitoring |
KR100592934B1 (en) | 2004-05-21 | 2006-06-23 | 한국전자통신연구원 | Wearable physiological signal detection module and measurement apparatus with the same |
US7333850B2 (en) | 2004-05-28 | 2008-02-19 | University Of Florida Research Foundation, Inc. | Maternal-fetal monitoring system |
US7548785B2 (en) | 2004-06-10 | 2009-06-16 | Pacesetter, Inc. | Collecting and analyzing sensed information as a trend of heart failure progression or regression |
US20050277841A1 (en) | 2004-06-10 | 2005-12-15 | Adnan Shennib | Disposable fetal monitor patch |
KR100624425B1 (en) * | 2004-06-17 | 2006-09-19 | 삼성전자주식회사 | Integrated multiple electrodes for bio signal measurement, method and apparatus for bio signal measurement using the same, and method of seaching leads using the same |
WO2006009767A1 (en) * | 2004-06-18 | 2006-01-26 | Neuronetrix, Inc | Wireless electrode for biopotential measurement |
US7206630B1 (en) | 2004-06-29 | 2007-04-17 | Cleveland Medical Devices, Inc | Electrode patch and wireless physiological measurement system and method |
KR20070048201A (en) | 2004-07-23 | 2007-05-08 | 인터큐어 엘티디 | Apparatus and method for breathing pattern determination using a non-contact microphone |
US20070299325A1 (en) | 2004-08-20 | 2007-12-27 | Brian Farrell | Physiological status monitoring system |
US20060047215A1 (en) | 2004-09-01 | 2006-03-02 | Welch Allyn, Inc. | Combined sensor assembly |
WO2006029034A2 (en) | 2004-09-02 | 2006-03-16 | Philometron, Inc. | Monitoring platform for detection of hypovolemia, hemorrhage and blood loss |
US20060066449A1 (en) | 2004-09-08 | 2006-03-30 | Industrial Widget Works Company | RFMON: devices and methods for wireless monitoring of patient vital signs through medical sensor readings from passive RFID tags |
US9820658B2 (en) | 2006-06-30 | 2017-11-21 | Bao Q. Tran | Systems and methods for providing interoperability among healthcare devices |
US20060135858A1 (en) | 2004-09-13 | 2006-06-22 | International Business Machines Corporation | Displaying information related to a physical parameter of an individual |
US20060064133A1 (en) | 2004-09-17 | 2006-03-23 | Cardiac Pacemakers, Inc. | System and method for deriving relative physiologic measurements using an external computing device |
US20070106132A1 (en) * | 2004-09-28 | 2007-05-10 | Elhag Sammy I | Monitoring device, method and system |
US7917196B2 (en) | 2005-05-09 | 2011-03-29 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes |
US7840275B2 (en) | 2004-10-01 | 2010-11-23 | Medtronic, Inc. | In-home remote monitor with smart repeater, memory and emergency event management |
US7341560B2 (en) | 2004-10-05 | 2008-03-11 | Rader, Fishman & Grauer Pllc | Apparatuses and methods for non-invasively monitoring blood parameters |
US7609145B2 (en) | 2004-10-06 | 2009-10-27 | Martis Ip Holdings, Llc | Test authorization system |
US20080058656A1 (en) | 2004-10-08 | 2008-03-06 | Costello Benedict J | Electric tomography |
US7865236B2 (en) | 2004-10-20 | 2011-01-04 | Nervonix, Inc. | Active electrode, bio-impedance based, tissue discrimination system and methods of use |
US7996075B2 (en) | 2004-10-20 | 2011-08-09 | Cardionet, Inc. | Monitoring physiological activity using partial state space reconstruction |
US7212849B2 (en) | 2004-10-28 | 2007-05-01 | Cardiac Pacemakers, Inc. | Methods and apparatuses for arrhythmia detection and classification using wireless ECG |
US8768446B2 (en) | 2004-11-02 | 2014-07-01 | Medtronic, Inc. | Clustering with combined physiological signals |
US7917199B2 (en) | 2004-11-02 | 2011-03-29 | Medtronic, Inc. | Patient event marking in combination with physiological signals |
US20080228084A1 (en) | 2004-11-09 | 2008-09-18 | Michel Bedard | Method and Apparatus for Reduction of Spurious Effects on Physiological Measurements |
US7751868B2 (en) | 2004-11-12 | 2010-07-06 | Philips Electronics Ltd | Integrated skin-mounted multifunction device for use in image-guided surgery |
JP2006343306A (en) | 2004-11-15 | 2006-12-21 | Denso Corp | Gas concentration detector |
WO2006056896A1 (en) | 2004-11-24 | 2006-06-01 | Koninklijke Philips Electronics, N.V. | An internet-protocol based telemetry patient monitoring system |
US20060116592A1 (en) | 2004-12-01 | 2006-06-01 | Medtronic, Inc. | Method and apparatus for detection and monitoring of T-wave alternans |
DE602005026054D1 (en) | 2004-12-17 | 2011-03-03 | Medtronic Inc | SYSTEM FOR MONITORING OR TREATING DISEASES OF THE NERVOUS SYSTEM |
US8108046B2 (en) | 2004-12-17 | 2012-01-31 | Medtronic, Inc. | System and method for using cardiac events to trigger therapy for treating nervous system disorders |
US8734341B2 (en) | 2004-12-20 | 2014-05-27 | Ipventure, Inc. | Method and apparatus to sense hydration level of a person |
FI20045503A (en) | 2004-12-28 | 2006-06-29 | Polar Electro Oy | Sensor systems, accessories and heart rate monitors |
WO2006074092A1 (en) | 2005-01-05 | 2006-07-13 | Rensselaer Polytechnic Institute | High precision voltage source for electrical impedance tomography |
US8577455B2 (en) | 2005-01-18 | 2013-11-05 | Medtronic, Inc. | Method and apparatus for arrhythmia detection in a medical device |
JP2006198334A (en) | 2005-01-24 | 2006-08-03 | Tanita Corp | Bioelectrical impedance measuring device and body composition measuring apparatus |
JP2006204742A (en) | 2005-01-31 | 2006-08-10 | Konica Minolta Sensing Inc | Method and system for evaluating sleep, its operation program, pulse oxymeter, and system for supporting sleep |
US20080021336A1 (en) | 2006-04-24 | 2008-01-24 | Dobak John D Iii | Devices and methods for accelerometer-based characterization of cardiac synchrony and dyssynchrony |
JP4731936B2 (en) | 2005-02-09 | 2011-07-27 | 本田技研工業株式会社 | Rotary variable resistor |
WO2006090371A2 (en) | 2005-02-22 | 2006-08-31 | Health-Smart Limited | Methods and systems for physiological and psycho-physiological monitoring and uses thereof |
US20060212097A1 (en) | 2005-02-24 | 2006-09-21 | Vijay Varadan | Method and device for treatment of medical conditions and monitoring physical movements |
US7722622B2 (en) | 2005-02-25 | 2010-05-25 | Synthes Usa, Llc | Implant insertion apparatus and method of use |
US7616110B2 (en) | 2005-03-11 | 2009-11-10 | Aframe Digital, Inc. | Mobile wireless customizable health and condition monitor |
CA2646131C (en) | 2005-03-21 | 2018-09-04 | Vicus Therapeutics Spe 1, Llc | Compositions and methods for ameliorating cachexia |
US20060252999A1 (en) | 2005-05-03 | 2006-11-09 | Devaul Richard W | Method and system for wearable vital signs and physiology, activity, and environmental monitoring |
US20060224079A1 (en) | 2005-03-31 | 2006-10-05 | Washchuk Bohdan O | Edema monitoring system and method utilizing an implantable medical device |
US20060224072A1 (en) | 2005-03-31 | 2006-10-05 | Cardiovu, Inc. | Disposable extended wear heart monitor patch |
JP2009500047A (en) * | 2005-04-14 | 2009-01-08 | イダルゴ リミテッド | Apparatus and method for monitoring |
US8480577B2 (en) | 2005-04-15 | 2013-07-09 | Ivy Biomedical Systems, Inc. | Wireless patient monitoring system |
RU2007142662A (en) | 2005-04-20 | 2009-05-27 | Конинклейке Филипс Электроникс Н.В. (Nl) | CONSTANT HEART FAILURE TREATMENT SYSTEM |
US20060241641A1 (en) | 2005-04-22 | 2006-10-26 | Sdgi Holdings, Inc. | Methods and instrumentation for distraction and insertion of implants in a spinal disc space |
US7657317B2 (en) | 2005-04-26 | 2010-02-02 | Boston Scientific Neuromodulation Corporation | Evaluating stimulation therapies and patient satisfaction |
US7991467B2 (en) | 2005-04-26 | 2011-08-02 | Medtronic, Inc. | Remotely enabled pacemaker and implantable subcutaneous cardioverter/defibrillator system |
US7822627B2 (en) | 2005-05-02 | 2010-10-26 | St Martin Edward | Method and system for generating an echocardiogram report |
US7907997B2 (en) | 2005-05-11 | 2011-03-15 | Cardiac Pacemakers, Inc. | Enhancements to the detection of pulmonary edema when using transthoracic impedance |
US9089275B2 (en) | 2005-05-11 | 2015-07-28 | Cardiac Pacemakers, Inc. | Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance |
US8688189B2 (en) | 2005-05-17 | 2014-04-01 | Adnan Shennib | Programmable ECG sensor patch |
EP1948015B1 (en) | 2005-05-18 | 2015-03-04 | Rachelle Van Wyk | System, method, and kit for positioning a monitor transducer on a patient |
US7340296B2 (en) | 2005-05-18 | 2008-03-04 | Cardiac Pacemakers, Inc. | Detection of pleural effusion using transthoracic impedance |
US8900154B2 (en) | 2005-05-24 | 2014-12-02 | Cardiac Pacemakers, Inc. | Prediction of thoracic fluid accumulation |
KR100634544B1 (en) | 2005-06-04 | 2006-10-13 | 삼성전자주식회사 | Apparatus and method for measuring moisture content in skin using portable terminal |
US7387607B2 (en) | 2005-06-06 | 2008-06-17 | Intel Corporation | Wireless medical sensor system |
FR2886532B1 (en) | 2005-06-07 | 2008-03-28 | Commissariat Energie Atomique | METHOD AND SYSTEM FOR DETECTING THE FALL OF A PERSON |
TW200642660A (en) | 2005-06-14 | 2006-12-16 | We Gene Technologies Inc | Auto diagnosing method and device thereof for high mountain disease |
US20060293571A1 (en) | 2005-06-23 | 2006-12-28 | Skanda Systems | Distributed architecture for remote patient monitoring and caring |
US7295879B2 (en) | 2005-06-24 | 2007-11-13 | Kenergy, Inc. | Double helical antenna assembly for a wireless intravascular medical device |
US7813778B2 (en) | 2005-07-29 | 2010-10-12 | Spectros Corporation | Implantable tissue ischemia sensor |
US20070033072A1 (en) * | 2005-08-04 | 2007-02-08 | Bildirici Nesim N | System and method for comprehensive remote patient monitoring and management |
US8494618B2 (en) * | 2005-08-22 | 2013-07-23 | Cardiac Pacemakers, Inc. | Intracardiac impedance and its applications |
US7775983B2 (en) | 2005-09-16 | 2010-08-17 | Cardiac Pacemakers, Inc. | Rapid shallow breathing detection for use in congestive heart failure status determination |
US7731663B2 (en) * | 2005-09-16 | 2010-06-08 | Cardiac Pacemakers, Inc. | System and method for generating a trend parameter based on respiration rate distribution |
US8992436B2 (en) | 2005-09-16 | 2015-03-31 | Cardiac Pacemakers, Inc. | Respiration monitoring using respiration rate variability |
US20080058614A1 (en) | 2005-09-20 | 2008-03-06 | Triage Wireless, Inc. | Wireless, internet-based system for measuring vital signs from a plurality of patients in a hospital or medical clinic |
US20070073361A1 (en) | 2005-09-23 | 2007-03-29 | Bioq, Inc. | Medical device for restoration of autonomic and immune functions impaired by neuropathy |
WO2007038607A2 (en) | 2005-09-27 | 2007-04-05 | Telzuit Technologies, Llc | Apparatus and method for monitoring patients |
US20070083092A1 (en) | 2005-10-07 | 2007-04-12 | Rippo Anthony J | External exercise monitor |
US20070082189A1 (en) * | 2005-10-11 | 2007-04-12 | Gillette William J | Waterproof, breathable composite material |
EP1948017B1 (en) | 2005-10-11 | 2014-04-02 | Impedimed Limited | Hydration status monitoring |
JP2007105316A (en) | 2005-10-14 | 2007-04-26 | Konica Minolta Sensing Inc | Bioinformation measuring instrument |
US7733224B2 (en) * | 2006-06-30 | 2010-06-08 | Bao Tran | Mesh network personal emergency response appliance |
US7420472B2 (en) | 2005-10-16 | 2008-09-02 | Bao Tran | Patient monitoring apparatus |
US8118750B2 (en) | 2005-10-21 | 2012-02-21 | Medtronic, Inc. | Flow sensors for penile tumescence |
US20070123904A1 (en) | 2005-10-31 | 2007-05-31 | Depuy Spine, Inc. | Distraction instrument and method for distracting an intervertebral site |
US20070123903A1 (en) | 2005-10-31 | 2007-05-31 | Depuy Spine, Inc. | Medical Device installation tool and methods of use |
US7942824B1 (en) | 2005-11-04 | 2011-05-17 | Cleveland Medical Devices Inc. | Integrated sleep diagnostic and therapeutic system and method |
US7682313B2 (en) | 2005-11-23 | 2010-03-23 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US7766840B2 (en) | 2005-12-01 | 2010-08-03 | Cardiac Pacemakers, Inc. | Method and system for heart failure status evaluation based on a disordered breathing index |
US8016776B2 (en) | 2005-12-02 | 2011-09-13 | Medtronic, Inc. | Wearable ambulatory data recorder |
US7957809B2 (en) | 2005-12-02 | 2011-06-07 | Medtronic, Inc. | Closed-loop therapy adjustment |
WO2007065015A2 (en) | 2005-12-03 | 2007-06-07 | Masimo Corporation | Physiological alarm notification system |
AU2006321574B2 (en) | 2005-12-06 | 2012-07-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US20080312524A1 (en) * | 2005-12-08 | 2008-12-18 | Koninklijke Philips Electronics N.V. | Medical Sensor Having Electrodes and a Motion Sensor |
US20070180047A1 (en) | 2005-12-12 | 2007-08-02 | Yanting Dong | System and method for providing authentication of remotely collected external sensor measures |
WO2007072239A2 (en) | 2005-12-19 | 2007-06-28 | Koninklijke Philips Electronics N.V. | Apparatus for monitoring a person's heart rate and/or heart rate variation; wristwatch comprising the same |
US7761158B2 (en) | 2005-12-20 | 2010-07-20 | Cardiac Pacemakers, Inc. | Detection of heart failure decompensation based on cumulative changes in sensor signals |
US20070142715A1 (en) | 2005-12-20 | 2007-06-21 | Triage Wireless, Inc. | Chest strap for measuring vital signs |
US8050774B2 (en) | 2005-12-22 | 2011-11-01 | Boston Scientific Scimed, Inc. | Electrode apparatus, systems and methods |
TWI311067B (en) | 2005-12-27 | 2009-06-21 | Ind Tech Res Inst | Method and apparatus of interactive gaming with emotion perception ability |
US20070162089A1 (en) | 2006-01-09 | 2007-07-12 | Transoma Medical, Inc. | Cross-band communications in an implantable device |
ATE441452T1 (en) | 2006-01-23 | 2009-09-15 | Koninkl Philips Electronics Nv | IMPROVED BIOMEDICAL ELECTRODE FOR EXTENDED USE ON PATIENTS WITH A CAP OR SNAPPER ISOLATED FROM THE RETAINING SEAL |
US20070172424A1 (en) | 2006-01-26 | 2007-07-26 | Mark Costin Roser | Enabling drug adherence through closed loop monitoring & communication |
WO2007092543A2 (en) | 2006-02-06 | 2007-08-16 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive cardiac monitor and methods of using continuously recorded cardiac data |
US20070255184A1 (en) | 2006-02-10 | 2007-11-01 | Adnan Shennib | Disposable labor detection patch |
US20090177145A1 (en) | 2006-02-28 | 2009-07-09 | Malin Ohlander | Medical device and method for monitoring hematocrit and svo2 |
US20070208232A1 (en) | 2006-03-03 | 2007-09-06 | Physiowave Inc. | Physiologic monitoring initialization systems and methods |
US8200320B2 (en) | 2006-03-03 | 2012-06-12 | PhysioWave, Inc. | Integrated physiologic monitoring systems and methods |
US7668588B2 (en) | 2006-03-03 | 2010-02-23 | PhysioWave, Inc. | Dual-mode physiologic monitoring systems and methods |
WO2007106455A2 (en) | 2006-03-10 | 2007-09-20 | Optical Sensors Incorporated | Cardiography system and method using automated recognition of hemodynamic parameters and waveform attributes |
DE102006015291B4 (en) | 2006-04-01 | 2015-10-29 | Drägerwerk AG & Co. KGaA | Procedure for setting a patient monitor |
US7359837B2 (en) | 2006-04-27 | 2008-04-15 | Medtronic, Inc. | Peak data retention of signal data in an implantable medical device |
US7818050B2 (en) | 2006-05-02 | 2010-10-19 | Lono Medical Systems, Llc | Passive phonography heart monitor |
US7616980B2 (en) | 2006-05-08 | 2009-11-10 | Tyco Healthcare Group Lp | Radial electrode array |
US7539532B2 (en) * | 2006-05-12 | 2009-05-26 | Bao Tran | Cuffless blood pressure monitoring appliance |
US7539533B2 (en) | 2006-05-16 | 2009-05-26 | Bao Tran | Mesh network monitoring appliance |
US20070282173A1 (en) | 2006-05-31 | 2007-12-06 | Bily Wang | Vital sign sending method and a sending apparatus thereof |
US7346380B2 (en) | 2006-06-16 | 2008-03-18 | Axelgaard Manufacturing Co., Ltd. | Medical electrode |
US20080013747A1 (en) * | 2006-06-30 | 2008-01-17 | Bao Tran | Digital stethoscope and monitoring instrument |
WO2008017042A1 (en) | 2006-08-03 | 2008-02-07 | Microchips, Inc. | Cardiac biosensor devices and methods |
US9773060B2 (en) | 2006-09-05 | 2017-09-26 | Cardiac Pacemaker, Inc. | System and method for providing automatic setup of a remote patient care environment |
US20080091089A1 (en) | 2006-10-12 | 2008-04-17 | Kenneth Shane Guillory | Single use, self-contained surface physiological monitor |
US20080091090A1 (en) | 2006-10-12 | 2008-04-17 | Kenneth Shane Guillory | Self-contained surface physiological monitor with adhesive attachment |
US20080215360A1 (en) | 2006-10-24 | 2008-09-04 | Kent Dicks | Systems and methods for medical data interchange interface |
US8214007B2 (en) * | 2006-11-01 | 2012-07-03 | Welch Allyn, Inc. | Body worn physiological sensor device having a disposable electrode module |
US8449469B2 (en) | 2006-11-10 | 2013-05-28 | Sotera Wireless, Inc. | Two-part patch sensor for monitoring vital signs |
US20080120784A1 (en) | 2006-11-28 | 2008-05-29 | General Electric Company | Smart bed system and apparatus |
BRPI0720148B8 (en) * | 2006-12-07 | 2021-06-22 | Koninklijke Philips Electronics Nv | EKG monitoring device, and, method of obtaining ecg data from an individual |
US8157730B2 (en) | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US20080171929A1 (en) | 2007-01-11 | 2008-07-17 | Katims Jefferson J | Method for standardizing spacing between electrodes, and medical tape electrodes |
WO2008091683A2 (en) | 2007-01-25 | 2008-07-31 | Senior Vitals, Inc. | System and method for physiological data readings, transmission and presentation |
US20090017910A1 (en) | 2007-06-22 | 2009-01-15 | Broadcom Corporation | Position and motion tracking of an object |
US9044136B2 (en) | 2007-02-16 | 2015-06-02 | Cim Technology Inc. | Wearable mini-size intelligent healthcare system |
US20080221399A1 (en) | 2007-03-05 | 2008-09-11 | Triage Wireless, Inc. | Monitor for measuring vital signs and rendering video images |
US20080220865A1 (en) | 2007-03-06 | 2008-09-11 | Wei Hsu | Interactive playstation controller |
EP2155042A1 (en) * | 2007-04-30 | 2010-02-24 | Clifford C. Dacso | Non-invasive monitoring of physiological measurements in a distributed health care environment |
US20080287752A1 (en) | 2007-05-10 | 2008-11-20 | Mayo Foundation For Medical Education And Research | Ear canal physiological parameter monitoring system |
US8750971B2 (en) | 2007-05-24 | 2014-06-10 | Bao Tran | Wireless stroke monitoring |
US8718742B2 (en) * | 2007-05-24 | 2014-05-06 | Hmicro, Inc. | Integrated wireless patch for physiological monitoring |
TW200846061A (en) | 2007-05-25 | 2008-12-01 | Asustek Comp Inc | Game controller |
US9754078B2 (en) | 2007-06-21 | 2017-09-05 | Immersion Corporation | Haptic health feedback monitoring |
US9380966B2 (en) | 2007-06-22 | 2016-07-05 | Vioptix, Inc. | Tissue retractor oximeter |
US20090005016A1 (en) | 2007-06-29 | 2009-01-01 | Betty Eng | Apparatus and method to maintain a continuous connection of a cellular device and a sensor network |
US8926509B2 (en) | 2007-08-24 | 2015-01-06 | Hmicro, Inc. | Wireless physiological sensor patches and systems |
US20090062670A1 (en) | 2007-08-30 | 2009-03-05 | Gary James Sterling | Heart monitoring body patch and system |
WO2009036319A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent emergency patient monitor |
WO2009036313A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent device with multiple physiological sensors |
EP2195076A4 (en) | 2007-09-14 | 2014-12-31 | Corventis Inc | Adherent device for cardiac rhythm management |
WO2009036348A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Medical device automatic start-up upon contact to patient tissue |
US8790257B2 (en) | 2007-09-14 | 2014-07-29 | Corventis, Inc. | Multi-sensor patient monitor to detect impending cardiac decompensation |
WO2009036256A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Injectable physiological monitoring system |
US8249686B2 (en) | 2007-09-14 | 2012-08-21 | Corventis, Inc. | Adherent device for sleep disordered breathing |
US20090076342A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Multi-Sensor Device with Empathic Monitoring |
US20090076349A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Multi-Sensor Device with Implantable Device Communication Capabilities |
WO2009036326A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent athletic monitor |
WO2009036333A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Dynamic pairing of patients to data collection gateways |
US8460189B2 (en) | 2007-09-14 | 2013-06-11 | Corventis, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
US8260439B2 (en) * | 2007-11-16 | 2012-09-04 | Ethicon, Inc. | Nerve stimulation patches and methods for stimulating selected nerves |
EP2257216B1 (en) | 2008-03-12 | 2021-04-28 | Medtronic Monitoring, Inc. | Heart failure decompensation prediction based on cardiac rhythm |
WO2009116906A1 (en) | 2008-03-19 | 2009-09-24 | Telefonaktiebolaget Lm Ericsson (Publ) | Nfc communications for implanted medical data acquisition devices |
US20090292194A1 (en) | 2008-05-23 | 2009-11-26 | Corventis, Inc. | Chiropractic Care Management Systems and Methods |
US20100191310A1 (en) | 2008-07-29 | 2010-07-29 | Corventis, Inc. | Communication-Anchor Loop For Injectable Device |
US20100061911A1 (en) | 2008-08-04 | 2010-03-11 | Hariharan Alleppey V | METHOD TO CONVERT SILICON POWDER TO HIGH PURITY POLYSILICON THROUGH INTERMEDIATE SiF4 |
WO2010025144A1 (en) | 2008-08-29 | 2010-03-04 | Corventis, Inc. | Method and apparatus for acute cardiac monitoring |
US8790259B2 (en) | 2009-10-22 | 2014-07-29 | Corventis, Inc. | Method and apparatus for remote detection and monitoring of functional chronotropic incompetence |
US9451897B2 (en) | 2009-12-14 | 2016-09-27 | Medtronic Monitoring, Inc. | Body adherent patch with electronics for physiologic monitoring |
US8965498B2 (en) | 2010-04-05 | 2015-02-24 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
AU2011252998B2 (en) * | 2010-05-12 | 2015-08-27 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
US9420952B2 (en) * | 2010-07-27 | 2016-08-23 | Carefusion 303, Inc. | Temperature probe suitable for axillary reading |
-
2008
- 2008-09-12 WO PCT/US2008/076226 patent/WO2009036313A1/en active Application Filing
- 2008-09-12 US US12/209,288 patent/US20090076345A1/en not_active Abandoned
- 2008-09-12 US US12/209,273 patent/US8116841B2/en active Active
- 2008-09-12 EP EP08831013A patent/EP2194847A1/en not_active Withdrawn
-
2012
- 2012-01-10 US US13/347,238 patent/US8285356B2/en active Active
- 2012-08-29 US US13/598,238 patent/US8795174B2/en not_active Expired - Fee Related
- 2012-10-08 US US13/647,284 patent/US8818481B2/en not_active Ceased
-
2014
- 2014-07-02 US US14/322,676 patent/US20140330136A1/en not_active Abandoned
- 2014-07-02 US US14/322,435 patent/US9770182B2/en active Active
-
2016
- 2016-08-25 US US15/247,458 patent/USRE46926E1/en not_active Expired - Fee Related
Patent Citations (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3170459A (en) * | 1962-03-20 | 1965-02-23 | Clifford G Phipps | Bio-medical instrumentation electrode |
US3370459A (en) * | 1964-04-16 | 1968-02-27 | Cescati Arturo | Device for detecting pressure existing in pneumatic tires |
US4008712A (en) * | 1975-11-14 | 1977-02-22 | J. M. Richards Laboratories | Method for monitoring body characteristics |
US4308872A (en) * | 1977-04-07 | 1982-01-05 | Respitrace Corporation | Method and apparatus for monitoring respiration |
US4185621A (en) * | 1977-10-28 | 1980-01-29 | Triad, Inc. | Body parameter display incorporating a battery charger |
US4141366A (en) * | 1977-11-18 | 1979-02-27 | Medtronic, Inc. | Lead connector for tape electrode |
US5862802A (en) * | 1981-04-03 | 1999-01-26 | Forrest M. Bird | Ventilator having an oscillatory inspiratory phase and method |
US4498479A (en) * | 1981-06-24 | 1985-02-12 | Kone Oy | Electrocardiograph (ECG) electrode testing system |
US4981139A (en) * | 1983-08-11 | 1991-01-01 | Pfohl Robert L | Vital signs monitoring and communication system |
US4721110A (en) * | 1984-08-06 | 1988-01-26 | Lampadius Michael S | Respiration-controlled cardiac pacemaker |
US4895163A (en) * | 1988-05-24 | 1990-01-23 | Bio Analogics, Inc. | System for body impedance data acquisition |
US4988335A (en) * | 1988-08-16 | 1991-01-29 | Ideal Instruments, Inc. | Pellet implanter apparatus |
US5080099A (en) * | 1988-08-26 | 1992-01-14 | Cardiotronics, Inc. | Multi-pad, multi-function electrode |
US5086781A (en) * | 1989-11-14 | 1992-02-11 | Bookspan Mark A | Bioelectric apparatus for monitoring body fluid compartments |
US5083563A (en) * | 1990-02-16 | 1992-01-28 | Telectronics Pacing Systems, Inc. | Implantable automatic and haemodynamically responsive cardioverting/defibrillating pacemaker |
US5482036A (en) * | 1991-03-07 | 1996-01-09 | Masimo Corporation | Signal processing apparatus and method |
US5282840A (en) * | 1992-03-26 | 1994-02-01 | Medtronic, Inc. | Multiple frequency impedance measurement system |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US20040015058A1 (en) * | 1993-09-04 | 2004-01-22 | Motorola, Inc. | Wireless medical diagnosis and monitoring equipment |
US5862803A (en) * | 1993-09-04 | 1999-01-26 | Besson; Marcus | Wireless medical diagnosis and monitoring equipment |
US6339722B1 (en) * | 1995-09-26 | 2002-01-15 | A. J. Van Liebergen Holding B.V. | Apparatus for the in-vivo non-invasive measurement of a biological parameter concerning a bodily fluid of a person or animal |
US5860860A (en) * | 1996-01-31 | 1999-01-19 | Federal Patent Corporation | Integral video game and cardio-waveform display |
US5718234A (en) * | 1996-09-30 | 1998-02-17 | Northrop Grumman Corporation | Physiological data communication system |
US6185452B1 (en) * | 1997-02-26 | 2001-02-06 | Joseph H. Schulman | Battery-powered patient implantable device |
US5865733A (en) * | 1997-02-28 | 1999-02-02 | Spacelabs Medical, Inc. | Wireless optical patient monitoring apparatus |
US6027523A (en) * | 1997-10-06 | 2000-02-22 | Arthrex, Inc. | Suture anchor with attached disk |
US6190313B1 (en) * | 1998-04-20 | 2001-02-20 | Allen J. Hinkle | Interactive health care system and method |
US20030009092A1 (en) * | 1998-10-15 | 2003-01-09 | Sensidyne, Inc. | Reusable pulse oximeter probe and disposable bandage apparatus |
US6181963B1 (en) * | 1998-11-02 | 2001-01-30 | Alza Corporation | Transdermal electrotransport delivery device including a cathodic reservoir containing a compatible antimicrobial agent |
US6687540B2 (en) * | 1999-03-12 | 2004-02-03 | Cardiac Pacemakers, Inc. | Discrimination of supraventricular tachycardia and ventricular tachycardia events |
US6190324B1 (en) * | 1999-04-28 | 2001-02-20 | Medtronic, Inc. | Implantable medical device for tracking patient cardiac status |
US6512949B1 (en) * | 1999-07-12 | 2003-01-28 | Medtronic, Inc. | Implantable medical device for measuring time varying physiologic conditions especially edema and for responding thereto |
US20070038038A1 (en) * | 1999-10-18 | 2007-02-15 | Bodymedia, Inc. | Wearable human physiological and environmental data sensors and reporting system therefor |
US6520967B1 (en) * | 1999-10-20 | 2003-02-18 | Cauthen Research Group, Inc. | Spinal implant insertion instrument for spinal interbody prostheses |
US6336903B1 (en) * | 1999-11-16 | 2002-01-08 | Cardiac Intelligence Corp. | Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof |
US7156808B2 (en) * | 1999-12-17 | 2007-01-02 | Q-Tec Systems Llc | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
US6985078B2 (en) * | 2000-03-14 | 2006-01-10 | Kabushiki Kaisha Toshiba | Wearable life support apparatus and method |
US6987965B2 (en) * | 2000-04-18 | 2006-01-17 | Motorola, Inc. | Programmable wireless electrode system for medical monitoring |
US6988989B2 (en) * | 2000-05-19 | 2006-01-24 | Welch Allyn Protocol, Inc. | Patient monitoring system |
US20060031102A1 (en) * | 2000-06-16 | 2006-02-09 | Bodymedia, Inc. | System for detecting, monitoring, and reporting an individual's physiological or contextual status |
US20020019588A1 (en) * | 2000-06-23 | 2002-02-14 | Marro Dominic P. | Frontal electrode array for patient EEG signal acquisition |
US6858006B2 (en) * | 2000-09-08 | 2005-02-22 | Wireless Medical, Inc. | Cardiopulmonary monitoring |
US20070038255A1 (en) * | 2000-09-27 | 2007-02-15 | Cvrx, Inc. | Baroreflex stimulator with integrated pressure sensor |
US20070021799A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Automatic baroreflex modulation based on cardiac activity |
US20070021797A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex stimulation synchronized to circadian rhythm |
US20070021792A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex Modulation Based On Monitored Cardiovascular Parameter |
US20070021796A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex modulation to gradually decrease blood pressure |
US20070021798A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex stimulation to treat acute myocardial infarction |
US20070021794A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex Therapy for Disordered Breathing |
US20070038262A1 (en) * | 2000-09-27 | 2007-02-15 | Cvrx, Inc. | Baroreflex stimulation system to reduce hypertension |
US20050027207A1 (en) * | 2000-12-29 | 2005-02-03 | Westbrook Philip R. | Sleep apnea risk evaluation |
US6993378B2 (en) * | 2001-06-25 | 2006-01-31 | Science Applications International Corporation | Identification by analysis of physiometric variation |
US20030028321A1 (en) * | 2001-06-29 | 2003-02-06 | The Regents Of The University Of California | Method and apparatus for ultra precise GPS-based mapping of seeds or vegetation during planting |
US6697658B2 (en) * | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
US20030023184A1 (en) * | 2001-07-23 | 2003-01-30 | Jonathan Pitts-Crick | Method and system for diagnosing and administering therapy of pulmonary congestion |
US20030028221A1 (en) * | 2001-07-31 | 2003-02-06 | Qingsheng Zhu | Cardiac rhythm management system for edema |
US20040010303A1 (en) * | 2001-09-26 | 2004-01-15 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
US7166063B2 (en) * | 2001-10-01 | 2007-01-23 | The Nemours Foundation | Brace compliance monitor |
US20050020935A1 (en) * | 2001-11-20 | 2005-01-27 | Thomas Helzel | Electrode for biomedical measurements |
US7318808B2 (en) * | 2001-12-14 | 2008-01-15 | Isis Innovation Limited | Combining measurements from breathing rate sensors |
US20070043301A1 (en) * | 2002-05-14 | 2007-02-22 | Idex Asa | Volume specific characterization of human skin by electrical immitance |
US20040006279A1 (en) * | 2002-07-03 | 2004-01-08 | Shimon Arad (Abboud) | Apparatus for monitoring CHF patients using bio-impedance technique |
US6997879B1 (en) * | 2002-07-09 | 2006-02-14 | Pacesetter, Inc. | Methods and devices for reduction of motion-induced noise in optical vascular plethysmography |
US7160253B2 (en) * | 2002-11-08 | 2007-01-09 | Polar Electro Oy | Method and device for measuring stress |
US20060004300A1 (en) * | 2002-11-22 | 2006-01-05 | James Kennedy | Multifrequency bioimpedance determination |
US20050027918A1 (en) * | 2002-12-23 | 2005-02-03 | Microtune (Texas), L.P. | Automatically establishing a wireless connection between adapters |
US7160252B2 (en) * | 2003-01-10 | 2007-01-09 | Medtronic, Inc. | Method and apparatus for detecting respiratory disturbances |
US20080024294A1 (en) * | 2003-06-23 | 2008-01-31 | Cardiac Pacemakers, Inc. | Systems, devices, and methods for selectively preventing data transfer from a medical device |
US20050027204A1 (en) * | 2003-06-26 | 2005-02-03 | Kligfield Paul D. | ECG diagnostic system and method |
US20050015094A1 (en) * | 2003-07-15 | 2005-01-20 | Cervitech, Inc. | Arrangement of a cervical prosthesis and insertion instrument |
US20050015095A1 (en) * | 2003-07-15 | 2005-01-20 | Cervitech, Inc. | Insertion instrument for cervical prostheses |
US20060004377A1 (en) * | 2003-07-15 | 2006-01-05 | Cervitech, Inc. | Insertion instrument for cervical prostheses |
US20050027175A1 (en) * | 2003-07-31 | 2005-02-03 | Zhongping Yang | Implantable biosensor |
US20050043675A1 (en) * | 2003-08-21 | 2005-02-24 | Pastore Joseph M. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
US20050113703A1 (en) * | 2003-09-12 | 2005-05-26 | Jonathan Farringdon | Method and apparatus for measuring heart related parameters |
US20070010750A1 (en) * | 2003-10-03 | 2007-01-11 | Akinori Ueno | Biometric sensor and biometric method |
US7184821B2 (en) * | 2003-12-03 | 2007-02-27 | Regents Of The University Of Minnesota | Monitoring thoracic fluid changes |
US20050192488A1 (en) * | 2004-02-12 | 2005-09-01 | Biopeak Corporation | Non-invasive method and apparatus for determining a physiological parameter |
US20060020218A1 (en) * | 2004-02-26 | 2006-01-26 | Warwick Freeman | Method and apparatus for continuous electrode impedance monitoring |
US7167743B2 (en) * | 2004-03-16 | 2007-01-23 | Medtronic, Inc. | Collecting activity information to evaluate therapy |
US20060009697A1 (en) * | 2004-04-07 | 2006-01-12 | Triage Wireless, Inc. | Wireless, internet-based system for measuring vital signs from a plurality of patients in a hospital or medical clinic |
US20060009701A1 (en) * | 2004-06-29 | 2006-01-12 | Polar Electro Oy | Method of monitoring human relaxation level, and user-operated heart rate monitor |
US20060010090A1 (en) * | 2004-07-12 | 2006-01-12 | Marina Brockway | Expert system for patient medical information analysis |
US7319386B2 (en) * | 2004-08-02 | 2008-01-15 | Hill-Rom Services, Inc. | Configurable system for alerting caregivers |
US20060025661A1 (en) * | 2004-08-02 | 2006-02-02 | Sweeney Robert J | Device for monitoring fluid status |
US20060030781A1 (en) * | 2004-08-05 | 2006-02-09 | Adnan Shennib | Emergency heart sensor patch |
US20060030782A1 (en) * | 2004-08-05 | 2006-02-09 | Adnan Shennib | Heart disease detection patch |
US20060041280A1 (en) * | 2004-08-19 | 2006-02-23 | Cardiac Pacemakers, Inc. | Thoracic impedance detection with blood resistivity compensation |
US20070015976A1 (en) * | 2005-06-01 | 2007-01-18 | Medtronic, Inc. | Correlating a non-polysomnographic physiological parameter set with sleep states |
US20070015973A1 (en) * | 2005-06-03 | 2007-01-18 | Reuven Nanikashvili | Communication terminal, medical telemetry system and method for monitoring physiological data |
US20070010721A1 (en) * | 2005-06-28 | 2007-01-11 | Chen Thomas C H | Apparatus and system of Internet-enabled wireless medical sensor scale |
US20070038078A1 (en) * | 2005-07-08 | 2007-02-15 | Daniel Osadchy | Relative impedance measurement |
US20070016089A1 (en) * | 2005-07-15 | 2007-01-18 | Fischell David R | Implantable device for vital signs monitoring |
US20070021678A1 (en) * | 2005-07-19 | 2007-01-25 | Cardiac Pacemakers, Inc. | Methods and apparatus for monitoring physiological responses to steady state activity |
US20070027497A1 (en) * | 2005-07-27 | 2007-02-01 | Cyberonics, Inc. | Nerve stimulation for treatment of syncope |
US20070027388A1 (en) * | 2005-08-01 | 2007-02-01 | Chang-An Chou | Patch-type physiological monitoring apparatus, system and network |
US20070043303A1 (en) * | 2005-08-17 | 2007-02-22 | Osypka Markus J | Method and apparatus for digital demodulation and further processing of signals obtained in the measurement of electrical bioimpedance or bioadmittance in an object |
US20090018410A1 (en) * | 2006-03-02 | 2009-01-15 | Koninklijke Philips Electronics N.V. | Body parameter sensing |
US20080004499A1 (en) * | 2006-06-28 | 2008-01-03 | Davis Carl C | System and method for the processing of alarm and communication information in centralized patient monitoring |
US20080024293A1 (en) * | 2006-07-28 | 2008-01-31 | Lee Stylos | Adaptations to optivol alert algorithm |
US20090018456A1 (en) * | 2007-07-11 | 2009-01-15 | Chin-Yeh Hung | Display storage apparatus capable of detecting a pulse |
Cited By (422)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8233974B2 (en) | 1999-06-22 | 2012-07-31 | Impedimed Limited | Method and device for measuring tissue oedema |
US9149235B2 (en) | 2004-06-18 | 2015-10-06 | Impedimed Limited | Oedema detection |
US8103337B2 (en) | 2004-11-26 | 2012-01-24 | Impedimed Limited | Weighted gradient method and system for diagnosing disease |
US11660013B2 (en) | 2005-07-01 | 2023-05-30 | Impedimed Limited | Monitoring system |
US11737678B2 (en) | 2005-07-01 | 2023-08-29 | Impedimed Limited | Monitoring system |
US8548580B2 (en) | 2005-07-01 | 2013-10-01 | Impedimed Limited | Monitoring system |
US20110087129A1 (en) * | 2005-07-01 | 2011-04-14 | Impedimed Limited | Monitoring system |
US20110054343A1 (en) * | 2005-07-01 | 2011-03-03 | Impedimed Limited | Monitoring system |
US8099250B2 (en) | 2005-08-02 | 2012-01-17 | Impedimed Limited | Impedance parameter values |
US20080270051A1 (en) * | 2005-08-02 | 2008-10-30 | Impedimed Limited | Impedance Parameter Values |
US9724012B2 (en) | 2005-10-11 | 2017-08-08 | Impedimed Limited | Hydration status monitoring |
US11612332B2 (en) | 2005-10-11 | 2023-03-28 | Impedimed Limited | Hydration status monitoring |
US9387338B2 (en) | 2006-01-17 | 2016-07-12 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
US9339641B2 (en) | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US9630004B2 (en) | 2006-01-17 | 2017-04-25 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US9002477B2 (en) | 2006-01-17 | 2015-04-07 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
US9757584B2 (en) | 2006-01-17 | 2017-09-12 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
US8761870B2 (en) | 2006-05-30 | 2014-06-24 | Impedimed Limited | Impedance measurements |
US10786669B2 (en) | 2006-10-02 | 2020-09-29 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US20100204538A1 (en) * | 2006-10-02 | 2010-08-12 | Daniel Rogers Burnett | Method and apparatus for magnetic induction therapy |
US20090227831A1 (en) * | 2006-10-02 | 2009-09-10 | Burnett Daniel R | Method and apparatus for magnetic induction therapy |
US11844943B2 (en) | 2006-10-02 | 2023-12-19 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US11628300B2 (en) | 2006-10-02 | 2023-04-18 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US20100160712A1 (en) * | 2006-10-02 | 2010-06-24 | Daniel Rogers Burnett | Method and apparatus for magnetic induction therapy |
US9005102B2 (en) | 2006-10-02 | 2015-04-14 | Emkinetics, Inc. | Method and apparatus for electrical stimulation therapy |
US20090234179A1 (en) * | 2006-10-02 | 2009-09-17 | Burnett Daniel R | Method and apparatus for magnetic induction therapy |
US11224742B2 (en) | 2006-10-02 | 2022-01-18 | Emkinetics, Inc. | Methods and devices for performing electrical stimulation to treat various conditions |
US8435166B2 (en) | 2006-10-02 | 2013-05-07 | Emkinetics, Inc. | Method and apparatus for magnetic induction therapy |
US20090227829A1 (en) * | 2006-10-02 | 2009-09-10 | Burnett Daniel R | Method and apparatus for magnetic induction therapy |
US20100168501A1 (en) * | 2006-10-02 | 2010-07-01 | Daniel Rogers Burnett | Method and apparatus for magnetic induction therapy |
US11247053B2 (en) | 2006-10-02 | 2022-02-15 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US20080306325A1 (en) * | 2006-10-02 | 2008-12-11 | Emkinetics | Method and apparatus for magnetic induction therapy |
US8430805B2 (en) | 2006-10-02 | 2013-04-30 | Emkinetics, Inc. | Method and apparatus for magnetic induction therapy |
US9504406B2 (en) | 2006-11-30 | 2016-11-29 | Impedimed Limited | Measurement apparatus |
US8594781B2 (en) | 2007-01-15 | 2013-11-26 | Impedimed Limited | Monitoring system |
US20100100003A1 (en) * | 2007-01-15 | 2010-04-22 | Impedimed Limited | Monitoring system |
US9298889B2 (en) | 2007-03-09 | 2016-03-29 | Spacelabs Healthcare Llc | Health data collection tool |
US20100109739A1 (en) * | 2007-03-30 | 2010-05-06 | Impedimed Limited | Active guarding for reduction of resistive and capacitive signal loading with adjustable control of compensation level |
US8487686B2 (en) | 2007-03-30 | 2013-07-16 | Impedimed Limited | Active guarding for reduction of resistive and capacitive signal loading with adjustable control of compensation level |
US10307074B2 (en) | 2007-04-20 | 2019-06-04 | Impedimed Limited | Monitoring system and probe |
US20100179421A1 (en) * | 2007-05-24 | 2010-07-15 | Joe Tupin | System and method for non-invasive instantaneous and continuous measurement of cardiac chamber volume. |
US8463361B2 (en) | 2007-05-24 | 2013-06-11 | Lifewave, Inc. | System and method for non-invasive instantaneous and continuous measurement of cardiac chamber volume |
US9492676B2 (en) | 2007-06-06 | 2016-11-15 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US11083886B2 (en) | 2007-06-06 | 2021-08-10 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US10029110B2 (en) | 2007-06-06 | 2018-07-24 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US10004893B2 (en) | 2007-06-06 | 2018-06-26 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US8965500B2 (en) | 2007-06-06 | 2015-02-24 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US10426946B2 (en) | 2007-06-06 | 2019-10-01 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US20080306560A1 (en) * | 2007-06-06 | 2008-12-11 | Macho John D | Wearable defibrillator with audio input/output |
US8774917B2 (en) | 2007-06-06 | 2014-07-08 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US8369944B2 (en) | 2007-06-06 | 2013-02-05 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US11207539B2 (en) | 2007-06-07 | 2021-12-28 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US10328275B2 (en) | 2007-06-07 | 2019-06-25 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US8271082B2 (en) | 2007-06-07 | 2012-09-18 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US20080306562A1 (en) * | 2007-06-07 | 2008-12-11 | Donnelly Edward J | Medical device configured to test for user responsiveness |
US10434321B2 (en) | 2007-06-07 | 2019-10-08 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US9370666B2 (en) | 2007-06-07 | 2016-06-21 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US10271791B2 (en) | 2007-06-13 | 2019-04-30 | Zoll Medical Corporation | Wearable medical monitoring device |
US20100312297A1 (en) * | 2007-06-13 | 2010-12-09 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US8140154B2 (en) | 2007-06-13 | 2012-03-20 | Zoll Medical Corporation | Wearable medical treatment device |
US11877854B2 (en) | 2007-06-13 | 2024-01-23 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US11013419B2 (en) | 2007-06-13 | 2021-05-25 | Zoll Medical Corporation | Wearable medical monitoring device |
US9283399B2 (en) | 2007-06-13 | 2016-03-15 | Zoll Medical Corporation | Wearable medical treatment device |
US7974689B2 (en) | 2007-06-13 | 2011-07-05 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US11395619B2 (en) | 2007-06-13 | 2022-07-26 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US9737262B2 (en) | 2007-06-13 | 2017-08-22 | Zoll Medical Corporation | Wearable medical monitoring device |
US9398859B2 (en) | 2007-06-13 | 2016-07-26 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US20100298899A1 (en) * | 2007-06-13 | 2010-11-25 | Donnelly Edward J | Wearable medical treatment device |
US10582858B2 (en) | 2007-06-13 | 2020-03-10 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US20080312709A1 (en) * | 2007-06-13 | 2008-12-18 | Volpe Shane S | Wearable medical treatment device with motion/position detection |
US8649861B2 (en) | 2007-06-13 | 2014-02-11 | Zoll Medical Corporation | Wearable medical treatment device |
US8676313B2 (en) | 2007-06-13 | 2014-03-18 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US11832918B2 (en) | 2007-06-13 | 2023-12-05 | Zoll Medical Corporation | Wearable medical monitoring device |
US11122983B2 (en) | 2007-06-13 | 2021-09-21 | Zoll Medical Corporation | Wearable medical monitoring device |
US8285356B2 (en) | 2007-09-14 | 2012-10-09 | Corventis, Inc. | Adherent device with multiple physiological sensors |
US8116841B2 (en) | 2007-09-14 | 2012-02-14 | Corventis, Inc. | Adherent device with multiple physiological sensors |
US8374688B2 (en) | 2007-09-14 | 2013-02-12 | Corventis, Inc. | System and methods for wireless body fluid monitoring |
US9770182B2 (en) | 2007-09-14 | 2017-09-26 | Medtronic Monitoring, Inc. | Adherent device with multiple physiological sensors |
US10028699B2 (en) | 2007-09-14 | 2018-07-24 | Medtronic Monitoring, Inc. | Adherent device for sleep disordered breathing |
US8684925B2 (en) | 2007-09-14 | 2014-04-01 | Corventis, Inc. | Injectable device for physiological monitoring |
US9320443B2 (en) | 2007-09-14 | 2016-04-26 | Medtronic Monitoring, Inc. | Multi-sensor patient monitor to detect impending cardiac decompensation |
US8790257B2 (en) | 2007-09-14 | 2014-07-29 | Corventis, Inc. | Multi-sensor patient monitor to detect impending cardiac decompensation |
US10599814B2 (en) | 2007-09-14 | 2020-03-24 | Medtronic Monitoring, Inc. | Dynamic pairing of patients to data collection gateways |
US8591430B2 (en) | 2007-09-14 | 2013-11-26 | Corventis, Inc. | Adherent device for respiratory monitoring |
US9411936B2 (en) | 2007-09-14 | 2016-08-09 | Medtronic Monitoring, Inc. | Dynamic pairing of patients to data collection gateways |
US9538960B2 (en) | 2007-09-14 | 2017-01-10 | Medtronic Monitoring, Inc. | Injectable physiological monitoring system |
US9579020B2 (en) | 2007-09-14 | 2017-02-28 | Medtronic Monitoring, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
US10405809B2 (en) | 2007-09-14 | 2019-09-10 | Medtronic Monitoring, Inc | Injectable device for physiological monitoring |
US8460189B2 (en) | 2007-09-14 | 2013-06-11 | Corventis, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
US9186089B2 (en) | 2007-09-14 | 2015-11-17 | Medtronic Monitoring, Inc. | Injectable physiological monitoring system |
US8897868B2 (en) | 2007-09-14 | 2014-11-25 | Medtronic, Inc. | Medical device automatic start-up upon contact to patient tissue |
US8249686B2 (en) | 2007-09-14 | 2012-08-21 | Corventis, Inc. | Adherent device for sleep disordered breathing |
US10925518B1 (en) | 2007-10-12 | 2021-02-23 | Bby Solutions, Inc. | Fall detection and fall risk detection systems and methods |
US9901290B2 (en) | 2007-10-12 | 2018-02-27 | BioSensics LLC | Fall detection and fall risk detection systems and methods |
US9005141B1 (en) | 2007-10-12 | 2015-04-14 | Biosensics, L.L.C. | Ambulatory system for measuring and monitoring physical activity and risk of falling and for automatic fall detection |
US20110025348A1 (en) * | 2007-11-05 | 2011-02-03 | Impedimed Limited | Impedance determination |
US8836345B2 (en) | 2007-11-05 | 2014-09-16 | Impedimed Limited | Impedance determination |
US20090287102A1 (en) * | 2008-02-15 | 2009-11-19 | Impedimed Limited | Blood flow assessment of venous insufficiency |
US9392947B2 (en) | 2008-02-15 | 2016-07-19 | Impedimed Limited | Blood flow assessment of venous insufficiency |
US8718752B2 (en) | 2008-03-12 | 2014-05-06 | Corventis, Inc. | Heart failure decompensation prediction based on cardiac rhythm |
US8412317B2 (en) | 2008-04-18 | 2013-04-02 | Corventis, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
US9668667B2 (en) | 2008-04-18 | 2017-06-06 | Medtronic Monitoring, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
US20100081960A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | Bioimpedance System and Sensor and Technique for Using the Same |
US8406865B2 (en) * | 2008-09-30 | 2013-03-26 | Covidien Lp | Bioimpedance system and sensor and technique for using the same |
US20100099958A1 (en) * | 2008-10-16 | 2010-04-22 | Fresenius Medical Care Holdings Inc. | Method of identifying when a patient undergoing hemodialysis is at increased risk of death |
US9883799B2 (en) | 2008-10-16 | 2018-02-06 | Fresenius Medical Care Holdings, Inc. | Method of identifying when a patient undergoing hemodialysis is at increased risk of death |
US20110137136A1 (en) * | 2008-10-16 | 2011-06-09 | Fresenius Medical Care Holdings, Inc. | Method of identifying when a patient undergoing hemodialysis is at increased risk of death |
US9615766B2 (en) | 2008-11-28 | 2017-04-11 | Impedimed Limited | Impedance measurement process |
US20120108917A1 (en) * | 2008-12-15 | 2012-05-03 | Corventis, Inc. | Patient monitoring systems and methods |
US9445719B2 (en) | 2008-12-15 | 2016-09-20 | Medtronic Monitoring, Inc. | Patient monitoring systems and methods |
US8823490B2 (en) * | 2008-12-15 | 2014-09-02 | Corventis, Inc. | Patient monitoring systems and methods |
WO2010105203A2 (en) * | 2009-03-12 | 2010-09-16 | Corventis, Inc. | Method and apparatus for elder care monitoring |
WO2010105203A3 (en) * | 2009-03-12 | 2011-01-13 | Corventis, Inc. | Method and apparatus for elder care monitoring |
US10660520B2 (en) | 2009-03-27 | 2020-05-26 | Braemar Manufacturing, Llc | Ambulatory and centralized processing of a physiological signal |
US9655518B2 (en) | 2009-03-27 | 2017-05-23 | Braemar Manufacturing, Llc | Ambulatory and centralized processing of a physiological signal |
US9002427B2 (en) | 2009-03-30 | 2015-04-07 | Lifewave Biomedical, Inc. | Apparatus and method for continuous noninvasive measurement of respiratory function and events |
US20110060215A1 (en) * | 2009-03-30 | 2011-03-10 | Tupin Jr Joe Paul | Apparatus and method for continuous noninvasive measurement of respiratory function and events |
US9078582B2 (en) | 2009-04-22 | 2015-07-14 | Lifewave Biomedical, Inc. | Fetal monitoring device and methods |
US20110021863A1 (en) * | 2009-07-24 | 2011-01-27 | Daniel Rogers Burnett | Cooling systems and methods for conductive coils |
US9610459B2 (en) | 2009-07-24 | 2017-04-04 | Emkinetics, Inc. | Cooling systems and methods for conductive coils |
US11311197B2 (en) * | 2009-08-18 | 2022-04-26 | Mingyoung Biomedical Corp. | Product, method and system for monitoring physiological function and posture |
US20120215076A1 (en) * | 2009-08-18 | 2012-08-23 | Ming Young Biomedical Corp. | Product, method and system for monitoring physiological function and posture |
US9797764B2 (en) | 2009-10-16 | 2017-10-24 | Spacelabs Healthcare, Llc | Light enhanced flow tube |
US9604020B2 (en) | 2009-10-16 | 2017-03-28 | Spacelabs Healthcare Llc | Integrated, extendable anesthesia system |
US10779737B2 (en) | 2009-10-22 | 2020-09-22 | Medtronic Monitoring, Inc. | Method and apparatus for remote detection and monitoring of functional chronotropic incompetence |
US9615757B2 (en) | 2009-10-22 | 2017-04-11 | Medtronic Monitoring, Inc. | Method and apparatus for remote detection and monitoring of functional chronotropic incompetence |
WO2011050283A2 (en) | 2009-10-22 | 2011-04-28 | Corventis, Inc. | Remote detection and monitoring of functional chronotropic incompetence |
US8790259B2 (en) | 2009-10-22 | 2014-07-29 | Corventis, Inc. | Method and apparatus for remote detection and monitoring of functional chronotropic incompetence |
US9615767B2 (en) | 2009-10-26 | 2017-04-11 | Impedimed Limited | Fluid level indicator determination |
US20120226170A1 (en) * | 2009-11-13 | 2012-09-06 | Omron Healthcare Co., Ltd. | Electronic sphygmomanometer |
US9572500B2 (en) * | 2009-11-13 | 2017-02-21 | Omron Healthcare Co., Ltd. | Electronic sphygmomanometer |
US9585593B2 (en) | 2009-11-18 | 2017-03-07 | Chung Shing Fan | Signal distribution for patient-electrode measurements |
US9451897B2 (en) | 2009-12-14 | 2016-09-27 | Medtronic Monitoring, Inc. | Body adherent patch with electronics for physiologic monitoring |
WO2011081891A1 (en) | 2009-12-14 | 2011-07-07 | Corventis, Inc. | Body adherent patch with electronics for physiologic monitoring |
US8798746B2 (en) | 2010-01-15 | 2014-08-05 | Cardiac Pacemakers, Inc. | Automatic mechanical alternans detection |
US20110178565A1 (en) * | 2010-01-15 | 2011-07-21 | Dan Li | Automatic mechanical alternans detection |
US20110178375A1 (en) * | 2010-01-19 | 2011-07-21 | Avery Dennison Corporation | Remote physiological monitoring |
WO2011090870A1 (en) * | 2010-01-19 | 2011-07-28 | Avery Dennison Corporation | Remote physiological monitoring |
US9152765B2 (en) | 2010-03-21 | 2015-10-06 | Spacelabs Healthcare Llc | Multi-display bedside monitoring system |
US9827478B1 (en) | 2010-03-22 | 2017-11-28 | Boisensics Llc | Providing visual motion feedback based on sensor data |
US8979665B1 (en) | 2010-03-22 | 2015-03-17 | Bijan Najafi | Providing motion feedback based on user center of mass |
US9173615B2 (en) | 2010-04-05 | 2015-11-03 | Medtronic Monitoring, Inc. | Method and apparatus for personalized physiologic parameters |
US8965498B2 (en) | 2010-04-05 | 2015-02-24 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
WO2011126951A1 (en) | 2010-04-05 | 2011-10-13 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
US10405799B2 (en) | 2010-05-12 | 2019-09-10 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
US9241649B2 (en) | 2010-05-12 | 2016-01-26 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
US10517500B2 (en) | 2010-05-12 | 2019-12-31 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
US11141091B2 (en) | 2010-05-12 | 2021-10-12 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
US9931050B2 (en) | 2010-05-18 | 2018-04-03 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US11944406B2 (en) | 2010-05-18 | 2024-04-02 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US11278714B2 (en) | 2010-05-18 | 2022-03-22 | Zoll Medical Corporation | Wearable therapeutic device |
US9457178B2 (en) | 2010-05-18 | 2016-10-04 | Zoll Medical Corporation | Wearable therapeutic device system |
US9462974B2 (en) | 2010-05-18 | 2016-10-11 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US9008801B2 (en) | 2010-05-18 | 2015-04-14 | Zoll Medical Corporation | Wearable therapeutic device |
US10183160B2 (en) | 2010-05-18 | 2019-01-22 | Zoll Medical Corporation | Wearable therapeutic device |
US11103133B2 (en) | 2010-05-18 | 2021-08-31 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US9956392B2 (en) | 2010-05-18 | 2018-05-01 | Zoll Medical Corporation | Wearable therapeutic device |
US11540715B2 (en) | 2010-05-18 | 2023-01-03 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US8706215B2 (en) | 2010-05-18 | 2014-04-22 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US9215989B2 (en) | 2010-05-18 | 2015-12-22 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US10405768B2 (en) | 2010-05-18 | 2019-09-10 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
US10589083B2 (en) | 2010-05-18 | 2020-03-17 | Zoll Medical Corporation | Wearable therapeutic device |
US11975186B2 (en) | 2010-05-18 | 2024-05-07 | Zoll Medical Corporation | Wearable therapeutic device |
US11872390B2 (en) | 2010-05-18 | 2024-01-16 | Zoll Medical Corporation | Wearable therapeutic device |
US8588884B2 (en) | 2010-05-28 | 2013-11-19 | Emkinetics, Inc. | Microneedle electrode |
US11264131B2 (en) | 2010-07-27 | 2022-03-01 | Carefusion 303, Inc. | System and method for saving battery power in a patient monitoring system |
US9585620B2 (en) * | 2010-07-27 | 2017-03-07 | Carefusion 303, Inc. | Vital-signs patch having a flexible attachment to electrodes |
US9357929B2 (en) | 2010-07-27 | 2016-06-07 | Carefusion 303, Inc. | System and method for monitoring body temperature of a person |
US11090011B2 (en) | 2010-07-27 | 2021-08-17 | Carefusion 303, Inc. | System and method for reducing false alarms associated with vital-signs monitoring |
US9615792B2 (en) | 2010-07-27 | 2017-04-11 | Carefusion 303, Inc. | System and method for conserving battery power in a patient monitoring system |
US9420952B2 (en) | 2010-07-27 | 2016-08-23 | Carefusion 303, Inc. | Temperature probe suitable for axillary reading |
US11311239B2 (en) | 2010-07-27 | 2022-04-26 | Carefusion 303, Inc. | System and method for storing and forwarding data from a vital-signs monitor |
US9055925B2 (en) | 2010-07-27 | 2015-06-16 | Carefusion 303, Inc. | System and method for reducing false alarms associated with vital-signs monitoring |
US8814792B2 (en) | 2010-07-27 | 2014-08-26 | Carefusion 303, Inc. | System and method for storing and forwarding data from a vital-signs monitor |
US11083415B2 (en) | 2010-07-27 | 2021-08-10 | Carefusion 303, Inc. | Vital-signs patch having a strain relief |
US9017255B2 (en) | 2010-07-27 | 2015-04-28 | Carefusion 303, Inc. | System and method for saving battery power in a patient monitoring system |
US9017256B2 (en) | 2010-09-22 | 2015-04-28 | Milieu Institute, Llc | System and method for physiological monitoring |
US11432769B2 (en) | 2010-09-22 | 2022-09-06 | Janell M. Gottesman | System and method for physiological monitoring |
US9872087B2 (en) | 2010-10-19 | 2018-01-16 | Welch Allyn, Inc. | Platform for patient monitoring |
US11691022B2 (en) | 2010-11-08 | 2023-07-04 | Zoll Medical Corporation | Remote medical device alarm |
US9925387B2 (en) | 2010-11-08 | 2018-03-27 | Zoll Medical Corporation | Remote medical device alarm |
US11198017B2 (en) | 2010-11-08 | 2021-12-14 | Zoll Medical Corporation | Remote medical device alarm |
US9937355B2 (en) | 2010-11-08 | 2018-04-10 | Zoll Medical Corporation | Remote medical device alarm |
US11951323B2 (en) | 2010-11-08 | 2024-04-09 | Zoll Medical Corporation | Remote medical device alarm |
US10159849B2 (en) | 2010-11-08 | 2018-12-25 | Zoll Medical Corporation | Remote medical device alarm |
US10881871B2 (en) | 2010-11-08 | 2021-01-05 | Zoll Medical Corporation | Remote medical device alarm |
US10485982B2 (en) | 2010-11-08 | 2019-11-26 | Zoll Medical Corporation | Remote medical device alarm |
US20120123223A1 (en) * | 2010-11-11 | 2012-05-17 | Freeman Gary A | Acute care treatment systems dashboard |
US10959683B2 (en) | 2010-11-11 | 2021-03-30 | Zoll Medical Corporation | Acute care treatment systems dashboard |
US11826181B2 (en) | 2010-11-11 | 2023-11-28 | Zoll Medical Corporation | Acute care treatment systems dashboard |
US11759152B2 (en) | 2010-11-11 | 2023-09-19 | Zoll Medical Corporation | Acute care treatment systems dashboard |
US10485490B2 (en) * | 2010-11-11 | 2019-11-26 | Zoll Medical Corporation | Acute care treatment systems dashboard |
US9384652B2 (en) | 2010-11-19 | 2016-07-05 | Spacelabs Healthcare, Llc | System and method for transfer of primary alarm notification on patient monitoring systems |
US10203321B2 (en) | 2010-12-02 | 2019-02-12 | Fresenius Medical Care Holdings, Inc. | Method of identifying when a patient undergoing hemodialysis is at increased risk of death |
US9987481B2 (en) | 2010-12-09 | 2018-06-05 | Zoll Medical Corporation | Electrode with redundant impedance reduction |
US11439335B2 (en) | 2010-12-09 | 2022-09-13 | Zoll Medical Corporation | Electrode with redundant impedance reduction |
US9037271B2 (en) | 2010-12-09 | 2015-05-19 | Zoll Medical Corporation | Electrode with redundant impedance reduction |
US8406842B2 (en) | 2010-12-09 | 2013-03-26 | Zoll Medical Corporation | Electrode with redundant impedance reduction |
US9007216B2 (en) | 2010-12-10 | 2015-04-14 | Zoll Medical Corporation | Wearable therapeutic device |
US10926098B2 (en) | 2010-12-10 | 2021-02-23 | Zoll Medical Corporation | Wearable therapeutic device |
US11717693B2 (en) | 2010-12-10 | 2023-08-08 | Zoll Medical Corporation | Wearable therapeutic device |
US10226638B2 (en) | 2010-12-10 | 2019-03-12 | Zoll Medical Corporation | Wearable therapeutic device |
US11504541B2 (en) | 2010-12-10 | 2022-11-22 | Zoll Medical Corporation | Wearable therapeutic device |
US10589110B2 (en) | 2010-12-10 | 2020-03-17 | Zoll Medical Corporation | Wearable therapeutic device |
US9427564B2 (en) | 2010-12-16 | 2016-08-30 | Zoll Medical Corporation | Water resistant wearable medical device |
US11141600B2 (en) | 2010-12-16 | 2021-10-12 | Zoll Medical Corporation | Water resistant wearable medical device |
US10130823B2 (en) | 2010-12-16 | 2018-11-20 | Zoll Medical Corporation | Water resistant wearable medical device |
US11883678B2 (en) | 2010-12-16 | 2024-01-30 | Zoll Medical Corporation | Water resistant wearable medical device |
US10463867B2 (en) | 2010-12-16 | 2019-11-05 | Zoll Medical Corporation | Water resistant wearable medical device |
US9827434B2 (en) | 2010-12-16 | 2017-11-28 | Zoll Medical Corporation | Water resistant wearable medical device |
US20120184878A1 (en) * | 2011-01-13 | 2012-07-19 | Bijan Najafi | Intelligent device to monitor and remind patients with footwear, walking aids, braces, or orthotics |
US8753275B2 (en) * | 2011-01-13 | 2014-06-17 | BioSensics LLC | Intelligent device to monitor and remind patients with footwear, walking aids, braces, or orthotics |
US20120191151A1 (en) * | 2011-01-21 | 2012-07-26 | Nader Kameli | Implantable cardiac devices and methods with body orientation unit |
US9907972B2 (en) * | 2011-01-21 | 2018-03-06 | Neurocardiac Innovations, Llc | Implantable cardiac devices and methods with body orientation unit |
WO2012106086A1 (en) | 2011-01-31 | 2012-08-09 | Medtronic, Inc. | External cardiac monitor |
US20140031663A1 (en) * | 2011-02-03 | 2014-01-30 | Isansys Lifecare Limited | Health Monitoring |
US10327660B2 (en) * | 2011-02-03 | 2019-06-25 | Isansys Lifecare Limited | Health monitoring |
WO2012107692A1 (en) * | 2011-02-09 | 2012-08-16 | Universite De Lorraine | Movement sensor combined with a diagnostic electrode for applications in medical imaging |
FR2971137A1 (en) * | 2011-02-09 | 2012-08-10 | Univ Nancy 1 Henri Poincare | MOTION SENSOR ASSOCIATED WITH A DIAGNOSTIC ELECTRODE FOR MEDICAL IMAGING APPLICATIONS. |
US9629566B2 (en) | 2011-03-11 | 2017-04-25 | Spacelabs Healthcare Llc | Methods and systems to determine multi-parameter managed alarm hierarchy during patient monitoring |
US11562825B2 (en) | 2011-03-11 | 2023-01-24 | Spacelabs Healthcare L.L.C. | Methods and systems to determine multi-parameter managed alarm hierarchy during patient monitoring |
US10699811B2 (en) | 2011-03-11 | 2020-06-30 | Spacelabs Healthcare L.L.C. | Methods and systems to determine multi-parameter managed alarm hierarchy during patient monitoring |
WO2012125135A1 (en) * | 2011-03-11 | 2012-09-20 | Spacelabs Healthcare, Llc | Methods and systems to determine multi-parameter managed alarm hierarchy during patient monitoring |
US11139077B2 (en) | 2011-03-11 | 2021-10-05 | Spacelabs Healthcare L.L.C. | Methods and systems to determine multi-parameter managed alarm hierarchy during patient monitoring |
US9684767B2 (en) | 2011-03-25 | 2017-06-20 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US10813566B2 (en) | 2011-03-25 | 2020-10-27 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
US8798729B2 (en) | 2011-03-25 | 2014-08-05 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
US10269227B2 (en) | 2011-03-25 | 2019-04-23 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US9659475B2 (en) | 2011-03-25 | 2017-05-23 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US11699521B2 (en) | 2011-03-25 | 2023-07-11 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US8897860B2 (en) | 2011-03-25 | 2014-11-25 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
US9990829B2 (en) | 2011-03-25 | 2018-06-05 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US10219717B2 (en) | 2011-03-25 | 2019-03-05 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
US9456778B2 (en) | 2011-03-25 | 2016-10-04 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
US11291396B2 (en) | 2011-03-25 | 2022-04-05 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
US9135398B2 (en) | 2011-03-25 | 2015-09-15 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US11417427B2 (en) | 2011-03-25 | 2022-08-16 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US9204813B2 (en) | 2011-03-25 | 2015-12-08 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
US8600486B2 (en) | 2011-03-25 | 2013-12-03 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
US11393584B2 (en) | 2011-03-25 | 2022-07-19 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US10755547B2 (en) | 2011-03-25 | 2020-08-25 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US9408548B2 (en) | 2011-03-25 | 2016-08-09 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
US9378637B2 (en) | 2011-03-25 | 2016-06-28 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US8744561B2 (en) | 2011-04-15 | 2014-06-03 | Infobionic, Inc. | Remote health monitoring system |
US8478418B2 (en) | 2011-04-15 | 2013-07-02 | Infobionic, Inc. | Remote health monitoring system |
US11663898B2 (en) | 2011-04-15 | 2023-05-30 | Infobionic, Inc. | Remote health monitoring system |
US9307914B2 (en) | 2011-04-15 | 2016-04-12 | Infobionic, Inc | Remote data monitoring and collection system with multi-tiered analysis |
US10332379B2 (en) | 2011-04-15 | 2019-06-25 | Infobionic, Inc. | Remote health monitoring system |
US10796552B2 (en) | 2011-04-15 | 2020-10-06 | Infobionic, Inc. | Remote data monitoring and collection system with multi-tiered analysis |
US10282963B2 (en) | 2011-04-15 | 2019-05-07 | Infobionic, Inc. | Remote data monitoring and collection system with multi-tiered analysis |
US8774932B2 (en) | 2011-04-15 | 2014-07-08 | Infobionic, Inc. | Remote health monitoring system |
US10297132B2 (en) | 2011-04-15 | 2019-05-21 | Infobionic, Inc. | Remote health monitoring system |
US9782578B2 (en) | 2011-05-02 | 2017-10-10 | Zoll Medical Corporation | Patient-worn energy delivery apparatus and techniques for sizing same |
US20150073285A1 (en) * | 2011-05-16 | 2015-03-12 | Alivecor, Inc. | Universal ecg electrode module for smartphone |
US9848826B2 (en) | 2011-09-01 | 2017-12-26 | Zoll Medical Corporation | Wearable monitoring and treatment device |
US8644925B2 (en) | 2011-09-01 | 2014-02-04 | Zoll Medical Corporation | Wearable monitoring and treatment device |
US11744521B2 (en) | 2011-09-01 | 2023-09-05 | Zoll Medical Corporation | Wearable monitoring and treatment device |
US9131901B2 (en) | 2011-09-01 | 2015-09-15 | Zoll Medical Corporation | Wearable monitoring and treatment device |
US10806401B2 (en) | 2011-09-01 | 2020-10-20 | Zoll Medical Corporation | Wearable monitoring and treatment device |
US9878171B2 (en) | 2012-03-02 | 2018-01-30 | Zoll Medical Corporation | Systems and methods for configuring a wearable medical monitoring and/or treatment device |
US11110288B2 (en) | 2012-03-02 | 2021-09-07 | Zoll Medical Corporation | Systems and methods for configuring a wearable medical monitoring and/or treatment device |
US9427165B2 (en) | 2012-03-02 | 2016-08-30 | Medtronic Monitoring, Inc. | Heuristic management of physiological data |
US11850437B2 (en) | 2012-03-02 | 2023-12-26 | Zoll Medical Corporation | Systems and methods for configuring a wearable medical monitoring and/or treatment device |
US11460430B2 (en) * | 2012-04-04 | 2022-10-04 | University Of Cincinnati | Sweat simulation, collecting and sensing systems |
US20150057515A1 (en) * | 2012-04-04 | 2015-02-26 | University Of Cincinnati | Sweat simulation, collecting and sensing systems |
US11857327B2 (en) | 2012-05-31 | 2024-01-02 | Zoll Medical Corporation | Medical monitoring and treatment device with external pacing |
US10384066B2 (en) | 2012-05-31 | 2019-08-20 | Zoll Medical Corporation | Medical monitoring and treatment device with external pacing |
US9814894B2 (en) | 2012-05-31 | 2017-11-14 | Zoll Medical Corporation | Systems and methods for detecting health disorders |
US9675804B2 (en) | 2012-05-31 | 2017-06-13 | Zoll Medical Corporation | Medical monitoring and treatment device with external pacing |
US10898095B2 (en) | 2012-05-31 | 2021-01-26 | Zoll Medical Corporation | Medical monitoring and treatment device with external pacing |
US8983597B2 (en) | 2012-05-31 | 2015-03-17 | Zoll Medical Corporation | Medical monitoring and treatment device with external pacing |
US10328266B2 (en) | 2012-05-31 | 2019-06-25 | Zoll Medical Corporation | External pacing device with discomfort management |
US11097107B2 (en) | 2012-05-31 | 2021-08-24 | Zoll Medical Corporation | External pacing device with discomfort management |
US11266846B2 (en) | 2012-05-31 | 2022-03-08 | Zoll Medical Corporation | Systems and methods for detecting health disorders |
US10441804B2 (en) | 2012-05-31 | 2019-10-15 | Zoll Medical Corporation | Systems and methods for detecting health disorders |
US11992693B2 (en) | 2012-05-31 | 2024-05-28 | Zoll Medical Corporation | Systems and methods for detecting health disorders |
US9320904B2 (en) | 2012-05-31 | 2016-04-26 | Zoll Medical Corporation | Medical monitoring and treatment device with external pacing |
US10993671B2 (en) | 2012-10-07 | 2021-05-04 | Rds | Health monitoring systems and methods |
US10244949B2 (en) | 2012-10-07 | 2019-04-02 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US11786182B2 (en) | 2012-10-07 | 2023-10-17 | Rds | Health monitoring systems and methods |
US10413251B2 (en) | 2012-10-07 | 2019-09-17 | Rhythm Diagnostic Systems, Inc. | Wearable cardiac monitor |
US10980486B2 (en) | 2012-10-07 | 2021-04-20 | Rds | Health monitoring systems and methods |
US11185291B2 (en) | 2012-10-07 | 2021-11-30 | Rds | Health monitoring systems and methods |
US11937946B2 (en) | 2012-10-07 | 2024-03-26 | Rds | Wearable cardiac monitor |
USD931467S1 (en) | 2012-10-07 | 2021-09-21 | Rds | Health monitoring apparatus |
US9782132B2 (en) | 2012-10-07 | 2017-10-10 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US10863947B2 (en) | 2012-10-07 | 2020-12-15 | Rds Sas | Health monitoring systems and methods |
US10959678B2 (en) | 2012-10-07 | 2021-03-30 | Rds | Health monitoring systems and methods |
US10610159B2 (en) | 2012-10-07 | 2020-04-07 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US10842391B2 (en) | 2012-10-07 | 2020-11-24 | Rds Sas | Health monitoring systems and methods |
US10080527B2 (en) | 2012-10-07 | 2018-09-25 | Rhythm Diagnostic Systems, Inc. | Health monitoring systems and methods |
US11627902B2 (en) | 2013-01-24 | 2023-04-18 | Irhythm Technologies, Inc. | Physiological monitoring device |
US11051738B2 (en) | 2013-01-24 | 2021-07-06 | Irhythm Technologies, Inc. | Physiological monitoring device |
US10271754B2 (en) | 2013-01-24 | 2019-04-30 | Irhythm Technologies, Inc. | Physiological monitoring device |
US10555683B2 (en) | 2013-01-24 | 2020-02-11 | Irhythm Technologies, Inc. | Physiological monitoring device |
US9999393B2 (en) | 2013-01-29 | 2018-06-19 | Zoll Medical Corporation | Delivery of electrode gel using CPR puck |
US10993664B2 (en) | 2013-01-29 | 2021-05-04 | Zoll Medical Corporation | Delivery of electrode gel using CPR puck |
US8880196B2 (en) | 2013-03-04 | 2014-11-04 | Zoll Medical Corporation | Flexible therapy electrode |
US9272131B2 (en) | 2013-03-04 | 2016-03-01 | Zoll Medical Corporation | Flexible and/or tapered therapy electrode |
US9132267B2 (en) | 2013-03-04 | 2015-09-15 | Zoll Medical Corporation | Flexible therapy electrode system |
US10687781B2 (en) * | 2013-03-15 | 2020-06-23 | Nilus Medical Llc | Hemodynamic monitoring device and methods of using same |
USD850626S1 (en) | 2013-03-15 | 2019-06-04 | Rhythm Diagnostic Systems, Inc. | Health monitoring apparatuses |
USD921204S1 (en) | 2013-03-15 | 2021-06-01 | Rds | Health monitoring apparatus |
US11529059B2 (en) | 2013-03-24 | 2022-12-20 | Seoul National University R&Db Foundation | Film-type biomedical signal measuring apparatus, blood pressure measuring apparatus using the same, cardiopulmonary fitness estimating apparatus, and personal authentication apparatus |
KR101489503B1 (en) | 2013-03-24 | 2015-02-04 | 서울대학교산학협력단 | Film-type bio-signal measurement device |
US10478082B2 (en) | 2013-03-24 | 2019-11-19 | Seoul National University R&Db Foundation | Film-type biomedical signal measuring apparatus, blood pressure measuring apparatus using the same, cardiopulmonary fitness estimating apparatus, and personal authentication apparatus |
WO2014157896A1 (en) * | 2013-03-24 | 2014-10-02 | 서울대학교산학협력단 | Film-type device for measuring biomedical signal, and blood pressure measurement device, cardiopulmonary endurance estimation device, and individual certification device using same |
US9173670B2 (en) | 2013-04-08 | 2015-11-03 | Irhythm Technologies, Inc. | Skin abrader |
US9451975B2 (en) | 2013-04-08 | 2016-09-27 | Irhythm Technologies, Inc. | Skin abrader |
US9311789B1 (en) | 2013-04-09 | 2016-04-12 | BioSensics LLC | Systems and methods for sensorimotor rehabilitation |
US10987026B2 (en) | 2013-05-30 | 2021-04-27 | Spacelabs Healthcare Llc | Capnography module with automatic switching between mainstream and sidestream monitoring |
US9579516B2 (en) | 2013-06-28 | 2017-02-28 | Zoll Medical Corporation | Systems and methods of delivering therapy using an ambulatory medical device |
US9987497B2 (en) | 2013-06-28 | 2018-06-05 | Zoll Medical Corporation | Systems and methods of delivering therapy using an ambulatory medical device |
US11872406B2 (en) | 2013-06-28 | 2024-01-16 | Zoll Medical Corporation | Systems and methods of delivering therapy using an ambulatory medical device |
US10806940B2 (en) | 2013-06-28 | 2020-10-20 | Zoll Medical Corporation | Systems and methods of delivering therapy using an ambulatory medical device |
US20150106020A1 (en) * | 2013-10-10 | 2015-04-16 | Wireless Medical Monitoring Inc. | Method and Apparatus for Wireless Health Monitoring and Emergent Condition Prediction |
US10055549B2 (en) * | 2013-10-10 | 2018-08-21 | Wireless Medical Monitoring, Inc. | Method and apparatus for wireless health monitoring and emergent condition prediction |
US10136831B2 (en) | 2013-10-18 | 2018-11-27 | University Of Cincinnati | Sweat sensing with chronological assurance |
US10368847B2 (en) | 2013-10-18 | 2019-08-06 | University Of Cincinnati | Devices for integrated, repeated, prolonged, and/or reliable sweat stimulation and biosensing |
US11266381B2 (en) | 2013-10-18 | 2022-03-08 | University Of Cincinnati | Devices for integrated, repeated, prolonged, and/or reliable sweat stimulation and biosensing |
US10888244B2 (en) | 2013-10-18 | 2021-01-12 | University Of Cincinnati | Sweat sensing with chronological assurance |
US9597523B2 (en) | 2014-02-12 | 2017-03-21 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US10588509B2 (en) | 2014-02-24 | 2020-03-17 | Medtronic Monitoring, Inc. | Separable monitoring device and method |
US11975209B2 (en) | 2014-02-24 | 2024-05-07 | Element Science, Inc. | External defibrillator |
US9848779B2 (en) | 2014-02-24 | 2017-12-26 | Medtronic Monitoring, Inc. | Separable monitoring device and method |
US11185709B2 (en) | 2014-02-24 | 2021-11-30 | Element Science, Inc. | External defibrillator |
WO2015127466A3 (en) * | 2014-02-24 | 2015-11-26 | Element Science, Inc | External defibrillator |
KR101524248B1 (en) * | 2014-02-27 | 2015-05-29 | 서울대학교산학협력단 | System and method for cardiopulmonary fitness estimatiion using film-type bio-signal measurement device |
WO2015177670A1 (en) * | 2014-05-19 | 2015-11-26 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Cutaneous device, in particular a pulse generator for electrical stimulation |
FR3020959A1 (en) * | 2014-05-19 | 2015-11-20 | Commissariat Energie Atomique | CUTANE DEVICE, IN PARTICULAR PULSE GENERATOR FOR ELECTROSTIMULATION. |
US11116970B2 (en) * | 2014-05-19 | 2021-09-14 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Cutaneous device, in particular a pulse generator for electrical stimulation |
US20170136228A1 (en) * | 2014-05-19 | 2017-05-18 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Cutaneous device, in particular a pulse generator for electrical stimulation |
US11129554B2 (en) | 2014-05-28 | 2021-09-28 | University Of Cincinnati | Sweat monitoring and control of drug delivery |
US10932761B2 (en) | 2014-05-28 | 2021-03-02 | University Of Cincinnati | Advanced sweat sensor adhesion, sealing, and fluidic strategies |
US10639015B2 (en) | 2014-05-28 | 2020-05-05 | University Of Cincinnati | Devices with reduced sweat volumes between sensors and sweat glands |
US9374698B2 (en) * | 2014-08-22 | 2016-06-21 | Verizon Patent And Licensing Inc. | Personalized emergency identification and communication |
US11317835B2 (en) | 2014-09-22 | 2022-05-03 | University Of Cincinnati | Sweat sensing with analytical assurance |
US11756684B2 (en) | 2014-10-31 | 2023-09-12 | Irhythm Technologies, Inc. | Wearable monitor |
US9955887B2 (en) | 2014-10-31 | 2018-05-01 | Irhythm Technologies, Inc. | Wearable monitor |
US11289197B1 (en) | 2014-10-31 | 2022-03-29 | Irhythm Technologies, Inc. | Wearable monitor |
US10667712B2 (en) | 2014-10-31 | 2020-06-02 | Irhythm Technologies, Inc. | Wearable monitor |
US10813565B2 (en) | 2014-10-31 | 2020-10-27 | Irhythm Technologies, Inc. | Wearable monitor |
US9597004B2 (en) | 2014-10-31 | 2017-03-21 | Irhythm Technologies, Inc. | Wearable monitor |
US10098559B2 (en) | 2014-10-31 | 2018-10-16 | Irhythm Technologies, Inc. | Wearable monitor with arrhythmia burden evaluation |
US10299691B2 (en) | 2014-10-31 | 2019-05-28 | Irhythm Technologies, Inc. | Wearable monitor with arrhythmia burden evaluation |
US11605458B2 (en) | 2014-10-31 | 2023-03-14 | Irhythm Technologies, Inc | Wearable monitor |
US10722133B2 (en) | 2014-11-17 | 2020-07-28 | Medtronic Monitoring, Inc. | QT interval determination methods and related devices |
WO2016081227A1 (en) | 2014-11-17 | 2016-05-26 | Medtronic Monitoring, Inc. | Qt interval determination methods and related devices |
US10201711B2 (en) | 2014-12-18 | 2019-02-12 | Zoll Medical Corporation | Pacing device with acoustic sensor |
US11179570B2 (en) | 2014-12-18 | 2021-11-23 | Zoll Medical Corporation | Pacing device with acoustic sensor |
US11766569B2 (en) | 2014-12-18 | 2023-09-26 | Zoll Medical Corporation | Pacing device with acoustic sensor |
US10485460B2 (en) | 2015-02-13 | 2019-11-26 | University Of Cincinnati | Devices for integrated indirect sweat stimulation and sensing |
US10321877B2 (en) | 2015-03-18 | 2019-06-18 | Zoll Medical Corporation | Medical device with acoustic sensor |
US11160511B2 (en) | 2015-03-18 | 2021-11-02 | Zoll Medical Corporation | Medical device with acoustic sensor |
US11937950B2 (en) | 2015-03-18 | 2024-03-26 | Zoll Medical Corporation | Medical device with acoustic sensor |
US10709350B2 (en) * | 2015-04-22 | 2020-07-14 | Falko Skrabal | Body impedance measuring device |
US20180153432A1 (en) * | 2015-04-22 | 2018-06-07 | Falko Skrabal | Body impedance measuring device |
US9636069B2 (en) | 2015-06-15 | 2017-05-02 | Medtronic Monitoring, Inc. | System and method for monitoring and classifying atrial fibrillations |
WO2016205187A1 (en) * | 2015-06-15 | 2016-12-22 | Medtronic Monitoring, Inc. | System and method for monitoring and classifying atrial fibrillations |
US10646142B2 (en) | 2015-06-29 | 2020-05-12 | Eccrine Systems, Inc. | Smart sweat stimulation and sensing devices |
US11116397B2 (en) | 2015-07-14 | 2021-09-14 | Welch Allyn, Inc. | Method and apparatus for managing sensors |
US10368810B2 (en) | 2015-07-14 | 2019-08-06 | Welch Allyn, Inc. | Method and apparatus for monitoring a functional capacity of an individual |
US10953234B2 (en) | 2015-08-26 | 2021-03-23 | Element Science, Inc. | Wearable devices |
US11701521B2 (en) | 2015-08-26 | 2023-07-18 | Element Science, Inc. | Wearable devices |
US10617350B2 (en) | 2015-09-14 | 2020-04-14 | Welch Allyn, Inc. | Method and apparatus for managing a biological condition |
US10964421B2 (en) | 2015-10-22 | 2021-03-30 | Welch Allyn, Inc. | Method and apparatus for delivering a substance to an individual |
US12027248B2 (en) | 2015-10-22 | 2024-07-02 | Welch Allyn, Inc. | Method and apparatus for delivering a substance to an individual |
US10918340B2 (en) | 2015-10-22 | 2021-02-16 | Welch Allyn, Inc. | Method and apparatus for detecting a biological condition |
US10506968B2 (en) | 2015-10-23 | 2019-12-17 | Eccrine Systems, Inc. | Devices capable of fluid sample concentration for extended sensing of analytes |
US10729910B2 (en) | 2015-11-23 | 2020-08-04 | Zoll Medical Corporation | Garments for wearable medical devices |
US10674946B2 (en) | 2015-12-18 | 2020-06-09 | Eccrine Systems, Inc. | Sweat sensing devices with sensor abrasion protection |
US11617538B2 (en) | 2016-03-14 | 2023-04-04 | Zoll Medical Corporation | Proximity based processing systems and methods |
US11931154B2 (en) | 2016-04-29 | 2024-03-19 | Infobionic, Inc. | Systems and methods for classifying ECG data |
USD794805S1 (en) | 2016-04-29 | 2017-08-15 | Infobionic, Inc. | Health monitoring device with a button |
US10595737B2 (en) | 2016-04-29 | 2020-03-24 | Infobionic, Inc. | Systems and methods for classifying ECG data |
US9968274B2 (en) | 2016-04-29 | 2018-05-15 | Infobionic, Inc. | Systems and methods for processing ECG data |
USD794806S1 (en) | 2016-04-29 | 2017-08-15 | Infobionic, Inc. | Health monitoring device |
USD794807S1 (en) | 2016-04-29 | 2017-08-15 | Infobionic, Inc. | Health monitoring device with a display |
US10471249B2 (en) | 2016-06-08 | 2019-11-12 | University Of Cincinnati | Enhanced analyte access through epithelial tissue |
US11253190B2 (en) | 2016-07-01 | 2022-02-22 | University Of Cincinnati | Devices with reduced microfluidic volume between sensors and sweat glands |
US10405794B2 (en) | 2016-07-19 | 2019-09-10 | Eccrine Systems, Inc. | Sweat conductivity, volumetric sweat rate, and galvanic skin response devices and applications |
US10973416B2 (en) | 2016-08-02 | 2021-04-13 | Welch Allyn, Inc. | Method and apparatus for monitoring biological conditions |
US10791994B2 (en) | 2016-08-04 | 2020-10-06 | Welch Allyn, Inc. | Method and apparatus for mitigating behavior adverse to a biological condition |
US10736565B2 (en) | 2016-10-14 | 2020-08-11 | Eccrine Systems, Inc. | Sweat electrolyte loss monitoring devices |
US20180116598A1 (en) * | 2016-11-02 | 2018-05-03 | Medtronic Monitoring, Inc. | System and methods of determining etiology of undiagnosed symptomatic events |
US10368808B2 (en) * | 2016-11-02 | 2019-08-06 | Medtronic Monitoring, Inc. | System and methods of determining etiology of undiagnosed symptomatic events |
US10342445B2 (en) | 2016-11-03 | 2019-07-09 | Medtronic Monitoring, Inc. | Method and apparatus for detecting electrocardiographic abnormalities based on monitored high frequency QRS potentials |
US20180206736A1 (en) * | 2017-01-25 | 2018-07-26 | Maisense Inc. | Blood pressure measurement device and method |
US20210000395A1 (en) * | 2017-06-02 | 2021-01-07 | Northwestern University | Microfluidic systems for epidermal sampling and sensing |
US11883165B2 (en) * | 2017-06-02 | 2024-01-30 | Northwestern University | Microfluidic systems for epidermal sampling and sensing |
US11009870B2 (en) | 2017-06-06 | 2021-05-18 | Zoll Medical Corporation | Vehicle compatible ambulatory defibrillator |
US10646707B2 (en) | 2017-11-30 | 2020-05-12 | Zoll Medical Corporation | Medical devices with rapid sensor recovery |
US11771886B2 (en) | 2017-11-30 | 2023-10-03 | Zoll Medical Corporation | Medical devices with rapid sensor recovery |
US11375930B2 (en) | 2018-02-01 | 2022-07-05 | Samsung Electronics Co., Ltd. | Electronic device for sensing biometric information and control method thereof |
US11894132B2 (en) | 2018-09-28 | 2024-02-06 | Zoll Medical Corporation | Systems and methods for device inventory management and tracking |
US11568984B2 (en) | 2018-09-28 | 2023-01-31 | Zoll Medical Corporation | Systems and methods for device inventory management and tracking |
US11890461B2 (en) | 2018-09-28 | 2024-02-06 | Zoll Medical Corporation | Adhesively coupled wearable medical device |
US11253715B2 (en) | 2018-10-10 | 2022-02-22 | Element Science, Inc. | Wearable medical device with disposable and reusable components |
US11406307B2 (en) * | 2018-12-21 | 2022-08-09 | Biosense Webster (Israel) Ltd. | Impedance measurements using burst pulses to prevent noise on ECG |
US11590354B2 (en) | 2018-12-28 | 2023-02-28 | Zoll Medical Corporation | Wearable medical device response mechanisms and methods of use |
US11903700B2 (en) | 2019-08-28 | 2024-02-20 | Rds | Vital signs monitoring systems and methods |
US11571561B2 (en) | 2019-10-09 | 2023-02-07 | Zoll Medical Corporation | Modular electrical therapy device |
CN113116355A (en) * | 2019-12-31 | 2021-07-16 | 吴智良 | Physiological monitor |
US11253185B2 (en) | 2020-02-12 | 2022-02-22 | Irhythm Technologies, Inc. | Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network |
US11083371B1 (en) | 2020-02-12 | 2021-08-10 | Irhythm Technologies, Inc. | Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network |
US11925469B2 (en) | 2020-02-12 | 2024-03-12 | Irhythm Technologies, Inc. | Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient |
US11998342B2 (en) | 2020-02-12 | 2024-06-04 | Irhythm Technologies, Inc. | Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network |
US11497432B2 (en) | 2020-02-12 | 2022-11-15 | Irhythm Technologies, Inc. | Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless |
US11246524B2 (en) | 2020-02-12 | 2022-02-15 | Irhythm Technologies, Inc. | Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient |
US11253186B2 (en) | 2020-02-12 | 2022-02-22 | Irhythm Technologies, Inc. | Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network |
US11382555B2 (en) | 2020-02-12 | 2022-07-12 | Irhythm Technologies, Inc. | Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient |
US11375941B2 (en) | 2020-02-12 | 2022-07-05 | Irhythm Technologies, Inc. | Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network |
US11523766B2 (en) | 2020-06-25 | 2022-12-13 | Spacelabs Healthcare L.L.C. | Systems and methods of analyzing and displaying ambulatory ECG data |
US11246523B1 (en) | 2020-08-06 | 2022-02-15 | Irhythm Technologies, Inc. | Wearable device with conductive traces and insulator |
US11589792B1 (en) | 2020-08-06 | 2023-02-28 | Irhythm Technologies, Inc. | Wearable device with bridge portion |
US11350864B2 (en) | 2020-08-06 | 2022-06-07 | Irhythm Technologies, Inc. | Adhesive physiological monitoring device |
US11337632B2 (en) | 2020-08-06 | 2022-05-24 | Irhythm Technologies, Inc. | Electrical components for physiological monitoring device |
US11350865B2 (en) | 2020-08-06 | 2022-06-07 | Irhythm Technologies, Inc. | Wearable device with bridge portion |
US11806150B2 (en) | 2020-08-06 | 2023-11-07 | Irhythm Technologies, Inc. | Wearable device with bridge portion |
US11399760B2 (en) | 2020-08-06 | 2022-08-02 | Irhythm Technologies, Inc. | Wearable device with conductive traces and insulator |
US11504041B2 (en) | 2020-08-06 | 2022-11-22 | Irhythm Technologies, Inc. | Electrical components for physiological monitoring device |
US11751789B2 (en) | 2020-08-06 | 2023-09-12 | Irhythm Technologies, Inc. | Wearable device with conductive traces and insulator |
Also Published As
Publication number | Publication date |
---|---|
US20090076363A1 (en) | 2009-03-19 |
US9770182B2 (en) | 2017-09-26 |
EP2194847A1 (en) | 2010-06-16 |
US20130253285A1 (en) | 2013-09-26 |
US20140330136A1 (en) | 2014-11-06 |
US8116841B2 (en) | 2012-02-14 |
USRE46926E1 (en) | 2018-07-03 |
WO2009036313A1 (en) | 2009-03-19 |
US8285356B2 (en) | 2012-10-09 |
US8818481B2 (en) | 2014-08-26 |
US20130085347A1 (en) | 2013-04-04 |
US8795174B2 (en) | 2014-08-05 |
US20150005589A1 (en) | 2015-01-01 |
US20120108920A1 (en) | 2012-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8795174B2 (en) | Adherent device with multiple physiological sensors | |
US9357932B2 (en) | System and methods for wireless body fluid monitoring | |
US8718752B2 (en) | Heart failure decompensation prediction based on cardiac rhythm | |
US10599814B2 (en) | Dynamic pairing of patients to data collection gateways | |
US10028699B2 (en) | Adherent device for sleep disordered breathing | |
US9173615B2 (en) | Method and apparatus for personalized physiologic parameters | |
US20090076397A1 (en) | Adherent Emergency Patient Monitor | |
US20090076559A1 (en) | Adherent Device for Cardiac Rhythm Management |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CORVENTIS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MANICKA, YATHEENDHAR D.;AMURTHUR, BADRI;BLY, MARK J.;AND OTHERS;REEL/FRAME:021883/0812;SIGNING DATES FROM 20080919 TO 20080930 |
|
AS | Assignment |
Owner name: TRIPLEPOINT CAPITAL LLC, CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:CORVENTIS, INC.;REEL/FRAME:021948/0001 Effective date: 20081112 |
|
AS | Assignment |
Owner name: MEDTRONIC, INC., MINNESOTA Free format text: SECURITY AGREEMENT;ASSIGNOR:CORVENTIS, INC.;REEL/FRAME:025826/0569 Effective date: 20110216 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: COMERICA BANK, MICHIGAN Free format text: SECURITY AGREEMENT;ASSIGNOR:CORVENTIS, INC.;REEL/FRAME:029608/0809 Effective date: 20121220 |
|
AS | Assignment |
Owner name: CORVENTIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:COMERICA BANK;REEL/FRAME:034478/0514 Effective date: 20141211 |
|
AS | Assignment |
Owner name: CORVENTIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:TRIPLEPOINT CAPITAL LLC;REEL/FRAME:034728/0676 Effective date: 20141204 Owner name: CORVENTIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MEDTRONIC, INC;REEL/FRAME:034728/0509 Effective date: 20141204 |
|
AS | Assignment |
Owner name: MEDTRONIC MONITORING, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:MEDTRONIC CORVENTIS, INC.;REEL/FRAME:035111/0259 Effective date: 20140805 Owner name: MEDTRONIC CORVENTIS, INC., CALIFORNIA Free format text: MERGER AND CHANGE OF NAME;ASSIGNORS:CORVENTIS, INC.;MEDTRONIC CORVENTIS, INC.;REEL/FRAME:035054/0955 Effective date: 20140620 |